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ABSTRACT 
 
Background 
Shoulder pain is a common, costly condition with variable prognosis. Commonly used 
treatments for shoulder pain in primary care include: (i) advice & analgesia, (ii) exercise 
and/or manual therapy, and (iii) corticosteroid injection. Current guidelines do not assist 
clinicians in optimal treatment selection for this condition. Prognostic factors help identify 
subgroups likely to have poor prognosis, however their potential to help clinicians decide 
between different treatments is unclear. 
 
Methods 
A systematic review identified which patient attributes modify effects of these three 
treatments. Clinical consensus workshops were conducted with 21 UK-based clinicians 
who manage shoulder pain to identify patient attributes relevant to treatment decision-
making. The impact of these attributes on treatment choice was studied in a conjoint 
analysis study of decision-making for shoulder pain. 
 
Results 
The review identified 20 potential treatment effect moderators, with low quality evidence. 
Clinical consensus workshops identified 12 salient patient attributes. The conjoint study 
received responses from 387 clinicians (31 countries, 64% UK). Results showed that 11 of 
the 12 attributes discriminated between treatment choices, following adjustment for 
responders’ country, profession, and experience. Recommending injection was most 
  
ii 
strongly associated with lack of improvement (OR 2.81, 95%CI 2.16; 3.65), previous 
positive response to injection (2.79, 2.07; 3.76), and patient preference (2.41, 1.82; 3.19). 
Recommending physiotherapy was most strongly influenced by patient preference (2.77, 
2.16; 3.55), presence of weakness/instability (2.05, 0.79; 1.23) and previous positive 
response to physiotherapy (2.22, 1.76; 2.80). Not recommending corticosteroid injection 
was associated with traumatic onset and unstable diabetes or cardiac issues, whereas not 
recommending physiotherapy was associated with sleep disturbance and high pain. 
 
Discussion 
The relative importance of patient attributes that influence shoulder treatment selection 
was quantified. Logical clinical patterns emerged suggesting that specific patient attributes 
guide clinicians treatment selection.  Future research is indicated to assess if identified 
attributes indeed modify treatment effects.  
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CHAPTER 1 - INTRODUCTION 
 
 
1.1 Epidemiology of Shoulder Pain 
Musculoskeletal (MSK) shoulder pain is common, with estimates of the one month 
period prevalence ranging from 14 to 48% (Pope et al. 1997) and lifetime 
incidence rate estimated at 50% of the population (Geraets et al. 2006; Urwin et 
al. 1998). Shoulder pain is the third most common MSK condition to present in UK 
Primary Care (Geraets et al. 2005; Jordan et al. 2010; Peters et al. 1994), with 
some affected individuals experiencing significant reductions in functional 
capacity, quality-of-life (Beaton & Richards, 1996; Gartsman et al. 1998) and work 
capacity (Kuijpers et al. 2006). The actual cost of shoulder pain in the UK is 
unknown but estimates from primary care in Sweden indicate an annual per 
patient cost of €4139 (£3777) with time-off-work accounting for 84% of the total 
costs (Virta et al. 2012). 	
 
1.2 Shoulder Pain in Primary Care 
Often primary care is the first point of healthcare access for individuals with 
shoulder pain, and therefore effective first-line management is paramount in 
improving the quality of life and social and occupational productivity of affected 
individuals. Although half of those with shoulder pain consult their GP only once 
(Dorresteijn et al. 2011; Greving et al. 2012), primary care consultation rates for 
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shoulder disorders are disproportionately higher than for other MSK conditions 
amongst working individuals (Jordan et al. 2010; Ostergren et al. 2005). This is an 
indication of the significant impact that shoulder pain can have on some working-
aged individuals. Furthermore, shoulder pain has a poor pattern of recovery 
(prognosis), with estimates that; over 70% have pain for longer than 6 weeks 
(Kuijpers et al. 2006), only half of all new episodes demonstrate complete recovery 
within six months (Croft et al. 1996; van der Windt et al. 1996; Winters et al. 
1999a); and at one year post consultation, only 60% of new episodes demonstrate 
complete recovery (van der Windt et al. 1996). These figures highlight that 
effective primary care treatment of MSK shoulder pain remains a significant clinical 
challenge.  
 
1.3 Current Guidance on the Clinical Management of Shoulder Pain 
Current UK primary care management of shoulder pain draws from an abundance 
of commonly accepted conservative treatment options such as; exercise and/or 
manual therapy (typically delivered by a physiotherapist), advice on activity 
modification and relative rest, non-steroidal anti-inflammatory drugs, and 
corticosteroid injections. Exercise has been shown to beneficial in the short-term 
with greater functional benefit accrued with a combination of exercise plus manual 
therapy (Page et al. 1996). Although in the longer term, no differences in outcome 
have been found between manual therapy and exercises compared to 
corticosteroid injection (Page et al. 1996), corticosteroid injection has been shown 
to be more effective in reducing pain and dysfunction than physiotherapy 
treatment (exercise and/or manual therapy) in the short-term (RR for ’cured’ 3.72 
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(1.88, 7.37)) however, effects are short-lived with no differences in the longer term 
(short term cure RR 1.23 (0.47, 3.26)) (Green et al. 2003). Therefore, questions 
remain about the relative superiority, duration of treatment effects and optimal 
timing of these treatments (Blanchard et al. 2010; Buchbinder et al. 2013a; Page 
et al. 1996). National and international guidelines for the management of shoulder 
pain (Carr & Rees, 2012; Hanchard et al. 2004; Kulkarni et al. 2015) generally  
recommend all of the above conservative treatments, but lack any guidance about 
how best to match individual patients to specific treatments. National research 
priorities therefore, highlight the need to find ways to improve treatment outcomes 
in primary care and to better understand which treatments should be provided for 
whom (Rankin et al. 2012). 
 
1.4 Current Approaches to Clinical Management of Shoulder Pain 
Routine UK primary care practice for shoulder pain currently involves a stepped 
care model where advice and analgesia are offered as the first tier of treatment 
(Artus et al. 2017). Typically, after a period of analgesia only, those patients whose 
shoulder pain persists are then offered either referral to physiotherapy or 
corticosteroid injection (Winters et al. 1999a). If these first-line treatments fail, then 
the next tier is usually a referral to secondary care for consideration of shoulder 
surgery via diagnostic interface services, such as those led by extended scope 
physiotherapists. However, due to spiraling frequency and costs of shoulder 
surgery (Judge et al. 2014, Ensor et al. 2013) in addition to a lack of clear 
evidence that orthopaedic surgery delivers superior clinical outcome to 
conservative management (Ryösä et al. 2016), important questions remain about 
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whether early primary care treatment decision-making for these patients, such as 
initial first-line treatment selection, could be optimised.  
 
1.5 Current Research Approaches 
Typically, the superiority or inferiority of a treatment in a particular sample of 
patients has been determined using treatment group mean scores in randomised 
controlled trials (RCTs). However unsurprisingly, this approach has failed to yield a 
universally effective treatment for shoulder disorders (Green et al. 2003). 
Considering the volume of existing research in this field that has tested and 
compared various treatments for superiority, it is perhaps time to re-conceptualise 
how MSK shoulder pain research is conducted.  
 
A traditional critique of randomised controlled trials is that group mean scores do 
not reflect the path of an individual, therefore Priestman & Baum (1976) advised 
that attention is paid to the path of individual patients through a trial, asserting that 
group mean change scores reflect the intervention effect on either no one or at 
most, a few individuals. Judgement of treatment effectiveness based solely on 
group mean change forfeits understanding of individual response as not all 
patients’ problems necessarily change in the same direction or to the same degree 
(Priestman & Baum, 1976). In clinical trials, considerable individual variation in 
treatment response may be seen in the standard error of the mean effect, resulting 
in wide confidence intervals. Such a broad variety of responses summarised in 
one mean score may add to an explanation for why many trials have been unable 
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to detect statistically significant treatment differences. Variation in patient 
characteristics and prognosis highlights potential explanatory relationships 
between an individual’s characteristics and prognosis. Research focus is 
beginning to shift towards understanding how each patient’s individual attributes 
impact on clinical outcome, i.e., identification of specific patient or disease 
characteristics that predict which patients responds better to a specific treatment, 
compared to others. 
  
1.6 Clinical Challenges 
In common with other medical and healthcare fields, a clear diagnosis often 
underpins clinical management of a patient’s presentation. However, the clinical 
management of shoulder pain suffers in this respect, as ascertaining an exact and 
accurate clinical diagnosis in patients with shoulder pain is challenging, even with 
the input of musculoskeletal imaging techniques such as ultrasound (Saulle & 
Gellhorn, 2017). Specific orthopaedic symptom provocation tests are highly 
sensitive to pain but lack the specificity that enables confident identification of the 
structure(s) that underlies or causes the presenting pain and/or dysfunction 
(Hegedus et al. 2012).  
 
A recent meta-analysis found that no single test demonstrated superior clinical 
performance but that the best performing tests (with respective sensitivity and 
specificity) include; supraspinatus test for diagnosing not just supraspinatus tears 
but any full thickness tendon tear (0.43 (0.31,0.56), 0.89 (0.67, 0.97); the 
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Compression-Rotation test for diagnosing a SLAP injury (0.58 (0.50, 0.66), 0.67 
(0.47, 0.83)) and the Hawkins test for subacromial impingement syndrome (0.74 
(0.39,0.92), 0.77 (0.69, 0.83)) (Gismervik et al. 2017). Therefore, even with 
reliance on these three best available tests, the sensitivity and specificity of 
specific orthopaedic tests remains low. Furthermore disagreement exists on 
whether physical tests and symptom reporting alone can accurately inform specific 
clinical diagnosis (Cadogan et al. 2013; Carter et al. 2012; McFarland et al. 2010). 
Existing attempts to help clinicians manage this diagnostic uncertainty and the 
limitations of making decisions for individual patients based on how a group 
responded in a RCT have drawn upon various methods of subgrouping shoulder 
patients on the basis of diagnostic classification systems. However such systems 
demonstrate inter-rater variability (percentage agreement) of 60-80% amongst 
physiotherapists (Carter et al. 1999) and remain incompletely evidenced in terms 
of their impact on treatment decision-making and subsequent patient outcomes 
across the variety of clinical environments in which patients with shoulder pain 
present. 	
 
1.7 Using Prognosis Research to Inform Clinical Practice 
Prognosis research has sought to identify patient attributes that estimate a 
patient’s likely outcome in the context of their chosen clinical management. With 
respect to shoulder pain, a number of patient attributes including more intense 
pain at baseline, longer symptom duration, gradual history of symptoms, frequent 
discomfort, more resting, being less energetic, and middle-age, low education 
level and, multisite musculoskeletal pain have been found to predict poorer 
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outcome, in the context of the various types of healthcare received in the cohort 
studies (Bot et al. 2005; Engebretsen et al. 2010; Feleus et al. 2007; Hoare et al. 
2010; Kuijpers et al. 2006; Kuijpers et al. 2004). As outlined in the PROGRESS 
Partnership’s framework for prognosis research, establishing which patient 
attributes are associated with poor outcome is the first step in the development of 
models of stratified care that seek to match individual patients with the treatment 
most likely to result in positive outcome (Hemingway et al. 2013; Riley et al. 
2013). The next stage requires building multivariable prognostic models to 
ascertain risk of specific outcomes in individual patients (Steyerberg et al, 2013).  
 
Clinical applications of multivariable prognostic models which can produce risk 
predictions for individual patients include the development of: (i) prognostic or 
prediction rules or (ii) decision tool/aids. Based on predictive or prognostic models 
containing variables obtained from patient history, physical examination and/or 
simple diagnostic tests, prediction rules are designed to predict outcome in the 
context of the type of treatment provided and are intended to provide a probability 
for the likelihood of a future event on the basis of the patient’s clinical profile 
(Laupacis et al. 1997). Likelihood of a future event in a prediction rule may be 
classified as low, medium or high risk. This is of some clinical utility but such tools 
do not provide guidance on a treatment decision for individual patients. 
 
Distinctions between ‘prediction rule’, ‘prediction guide’, ‘decision rule’ and 
‘decision guide’ are subtle with some arguing that decision rules/guides are the 
  
8 
same as prediction tools/guides (Fritz, 2009; Hebert & Fritz, 2012; Schneider et al. 
2012). Prediction models or rules are designed to optimally predict (using baseline 
clinical information) a specific outcome for individual patients (Reilly & Evans, 
2006). This can inform treatment decisions, especially where the decision 
concerns treatments that carry risks as well as benefits, and the aim is to only 
offer treatment to those for whom the benefits of treatment outweigh the risks. In 
specific circumstances, a clinical prediction rule based on risk can validly suggest 
a therapeutic course of action. In the context of a disease such as osteoporosis 
for example, use of specific risk assessment tools to estimate risk of fracture can 
guide decisions on the appropriateness, or not of relevant intervention (e.g. 
prescription of medication to reduce fracture risk) (NICE, 2017). 
 
In contrast, in the context of shoulder pain, decision rules are proposed to assist 
with treatment decisions that are not based on risk associated with likely future 
outcomes or course of symptoms but rather, on predictors of response to specific 
treatments. This may be problematic as it assumes that the prognostic model 
underpinning the rule has been designed specifically to identify which prognostic 
variables are associated with a particular direction of response for each treatment 
under consideration. Prediction rules that intend to support treatment decision-
making have in the past mistakenly been developed using single arm of a trial or 
observational data where only one treatment is studied. In such cases, it is not 
clear whether the patients who respond well to the intervention would have 
responded the same, better or worse to another intervention. Furthermore, it is 
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unclear which patients simply have a good prognosis and are highly likely to 
achieve a good outcome, irrespective of receipt of treatment.  
 
Few clinical prediction rules that recommend treatment decisions have undergone 
formal validation, replication or clinical and cost effectiveness impact analysis (as 
per (McGinn et al. 2000) to determine whether they improve real world decision-
making and outcomes when used in clinical practice (Steyerberg et al. 2013). 
Therefore, given the lack of clarity and evidence of clinical impact, a more 
cautious and discriminative approach to the definition of terms in this field has 
been advised. Foster et al. (2013) suggest a distinction between prognostic 
models and clinical decision tools: prognosis could guide the decisions about 
whether treatment is indicated or not on the basis of likely outcome whilst 
approaches targeting mechanisms could support decision-making about specific 
treatments for individual patients.  As different clinical questions require specific 
research methods to be appropriately answered, the clinical question therefore in 
this situation also drives the decision to create either a prediction tool or clinical 
decision tool. A prognostic model will provide useful information when the clinical 
question centres on identifying the risk of poor outcome. If however, the clinical 
question centres on specific treatment selection in order to gain a positive 
outcome, a decision tool is required and this requires a slightly different 
methodology.  A decision tool should be based on a prognostic model that 
demonstrates an interaction between prognostic variables and the effect of 
treatment over the control intervention effect, e.g., if gender interacted with 
treatment, a different response would be observed for males compared with 
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females in response to the same treatment. This approach may appropriately 
enable identification of patients who are uniquely likely to respond to a specific 
treatment in comparison to other specific treatments or control, thereby allowing 
clinicians to ‘match’ individual patients to the most beneficial treatment, i.e., 
conduct evidence based treatment selection for individual patients.  
 
Decision tools can also be based on a mix of prognostic information and treatment 
targeting. The  STarT-Back Tool helps to distinguish between patients who can be 
reassured (low risk); who need more help, e.g. by a physiotherapist (medium risk); 
and those who need to more intensive combined physical and psychologically 
informed treatment (high psychosocial risk) (Hill et al. 2008). The psychologically 
informed intervention matched to patients with high psychosocial risk was based 
on the assumption that an interaction exists between scoring highly on the 
psychological subscale of the tool and response to the psychologically informed 
intervention, although this interaction is currently under investigation and has yet 
to be demonstrated. The STarT-Back approach, where clinicians use the 
prognostic tool to inform decision-making, has been demonstrated to be more 
clinically and cost effective than usual care (delivering greater reduction in 
disability, healthcare utilisation and time off work and greater functional gains 
whilst also being more cost effective (with average annual savings of £34.39 per 
patient) (Hill et al. 2011). On-going work seeks to understand the mechanisms 
underpinning the particular success of this approach to targeted treatment 
(Mansell et al. 2013). The academic field of shoulder disorders, including its 
evidence base and mass of literature is less mature than low back pain. 
Therefore, an opportunity exists to define a system of treatment targeting in 
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shoulder disorders constructed upon understanding of how patient attributes are 
responsible for differential treatment response at the individual patient level.  
 
1.8 Moderators of Treatment Effect as Drivers of Clinical Decision-Making 
This differential treatment effect can be termed moderation. Treatment effect 
moderators (also termed treatment effect modifiers) are patient attributes which 
enable researchers to identify who responds to a given treatment and who does 
not (Kraemer et al. 2008). Moderators of treatment effect are patient 
characteristics measured at baseline that influence the relationship between a 
specific intervention and outcome (Hill & Fritz, 2011). Moderators of treatment 
effect are ideally identified with a priori hypothesis in large RCTs investigating 
interventions of interest (Pincus et al. 2011), however a recent review of 
moderators in the more mature field of low back pain research suggests that this 
is not yet commonplace (Gurung et al. 2015). It is often stated that RCTs are 
required to test for moderation as attempting to identify potential moderators in a 
single arm cohort study do not allow for comparison of the interaction between the 
prognostic factor and each of the interventions of interest, i.e., it is not possible to 
determine whether the patient attribute has a moderating effect in that treatment 
alone or in some but not other treatments (Hancock et al. 2009), or if a patient 
attribute is a generic prognostic factor, predicts outcome regardless of the type of 
treatment. However, it could also be possible to test moderators of treatment 
effect in a sufficiently large cohort study containing the treatments of interest if a 
priori hypotheses were stated, with careful attention paid to the baseline 
characteristics of each treatment group and sufficient adjustment for confounding 
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is incorporated in the analysis, since randomisation is not a feature of a cohort 
study. 
 
1.9 Rationale for this Thesis 
Despite the common usage of conservative treatment options such as; exercise 
and/or manual therapy (typically delivered by a physiotherapist), advice on activity 
modification and relative rest, non-steroidal anti-inflammatory drugs, and 
corticosteroid injections in UK primary care, clear indications for the selection of 
optimal treatment tailored for each individual with MSK shoulder pain is lacking. 
Given this paucity of evidence on how to target treatment for shoulder disorders, 
identification of moderators of treatment effect for these treatments and definition 
of profiles of patients who are likely to respond to specific treatments is indicated 
to guide treatment decision-making for individual patients.  
 
This PhD aims to contribute to the evidence for primary care practice by identifying 
factors that potentially moderate response to three commonly used treatment 
options: (i) advice and analgesia, (ii) exercise and/or manual therapy as delivered 
by a physiotherapist and (iii) corticosteroid injection. It is anticipated that the 
outcome of this PhD will be the formulation of clinically derived and weighted 
profiles of patients most likely to respond to the above-mentioned treatments. It is 
anticipated that these factors and profiles will inform a future treatment decision 
tool and a future RCT of stratified care using this approach in primary care patients 
with shoulder pain.   
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1.10 Thesis Aims 
This thesis aims to use appropriate and robust methods to derive a list of 
candidate moderators of treatment response suitable for testing in future purposive 
research by: 
Identifying and summarising available evidence relevant to moderators of 
response to: (i) advice and analgesia, (ii) exercise and/or manual therapy and (iii) 
corticosteroid injection  
Using clinical expertise to identify patient characteristics that may moderate patient 
response to: (i) advice and analgesia, (ii) exercise therapy and/or manual therapy 
and (iii) corticosteroid injection 
Identifying candidate moderators of treatment effect for each of the above three 
treatments based on healthcare practitioners expertise and opinion regarding 
differential decision-making for shoulder pain. 
 
This thesis will identify and quantify the impact of clinically relevant candidate 
moderators on differential decision-making for patients with shoulder pain using a 
variety of relevant and sequential methodologies. Firstly, a systematic review will 
identify and summarise existing evidence on moderators of treatment effect for the 
three conservative primary care treatments for shoulder pain. Theories of 
expertise and decision-making will be portrayed in light of differential treatment 
decision-making for patients with shoulder pain.  The potential of studying the 
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experientially constructed knowledge of clinical experts to identify additional 
potential moderators of treatment effect will be discussed. Findings from the 
review will be supplemented by clinical expertise in a series of focus groups using 
nominal group technique to arrive at a parsimonius list of highly clinically relevant 
attributes of patients with shoulder pain that assist clinicians with differential first-
line treatment decision-making. A multi-modal recruitment strategy will be used to 
recruit a multi-disciplinary and international sample of clinicians who routinely 
manage patients with shoulder pain to the final study of clinical decision-making. 
The impact of each of the patient attributes on differential decision-making will be 
quantified in an empirical study of clinical decision-making using conjoint analysis. 	
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CHAPTER 2: MODERATORS OF TREATMENT 
RESPONSE IN PATIENTS WITH MUSCULOSKELETAL 
SHOULDER PAIN: A SYSTEMATIC REVIEW 
 
2.1. Introduction 
In spite of numerous high quality randomised controlled trials (RCTs) in shoulder 
pain that demonstrate short-term effectiveness of several interventions including 
exercise and corticosteroid injection (Abdulla et al. 2015; Dong et al. 2015; 
Littlewood et al. 2012; Murphy & Carr, 2010; Page et al. 2014; Song et al. 2014), 
evidence regarding long-term effectiveness and clinically directive differences in 
treatment effect is lacking. The variable prognosis of patients with shoulder pain 
(Croft et al. 1996; van der Heijden et al. 1997; Winters et al. 1999a), coupled with 
acknowledged diagnostic challenges (Hegedus et al. 2012), has prompted 
clinicians and researchers alike to search for strategies to identify patients at risk 
of poor outcome. Recent systematic reviews of prognostic factors in shoulder pain 
have focused on identifying predictors of outcome irrespective of treatment 
(prognostic factors) or predictors of outcome in patients receiving a single 
treatment only (Chester et al. 2013; Vergouw et al. 2011). However, predictors of 
outcome of a single treatment do not aid understanding of how individual patient 
outcomes may vary in response to different treatments.  
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Distinct from prognostic factors, moderators of treatment effect are patient 
attributes or clinical characteristics measured at baseline that influence the effect 
of the treatment on the outcome (Hill & Fritz, 2011).  Treatment effect moderators 
(also termed treatment effect modifiers) therefore facilitate identification of who is 
likely to respond or not respond to given treatments (Kraemer et al. 2008).  
Evidence of moderation of effect of specific treatments exists in analyses 
concerning other musculoskeletal conditions such as low back pain, tempo-
mandibular joint and chronic musculoskeletal pain (Miles et al. 2012; Turner et al. 
2007; Underwood et al. 2007). As such, a wide range of potential predictive 
factors are now recognised, but to date little is known about the patient attributes 
that specifically moderate the effect of the commonly used primary care 
interventions for shoulder pain: (i) advice & analgesia, (ii) exercise and/or manual 
therapy delivered by a physiotherapist and (iii) corticosteroid injection, and indeed 
which subgroups of patients with shoulder pain are most likely to respond to each 
of these specific and commonly offered treatments.  
 
It is hypothesised that moderators of treatment effect for patients with shoulder 
pain and profiles of likely best responders to specific treatments exist, however 
these have not thus far been studied or identified. It is therefore logical that 
targeting treatment to patients whose clinical attributes match the profile of likely 
best responder is likely to result in clinical improvements in pain and dysfunction 
in these subgroups as well as health economic benefits in those unlikely to 
respond by avoiding costs and potential harm from less effective treatments 
(Hingorani et al. 2013).  Investigation of treatment moderation in principle requires 
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a randomised controlled trial to explore or test the interaction between the patient 
factor(s) expected to moderate treatment effect and the different treatment 
options, a vital component in establishing whether the factor has a moderating 
effect in that treatment alone or in some but not other treatments (Hancock et al. 
2009), or if it concerns a generic prognostic factor, predicting outcome regardless 
of the type of treatment. 
 
Considering that the focus of recent shoulder studies and reviews has been on 
identifying predictors of outcome in general or of outcome of specific single 
treatments (Chester et al. 2013; Engebretsen & Soberg, 2010), the extent of 
evidence for moderators of treatment effect in musculoskeletal shoulder pain is 
currently unclear.  Therefore, this review aims to take the first step in the 
identification of treatment moderators by summarising available evidence for 
moderation and identify suggested potential moderators of outcome of three 
commonly used primary care treatments: advice and analgesia, exercise and/or 
manual therapy and corticosteroid joint injection. 
 
2.2 Aims of Review 
A systematic review was undertaken to identify and appraise the evidence for 
potential moderators of the effects of education, advice, analgesia, exercise 
and/or strengthening exercise and corticosteroid injections in patients with 
musculoskeletal shoulder pain. 
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2.3 Objectives of Review 
This systematic review: 
1) Searched for randomised controlled trials in shoulder pain that either 
analysed moderation or included suggestions regarding potential 
moderators of effect of commonly used first line treatments in primary 
care treatments: a) education, advice, analgesia, b) exercise and/or 
strengthening exercise and c) corticosteroid injections 
2) Identified and appraised the statistical methods used to identify potential 
moderators of treatment effect 
3) Taking strength of evidence into account, identified patient attributes 
that potentially moderate effect of: a) advice and analgesia, b) exercise 
and/or strengthening exercise and c) corticosteroid injections in patients 
with musculoskeletal shoulder pain. 
 
2.3 Methods 
A systematic review was undertaken. Criteria for the identification and selection of 
studies included in this review are described below. 
 
2.3.1 Types of studies 
Included studies were randomised controlled trials that conducted treatment effect 
moderation analysis or any form of subgroup analysis where patients were 
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grouped on the basis of pre-determined prognostic factors and the treatment effect 
was compared across subgroups. As randomised controlled trials are the gold 
standard for revealing moderators of outcome, other study types were not included 
in this review (Kraemer et al. 2002; Pincus et al. 2011). In line with minimum 
recommended sample size for the identification of moderators of treatment effect, 
included studies had a minimum number of 10 participants in the smallest 
subgroup (Sun et al. 2011). Therefore at the inclusion/exclusion stage of the 
review, studies with less than 20 participants in the trial were excluded, i.e., at 
least 10 participants per arm as they were unlikely to have sufficient sample size in 
which to determine meaningful subgroup effects (Sun et al. 2010). 
 
2.3.2 Types of participants 
Studies were selected if they included adult patients (aged 18 years or older) with 
non-traumatic unilateral musculoskeletal shoulder pain. Non-traumatic 
musculoskeletal shoulder pain for the purposes of this review was defined as soft 
tissue strains/sprains, tendonitis, bursitis, capsulitis within or local to the gleno-
humeral joint. Studies including patients with traumatic, rheumatological or 
degenerative conditions were excluded from this review. Shoulder pain arising 
from trauma was excluded from this review as traumatic onset is considered a red 
flag for shoulder pain and an indication for urgent shoulder clinic review (Carr & 
Rees, 2012). Sign(s) or diagnosis of an inflammatory condition are considered as 
rheumatological red flags and an indication for review in rheumatology, 
rheumatological conditions were therefore excluded from this review (Carr & Rees, 
2012). Separate guidelines exist for the shoulder osteoarthritis management, 
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therefore trials in patients with osteoarthritis of the shoulder joints were also 
excluded from this review (AAOS, 2009).  
 
2.3.3 Types of interventions 
Included studies involved one or more of the following primary care interventions: 
(i) Education, advice and/or pain relief delivered by a healthcare 
practitioner 
(ii) Mobilising or strengthening exercise or manual therapy treatment to 
joints and/or soft tissue delivered by a physiotherapist or physical 
therapist (USA definition) 
(iii) Corticosteroid injection delivered by a GP, rheumatologist, 
orthopaedic surgeon, physiotherapist or physical therapist 
 
2.3.4 Outcomes of interest 
Studies were included if they had at least one functional (including joint 
assessment, disability, work) or pain-related outcome, either individually or 
combined.  
 
2.3.5 Search Methods for Identifying Studies 
Databases searched include: Medline, Embase, PsycINFO, CINAHL, AMED, 
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Pedro, and Cochrane. Database searches began at the earliest date offered by 
each database and were completed in January 2015. No backward date limit was 
applied so that all possible hits were returned. All publications that were published 
by January 2015 were eligible for inclusion in the review. Search terms for 
shoulder conditions and relevant interventions were identified from reviews 
conducted by the Cochrane Musculoskeletal Review Group (Buchbinder et al. 
2013a; Green et al. 2003) and key words gained from previous reviews and 
relevant research studies were used as search terms. The specific methods filter 
for randomized controlled trials was used to identify RCTs (Cochrane, 2011). 
Search terms for Medline are included in table 2.1. Search terms were modified as 
required in order to optimally search each of the listed databases. Electronic 
database searches were supplemented by searching the reference lists of 
included articles and liaison with clinical and academic experts in the field of 
shoulder pain to check that any additional publications or grey literature had not 
been omitted.  
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Table 2.1: Systematic Review Search Terms 
 1 Shoulder Pain/ 
2 Shoulder Impingement Syndrome/ 
3 Rotator Cuff/ 
4 
((shoulder* or rotator cuff) adj5 (bursitis or frozen or impinge* or tendinitis or tendonitis or 
pain*)).mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
protocol supplementary concept, rare disease supplementary concept, unique identifier] 
5 rotator cuff.mp. [mp=title, abstract, original title, name of substance word, subject heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier] 
6 
adhesive capsulitis.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, protocol supplementary concept, rare disease supplementary concept, unique 
identifier] 
7 
capsular syndrome.mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, protocol supplementary concept, rare disease supplementary concept, unique 
identifier] 
8 exp Bursitis/ 
9 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 
10 exp Rehabilitation/ 
11 exp Physical Therapy Modalities/ 
12 exp Musculoskeletal Manipulations/ 
13 exp Exercise Movement Techniques/ 
14 
(rehabilitat* or physiotherap* or physica therap* or manual therap* or exercise* or 
mobilis*).mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
protocol supplementary concept, rare disease supplementary concept, unique identifier] 
15 10 or 11 or 12 or 13 or 14 
16 exp Injections/ 
17 
((steroid* or corticosteroid* or subacromial or sub-acromial) adj5 inject*).mp. [mp=title, 
abstract, original title, name of substance word, subject heading word, protocol supplementary 
concept, rare disease supplementary concept, unique identifier] 
18 Injections, Intra-Articular/ 
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19 "joint inject*".mp. [mp=title, abstract, original title, name of substance word, subject heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier] 
20 ((corticosteroid or triamcinolone or lederspan or hydrocortisone or methylprednisolone or depo medro* or anti inflammat*) adj inject*).ab,ti. 
21 16 or 17 or 18 or 19 or 20 
22 clinical trial.pt. 
23 random*.mp. [mp=title, abstract, original title, name of substance word, subject heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier] 
24 
((single or double) adj (blind* or mask*)).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, protocol supplementary concept, rare disease 
supplementary concept, unique identifier] 
25 placebo*.mp. [mp=title, abstract, original title, name of substance word, subject heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier] 
26 22 or 23 or 24 or 25 
27 9 and 15 and 21 and 26 
 
 
2.3.6 Study Selection 
Studies were selected on the basis of the criteria outlined in table 2.2. CM applied 
the selection criteria to the titles of publications retrieved by the search, retaining 
any ambiguous or unclear results for review at the abstract stage. CM repeated 
this process to ensure that potentially included studies were not excluded in error. 
At abstract stage, two reviewers independently reviewed each abstract: CM & 
DvdW (first half in alphabetical author order), and CM & JH (second half). A 
sample of 10 abstracts was triple reviewed (CM, DvdW, JH) to ensure consistency 
of application of the selection criteria. Full texts were subjected to data extraction, 
risk of bias assessment and methodological appraisal (see appendix 1) by CM & 
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DvdW. CM and JH conducted data extraction, risk of bias and methodological 
appraisal on publications where DvdW declared conflict of interest by authorship 
or collaboration. 
 
Table 2.2: Selection Criteria for studies to be included in the review 
Inclusion Criteria Exclusion Criteria 
RCT design Non-RCT design 
Adult human participants Non-human or child participants 
Musculoskeletal shoulder pains: Dysfunction, 
pain or symptoms in the glenohumeral region 
+/- surrounding soft tissue including but not 
limited to: soft tissue strains/sprains, tendonitis, 
bursitis, capsulitis 
Traumatic shoulder pains e.g., fracture or 
dislocation 
 
Comparison of one or more of the below 
against each other or any other intervention: 
(i) Advice, education and pain relief (delivered 
by G.P.) 
(ii) Manual therapy and/or strengthening and/or 
mobilising exercises delivered by a 
Physiotherapist or Physical Therapist 
(iii) Corticosteroid injection (+/- analgesia) 
 
 
Comparison of any of the below exclusively 
against a control: 
(i) Advice, education and pain relief (delivered 
by G.P.) 
(ii) Manual and/or strengthening and/or 
mobilizing exercises delivered by a 
Physiotherapist or Physical Therapist 
(iii) Corticosteroid injection 
 
Non-steroid and/or analgesic injections e.g., 
hyaluronic acid 
Any attempt at subgroup analysis 
 
Failure to conduct any form of subgroup 
analysis 
Outcome measured using multiple measures: 
Physical, functional or pain 
Solely occupational/work function or 
absenteeism/presenteeism outcome measures 
More than 20 participants in trial (minimum 10 
per arm) 
Less than 20 participants in trial (under 10 per 
arm) 
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2.3.7 Data Extraction 
The data extraction and appraisal form was trialed using a publication that 
described a secondary data analysis of a large RCT in low back pain (UK BEAM 
trial, Underwood et al. 2007) and then amended to improve clarity and 
consistency. Data extracted included: inclusion criteria, primary outcome 
measures, follow-up periods, interventions studied, statistical methods used for 
moderation analysis, prognostic factors tested and findings of moderation analysis. 
The data extraction from included risk of bias assessment and assessment of 
methodological quality of moderation analysis.   
 
2.3.8 Assessment of Bias 
Bias is a systematic error or deviation from the truth in results or inferences 
(Cochrane, 2011). The Cochrane Risk of Bias (ROB) tool estimates the risk of 
systematic error in each included study in order to provide an estimation of the 
likelihood that the reported intervention effect is true, i.e., the extent to which the 
results of a study present a valid estimate. The Cochrane ROB tool is domain 
rather than scale based. Domain-based tools are preferable as they do not imply 
equal weighting of each domain or imply a cumulative effect (Higgins et al. 2011). 
Each of the seven questions pertaining to the five domains of bias are answered 
with “Yes, No or Unclear’ and scored separately, which allows assessment of the 
risk of bias for each specific domain. 
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Pilot application of the data extraction and methodological evaluation tools in the 
paper reporting the moderation analysis of the UK BEAM trial highlighted the 
shortage of detail regarding general trial methods in the moderation analysis 
paper, making it difficult to judge the RoB. Therefore original trial papers were 
accessed and subjected to ROB assessment for those studies that reported 
moderation analyses in a separate publication. Although this review focused on 
the analysis of moderation, the Cochrane RoB tool was used to assess the risk of 
systematic error in the original or full trials in which the moderation analyses were 
conducted. Explanation of the agreed meaning of each question including 
guidance notes for completion of each question was provided to authors prior to 
their independent completion of data extraction, risk of bias assessment and 
methodological appraisal (see appendix 2).  
 
2.3.9 Assessment of Methodological Quality of Moderation Analysis 
Assessment of bias may be distinguished from quality assessment, quality 
assessment suggests investigation of the extent to which study authors conducted 
their research to the highest possible standards (Cochrane, 2011). Assessment of 
moderation analysis may be conducted in a number of ways. Currently, two 
primary approaches to appraisal of moderation analysis exist (Pincus et al. 2011; 
Sun et al. 2010). For the purposes of this review, the quality of the moderation 
analysis conducted in included studies were assessed using criteria defined by 
Pincus et al. (Pincus et al. 2011). These criteria were chosen as they recommend 
a more conservative adjustment of the p value to take into consideration the risk of 
type I error (incorrectly rejecting the null hypothesis) when multiple moderators are 
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tested in a trial. Furthermore at the recommended minimum subgroup sample size 
of 20, the Pincus criteria attempts to minimise the risk of a type 2 error (incorrectly 
accepting the null hypothesis), where small sample size makes it more likely that a 
true effect will be missed (Pincus et al. 2011). The Pincus criteria produce a score 
that aligns with a judgement on the quality of the analysis providing an estimation 
of the level of moderation evidence. The tool contains 19 questions in total 
however only 5 criteria are considered when making a judgement on the overall 
level of moderation evidence. Each question is answered with a yes or no 
response. Each criterion is scored as either met or not met, resulting in a total 
score ranging from 0-5. A score of 5 out of a maximum 5 allows findings to be 
regarded as confirmatory evidence, while the presence of the final three criteria 
allow findings to be regarded as exploratory evidence (Pincus et al. 2011). 
The 5 criteria considered when scoring each study for level of evidence for 
moderation are:  
(i) A priori hypothesis It is agreed that a priori statement of hypotheses is vital in 
order to ensure adequate statistical power and to prevent subjecting the sample to 
the testing of every single potential moderator (Sun et al. 2011; 2012). 
(ii) Theory or evidence-based selection of moderators to be tested The importance 
of testing potential moderators that are theoretically or evidence-based is founded 
upon the scientific ideal that hypotheses are “initially theory driven, then 
empirically confirmed, and finally clinically evaluated to establish their real-world 
existence” (Nicholson et al. 2005). 
(iii) Measurement of moderators prior to randomisation Measurement of 
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moderators prior to randomisation ensures that potential presence of, or variance 
within moderators is similar among treatment groups. 
(iv) Quality of measurement of baseline factors As moderation analysis can be 
highly prone to type 1 error (false positive, rejection of the null hypothesis when it 
should be accepted) when a large number of moderators are tested, as well as 
type 2 error (false negative, when the null hypothesis is accepted when it should 
have been rejected) due to insufficient statistical power (Good, 1983), 
measurement properties of all included variables must meet stringent levels of 
internal consistency and validity in order to protect against type I and II error. Risk 
of type I error and type II error is increased in moderation and subgroup analyses 
due to the effective sample size being reduced by only a proportion of the 
treatment arm sample matching the level of attribute being tested (e.g., females 
receiving physiotherapy treatment).  
 
Evidence of validity and reliability of the measures used to assess potential 
moderators allows us to gauge whether the measurement error of the instrument 
is likely to be sufficiently small to detect the differences between sub-groups (or 
predictive value of moderators) that are likely to be important. For the purposes of 
this review, simple and common clinical constructs such as age, gender, treatment 
preference etc., which are commonly observed and easily understood are not 
required to demonstrate validity and responsiveness data. More complex clinical 
observations or measures, tools or scales require presentation of validity and 
responsiveness data (e.g. questionnaires to assess psychological factors; physical 
examination tests). 
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(v) Explicit test of interaction between moderators and treatment A statistical test 
for interaction between a baseline factor and treatment is required in order to test 
whether the difference in treatment effect between subgroups is statistically 
significant, or a moderator has a statistically significant association with treatment 
effect (Brookes et al. 2001). 
 
2.3.10 Evidence Synthesis 
Studies included in this review were divided into two groups: (i) studies with formal 
moderation or subgroup analysis that constituted the main purpose of the 
publication, and (ii) studies that suggested potential moderators of treatment effect 
without formal analyses. Formal and valid moderation analysis in a randomized 
controlled trial generally consists of stratified or subgroup analysis defined a priori 
in the trial protocol, ideally powered to detect significant differences with 
presentation of treatment effects for categories of the potential moderator 
(Brookes et al. 2001; Hingorani et al. 2013). Testing of significance of the 
subgroup effect (moderation) is generally carried out using regression analysis by 
adding a ‘moderator * treatment’ interaction term to the regression model, which 
also includes the treatment and predictor variable) (Hingorani et al. 2013). The 
results of this review are presented in two parts. Description and results of studies 
that conducted a formal analysis of potential treatment moderators are presented 
separately to studies that make reference to potential treatment moderators but 
did not formally analyse potential treatment moderators. Assessment of risk of bias 
and quality appraisal was conducted only on studies that had conducted 
moderation analysis. In the studies without moderation analysis, the results 
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regarding proposed potential moderators were narratively synthesized and were 
not subjected to Cochrane Risk of Bias assessment or moderation methodological 
critique, as these studies do not provide empirical evidence of moderation. A 
meta-analysis or meta-regression was not possible because of the substantial 
differences in patient population, settings, interventions, and outcomes used.  
 
2.4 Results 
A PRISMA flow diagram (Moher et al. 2009) of this systematic review is presented 
in figure 2.1 below. Electronic database searches identified a total of 1675 
citations. After the removal of duplicates, titles of the 1081 citations were screened 
against the criteria outlined in table 2.2 and 702 studies not pertaining to the 
purpose of this review were removed. After two reviewers independently applied 
the selection criteria, and consensus was reached, a further 293 studies were 
removed. Eighty-six full texts were read and 21 articles were deemed to be 
relevant by both reviewers. Screening of the reference lists of relevant papers and 
all published Cochrane reviews in the field identified seven further articles, one of 
which was included in the review. In total 22 studies are included in this review. 
Studies were presented into two groups: (i) studies formally evaluating moderation 
and (ii) studies suggesting potential moderators. Table 2.3 outlines the design of 
each of the included studies that have conducted a formal analysis of potential 
treatment moderators. Data on inclusion and exclusion criteria, primary outcome, 
follow-up, interventions studies and treatment duration are presented. Table 2.4 
details the moderation analysis design of each study listed in table 2.3. 
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Studies included in review (n = 21) 
 
Studies containing moderation analysis (n= 7) 
Studies suggesting potential moderators (n= 14) 
 
Records identified through database searching  
(Medline, Embase, PsycINFO, CINAHL, AMED, Pedro, and Cochrane)  
(n = 1675) 
 
(n =   ) 
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Id
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at
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n  
Records after duplicates removed 
(n = 594) 
Titles screened 
(n = 1081) 
Titles excluded (n = 702) 
Non-RCT (n=235) 
Musculoskeletal shoulder disorders other 
than inclusion criteria (e.g., soft tissue 
tears, labral issues, fractures, Post-stroke, 
other neurological cause) (n=167) 
Electrotherapy trial (U/S, PSWD, laser) (n=118) 
Acupuncture trial (n=45) 
Surgery intervention (n=61) 
Non-steroidal or soft tissue injectate (n=76) 
Full-text articles assessed for 
eligibility 
(n = 86) 
Full-texts excluded (n = 64) 
No moderation or subgroup analysis  
(n= 59) 
Non-RCT (n=2) 
Conference proceeding only, not published in 
full (n=3) 
Abstracts screened 
(n = 379) 
Abstracts excluded (n = 293) 
Non-RCT (n=112) 
Electrotherapy in all arms (n=67) 
No functional or pain outcome measure 
(n=39) 
Other treatment as control (n=8) 
Interventions not of Interest (n=54) 
Double Entry (Translated article) (n=1) 
Trial arm sample size <20 (n=12) 
Hand Search of reference lists 
Full Texts sourced (n= 7) 
 
Full-texts excluded (n = 7) 
No moderation or subgroup analysis (n= 7) 
Figure 2.1: PRISMA Systematic Review Flow Chart 
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Table 2.3: Description of Studies Containing Moderation Analysis 
Author, Date, 
Setting, 
Country 
Inclusion Criteria Primary Outcomes Follow-Up Interventions 
Studied 
Geraets et 
al. 2005, 
Primary 
Care, 
Netherlands 
Chronic shoulder complaints > 3 
month duration, living in Limburg, 
the Netherlands  
Main Complaints Instrument, 
Shoulder Disability 
Questionnaire (SDQ), 
Perceived recovery (yes/no) 
12/52  Up to 18 graded exercise therapy sessions (60mins) 
during 12 weeks 
Usual care as per the Dutch College of General 
Practitioners 
Hsu et al. 
2011, Long-
term care 
home 
residents, 
Canada 
> 50 years; self-reported 
impairments or bothersome 
symptoms of the upper extremity 
limiting function 
Nursing Home Physical 
Performance Test (NHPPT), 
modified Physical Activity 
Enjoyment Scale (PACES), 
Numeric Rating Scale (NRS), 
active ROM, Global Perceived 
Rating of Change (GPRC) 
4/52 Standard exercise regimen   
20 min simulated bowling video game via the 
Nintendo Wii gaming system plus standard exercise 
regimen, twice weekly 
 
Thomas et 
al. 2004, 
Primary 
Care, UK 
Patients consulting with an episode 
of unilateral shoulder pain 
Shoulder Disability 
Questionnaire (SDQ) 
6/52, 6/12  Up to 8 20 min. physiotherapy sessions (exercise, 
manual therapy) (20mins) during 6 weeks 
 
One local corticosteroid injection  
van der 
Windt et al. 
2000, 
Primary 
Care, The 
Netherlands 
(Secondary 
Patients who consulted their 
general practitioner (GP) for a 
painful stiff shoulder were 
considered for participation 
General improvement,  
Main complain severity,  
Pain,  
Functional disability 
3/52, 7/52 post 
treatment, 
3/12, 6/12, 
12/12 post 
randomisation 
Up to 3 intra-articular 40 mg triamcinolone acetonide 
injections during 6 weeks 
6 week physiotherapy programme (joint mobilisation, 
exercise) 
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Analysis of 
van der 
Windt, 1998)   
Zheng et al. 
2005, 
Primary 
Care, 
Netherlands 
(Secondary 
Analysis of 
van der 
Windt, 1998)  
Painful restriction of glenohumeral 
mobility, aged >18 years 
General improvement 
according to the patient, 
severity of main complaint, 
pain, and functional disability 
3/52, 7/52 post 
treatment, 
3/12, 6/12, 
12/12 post 
randomisation 
Up to 3 40 mg tri-amcinolone acetonide intra-articular 
injections during 6 weeks 
Physiotherapy (6 weeks) (joint mobilization, exercise) 
Yang et al. 
(Man. Ther.), 
2012, 
Secondary 
Care, 
Taiwan 
Shoulder complaints > 3 months & 
> 50% loss of passive range in 2 or 
more of:  forward flexion, abduction, 
or external rotation in neutral); and 
>3 months complaint duration 
Shoulder ROM, disability 
assessment (FLEX-SF), 
Shoulder complex kinematics 
(FASTRAK motion analysis 
system) 
4/52, 8/52  Control and criteria-control groups: passive 
mobilization & stretching techniques, electrotherapy 
modalities, and active exercises, twice weekly, 3 
months.  
 
End-range mobilization/scapular mobilization 
treatment approach (EMSMTA): control treatment 
PLUS mobilization and scapular mobilization, twice 
weekly, 3 months. 
Yang et al. 
(BMC), 
2012, 
Secondary 
Care, 
Taiwan 
Patients with glenohumeral internal 
rotation limitation & tightness in 
posterior shoulder region 
Glenohumeral ROM and 
muscle tightness 
measurements of posterior 
deltoid, infraspinatus, and 
teres minor muscles 
4/52 Massage on the posterior deltoid, infraspinatus, and 
teres minor, 18 mins, twice weekly for 4 weeks 
 
Placebo Control: Light hand touch on the muscles,  
10 mins, twice weekly for 4 weeks 
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Table 2.4: Results of Moderation Statistical Analysis 
Author, 
Date 
Prognostic Factors 
Tested as Potential 
Moderators 
Moderation Statistical Analysis Methodology Moderation Findings Reported 
Level of 
Moderation 
Evidence 
(from Table 2.5) 
Garaets et 
al. (2005) 
	
Passive range of 
external rotation, 
active range of 
abduction/elevation, 
and presence of 
painful arc, anxiety, 
depression, 
somatisation, distress, 
treatment preference 
On outcomes, main complaint instrument and shoulder disability 
questionnaire, multiple linear regression analyses with stepwise forward 
procedure (p < 0.10) tested influence of prognostic factors and post-
randomisation differences between groups. Regression coefficients 
adjusted for interaction between treatment and painful arc at baseline and 
change in pain intensity. 
Painful arc: Less 
improvement in the 
shoulder disability 
questionnaire scores 
with graded exercise 
therapy in patients with 
a painful arc at baseline. 
Confirmatory 
Hsu et al. 
(2011) 
N/A Outcomes analysed by group with Student’s t-test or Wilcoxin’s sign-rank 
test for paired samples. A subgroup analysis was performed to identify 
baseline patient attributes that could discriminate between responders and 
non-responders to the Wii intervention. 
 
Shoulder & hand 
complaints: 
Responders to Wii 
intervention more likely 
to have shoulder 
symptoms & hand 
symptoms  
Insufficient 
Thomas et 
al. (2004) 
	
Treatment preference Demographic and baseline clinical attributes were compared across the 
three groups of pre-randomisation treatment preference (no preference, 
preference for physiotherapy, preference for injection). The relationship of 
pre-randomisation treatment preference and functional outcome was 
examined within three groups: those with no treatment preference, those 
who received preferred treatment, and those who did not receive preferred 
Treatment preference: 
Outcome was not 
affected by having 
preference or whether 
preference was met. 
Insufficient 
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treatment. 	
van der 
Windt et 
al. (2000) 
	
Treatment preference All patients disclosed treatment preferences before randomisation. 
Exploratory subgroup analyses compared treatment success rates across 
6 subgroups: 3 groups relating to those who received injection (patients 
receiving their preference, patients who did not receive their preference, 
patients without a preference) and 3 groups for those who received 
physiotherapy (patients receiving their preference, patients who did not 
receive their preference, patients without a preference).	
Patient preference: 
Allocation of preferred 
treatment moderates 
treatment effect for 
injections but not 
physiotherapy 
Insufficient 
Xheng et 
al. (2005) 
	
Age, gender, pain 
duration of the current 
episode, previous 
trauma, previous 
episode of shoulder 
pain, overuse of 
shoulder due to usual 
activities and overuse 
of shoulder due to 
unusual activities 
preceding shoulder 
pain 
Analyses performed in three steps: (i) Principal components analysis 
(PCA) and cluster analysis used to classify patients into persistent-
recurrent and recovery groups.  (ii) Asymptotic regression models used to 
fit the shoulder pain recovery profiles; estimates of three parameters were 
included in the models: pain severity at baseline, pain severity at week 52, 
and logarithm of the decline rate of pain severity over time (recovery rate). 
(iii) Covariates, such as age, gender, pain duration of the current episode, 
previous trauma, previous episode of shoulder pain, overuse of shoulder 
due to usual activities and overuse of shoulder due to unusual activities 
preceding shoulder pain, and type of treatment (an indicator variable, 1 for 
injection and 2 for physiotherapy) examined to explain between-patient 
variations using univariate regression analysis.	
Age, gender: In the 
injection group (mostly 
younger than 60 years 
old and male), pain 
severity reduced faster 
than in those treated 
with physiotherapy.  
Insufficient 
Yang et al. 
(2012) 
(Man. 
Ther.) 
	
Scapular orientation 
relative to thorax: 
rotation about 
protraction/retraction 
(Z°s), rotation about 
downward/upward 
rotation (Y°s), and 
rotation about 
posterior/ anterior 
tipping (X°s)	
All subjects had at least 50% loss of passive shoulder movement of the 
shoulder joint, in 2 or more of 3 directions and complaints for >3 months. 
Baseline variables compared between groups using independent analysis 
of variance (ANOVA) tests. Testing for a difference of treatment efficacy 
among the control, criteria control and criteria intervention groups and 
controlling for baseline differences between groups, 2-factor ANCOVA 
mixed models with the initial outcome data as covariate and factors of 
group and time (follow-up data at 4 and 8 weeks) performed on all 
outcomes. 	
8°scapular posterior 
tipping, 97° humeral 
elevation, and 39° 
humeral external 
rotation during arm 
elevation moderated 
ROM and shoulder 
kinematics 
improvements following 
Insufficient 
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standardized treatment 
Yang et al. 
(2012) 
(BMC) 
	
Sex, age, BMI, 
duration of symptoms, 
glenohumeral internal 
rotation, muscle 
tightness in each 
muscle, and FLEX-SF 
score	
2-factor ANOVA mixed models with factors of treatment group and time 
(initial and 4 weeks) performed on each outcome to test for a difference of 
treatment efficacy. Potential predictors for massage treatment evaluated 
by comparing responders versus non-responders with chi-square or t test. 
Predictor variables with a p-value ≤ .10 entered into a logistic regression 
model. Variables with least predictive value removed one by one, in a 
backwards, stepwise fashion until all predictors in the model had p-values 
≤ 0.05.	
Less baseline 
symptom duration, 
muscle tightness & 
shoulder function in 
responder group  
Insufficient 
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2.4.1 Characteristics of Studies Formally Evaluating Moderation  
Of the 21 studies included in this review, seven studies formally evaluated 
moderation, as outlined in Table 2.1. These were conducted in a variety of 
settings: four studies were set in primary care, three in the Netherlands and one in 
the UK. Two studies were set in secondary care in Taiwan, and one in a long-term 
care home in Canada. Diagnoses of included trial participants in this review varied 
greatly: three studies involved patients with chronic shoulder pain, one study 
involved patients with shoulder pain, one study painful stiff shoulder, one study 
unilateral shoulder pain, and one study upper limb disorder. Interventions studied 
were wide-ranging: Seven studies examined a form of physiotherapy or exercises 
(mobilising, stretching or strengthening exercises, joint mobilisations or soft tissue 
massage, three studies trialed corticosteroid injection and one study examined 
electrotherapy (pulsed ultrasound, short wave diathermy, laser and radial	
extracorporeal shockwave treatment). Regarding outcomes tested for the 
moderation analysis: all seven studies used outcomes for function, disability, 
and/or work whilst three used visual analogue scales (VAS) for pain, however, 
different instruments were used to assess function or disability. 	
 
2.4.2 Risk of Bias 
Risk of bias was assessed using the information presented in the included 
publications (figure 2.2). In the cases where moderation analysis was presented in 
a separate article and additional information was required to judge risk of bias, the 
primary trials or protocols were sourced. The Cochrane Risk of Bias tool (Higgins 
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et al. 2011) identified four trials with minimum risk of bias (Geraets et al. 2005; Hay 
et al. 2003; Hsu et al. 2011; Yang 2012a). The remaining three trials demonstrated 
some potential for bias. Van der Windt et al. (1998) and Zheng et al. (2005) 
(separate analysis of the same trial) demonstrated potential for selection bias and 
attrition bias as the attrition rate and sequence generation methods were not 
reported. Furthermore as only one subgroup analysis was reported and long-term 
data not presented by either van der Windt et al. (2000) and Zheng et al. (2005), 
there is potential for selection reporting bias as presence or absence of 
moderating effect of the other baseline patient attributes is unclear. Yang et al.  
(2012b) demonstrated potential for bias in attrition and selective reporting by 
failing to present reasons for attrition and for only presenting incomplete short-term 
data. 
 
2.4.3 Quality Appraisal of Statistical Methods for Moderation 
Moderators may be conventionally identified through testing of the interaction 
between a prognostic factor and the treatment variable ( Baron & Kenny, 1986; 
Gartsman et al. 1998), and/or through a priori defined subgroup analyses. 
However this review has identified a variety of methods of identifying potential 
moderators of treatment effect. Table 2.4 outlines the approaches taken to identify 
potential moderators of treatment effect in studies included in this review. Table 
2.5 shows how each of the studies performed when considered against the Pincus 
criteria (Pincus et al. 2011) for the identification of moderators.  
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Garaets (2005) 
        
Hsu (2011) 
       
Thomas (2004) 
        
van der Windt (2000) 
       
Xheng (2005) 
       
Yang (2012) (Man. Ther.) 
       
Yang (2012) (BMC) 
       
   
Yes (Low risk of bias) No (High risk of bias) 
 
Unclear (Insufficient 
information to assess) 
 
Figure 2.2: Review authors’ judgments about each risk of bias item for studies containing 
moderation analysis
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Table 2.5: Methodological Assessment of Moderation Analysis (as per Pincus et al. 2011) 	
Study 
 
A priori 
Hypothesis 
Theory and/or 
Evidence 
driven 
hypothesis 
 
Moderators 
measured prior 
to 
randomisation 
 
Valid and 
reliable 
baseline and 
process factors 
Explicit test of 
interaction 
Total 
Score 
Level of Moderation 
Evidence 
Garaets (2005) Yes Yes Yes Yes Yes 5 Confirmatory 
Hsu (2011) No No Yes Yes No 2 Insufficient 
Thomas (2004) Yes Yes Yes Yes No 4 Insufficient 
van der Windt (2000) No No Yes Yes No 2 Insufficient 
Xheng (2005) Yes Yes Yes Yes Unclear 4 Insufficient 
Yang (2012) (Man. Ther.) Yes Yes Yes Yes No 4 Insufficient 
Yang (2012) (BMC) No No Yes Yes No 2 Insufficient 
 
Levels of Moderation Evidence:  
Confirmatory Evidence: All 5 items met;  
Exploratory Evidence: Final 3 items met;  
Insufficient Evidence: Failure to meet final 3 items 
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One of the seven studies, only Geraets et al. (2006) demonstrated ‘confirmatory’ 
evidence of moderation of the effect of graded exercise treatment by presence of 
painful arc. On methodological grounds, all other trials included in this review 
demonstrated insufficient evidence of moderation of treatment effect. Aside from 
Geraets et al. (2006), the six other trials included in this review (Hsu et al. 2011; 
Thomas et al. 2004; van der Windt et al. 2000; Yang et al. 2012a; Yang et al. 
2012b; Zheng et al. 2005) lacked a specific test of interaction between the 
moderator and treatment. In addition to lacking a specific test of interaction, three 
trials (Hsu et al. 2011; van der Windt et al. 2000; Yang at al. 2012b) also lacked a 
description of the theory or evidence based hypotheses of moderation. All trials 
demonstrated measurement of moderators prior to randomisation using valid and 
reliable measurement tools. This review identified a variety of methods of 
identifying potential moderators of treatment effect. Only one study (Geraets et al. 
2005) followed the conventional method of identifying moderators of treatment 
effect by testing the interaction between a known predictor of outcome and the 
treatment variable and subsequent presentation of subgroup effects (Baron & 
Kenny, 1986; Kraemer et al. 2002).  
 
2.4.4 Results of studies investigating moderation 
One study Geraets et al. (2006), demonstrated that painful arc moderates graded 
exercise therapy with confirmatory level evidence as per the Pincus criteria 
(Pincus et al. 2011). Five studies (Hsu et al. 2011; Thomas et al. 2004; Yang et al. 
2012a; Yang et al. 2012b; Zheng et al. 2005) identified moderators with insufficient 
evidence as they did not explicitly test the interaction between the potential 
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moderator and the treatment. Moderators of treatment effect with insufficient 
evidence include: treatment preference, age, gender, symptom duration, muscle 
tightness and shoulder function (Thomas et al. 2004; van der Windt et al. 2000; 
Yang et al. 2012a; Yang et al. 2012b). Many moderators were examined in one 
study only. 
 
2.4.4.1 Painful Arc 
In a trial of graded exercise therapy compared with usual care in patients with 
shoulder pain lasting longer than three months Geraets et al. (2006) demonstrated 
that the presence of a painful arc at baseline was associated with the effect of 
graded exercise therapy on outcome (disability reduction). A regression model 
adjusted for presence of painful arc indicated that graded exercise therapy was 
more effective in patients without a painful arc. In patients receiving graded 
exercise therapy, reduction in shoulder disability (SDQ) score for graded exercise 
compared with usual care was lower in the subgroup with a painful arc (-0.2) 
compared with the subgroup without a painful arc (7.3) (standard deviation data 
not published). As demonstrated in table 2.4, Geraets et al. (2006) employed a 
methodologically sound approach to moderation analysis by pre-specifying a priori 
hypotheses that are evidence/theory based, measured the moderator before 
randomisation, used adequate instruments to assess outcome measures, and 
conducted an explicit test of interaction between the moderator and treatment. 
This study provides confirmatory evidence that painful arc moderates outcome of 
graded exercise therapy (table 2.5).  
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2.4.4.2 Gender 
Zheng et al. (2005) conducted subgroup analysis based on gender that showed 
with an insufficient level of moderation evidence that gender demonstrates 
potential to moderate the effect of joint injection in patients with a painful, stiff 
shoulder. When treated with corticosteroid injection (compared with 
physiotherapy), male patients attained faster recovery than females. 
  
2.4.4.3 Treatment Preference  
Two studies identified treatment preference as a potential moderator of treatment 
effect with insufficient level of moderation evidence (Thomas et al. 2004; van der 
Windt et al. 2000). Thomas et al. (2004) examined the relationship between pre-
randomisation treatment preference and functional outcome within the preference 
groups: those with no treatment preference, those who did receive their preferred 
treatment, and those who did not receive their preferred treatment. Outcome was 
not affected by whether preference was met or not (good outcome in those 
receiving preferred treatment = 56%; not receiving preferred treatment = 69%) and 
outcome was similar in spite of treatment allocation (good outcome in those 
receiving preferred treatment = 55% injection, 58% physiotherapy; not receiving 
preferred treatment = 71% injection, 68% physiotherapy). Therefore treatment 
preference did not moderate outcome of either steroid injection or physiotherapy in 
patients with unilateral shoulder pain in this trial, although interaction between 
treatment preference and treatment was not explicitly tested.  
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Although supportive of results by Thomas et al. (2004), the study by van der Windt 
(2000) also constituted insufficient evidence to identify treatment preference as a 
moderator of outcome. Van der Windt et al. (2000) employed comparative 
subgroup analysis on patient preference for treatment and success rate of 
treatment (complete recovery or considerable recovery) on a randomised 
controlled trial comparing the effects of corticosteroid injections and physiotherapy 
for patients with a painful stiff shoulder. Treatment preference for joint injection 
was associated with higher recovery success rate following injection, while this 
pattern was not observed for physiotherapy. Although this subgroup finding 
suggests a moderation effect, the association between treatment preference and 
treatment was not tested. 
 
2.4.4.4 Age 
One study in this review examined a potential moderating effect of age on 
treatment effect. Zheng et al. (2005) found that in patients who were younger than 
60 years of age, symptom severity reduced faster in the group of patients who 
received injection compared with those who received physiotherapy. Thus, age 
appears to have potential to moderate the effect of joint injection in patients with a 
painful, stiff shoulder, however the interaction between age and treatment was not 
specifically tested, providing insufficient level of moderation evidence. 
 
2.4.4.5 Symptom Duration, Muscle tightness & Shoulder Function 
One study (Yang et al. 2012a) showed using logistic regression analysis that 
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duration of symptoms, shoulder function (FLEX-SF score), and muscle tightness 
(posterior deltoid slope) correlated with outcome in the massage group (p < 0.05). 
However, predictors of response were analysed in the massage group only, 
therefore it is not known if these factors also predict outcome of the placebo 
massage or any other intervention. Therefore this study provides insufficient 
evidence of moderation. A further study by Zheng et al. (2005) examined all 
covariates including pain duration, however pain duration was not significant in 
univariable analysis and therefore not carried forward into multivariable prognostic 
models. 
 
2.4.4.6 Specific Degrees of Shoulder Range of Movement 
One study (Yang et al. 2012b) used 2-factor ANCOVA mixed models to show that 
patients who met the criteria  of < 8° scapular posterior tipping, 97° humeral 
elevation, and 39° humeral external rotation during arm elevation had 
improvements when they received end-range mobilization/scapular mobilization 
treatment approach (EMSMTA)  plus standard treatment, but similar patients did 
not improve when receiving standard treatment alone. However, this study did not 
test for a specific interaction between meeting the criteria and treatment. Despite 
concordance with the Pincus criteria in all four other criteria (table 2.5), there is 
insufficient evidence to confirm 8° of scapular posterior tipping, 97° of humeral 
elevation, and 39° of humeral external rotation during arm elevation as moderators 
of EMSMTA outcome. 
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2.4.4.7 Hand Complaint 
One study Hsu et al. (2011) conducted a trial of standard exercise and standard 
exercise plus Nintendo Wii shoulder flexion exercises in residents of long-term 
care with an upper extremity dysfunction. Hsu identified a subgroup of responders 
to the Wii intervention. Responders were more likely to report hand complaint 
(X2=6.35; p=0.012) at baseline compared to non-responders. As Hsu et al. only 
conducted subgroup analysis for one intervention group, this study did not 
hypothesise that there would be a differential treatment response or conducted a 
specific test of interaction between potential moderator and treatment. It is 
therefore not possible to ascertain whether responders and non-responders to the 
standard treatment group would have been similar to the Wii group. Therefore this 
study meets two of the five Pincus criteria, providing insufficient evidence of 
moderation of treatment effect. 
 
All results on moderators of treatment effect identified in the review are caveated 
by the observation that only Zheng et al. (2005) actually use the term treatment 
effect modifier. All other studies did not mention moderation analysis, moderators, 
treatment effect modification, or treatment effect modifiers. 
 
2.4.5 Results of Studies Suggesting Suggesting Moderation (Not Formally 
Reviewed) 
This review identified 14 additional studies that suggest or consider factors that 
may be moderators of a treatment effect in shoulder patients. As explained in the 
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methods (paragraph 2.3.10) these studies were not included in table 2.4, and not 
subjected to Cochrane Risk of Bias assessment or methodological appraisal. 
Table 2.6 outlines the 14 studies that suggest potential moderators. Study setting, 
interventions and suggested potential moderators are indicated and suggested 
potential moderators are marked with ‘A’, ‘B’ or ‘C’. ‘A’ indicates a study that 
reported exploratory subgroup findings without clear presentation of the methods 
and results of these analyses, ‘B’ indicates a study that reported prognostic 
factors or potential confounders but without moderation or subgroup analysis and 
‘C’ indicates a study that narratively suggests potential moderators in the 
discussion of the trial findings.  
 
2.4.6 Studies Reporting Exploratory Subgroup Analysis Without Sufficient 
Methodological Detail 
Hay et al. (2003) conducted a trial of physiotherapy and joint injection in patients 
with a new episode of unilateral shoulder pain. Hay et al. included gender, age, 
symptoms duration, shoulder restriction, painful arc and neck restriction in 
exploratory subgroup analyses. No significant subgroup effects were found and 
data from the subgroup analyses were not shown, limiting methodological critique 
and assessment of potential for moderation effects. 
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2.4.7 Studies Reporting Prognostic Factors or Potential Confounders but 
Without Moderation or Subgroup Analysis 
Four studies (Arslan & Celiker, 2001; Bron et al. 2011; Crawshaw et al. 2010; 
Engebretsen et al. 2009) explored the prognostic value of baseline patient 
attributes, without investigating whether these factors moderated the effects of 
treatment. Factors included baseline symptom duration (Arslan & Celiker, 2001), 
number of muscles with active trigger points, passive shoulder range of movement 
and baseline DASH score (Bron et al. 2011), baseline pain and disability scores 
(Crawshaw et al. 2010), and gender (Engebretsen et al. 2009).  
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Table 2.6: Results of Studies Suggesting Potential Moderators 
 
Author, 
Date, 
Setting, 
Country 
Inclusion 
Criteria 
Primary 
Outcomes 
Follow
-Up 
Interventions Studied ‘Potential Moderators’ Suggested 
Abdelshafi, 
2011, 
Rheumatolo
gy & 
Rehabilitatio
n Out-
Patient 
Depts., 
Egypt 
Chronic 
shoulder pain 
> 3 months 
duration, 
unresponsive 
to 
conventional 
treatment  
Active and passive 
ROM, Shoulder 
pain and disability 
index (SPADI) 
1/52, 
4/52, 
12/52 
Rehabilitation program only (Exercises, Ultrasound, 
Short Wave), three times weekly, duration unclear 
 
Continuous supra-scapular nerve block (SSNB) 
under ultrasound guidance in addition to 
rehabilitation program, three times weekly, duration 
unclear  
 
Intra-articular corticosteroid injection in addition to 
rehabilitation program 
In those who received SSNB, having 
a diagnosis of rheumatoid arthritis 
(B) was associated with improvement 
in pain (p= 0.018) and pain and 
disability (p=0.018 & 0.04) and 
having frozen shoulder (B) was 
associated with improvement in pain 
and disability (SPADI) (p=0.02)  
Arslan, 
2001, Dept 
Physical 
Medicine & 
Rehabilitatio
n, Turkey 
Total range of 
motion <50% 
 
ROM, Pain VAS 2/52, 
12/522 
Local corticosteroid injection 
Physiotherapy and a non-steroidal anti- 
inflammatory drug  
 
Analysis stratified by baseline 
symptom duration (B) but no 
differences were found  
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Bennell, 
2010 
Chronic rotator 
cuff disease 
Shoulder pain and 
disability index 
(SPADI), Pain VAS, 
Participants’ 
perceived global 
rating of change 
overall 
11/52, 
22/52 
10 active treatments comprised a manual therapy 
and home exercise programme, 10 weeks 
10 Placebo treatment comprised inactive ultrasound 
therapy and application of an inert gel, 10 weeks 
Whether pain, dysfunction, or both 
are the patients primary problems 
(C) may help indicate what kind of 
treatment is appropriate (C) 
Bron, 2011, 
Primary 
Care, 
Netherlands 
Unilateral non-
traumatic 
shoulder pain 
for > 6 months, 
aged 18 and 
65 years  
Passive ROM, 
Number of trigger 
points, 
Disabilities of the 
arm and shoulder 
(DASH), 
Quality of life 
(RAND-36),  
Beck Depression 
Infantry (BDI-II) 
6/52, 
12/52 
Intervention Group (Trigger point release, 
intermittent ice application, stretching exercises), 
weekly up to 12 weeks  
 
Wait-and-See 
No. of muscles with active trigger 
points (B), Passive ROM (B), 
Baseline Disability (DASH) (B) 
Carette, 
2003, Out-
patient 
Rheumatolo
gy clinics, 
Canada 
Adhesive 
capsulitis of <1 
year’s duration 
 
Shoulder pain and 
disability index  
(SPADI), quality of 
life (SF-36),  
Active and passive 
ROM 
6/52, 
3/12, 
6/12, 
12/12 
All patients were taught a simple, 10-minute 
exercise program and randomized into 1 of 4 
groups: 
Corticosteroid injection followed by supervised 
physiotherapy)  
Corticosteroid injection alone  
Saline injection followed by supervised 
Pain at rest, pain frequency, pain 
on movement, night pain and joint 
end-feel (C) implied as different 
treatment provided for acute and 
chronic patients 
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physiotherapy  
Saline injection alone 
Crawshaw, 
2010, 
Primary 
Care, UK. 
Adults >40 
years with 
sub-acromial 
impingement 
syndrome, 
moderate or 
severe 
shoulder pain 
Shoulder pain and 
disability index  
(SPADI) 
12/52 Injection plus exercise  
Exercise only, up to 12 weeks 
Baseline pain and disability score 
(B), baseline pain VAS (B) 
Dickens, 
2005, 
Secondary 
Care, UK. 
Subacromial 
impingement 
syndrome 
Constant Score 6/12  Physiotherapy (individualised treatment), < 6 
months 
 
Control (No treatment) 
Younger age (C), higher baseline 
disability (Constant) score (C) 
Diercks, 
2004, 
Secondary 
Care, 
Netherlands 
Idiopathic 
frozen 
shoulder 
syndrome 
ROM: Forward 
elevation, lateral 
elevation, external 
& internal rotation. 
3/12, 
6/12, 
9/12, 
12/12, 
15/12, 
18/12, 
21/12, 
24/12 
Intensive physical rehabilitation treatment 
(stretching group), 2 X 45 min. exercise sessions 
weekly, up to 12 weeks 
Supportive therapy and exercises within the pain 
limits (supervised neglect group) 
  
Stage of Frozen Shoulder (C) 
Engebretse
n, 2009, 
Outpatient 
Subacromial 
shoulder pain 
lasting at least 
Shoulder pain and 
disability index  
6/52, 
12/52, 
Supervised exercise regimen, 2 X 45 min. exercise 
sessions weekly, up to 12 weeks 
Gender (adjusted for in regression 
and analysis stratified for gender) (B) 
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physical 
medicine 
and 
rehabilitation
, Norway 
three months 
 
(SPADI) 18/52 Radial extracorporeal shockwave treatment 
(REST), weekly for 4-6 weeks 
Gialanella, 
2011, 
Secondary 
Care, Italy 
Full thickness 
rotator cuff 
tears 
Constant–Murley 
scale, Pain VAS   
3/12, 
6/12 
Single intra-articular injection  
Two injections at 21-day intervals 
No treatment (control group) 
Failure of conservative treatments, 
increasing night pain, acute or 
inflammatory stages of disease (all 
C) 
Hay, 2003, 
Primary 
Care, UK 
Those > 18 
years, 
consulting 
general 
practitioner 
with new 
episode of 
unilateral 
shoulder pain 
Shoulder disability 
questionnaire 
(SDQ) 
6/52, 
6/12 
Corticosteroid injections 
 
Community based physiotherapy, up to 8 20 min 
sessions in 6 weeks 
Age, sex, symptom duration, 
shoulder restriction, painful arc of 
movement, restricted neck 
movements (all A) 
 
Pajareya, 
2004, 
Rehabilitatio
n Dept, 
Thailand. 
Shoulder pain, 
limitation of 
passive ROM, 
interference 
with activities 
of daily living 
Shoulder pain and 
disability index 
(SPADI), ROM, 
3/52 Ibuprofen 
Ibuprofen and physical therapy, 3 times weekly, 3 
weeks 
Patient treatment preference (C) 
 
Petri, 1987, 
Veterans 
Screening & 
Painful 
abduction, 
painful arc, or 
Active and passive 
ROM, presence of 
painful arc, whether 
2/52, 
4/52 
1) subacromial bursa injection with 4 cc of 1% 
lidocaine, plus naproxen  
Symptom duration (C), pre-
treatment clinical index (C) 
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Rheumatolo
gy Clinics, 
USA   
tenderness 
over the 
supraspinatus 
insertion 
shoulder pain was 
exacerbated by 
resisted internal or 
external rotation 
pain VAS, limitation 
of function  
 
2) subacromial bursa injection with 3 cc of 
1%lidocaine and 1cc of 40 mg/ml triamcinolone, 
plus naproxen  
3) subacromial bursa injection with 3 cc of 1% 
lidocaine and 1 cc of 40 mg/ml triamcinolone, plus 
placebo pill  
4) subacromial bursa injection with 4 cc of 1% 
lidocaine, plus placebo pill  
Ryans, 
2005, 
Primary 
Care, UK 
Adhesive 
capsulitis  
SF-36, Hospital 
Anxiety and 
Depression Scale 
(HADS), Active and 
passive ROM, 
Shoulder Disability 
Questionnaire 
(SDQ) 
6/52, 
16/52, 
24/52 
1)Intra-articular triamcinolone injection 
2) Physiotherapy, 8 session, 4 weeks 
3) Injection plus physiotherapy 
4) Saline injection alone 
Baseline disability (C) 
A = Exploratory Subgroup Analysis 
B = Prognostic factors or potential confounders but not tested as moderator  
C = Attributes mentioned or discussed as potential moderators but not tested in a way as a moderator 
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2.4.8 Studies Suggesting Potential Moderators in the Discussion of Trial 
Findings 
In addition, to obtain the broadest and most inclusive approach to the identification 
of potential moderators of treatment effect, suggestions regarding potential 
moderators were extracted from other studies included in this review (Table 2.6). 
These studies used a variety of methods suggestive of potential moderation 
including: using factors as potential confounders or prognostic factors (without 
formal moderation analysis), conducting exploratory subgroup analyses without 
reporting full methods or results for these analyses or making untested or 
supported suggestion(s) or observation(s) regarding potential moderators based 
on their trial (e.g. in the discussion section of the paper).	Table 2.6 outlines study 
inclusion criteria, primary outcomes, follow-up, interventions studied, treatment 
duration and details the potential moderators suggested. Studies listed in table 2.6 
were not subjected to risk of bias assessment or methodological critique for 
moderation analysis as no formal tests of moderation were conducted. 
Suggestions are briefly summarised narratively in the results section of this review. 
 
Seven studies (Bennell et al. 2010; Carette et al. 2003; Diercks & Stevens, 2004; 
Gialanella & Prometti, 2011; Pajareya et al. 2004; Ryans et al. 2005), made 
narrative suggestions regarding potential moderators of outcome in the discussion 
section of their paper on the basis of their trial findings. Authors suggested that 
potential confounding variables, unevenly distributed across groups at baseline, 
may have influenced their study results, and might potentially be associated with 
different treatment effects. Studies from which these suggestions arise are 
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outlined in table 2.5 and ‘C’ denotes patient variables discussed as potential 
moderators in table 2.6. 
   
Suggested potential moderators of the effects of physiotherapy treatments include: 
presence of pain, dysfunction or pain and dysfunction (Bennell et al. 2010), pain at 
rest, pain frequency, pain on movement, night pain and joint end-feel (Carette et 
al. 2003), age (Dickens et al. 2005), stage of frozen shoulder (Diercks & Stevens, 
2004), baseline disability (Ryans et al. 2005). Suggested potential moderators of 
the effects of steroid injection include: presence of pain, dysfunction or pain and 
dysfunction (Bennell et al. 2010), pain at rest, pain frequency, pain on movement, 
night pain and joint end-feel (Carette et al. 2003), baseline disability (Ryans et al. 
2005), failure of other conservative treatments, increased resting or night pain,  in 
acute or inflammatory stages of disease (Gialanella & Prometti, 2011), treatment 
preference (Petri et al. 1987), symptom duration and pre-treatment clinical index 
(Pajareya et al. 2004). Suggested potential moderators of the effects of pain relief 
and analgesic agents include: presence of ‘pain, dysfunction or pain and 
dysfunction’ (Bennell et al. 2010), symptom duration and pre-treatment clinical 
index (Pajareya et al. 2004). 
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2.5 Discussion 
2.5.1 Brief Summary of Findings 
This review aimed to systematically identify moderators or potential moderators of 
the effects of three commonly used treatments in primary care: advice and pain 
relief, strengthening and/or mobilising exercise delivered by a physiotherapist, and 
corticosteroid injection in patients with musculoskeletal shoulder pains. Seven 
relevant randomised controlled trials that included an evaluation of potential 
treatment moderators, and 14 trials that included suggestions regarding potential 
moderators, but did not formally investigate these, were identified. Only one study 
provided a methodologically valid and statistically confirmed moderator of 
treatment effect:  the presence of a painful arc led to significantly less disability 
reduction with graded exercise therapy than in patients without a painful arc. 
Affected by methodological issues, 12 other potential moderators of outcome 
supported by exploratory level evidence were identified by six other studies in this 
review. Table 2.7 summarises the findings of this review. 
 
2.5.2 Methodological Issues Identified 
This review highlights many potential methodological and statistical pitfalls in 
identifying moderators of treatment effect, including the importance of a priori, 
evidence-based hypotheses, adequate statistical power, and crucially the 
importance of testing interaction between the potential moderator and treatment. 
Although it is accepted that interactions between potential moderators and 
outcome are likely to be statistically insignificant due to the original trials being 
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underpowered to detect moderators of treatment effect. Pincus et al. (Pincus et al. 
2011)  recommend less than 5 a priori subgroup hypotheses in order to minimise 
the risk of type 1 error (i.e. incorrectly rejecting a null hypothesis of no 
moderation). Furthermore, recommendation of (i) a priori hypothesis and (ii) 
evidence or theory-based hypothesis in the moderation methodological 
assessment criteria (Pincus et al. 2011) encourage development of clinically 
relevant, plausible hypotheses. In line with such increasing risk of type 1 error, 
application of the more conservative p value, p < 0.01 is recommended when 
testing more than three hypotheses (Turner et al. 2007). All studies identified by 
this review failed to adhere to this recommendation. Adjustment of p values should 
be considered in future moderation analyses. 
 
This review demonstrates that suggestion of moderation or moderators occurred 
post-hoc or as secondary analysis in many of the trials in Table 2.4. Therefore, it is 
important to highlight that post hoc moderation or sub group analyses are 
especially prone to error due to multiplicity or insufficient sample sizes (Sleight, 
2000). Pincus et al. (2011) updated the arbitrary cut-point of at least 10 in smallest 
study arm to sub-groups below 20 being considered unlikely to be informative. 
Given the need for an appropriate sample size for moderation analysis, preferably 
underpinned by a formal sample size calculation, none of these trials were 
powered to support moderation analysis, even if a priori moderation analysis were 
planned. Many potential reasons exist for this review’s finding of more exploratory 
subgroup analyses than pre-planned moderation analysis. Difficulty in gaining 
funding for moderation analysis is likely especially  
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Table 2.7: Summary of Review Findings 
 
 
 
Patient Factor 
Level of Evidence Found 
Potential Moderator Moderator Suggested 
Confirmatory 
Evidence 
Exploratory 
Evidence 
Insufficient 
Evidence 
Exploratory 
subgroup 
analysis 
Potential 
confounding 
effect 
Without 
statistical 
analyses 
Painful arc P      
Gender   P P P  
Shoulder restriction    P   
< 8° of scapular posterior tipping   P    
< 97° of humeral elevation   P    
< 39° of humeral external rotation during arm elevation   P    
Symptom Duration   P P   
Functional Limitation   P    
Muscle Tightness   P    
Treatment Preference   P   P 
Age   P P   
Shoulder Complaint   P    
Hand Complaint   P    
Neck restriction    P   
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Diagnosis of rheumatoid arthritis     P  
Diagnosis of frozen shoulder     P  
Baseline symptom duration     P P 
Number of muscles with active trigger points     P  
Baseline disability     P P 
Baseline pain     P  
Presence of pain, dysfunction or both pain and 
dysfunction 
     P 
Pain at rest      P 
Pain frequency      P 
Pain on movement      P 
Night pain      P 
Joint end feel      P 
Stage of frozen shoulder      P 
Failure of conservative treatments      P 
Pre-treatment clinical index      P 
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when adequately powered analysis requires at least four times the sample size to 
test for interaction between prognostic factors and treatment (Brookes et al. 2004). 
 
The stringent criteria employed for the methodological assessment of moderation 
analysis in the Pincus tool (Pincus et al. 2011) set a high bar and may prompt the 
disregard of potentially valid moderators. This review concludes that only one trial 
offered sufficient evidence for moderation according to published quality criteria. 
Reflective of the current level of evidence available in the field of musculoskeletal 
shoulder pains, this conclusion may disappoint clinicians and researchers who are 
keen to progress knowledge in relation to clinical decision-making. To progress 
towards the development of such tools, the work of Pincus et al. (2011), Sun et 
(2011; 2012), the special series on subgroup analysis by The LANCET (Rothwell, 
2005) and The PROGnosis RESearch Strategy (PROGRESS) Partnership 
(Hingorani et al. 2013) all highlight the importance of robust methodology and 
statistical analysis in providing clinically informative moderation and sub-group 
analysis. Existing prognosis studies provide a valuable springboard for the crucial 
developmental work required prior to undertaking large moderation studies. On the 
basis of these, this review provides: a) a reminder of the clinical relevance of 
sound moderation analysis, b) a list of identified potentially important factors in 
need of further evaluation.  
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2.5.3 Comparison with other Reviews and Studies 
To date, previous studies investigating prognostic factors in musculoskeletal 
shoulder pain have produced a very similar list of patient attributes to that 
identified by this review.  A systematic review by Chester et al. (2013) aimed to 
specifically identify predictors of response to physiotherapy treatment in patients 
with musculoskeletal shoulder pain. Chester et al. aimed to review the predictors 
of outcome of physiotherapy, however prediction of outcome of physiotherapy is 
not an equivalent to the identification of moderators of physiotherapy outcome or 
other treatment. Prediction of outcome of one treatment does not necessarily 
assist in the clinical decision of which patient should get which treatment. In spite 
of this, some findings were similar to this review: increased baseline disability and 
longer symptom duration were predictors of outcome of physiotherapy treatment, 
with inconsistent findings for age and baseline range of movement.  
 
This review’s finding that gender is a potential treatment effect moderator in 
patients with shoulder disorders is also in line with Blangsted et al. (2008) whose 
occupational study looking at an intervention designed to prevent musculoskeletal  
conditions demonstrated an interaction between gender and treatment in a 
subgroup analysis; women had less symptom development when treated with 
specific resistance training rather than encouragement to be active & health 
vigilant, whereas men had less symptom development with specific resistance 
training than all-round physical exercise.  
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Authors examining other musculoskeletal concerns have sought to identify 
moderators of the effect of specific interventions. In the field of back pain, 
Underwood et al. (2007) conducted secondary data analysis of the UK BEAM trial 
to assess the impact of baseline participant attributes on response to treatment. 
Underwood et al. tested for the statistical significance of the interaction between 
treatment allocation, baseline patient attributes and outcome. Results suggested 
that allocation to combined treatment in those with a positive treatment 
expectation gains an additional 4.0 and 3.8 points improvement on the Roland 
Morris Disability Questionnaire (RMDQ) at 1yr when compared with those who did 
not think the treatment would be helpful. Not dissimilar, this review identified 
treatment preference as an insufficiently evidenced potential moderator indicating 
that patient attitudes and beliefs about their physiotherapy intervention may affect 
outcome of treatment.  
 
Similar to this review, Gurung et al. (2015) conducted a systematic review of 
moderators of treatment effect in low back pain identifying low quality data on 
moderators. Gurung et al. suggest that strong evidence exists that age, 
employment status, narcotic medication use, treatment expectation and education 
moderate treatment response in patients with low back pain. In contrast, this 
review did not find confirmatory evidence that age or treatment expectation were 
moderators of response to treatment in patients with shoulder pain. Gurung et al. 
also suggest that weaker evidence exists that gender, psychological distress, 
pain/disability and quality of life moderate response to treatment in patients with 
low back pain. This review also indicates that there is at best, exploratory level 
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evidence to suggest that age and pain/disability and quality of life moderate 
treatment effect in patients with shoulder pain. 
  
Although this review identified 20 patient attributes thought to potentially moderate 
treatment effect, attributes absent from this review include psychological attributes 
such as anxiety, depression, psychosocial determinants of health and well-being 
including work-load and sport participation, chronic widespread pain, multi-site 
pain, employment status, analgesic medication and education. Although many of 
these attributes have already been identified as predictors of outcome in shoulder 
pain (Kennedy et al. 2006a; Kennedy et al. 2006b; Vergouw et al. 2011), it is not 
currently known whether they moderate treatment effect of the three commonly 
used primary care interventions for musculoskeletal shoulder disorders.  
 
Moderation analysis to enable treatment targeting is of relevance to many 
disciplines of health and medicine and is increasingly used in analysis of 
interventions such as self-management and Cognitive Behavioural Therapy (CBT), 
with some evidence of this in musculoskeletal pain (Miles et al. 2012; Turner et al. 
2007). Miles et al. (2012) conducted a systematic review and meta-regression to 
test the impact of age and gender on effectiveness of self-management 
intervention in musculoskeletal pain, however no moderating effect was found. In 
secondary data analysis of a trial of patients with chronic pain undergoing CBT, 
Turner et al. (2007) found a number of predictors of worse response to CBT 
(greater baseline somatization, greater depressive symptoms, higher number of 
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pain sites, more rumination, catastrophising, and higher perceived stress), 
however, moderators of treatment effect were not identified. These studies 
identified a number of psychological patient attributes in patients with chronic pain 
that were not identified by this review, indicating that future investigation of the 
relevance of psychological and social factors as treatment effect moderators is 
indicated. 
 
2.5.4 Strengths of the Review 
In the absence of the currently most advocated approach to the identification of 
moderators of outcome, that is meta-analysis of multiple trials or meta-analysis 
based on individual patient data from multiple trials (Moher et al. 2009; Riley et al. 
2010), systematic review of potential moderators of outcome represents a worthy 
starting point.	 This is the first systematic review to attempt to identify moderators 
and potential moderators of effect of commonly used primary care treatments in 
patients with musculoskeletal shoulder disorders. Use of search strategies from 
existing systematic reviews (Buchbinder et al. 2013a; Green et al. 2003) in the 
field ensured that searches were appropriately specified and risk of missing 
relevant publications minimised. Classification of results into two categories of 
evidence of moderation: (i) studies with moderation analysis, and (ii) studies 
suggesting potential moderators, allows for clear interpretation of the level of 
evidence offered by each of the identified studies. Methodological appraisal of 
moderation analyses was conducted using a previously published appraisal tool 
that enabled a robust and justly cautious approach to the identification of potential 
moderators.  
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2.5.5 Weaknesses of the Review 
Due to the variety of interventions and diagnoses studied, meta-analysis methods 
were not possible, therefore only a narrative synthesis was conducted. Aside from 
the potential moderators identified by this review (table 2.4), other suggested 
moderators identified (table 2.6) are heavily caveated, as they have not been 
statistically tested. However, these suggestions could be considered in the design 
of studies for future testing.  
 
Caution is advised in the interpretation of the results of this review. This review did 
not reveal a clear-cut set of patient attributes that differentially moderate response 
to commonly used treatments for musculoskeletal shoulder pain in primary care. 
Instead, this review identified only one methodological sound and statistically valid 
moderator of the effect of one specific treatment. Therefore this review offers a 
glimpse of the potential for better targeting of treatments that may be derived from 
sound statistical analysis of randomised controlled trials relevant to clinical 
practice. Given studies included in this review varied in respect to the optimal 
methodological considerations in moderation analysis (table 5), the fundamental 
issues with trial design as evidenced by the Risk of Bias assessment must also be 
noted (figure 2.2).  
 
Aside from the potential moderators identified by trials conducting some form of 
moderation analysis (table 2.4), other suggested moderators identified by this 
review (diagnosis of rheumatoid arthritis, diagnosis of frozen shoulder, stage of 
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frozen shoulder, symptom duration, patient’s primary problem (pain, dysfunction or 
both), number of muscles with active trigger points, passive range of shoulder 
movement, pain, failure of conservative treatment, increasing night pain, acute or 
inflammatory stage of disease, shoulder restriction, and restricted neck range of 
movement) are heavily caveated as they constitute suggestions and observations 
of trial authors which have not been adequately analysed or statistically tested. 
These patient attributes are mere suggestions to be considered in the design of 
future studies. Subgroup analyses are often post-hoc and conducted as 
‘hypotheses generating’ exercises and therefore, despite these results being 
heavily caveated, important lessons on conducting trials with an a priori intention 
of including moderation analysis may be learned.  
 
2.5 Conclusions & Next Steps  
This review demonstrates the potential utility of individual patient attributes as 
moderators of treatment effect. Moderators of treatment effect have strong 
relevance to clinical practice as they can aid understanding of why certain patients 
respond differently to specific interventions. Future research should take into 
account the different approaches required for identifying generic prognostic factors 
(non-treatment specific) and moderators of treatment effect. This field would 
benefit from studies to test the predictive performance of the identified potential 
moderators in appropriately designed and adequately powered randomised 
controlled trials, although it is accepted that challenges to this are numerous. 
Further research is required in order to develop a clinical decision tool to assist 
primary care clinicians in the management of musculoskeletal shoulder disorders. 
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Although this review has begun this process by populating a list of 20 patient 
attributes thought to moderate or potentially moderate treatment effect, many 
commonly considered patient attributes do not feature in this review. Attributes 
absent from this review include psychological attributes such as anxiety or 
depression, other determinants of health and wellbeing including workload and 
sport participation and chronic widespread pain or multi-site pain. Although these 
attributes have already been identified as predictors of outcome in shoulder pain in 
earlier studies (Kennedy et al. 2006a; Kennedy et al. 2006b; Vergouw et al. 2011), 
it is not currently known whether they moderate treatment effect of the three 
commonly used primary care interventions for musculoskeletal shoulder pain. 
Expert clinician consensus has previously been shown to reflect most statistically 
selected predictors and also suggests additional predictors not identified by 
statistical selection (Vergouw et al. 2011). Therefore, future research should seek 
to identify expert clinician consensus on the likely most appropriate patient 
attributes to include in an a priori, appropriately powered and statistically robust 
moderation analysis in shoulder pain.    
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CHAPTER 3: ROLE OF EXPERTISE AND CLINICAL 
DECISION-MAKING IN THE MANAGEMENT OF 
SHOULDER PAIN 
 
3.1 Background 
The overall aim of this PhD is to underpin the development of a model of stratified 
care for musculoskeletal shoulder pain in Primary Care by identifying the clinical 
attributes of patients with shoulder pain thought to potentially moderate response 
to three commonly used primary care treatments. Chapter 2 presented a 
systematic review of shoulder pain RCTs that identified the patient attributes 
thought to potentially moderate or interact with these treatments. Evidence from 
the review of moderation of treatment effect highlighted the considerable 
challenges in conducting methodologically sound moderation analyses including: 
identifying testable hypotheses, having sufficiently large sample sizes, appropriate 
statistical analysis and avoiding reporting bias. The review identified 29 potential 
moderators of treatment effect in the management of shoulder pain. However, 
several known prognostic factors expected to moderate treatment effects in 
patients with shoulder conditions were not identified as candidate moderators, 
such as psychosocial factors (Westman et al. 2012), physical work-load (Miranda 
et al. 2008), chronic widespread pain or multi-site pain (Coggon et al. 2013), and 
overuse from certain activities or hobbies  (Lo et al. 1990).  
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In order to develop a clinically relevant as well as parsimonious model for stratified 
care for shoulder pain, a comprehensive list of relevant hypothetical moderators is 
required, alongside some understanding about which of the identified moderators 
are likely to be the most salient for treatment decision-making. It is therefore clear 
that the review, although representative of the current literature, did not identify a 
fully comprehensive list of potentially important attributes of patients with shoulder 
pain. It is therefore hypothesised that further patient attributes might exist that 
clinicians also value to guide decisions about recommendation of specific 
treatments to individual patients with shoulder pain. The range of clinical and 
patient variables considered by clinicians when making treatment decisions for 
patients with musculoskeletal shoulder pain has not yet been reported. 
Furthermore, how clinicians process such clinical information in order to make a 
reasoned clinical treatment selection decision for patients with shoulder pain is 
currently unknown.  
 
Therefore, exploration of the clinical decision-making processes of experienced 
clinicians who clinically manage the care of patients with shoulder pain could: (i) 
identify salient clinical attributes that guide treatment decision-making for patients 
with shoulder pain and (ii) assist the development of a meaningful and useable 
treatment decision tool, which has strong face validity among clinicians.  
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3.2 Theoretical Models of Clinical Decision-Making 
Development of appropriate and feasible research studies to achieve these aims 
required an understanding of the existing theories of how clinicians make 
treatment decisions. Clinical decision-making is understood as the process of 
choosing between treatment alternatives (Thompson & Dowding, 2002). 
Thompson et al. (2004) outline a range of types of clinical decisions including 
three of relevance to this PhD: diagnostic, intervention/effectiveness and targeting 
decisions. Diagnostic decisions involve the classification of signs and symptoms 
as a basis for clinical treatment strategy (Thompson et al. 2004). Conversion of 
knowledge into action occurs when making intervention or targeting decisions. 
Intervention decisions involve choosing a treatment from many possible options 
(Thompson et al. 2004). Targeting decisions are a sub-category of effectiveness 
decisions that relate to subgroups of best responders to one particular treatment 
(Thompson et al. 2004). In context of this thesis, such intervention and targeting 
decisions involve clinicians deciding between treatments for a patient with 
shoulder pain, whilst thinking about exactly which treatment is most likely to work 
best or ‘match’ an individual patient.  
 
Many theories of clinical decision-making exist that attempt to describe the 
processes involved in clinical decision-making. Theories exist on a spectrum 
ranging from scientific, logic driven Bayesian approaches to the experiential 
knowledge domains of clinical expertise and intuition. Ashby & Smith (2000) 
describe the potential for Bayesian approaches in clinical decision-making. This 
approach involves consideration of the prior probability of effectiveness of a 
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treatment based on existing evidence or clinical experience/expertise, with 
effectiveness probability being modified by the addition of single pieces of clinical 
evidence (clinical features, observation, test results) until a final posterior 
probability is reached which drives the treatment decision. In the context of this 
thesis, a Bayesian approach might involve methodical calculation of the likelihood 
of each competing clinical hypothesis as information is received. Bayesian 
approaches are therefore very logical and thorough methods of arriving at a 
diagnosis but also highly cognitively taxing and time intensive.  
 
Alternatively it is suggested that whilst clinicians are logical, rational clinical 
decision-makers (Thompson & Dowding, 2002), a variety of clinical reasoning 
approaches are employed in tandem to streamline decision-making. It is thought 
that this combination of approaches potentially begins with use of a Bayesian 
approach to collating clinical evidence. The information-processing model (Joseph 
& Patel, 1990) further argues that clinicians adopt analytical hypothetico-deductive 
strategies in order to guide information gathering facilitating arrival at a diagnosis 
or clinical decision. The hypothetico-deductive approach is divided into a series of 
logical stages including: cue recognition or cue acquisition, hypothesis generation, 
cue interpretation and finally, hypothesis evaluation (Tanner et al. 1987). Distinct 
from a systematic Bayesian method, diagnosis using a hypothetico-deductive 
approach employs a guided information search in response to emerging 
information where possible diagnosis hypotheses prompt additional information 
gathering, thus enabling the ruling in/out of possible diagnoses (Elstein et al. 
2002). The hypothetico-deductive approach is a largely rule-governed decision 
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process. Rule governed decision processes involve highly rational and sequential 
consideration of each piece of clinical information against a series of accepted 
facts or truths. Application of such rule-based thinking in the context of this thesis 
would involve, for example, the attempt to arrive at a diagnosis based on the 
interpretation of specific clinical signs and symptoms.  Therefore this is also a 
relatively slow and cognitively demanding process (Kahneman, 2003). Two 
barriers to the seamless application of such processes to clinical decision-making 
for shoulder pain exist: (i) the imperfect correlation between clinical sign and 
symptoms and diagnosis and, (ii) the unclear relevance of diagnosis to outcome 
(Cadogan et al. 2012; Hegedus et al. 2012; McFarland et al. 2010; Saulle & 
Gellhorn, 2017). Therefore, rule-based decision processes do not offer a complete 
theoretical underpinning for clinical decision-making in the assessment or 
management of shoulder pain. Yet, clinicians still manage to arrive at reasoned 
treatment decisions. Given that human reason is limited by the extent of long-term 
memory, cognitive strategies have evolved to enable more refined interaction with 
complex information and to expedite arrival at clinical judgements and decisions 
(Elstein et al. 2008). 
 
“It’s interesting that. Don’t you get a feel, because I always get a feel that this 
person is going to respond to an injection but you can’t say why. You try to work 
out, well, why do I think that? You try to think why? It would be interesting if you 
could try to do a little project there.” (Personal communication with a 
Physiotherapist). 
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Elstein et al.’s (2002) challenge of the hypothetico-deductive model suggests that 
clinical problem solving proficiency varies amongst clinicians and is highly 
dependent on the clinician’s mastery of the clinical area. Experienced clinicians 
often use shortcuts, heuristics or ‘rules of thumb’ to simplify the complexity of 
decision-making task by comparing examination findings to previous successfully 
diagnosed or managed patients using pattern recognition (Cioffi & Markham, 
1997). Pattern recognition, also termed similarity recognition or a categorisation 
approach, concerns the comparison of clinical signs and symptoms of a presenting 
patient to experienced and/or remembered patterns of symptoms (Pelaccia et al. 
2011). Pattern recognition is often associated with intuition, perception and 
expertise (Benner & Tanner, 1987), constructs that are difficult to observe and 
measure. A review by Banning (2008) highlights that intuition has been defined in 
many ways including: a gut feeling, ‘understanding without a rationale’ (Benner & 
Tanner, 1987), and ‘a component of complex judgment, the act of deciding what to 
do in a perplexing, often ambiguous and uncertain situation’ with an immediacy 
that does not require conscious reasoning.  
 
Dreyfus & Dreyfus (2004) outlined their model of professional expertise (Dreyfus & 
Dreyfus, 2004) which deals with clinical decision-making skill acquisition and 
proposes that differences exist at various stages of professional development. 
Intuitive decisions are proposed to occur more readily in later expertise and 
mastery stages compared to in the novice, competence and proficiency stages 
(Dreyfus & Dreyfus, 2004). The Intuitive-Humanist Model (Benner, 1984) focuses 
on the relationship between clinical experience and exposure and progression of 
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clinical decision-making capacity. Strategies such as the hypothetico-deductive 
approach used by novice decision makers to deal with and learn from the vast 
array of potential clinical clues do not appear to be the same strategies as those 
used by experienced clinicians; experienced clinicians are said to form higher 
quality diagnostic hypotheses more rapidly than novices (Elstein et al. 2002). 
Furthermore, it is now accepted that logic based and intuition/expertise based 
approaches are not mutually exclusive but are used interchangeably by clinicians 
(Pelaccia et al. 2011).  
 
It is probable that experienced physicians use a hypothetico-deductive strategy 
only with difficult cases that do not fit with existing recognized clinical patterns and 
that pattern recognition is a more efficient, less cognitive decision strategy for 
more routine or familiar clinical reasoning (Elstein et al. 2002). Therefore the dual 
process theory, which highlights the inter-play between intuitive judgement and 
cognitive use of contextual clinical factors is a seemingly more robust theory to 
describe how clinicians make decisions (Pelaccia et al. 2011). Indeed a variety of 
cognitive processes including hypothetico-deductive and diagnostic pattern 
recognition approaches, have been witnessed to facilitate clinical decision-making 
during shoulder pain assessment amongst expert physiotherapists (May et al. 
2008).  
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3.3 Role of Diagnosis and Prognosis in First-line Decision-Making for 
Shoulder Pain 
First-line treatment decisions in UK Primary Care for shoulder pain patients 
include the choice between three commonly used treatment options each with 
good evidence of effectiveness: General Practitioner (GP)-provided advice and 
analgesia, exercise and/or manual therapy as delivered by a physiotherapist, and 
corticosteroid injection. In context of diagnostic uncertainty, it is unsurprising that 
evidence suggests that clinicians including GPs, rheumatologists and 
physiotherapists make variable and often inconsistent diagnoses, develop variable 
and sub-optimal management plans and that clinical confidence in making 
treatment decisions for patients with shoulder pain is low (Artus et al. 2017), as 
evidenced by the high reliance on imaging to inform diagnosis and subsequent 
management plans (Buchbinder et al. 2013b; Miller-Spoto & Gombatto, 2014; 
Liesdek et al. 1997; Johal et al. 2008; Patel el al. 2010).  
 
To improve diagnosis, clinical management and outcome of shoulder pain by GPs 
in primary care, Farmer (2014) developed a clinical decision support system 
consisting of 34 subjective questions and objective orthopaedic tests to suggest a 
likely clinical diagnosis. Whilst this system has a high level of validity and reliability 
(Farmer, 2014), if the purpose of a clinical decision support system or clinical 
decision tool is to support treatment decision-making, it is unclear how such a 
probabilistic diagnostic model can provide the subsequent treatment 
recommendations offered (Hill & Fritz, 2011). Such treatment recommendations 
assume that diagnosis is central to treatment decision-making. In the clinical 
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scenario where clinical management serves to directly target and eliminate a 
specific identifiable disease, disease process or bodily insult, diagnosis is of 
paramount importance (Croft et al. 2015). However, with musculoskeletal shoulder 
pain, where more serious conditions have been excluded, patho-anatomical 
diagnoses are not clearly related to treatment effectiveness (Dinant et al. 2007). 
Therefore the case for the use of prognostic information in complementing a 
diagnostic framework, to strengthen clinical decision-making has been made 
(Dinant et al. 2007; Croft et al. 2015). 
 
The accuracy of diagnostic labels to classify shoulder pain is questionable with 
most orthopaedic special tests failing to demonstrate sensitivity or specificity with 
poor correlation between symptoms, diagnosis and imaging (Magarey et al. 2016; 
Wylie et al. 2016).  Although the same clinical factors can act as both a prognostic 
factor and a diagnostic factor, it would be remiss to assume that factors that 
indicate diagnosis are the same factors that predict overall outcome or indeed 
moderate response to treatment. Uncertainty therefore remains about whether 
diagnosis is a sound or necessary basis for first-line treatment decisions in 
patients with shoulder pain. Instead, a prognostic approach to clinical decision-
making seeks to use an individual patient’s unique characteristics to inform their 
prognosis as well as their likely response to specific treatments (Croft et al. 2015). 
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3.4 Understanding How Clinicians Navigate Clinical Uncertainty in Treatment 
Decision-Making for Shoulder Pain 
Current primary care guidelines for the management of shoulder pain do not 
advocate specific treatments for specific patients but rather suggest a range of 
treatments (as discussed in chapter 1, introduction). Therefore for patients with 
non-traumatic shoulder pain, clinicians routinely choose between: (i) exercise and 
manual therapy, (ii) corticosteroid injection and (iii) advice and analgesia, without 
specific guidance from guidelines. It can be assumed that clinicians recommend 
the treatment they believe to be most likely to work for each individual patient. 
However, in light of the reported variable patient prognosis (Croft et al. 1996; van 
der Windt et al. 1996; Winters et al. 1999b), it is clear that some patients do well in 
response to this first-line decision-making whilst over half of patients do not.  
 
A main hypothesis of this thesis is that clinicians make decisions on the basis of 
experientially constructed knowledge about which treatments individual patients 
are likely to respond well to and therefore, which patients are suitable candidates 
for specific treatments. It is currently not understood how clinicians use and weigh 
up the breadth of available clinical information to inform these first-line treatment 
decisions for patients with shoulder pain. Specifically, it is unknown if and how 
clinicians make treatment recommendations on the basis of potential moderators 
of treatment response using experience and observations gained from their own 
clinical practice and experience.  
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The comparative performance of statistically derived versus expertise driven 
models for estimating the prognosis of musculoskeletal conditions remains 
unclear. Vergouw et al. (2011) found that a statistically derived prognostic model 
for estimating prognosis of shoulder pain was slightly superior to a clinically 
derived model. However, Vergouw et al. highlight that the result is less than clear 
cut, as the performance of the statistically derived model may be over-stated, 
because it was tested in the same dataset as it was derived from when compared 
to the externally clinically derived model. In addition, in Vergouw et al.’s work, 
clinicians suggested a range of clinical factors that were not identified by the 
statistical model indicating that clinicians consider a breadth of clinical factors 
when estimating prognosis including those not previously studied, as also 
demonstrated by the systematic review in chapter 2.  
 
In addition to the narrow range of clinical factors available in current moderation 
analyses, the review (chapter 2) highlighted the challenges in gaining clinically 
applicable insights from moderation analysis and meta-analysis due to lack of 
power, design consistency in existing studies. Furthermore since clinicians do not 
consider patient attributes in isolation when making treatment recommendations, 
but instead use pattern recognition to inform clinical judgements. Since clinicians 
are managing to make first-line treatment recommendations for patients with 
shoulder pain in the absence of guidance, individual clinicians are likely to have 
developed their own unique clinical short cuts or heuristics. Therefore, a collective 
wisdom is likely to exist amongst the range of clinicians who manage patients with 
shoulder pain. Therefore, this thesis will use clinician input to identify potential 
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moderators of first-line treatment effect in patients with shoulder pain. 
 
3.5 Role of Clinical Decision-Making in this Thesis 
To achieve this, a formal study of clinical decision-making for shoulder pain was 
planned and is outlined in full detail in chapters 5-8. This decision-making study 
aimed to examine how clinicians respond to systematically-varied hypothetical 
patient presentations to assess the impact of relevant clinical factors (patient 
attributes) on decision-making. To begin the process of designing this formal study 
of clinical decision-making, a list of highly relevant attributes of patients with 
shoulder pain was required. Since the systematic review began this process but 
provided an incomplete picture of the clinical considerations for decision-making, 
additional input from experienced clinicians who frequently manage the care of 
patients with shoulder pain was required to obtain an inclusive and parsimonious 
list of patient attributes that may drive differential treatment decisions. The next 
chapter outlines a study that addressed this aim.  
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CHAPTER 4: USING EXPERIENTIALLY CONSTRUCTED 
KNOWLEDGE OF CLINICIANS WHO MANAGE PATIENTS 
WITH SHOULDER PAIN TO IDENTIFY CLINICALLY 
RELEVENT MODERATORS OF TREATMENT RESPONSE 
 
4.1 Background 
The previous chapter outlined the theories of clinical decision-making relevant to 
how clinicians make treatment decisions for patients with shoulder pain, 
highlighting that pattern recognition is likely to be combined with logical 
information-seeking approaches. Therefore, in order to identify the range of patient 
attributes considered as relevant in treatment decision-making for patients with 
shoulder pain, a study that enables clinicians to gather their clinical experiences 
using the recognisable format of pattern recognition was conducted.  
 
4.2 Aim 
This study aimed to populate a list of clinical and patient attributes considered as 
important for first-line clinical decision-making by experienced clinicians who 
routinely make treatment decisions for patients with shoulder pain.  
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4.3 Methods 
An efficient way to obtain the clinical breadth of patient attributes relevant to the 
differential treatment response of shoulder patients is to involve clinicians with 
experience of managing shoulder pain in a structured, clinical consensus research 
exercise. This study used a pragmatic and iterative mixed methods approach to 
identify the patient attributes considered by experienced clinicians when making 
treatment recommendations for patients with musculoskeletal shoulder pain. A 
number of methods have precedence in eliciting the experience and opinions of 
expert clinicians including the Delphi technique and focus group methods 
(Gooberman-Hill et al. 2007; Rankin et al. 2012). The Delphi technique offers a 
systematic aggregation of judgments from expert participants over a series of 
rounds but was not selected for this study due to lack of clinician interaction (Sim 
& Wright, 2000). Interaction between clinicians was considered particularly 
important in this study in order to achieve lists of patient attributes that are both 
internally and externally valid and make shared logical sense to the variety of 
professionals involved and it would have been difficult to study pattern recognition. 
Whilst focus groups offer clinician interaction, it was anticipated that the clinicians 
would identify a sizeable list of potential patient attributes; therefore a method for 
quantification of consensus on the most relevant factors was needed.  
 
The focus group using nominal group technique (NGT) is described as a hybrid of 
focus groups and Delphi technique (Sim & Wright, 2000), and is said to be ‘semi 
quantitative and qualitative’ (Perry & Linsley, 2006). NGT offer the benefits of 
focus group interaction in stimulating clinical discussion as well as the 
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quantification of consensus using anonymous voting. Furthermore, relative to 
other qualitative techniques, NGT is less time consuming and more productive at 
producing a ranked series of ideas which can easily be translated into 
questionnaire items or studied further (He et al. 2014). NGT also offers a highly 
structured and time efficient process, helps balance individual participation levels 
by providing equal opportunity to suggest relevant factors followed by anonymous, 
private individual voting to identify the most relevant patient attributes (He et al. 
2014). 
 
The conventional steps of a nominal group technique (Delbecq, 1971) were used: 
1. Introduction and Explanation 
2. Generating Ideas 
3. Recording Ideas 
4. Discussion 
5. Voting 
 
To facilitate time efficient and focused data collection, participants were asked to 
complete clinical case vignettes from their own clinical practice prior to attending 
the workshop (Perry & Linsley, 2006). Participants were asked to think about 
patients encountered during their own clinical practice and:  
(a) Complete a clinical vignette to outline the clinical attributes of patients that 
either had responded well or were likely respond well to the three 
commonly used shoulder treatments: (i) advice and analgesia, (ii) exercise 
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and/or manual therapy delivered by a physiotherapist and (iii) corticosteroid 
injection (table 4.1).  
(b) Identify the key patient attributes from their own patient vignettes that 
explained the patient’s response or likely response to the specific 
intervention.  
In line with the purpose of the silent idea generation stage of the NGT process, 
completion of the vignettes prior to attending and/or at the very beginning of the 
workshop enabled participants to generate their own thoughts and ideas without 
interruption or influence from other members of the group (Perry & Linsley, 2006). 
 
4.3.1 Running of Workshops 
All workshops took place in a meeting room at the Arthritis Research UK Primary 
Care Centre at Keele University. Democratic group working was facilitated by 
seating participants around an oblong table in a level room (Perry & Linsley, 2006) 
with the group facilitator at front of the room noting emerging patient attributes 
suggested by the participants on an electronic smart board.  
 
 
 
 
 
 
  
84 
Table 4.1: Example of a vignette for physiotherapy completed by a respondent  
Patient Vignette 1 - Physiotherapy 
 
1) Think about the last patient with shoulder pain that you referred to / provided with 
physiotherapy, confident that they would achieve a positive clinical outcome. 
2) Without identifying the 
patient, please describe 
the patient’s presentation 
(demographics, clinical 
features, clinical 
observations, tests results 
etc..). 
 
Young patient with impingement symptoms and subtle 
instability. 29 years old new mum, baby 6 months old. Pain 
with repetitive movements, pain with movement overhead. 
Worse at night, unable to sleep on shoulder. Pain in lateral 
arm. No cervical spine or neural irritation. 
 
Slim built lady. Normal scapular position. Normal cervical and 
thoracic posture. Good cervical spine movement. Shoulder 
flexion full, pain at end of range only. 
Shoulder abduction –pain 120 degrees to end of range. 
Pain end of range lateral rotation, reduced hand behind back 
by pain to T10. 
 
Normal cuff strength in neutral but resisted low load lateral 
rotation demonstrated poor humeral head centering. 
Positive Hawkins Kennedy, positive Neer sign. 
No acromio-clavicular findings. 
3) What was it about this 
patient or this patients 
presentation that made 
you feel confident that the 
patient was likely to 
achieve a positive clinical 
outcome with 
physiotherapy treatment? 
Minor associated problems. No neural irritation or cervical or 
thoracic influence apparent. 
 
Likely to be change in habit and increased loading – overload 
for cuff – secondary impingement. 
4) Which characteristics were 
most important in guiding 
this decision? 
Recognising normal findings around spine and scapula. 
Accurately diagnosing subtle movement fault and poor cuff 
control. 
5) Can you think of any other 
characteristics, not present 
in the above patient which 
might have led you to also 
refer /provide a patient 
with shoulder pain with 
physiotherapy treatment? 
Lots – this is just one example! 
 
Patients with movement faults causing pain/poor function. 
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4.3.2 Participants 
According to Surowiecki (2004), groups of people work well under certain 
circumstances and less well under others. Surowiecki suggests two basic 
principles need to be met in order for a crowd to be ‘smart’, i.e., collectively reach 
the correct decision: diversity and independence. Diversity in the context of this 
study was achieved by extending the invitation to all medical and allied health 
professionals who treat patients with shoulder pain in the context of the UK 
National Health Service (NHS) (i.e., physiotherapists, GPs, orthopaedic surgeons 
and rheumatologists). Independence was achieved by using the NGT method 
where the collective group decision on the importance of an attribute is achieved 
by aggregating each participant’s impression of importance of the attribute to 
produce a collective group judgment that represents:  
“not what any one person in the group thinks but rather,  
in some sense, what they all think” (Surowiecki, 2004, pg. XIX). 
 
The study invited medical and allied health professionals who identified 
themselves as having a recognised expertise or special interest in the assessment 
and treatment of musculoskeletal shoulder pain, this included those with 
experience of managing patients with shoulder pain as part of their clinical 
practice. Jones et al. (1995) state that there are no rules about who to include as 
participants in clinical consensus research “except that each must be justifiable as 
in some way “expert” on the matter under discussion” pg. 383. Qualification for 
invitation included currently working as a clinical specialist in shoulder or upper 
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limb musculoskeletal disorders and/or having a specific clinical interest in the 
clinical management of musculoskeletal shoulder disorders. In addition to 
clinicians most likely to be identified as experts in shoulder disorders 
(physiotherapists and orthopaedic surgeons), general practitioners and 
rheumatologists were also invited to contribute in order to gain a broad sense of 
the patient attributes considered by clinicians who encounter shoulder patients in 
the course of their clinical practice. Jones et al (Jones & Hunter, 1995) 
recommend this approach as a way of gaining alternative clinical viewpoints when 
it is anticipated that the research output will:  
“have impact beyond a particular specialist field” pg. 383. 
 
The purpose of the consensus workshops was to obtain consensus on the patient 
characteristics likely to affect treatment response from clinicians who are experts 
in the clinical management of musculoskeletal conditions. Other professionals and 
non-experts were excluded from participation as they lack the specific clinical 
expertise and experience of undertaking the clinical decision-making process 
related to patients with shoulder disorders. A discussion was held with the lead for 
Patient and Public Involvement and Engagement (PPIE) at the Arthritis Research 
UK Primary Care Centre at Keele University about the potential for utilising PPIE 
to check that factors relevant to patients had not been omitted. It was agreed 
following informal discussion that as the focus was not on patients’ perspective or 
indeed shared decision-making that involvement of PPIE would appear tokenistic 
and not prove to be a worthwhile experience for patients or other members of the 
public.  
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4.3.3 Recruitment 
Expert clinicians were identified using the professional, research and local network 
contacts of the research team and Arthritis Research UK Primary Care Centre at 
Keele University. Clinicians were invited to participate in consensus workshops via 
email from senior members of the Centre. In addition, email invitations were sent 
to upper limb physiotherapists, GPs, rheumatologists and orthopaedic surgeons 
local to Keele University (including Staffordshire, Cheshire, Merseyside, Greater 
Manchester, Shropshire, South Yorkshire, and Derbyshire). An advert for the study 
was also posted on the social media platform Twitter and on Physiopedia (a 
website with a dedicated page for adverts for health and medical professionals to 
get involved in research). The study invitation contained a brief overview of the 
study aim and invited interested clinicians to indicate their interest in taking part by 
contacting the PhD student via the email address provided.	
 
The study invitation used the phrase ‘expert in managing musculoskeletal shoulder 
disorders’. Shortly after recruitment commenced, it was expressed to the team that 
experienced clinicians were not comfortable applying the word ‘experts’ to 
themselves. Clinicians who made contact with the research team were reassured 
that a variety of clinical experience and special clinical interest in the management 
of shoulder disorders was sufficient. Clinical academics with an interest in the 
clinical management of shoulder pain were also invited to participate in the 
workshops.  
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4.3.4 Ethical Approval and Informed Consent 
Ethical approval was obtained from Keele University’s ethical approval panel in 
February 2013 (ERP 2157) (appendices 3 and 4). Participants were asked to sign 
and complete a consent form before each workshop, providing consent for 
participation in the workshop, permission to audio record the workshop and 
permission to use any relevant quotations from the workshop discussions 
(appendix 3). After providing consent, participants were asked to complete a brief 
anonymised form to obtain participants’ characteristics at the beginning of each 
workshop (appendix 3).  
 
4.4 Workshop Objectives 
This series of workshops consisted of three iterative phases that aimed to: 
(i) Identify using consensus methods the patient attributes that potentially 
moderate response to the three commonly used primary care 
treatments: 
a. Exercise and/or manual therapy delivered by a physiotherapist 
b. Corticosteroid injection 
c. Advice and analgesia  
(ii) Consolidate the suggested attributes under parent attributes 
(iii) Agree final attribute & relevant clinical question wording  
 
Due to differences in attendance and availability amongst professional groups, 
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phases 1 and 2 were run twice using the same approach by the same researcher. 
Phase 3 included a single group of clinicians and clinical academics with an 
interest in shoulder pain consisting of participants who had contributed to either or 
both phase 1 and 2. 
 
4.5 Phase 1- Clinical Attribute Identification Workshops  
4.5.1 Phase 1 Aim 
This phased aimed to use experienced clinicians with a special clinical interest in 
the management of patients with shoulder pain, to obtain a list of patient attributes 
relevant to predicting outcome of individual patients with shoulder pain in response 
to either: advice and analgesia, exercise and/or manual therapy delivered by a 
physiotherapist or corticosteroid injection.  
 
4.5.2 Phase 1 Method: Modified Nominal Group Technique with 
Categorisation Exercise 
4.5.2.1   Step 1: Introduction and Explanation 
The workshop purpose and plan was outlined and results of the systematic review 
were shared in order to provide examples of treatment moderators that have been 
suggested in existing literature. Participants were free to draw upon and suggest 
these examples during the workshop as relevant patient attributes, however 
participants voted only patient attributes suggested by the group, whether or not 
these were also contained in the systematic review. 
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4.5.2.2   Step 2: Round Robin Idea Generation 
Workshop participants took it in turn to use examples from their clinical case 
vignettes to share descriptions of patients who they were confident would achieve 
a good clinical outcome in response to the specific treatments. To identify potential 
moderators of treatment effect, each participant suggested the most salient clinical 
features of their patients that prompted the decision to refer to each treatment. 
This process was repeated for each of the treatments ((i) physiotherapy, (ii) 
corticosteroid injection and (iii) advice and analgesia) until the group suggested no 
new ideas.  
 
4.5.2.3   Step 3: Consolidation of Ideas, Removal of Duplicates  
Participants discussed the suggested attributes to determine their clarity, 
relevance and importance. Although this is at odds with the usual approach taken 
in an NGT, where idea generation and voting is done without discussion, it was 
decided that this would better enable the workshop objectives to be met by helping 
to create a comfortable, positive, discursive and philosophical environment for 
clinicians to participate in. All potential moderators noted on the smart board were 
copied into a power point presentation and made ready for electronic voting. 
Although some attributes were correlated, these were included if it was felt by the 
group that each attribute constituted a distinct moderator of treatment effect. 
Attributes were amalgamated at the discretion of the group, but only if the group 
agreed that the new wording still represented the original ideas (Perry & Linsley, 
2006), otherwise the original wording of the patient attributes as suggested by the 
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respondents was retained. Participants were not permitted to suggest removal of 
attributes from the list at this stage. 
 
4.5.2.4   Step 4: Consensus Exercise using Anonymous Voting  
Participants agreed by consensus a small set of highly clinically relevant patient 
attributes to test in the planned conjoint analysis study. Attributes were projected 
singularly on a large screen and participants were asked to indicate how important 
each attribute was for guiding selection of a shoulder pain treatment by selecting 
one response on the 5-point Likert scale: ‘Very important, important, neither 
important nor unimportant, unimportant, or very unimportant’. Respondents voted 
without conferring. Consensus agreement was defined as an attribute having been 
selected as ’agree’ or ‘strongly agree’ by more than 50% of the participants 
present at the time of voting. Voting was confidential and blinded using real-time 
electronic voting using the classroom voting technology system, Turning Point 
(Turning Technologies, UK). 
 
4.5.2.5   Step 5: Post-workshop Attribute Consolidation 
To distil the findings of phase 1, suggested attributes were collated into logical 
categories by the research team in a categorisation exercise. Options for the 
categorization of clinical attributes were considered, namely thematic analysis 
using the long table method (Guest et al. 2012).  However, since data collection in 
this study occurred over specific and limited time periods (during scheduled 
workshops), it was not practical to continue to sample participants until theoretical 
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saturation was achieved, the point at which no new attributes, concepts or themes 
were identified (Glazer & Strauss, 1967). Thematic analysis was therefore not 
considered likely to provide meaningful interpretation of the data over the simple 
categorization exercise conducted. Instead a more straightforward categorisation 
exercise was conducted. 
 
The categorisation exercise grouped the list of suggested attributes into clinical 
clusters of patient attributes that relate to similar areas of clinical decision-making 
e.g., the parent attribute ‘Pain’ was comprised of the attributes: pain location, pain 
intensity/severity, pain/symptom frequency and pain type (extreme or distressing 
pain). These categories were then provided with a clinically sensible parent 
attribute label that described the category, where possible using terminology from 
the list of characteristics suggested in Phase 1. The PhD student and supervisory 
team (CJM, DvdW & JH) reviewed the categories to guard against biases of one 
individual researcher.  
 
4.6 Phase 2: Clinical Attribute Definition 
The conjoint analysis study proposed for the next stage of the PhD seeks to 
understand how clinicians use patient attributes to make treatment decisions and 
to identify potential profiles of likely best responders to the three treatments of 
interest. A number of constraints to the generation of attributes for a conjoint 
analysis study exist. Increasing the number of attributes in a conjoint analysis 
increases the number of questions each respondent is required to answer, the 
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sample size and the risk of non-convergence (failure of the underpinning statistical 
model). Furthermore, an important consideration in deciding how many attributes 
to include is an estimation of how many attributes a clinician will be able to 
cognitively engage with. Definitive guidance on absolute maximum recommended 
number of attributes to include in a conjoint analysis study is lacking. However, the 
average number of attributes is seven or eight and the absolute maximum number 
of attributes recommended is 12 (Carson et al. 1994; Ryan et al. 2008). It is 
essential that attributes are mutually exclusive, i.e., not dealing with the same 
underpinning construct as any other attribute and that the level of each attribute is 
theoretically combinable with any level of any other attribute. Many attributes from 
workshop 1 such as ‘psychosocial complexity’ lack clear cut-off points or 
categories from existing literature. Therefore, phase 2 aimed to agree appropriate 
levels for each final attribute and identify simple, clinically relevant questions that 
represent each of the final attributes. Phase 2 also aimed to further consolidate 
and reduce the total number of suggested attributes suggested in phase 1 to be 
taken forward to the conjoint analysis study.  
 
4.6.1 Phase 2 Aims 
 Use the categorisation exercise as a platform for discussion to enable participants 
to: 
1) Collapse the list of attributes into as few clinically sensible parent attributes 
as possible that encompass the suggested attributes 
2) Identify clinically relevant levels/categories for each parent attribute 
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3) Consider whether any relevant clinical information is absent 
4) Define the clinical questions that cover each parent attribute 
 
 
4.6.2 Phase 2 Method: Clinical Attribute Definition Workshops using 
Consensus Groups 
Participants for phase 2 workshops were invited from the pool of individuals who 
responded to the initial study invitation. Consensus group methodology (List, 
2001) was used to facilitate discussion and amendments to the categorisation 
exercise summary of phase 1. Whilst both focus and consensus groups are 
participatory methods, in a focus group, the facilitator loosely steers the direction 
of the group and collates the findings, where as in consensus groups, the group 
negotiate and decide the findings themselves (List, 2001). The small groups 
consisted of members who were familiar with and shared ownership of the phase 
one material. Formal consensus voting was not conducted, as group numbers 
were small. Groups were instead instructed to self-regulate, involve all members 
and to organically edit the phase one output into a more meaningful consensus 
agreed version. The group facilitator posed questions to the group to clarify 
agreement and consensus when decisions were being made. Participants verbally 
agreed or disagreed with amendments proposed by the group. If new parent 
attributes were suggested, the group checked whether the new parent attribute still 
expressed all of the previous attributes contained in the previous parent attribute.  
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Each parent attribute was allocated appropriate levels that the group was satisfied 
represented the attributes in the parent attribute and did not over-simplify or lose 
information relevant to differential treatment decision-making. This process was 
repeated until the group was content with the wording of all of the parent attributes 
names and levels on the map. A further consensus exercise was required to 
decide upon the final parent attributes to be included in the conjoint analysis from 
those identified and to decide the most optimal wording for each parent attribute. 
To facilitate the next workshop, output from both phase 2 workshops were 
compared. A traffic light system of agreement was applied: green (attribute and 
levels dealt with the same constructs and worded very similarly), amber (attribute 
and levels dealing with the same constructs, but worded differently) and red 
(different attribute and level suggested by each group). 
 
4.7 Phase 3- Clinical Attribute Finalising 
Assessment of logical and content validity of the attributes was indicated before 
beginning the design of the conjoint analysis study. In addition, the number of 
attributes suggested in phase 3 of this study exceeded the maximum 
recommended number of attributes (12) for a conjoint analysis study, participants 
were asked to discuss how best to approach this challenge i.e., consolidate and/or 
remove some of the parent attributes. Consensus group methods, as used in 
phase two, were repeated with a group of academics with experience of 
developing large programmes of research, randomised controlled trials and a 
model for stratified care in order to guard against potential biases of the PhD 
student and the supervisory team. Participants discussed where the attributes 
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over-lapped and suggested the final 12 attributes. The discussion focused on 
agreeing wording for the amber-coloured attributes and discussing which of the 
red-coloured attributes were most relevant to differential decision-making for 
shoulder pain in primary care. This phase ensured the translation of clinical 
opinion into a series of testable scientific hypotheses. Meeting attendees used the 
colour-coded output of phase 2 as the basis for group-led discussion of their 
preferences on the wording, appropriateness and conciseness of the attribute, 
levels and clinical questions suggested.  
 
4.8 Results 
In total, 21 UK-based clinicians took part in this series of consensus groups. Table 
4.2 outlines demographics of the participants. Participants consisted of 
experienced clinicians from a range of professional backgrounds including 
physiotherapists, GPs, rheumatologists and orthopaedic surgeons working 
clinically and managing patients with shoulder pain in the National Health Service 
setting (UK NHS). Number of years of clinical experience of all participants in 
phase 1 and 2 was (mean (S.D.)) 18.4 (7.7) years. All participants took part in 
phase 1 but due to participant availability, not all participants who took part in 
phase 1 subsequently took part in phases 2 and/or 3. 
 
4.8.1 Phase 1 Results 
Clinical attributes identified by the consensus workshop participants in phase 1 are 
listed in table 4.3 with percentage agreement on importance of each attribute in 
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treatment decision-making. Additional attributes identified after the workshops 
using the audio transcripts of the workshops are also included. Clinicians 
suggested 63 patient attributes relevant to treatment decision-making in patients 
with shoulder conditions. Of these, 53 attributes were voted as ‘important’ or ‘Very 
Important’ during the voting stage of the NGT. As table 4.3 shows, the 53 
attributes demonstrate the breadth of clinical information considered by clinicians 
when making a treatment decision for patients with shoulder pain. Results of the 
categorisation exercise of the 53 attributes can been seen in figure 4.1. During the 
categorisation exercise, eight attributes were removed. Table 4.4 outlines rationale 
for the removal of these attributes. 
Table 4.2: Demographic characteristics of participants of the first two phases of the 
consensus study 
 Workshop 
1a 
n = 8 
1b 
n = 14 
2a 
n = 4 
2b 
n = 7 
3 
n = 6 
Clinical 
Background 
(n,%) 
Rheum. (1/8) 
GP (5/8) 
Physio. (1/8) 
Ortho. Surg. 
(1/8) 
Physio. 
(13/14) 
Ortho. Surg. 
(1/14) 
 
GP (2/4) 
Physio. (2/4) 
Physio. (7/7) 
Physio. (2/6) 
GP(3/6) 
Rheum. (1/6) 
Currently 
Treats 
Shoulder Pain 
5/8 12/14 2/4 7/7 6/6 
Treatments 
currently 
provided 
(n,%) 
Education, 
advice & 
analgesia 
 
 
7/8 
 
 
10/14 
 
 
3/4 
 
 
7/7 
 
 
4/6 
Analgesia 7/8 7/14 2/4 5/7 4/6 
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Physiotherapy 5/8 10/14 1/4 7/7 2/6 
Corticosteroid 
Injection 6/8 5/14 1/4 3/7 3/6 
Other 
0/8 
Acupu. (1/14) 
Surg. (1/14) 
0/4 0/7 0/6 
Mean (SD) 
Clinical Exp. 
(years) 
22.5 
(10.5) 
18.4  
(7.7) 
20.5  
(13.2) 
19.2 
(8.5) 
20 
(11.8) 
Post-graduate 
training in 
shoulder pain 
6/8 8/14 4/4 6/7 6/6 
Mean (SD) 
age (years) 
45.2  
(9.8) 
41.4  
(8.7) 
44.5  
(12.7) 
42.8 ( 
9.6) 
44  
(14.3) 
Female 4/8 11/14 2/4 6/7 3/6 
Clinical 
Practice in 
West 
Midlands, UK 
5/8 6/14 3/4 5/7 4/6 
Rheum. = Rheumatologist, GP =General Practitioner 
Physio. = Physiotherapist, Ortho. Surg.= Orthopaedic Surgeon,  
Acupu. = Acupuncture, Surg. = Surgery 
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Table 4.3: Patient attributes proposed as relevant by clinicians in shoulder treatment decision-making (Phase 1) 
 Attribute Name 
Suggested 
by 
Systematic 
Review (Y/N) 
Workshop 1a 
8 
Workshop 1b 
14 
Attribute 
later 
identified in 
audio 
transcripts 
of 
workshops 
(Y/N) 
Discuss in 
next 
round? 
(Y/N) 
(% voted 
very important or important) 
1 Employment status/ Occupation/ self-employment Y 5/8 14/14 N Y 
2 Gender Y - 2/14 N N$ 
3 Compensation claim/ Litigation pending Y - 7/14 N Y 
4 No. of previous episodes Y - - N Y 
5 No. of muscles with active trigger points Y - - N N$ 
6 Restricted ROM Y 7/8 - N N$ 
7 Neck involvement / neck range restriction Y - - N Y 
8 Pain location Y - - N Y 
9 Pain intensity Y - - N Y 
10 Pain Type (Extreme or distressing pain) Y 6/8 - N Y 
11 Symptom duration Y 7/8 14/14 N Y 
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12 Work Impact (Dysfunction/disability) Y - - N Y 
13 Functional deficit (Dysfunction/disability) Y - - N Y 
14 Affected limb dominance Y - - N Y 
15 Painful arc Y - - N Y 
16 Patient treatment preference Y 8/8 14/14 N Y 
17 Age Y 5/8 4/14 N Y 
18 
Previous treatment response (separately for each 
treatment) 
Y 7/8 14/14 N Y 
19 Diagnosis Y 7/8 14/14 N Y 
20 Pain type (pain or stiffness) Y 5/8 - N Y 
21 Nighttime pain Y 7/8 12/14 N N$ 
22 Impact on Quality of Life Y - - N Y 
23 Otherwise fit & well / Comorbidity (e.g., diabetes, RA) Y 7/8 12/14 N Y 
24 Pain severity N - 14/14 N Y 
25 Usual level of physical activity N 3/8 9/14 N Y 
26 Over-use / Over-head activities / racquet sports N - 7/14 N Y 
27 Cognitive capacity N - 9/14 N N$ 
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28 
Psychosocial complexity: Psychosocially burdened / 
Psychological problems 
N 6/8 14/14 N Y 
29 Health literacy/understanding N 7/8 9/14 N Y 
30 Motivation N 7/8 - N Y 
31 Patient Compliance N 7/8 14/14 N Y 
32 Self-efficacy N 7/8 - N Y 
33 Pain elsewhere / isolated clinical problem N 5/8 9/14 N Y 
34 Re-assurance re: diagnosis/ Diagnostic certainty N 7/8 9/14 N Y 
35 Current response to analgesia/ Painkiller response N - 7/14 N Y 
36 
Inadequate previous treatment / Incomplete previous 
physiotherapy 
N 7/8 - N Y 
37 Muscle weakness N 7/8 - N Y 
38 Instability / recurrent dislocation N 7/8 14/14 N Y 
39 History of injury: trauma or over-use N - 12/14 N Y 
40 Sleep disturbance/problems sleeping N 6/8 14/14 N Y 
41 Response to physical test N 7/8 - N Y 
42 Imaging results N 7/8 - N Y 
43 Modifiable biomechanics N - 9/14 N Y 
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44 Symptoms / pain frequency  N 5/8 - N Y 
45 Course of symptoms (improving/deteriorating) N 7/8 - N Y 
46 Active Inflammatory process N - 12/14 N Y 
47 Red flags/serious pathology N 7/8 14/14 N Y 
48 Not a surgical candidate N - - Y N$ 
49 Benefit/ Welfare Concerns N - - Y Y 
50 Is analgesia already optimised? N - - Y Y 
51 No. of previous injections N - - Y Y 
52 Capsular pattern N - - Y Y 
53 Socio-cultural issues (language or cultural difficulties) N 3/8 - N Y ^ 
54 Litigation or retired or on benefits N 1/8 - N N@3 
55 Fear avoidance N 6/8 - N N@28 
56 Positive outlook, coping N 6/8 - N N@28 
57 Patient expectations and assumptions N 8/8 14/14 N N@10 
58 Medication compliance N 6/8 - N N@34 
59 Mechanism of injury N - 14/14 N N@44 
60 Need to RTW/activity quickly / Speed of treatment results N 6/8 12/14 N N* 
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61 Speed of treatment access N - 14/14 N N* 
62 No further indication for treatment / Good prognosis N 5/8 - N N* 
63 
Physical immobility/General mobility/Physically active or 
sporty 
N - - Y N@25 
$ = Not taken forward to next round, see Table 4.4 
^ = Not agreed by consensus but research team thought it was worth exploring this attribute further 
@ = Covered by another attribute 
* = A health service-related factor, not a patient attribute 
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Figure 4.1: Output from categorisation exercise (Phase 1) 
  
Psychosocial complexity  
- Psychosocial complexity: 
Psychosocially burdened / 
Psychological problems	
- Health literacy/understanding	
- Motivation	
- Compliance	
- Self-efficacy	
- Pain elsewhere/isolated clinical 
problem	
- Benefit/welfare concerns	
- Socio-cultural issues	
- Compensation claim/ Litigation 
pending	
- eassurance re: diagnosis	
Previous treatment response 
- Previous response to corticosteroid injection 
- Previous response to physiotherapy	
- Previous response to education, advice and 
analgesia	
- Current response to analgesia/ Painkiller response 	
- Is analgesia already optimised?	
- Inadequate previous treatment / Incomplete previous 
physiotherapy 	
- No. of previous injections		
Presentation 
- Muscle weakness 
- Pain or Stiffness 
- Instability /recurrent dislocation 
- History of injury (trauma/overuse) 
- No. of previous episodes 
Trajectory 
- Symptom duration 
- Course of symptoms 
(improving/deteriorating) 
Diagnosis 
- Diagnosis  
- Re-assurance re: diagnosis/ 
Diagnostic certainty 
- Capsular pattern 
- Painful arc 
- Response to physical test 
- Imaging results 
- Neck involvement / neck range 
restriction 
- Modifiable biomechanics 
Over-use 
- History of overuse 
- Overhead activities 
- Racket sports 
Otherwise Fit & Well 
- Otherwise fit and 
well 
- Comorbidity (e.g., 
diabetes, RA) 
- Active inflammatory 
process 
- Red flags 
Functional Impact 
- Impact on Quality of Life 
- Work impact (dysfunction/disability) 
- Sleep disturbance/problems sleeping 
- Functional deficit (dysfunction/disability) 
- Affected limb dominance 
Patient treatment preference 
- Patient treatment preference 	
- Employment status/ Occupation/ 
self-employment	
- Usual level of physical activity	Pain 
- Pain location 
- Pain 
intensity/severity 
- Pain/symptom 
frequency 
- Pain Type (Extreme 
or distressing pain) 
Age 
- Age 
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Table 4.4: Attributes removed during Phase 1 
Attribute Reason for removal 
No. of muscles with active trigger points Not an easily identifiable clinical factor by GPs 
Restricted ROM All patients with shoulder pain have restricted 
ROM, not a moderator 
Not a surgical candidate Not relevant to primary care, unlikely to be a 
moderator 
Usual level of physical activity Included in sport and work impact attributes 
Cognitive capacity 
Potential moderators, but unethical criteria 
upon which to base treatment decisions Education level 
Gender 
Night pain Similar to sleep impact, also reflected in active 
inflammatory process 
 
 
4.8.2 Phase 2 Results 
Both parallel workshops in phase two succeeded in re-organising the 
categorisation exercise into a smaller number of parent attributes namely: 
psychosocial complexity, previous treatment response, presentation, trajectory, 
diagnosis, over-use, pain, otherwise fit and well, functional impact, patient 
treatment preference and age (see figure 4.1).  Table 4.5 shows that each group 
identified 13 parent attributes to describe all of the suggested attributes. 
Agreement between the two groups is depicted using a traffic light system in table 
4.5. Five parent attributes, shaded green were very similar between both groups. 
Five parent attributes were shaded yellow address very similar constructs but were 
worded differently. Each group identified three parent attributes (shaded red) that 
were not identified by the other group.  
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Participants of workshop 2 acknowledged that this process of reducing and 
consolidating the number of attributes was highly pragmatic and that there may be 
inconsistencies or errors. Repeating this process in two separate clinical groups 
helped to mitigate possible effects of this limitation. Member checking was 
conducted to further assist this process by sending a copy of the final workshop 
output to workshop participants and asking them to respond with any suggestions 
or amendments. The researcher also presented the final attributes and questions 
to three specialist physiotherapists who were unable to attend the workshops in 
order to check the external validity of the final workshop output. No new attributes 
were identified through these steps. 
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Table 4.5: Parent attributes suggested by participants of Workshops 2a and 2b (Phase 2) 
Workshop 2a Workshop 2b 
(Green: Perfect agreement on constructs and clinical wording between groups) 
 
Otherwise fit & well? Otherwise fit & well? 
Positive Previous Treatment Response Positive Previous Treatment Response 
Improving? Improving? 
Patient treatment preference? Strong patient treatment preference? 
Significant functional impact? Substantial functional impact? 
(Yellow: Constructs agreed but clinical wording not agreed between groups) 
 
Recent injury +/- overuse? History of injury? 
Pain severity Severe pain? 
Primary problem Primary presenting problem 
Complex Contributing Psychosocial Issues? 1+ psychosocial issue/yellow flag +/- 
widespread pain? 
Neck involvement Symptoms indicative of a local shoulder 
pathology 
(Red: Different constructs identified by the two groups) 
 
Episode type No. of previous injections 
Inflammatory process Age 
Urgency of need of treatment Disturbed sleep due to shoulder? 
 
4.8.4 Phase 3 Results 
This stage involved the removal of four attributes from the red-coloured list from 
table 4.5, attributes that were suggested by one of but not both of the previous 
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consensus groups. Participants suggested that the number of previous injections 
was important but since no actual guidance exists on maximum number of 
injections that it would be very difficult to agree upon logical categorical levels to 
test in a future conjoint analysis study. Urgency of need of treatment was removed 
since participants expressed that they struggled with the concept that one patient’s 
urgency of need for resolution of symptoms was more urgent than another 
patient’s. Participants acknowledged that although this was not a patient factor, 
their knowledge of local waiting times for access to physiotherapy or for an 
injection was likely to be a factor in their decision.  Participants also removed the 
attribute of age, as although it was acknowledged that certain conditions such as 
rotator cuff tears and osteoarthritis become more prevalent with age, participants 
did not feel that age on its own was likely to be a moderator of treatment effect for 
the primary care treatments under consideration. Although participants recognised 
that it would be helpful to know whether patients have any relevant and/or 
additional active or ongoing inflammatory process, when given the task of reducing 
the final 13 attributes to 12, in order to meet the design requirements for the 
arising conjoint study, participants opted to remove this attribute. 
 
Table 4.6 shows the final 12 attributes deemed appropriate for studying in the next 
phase of the PhD, the conjoint analysis. Participants agreed upon a simple clinical 
question and either dichotomous or trichotomous response options for each of the 
12 attributes. Three attributes (pain severity, previous treatment response and 
patient treatment preference) were considered to need three response options, 
while the remaining nine could be answered using dichotomous (Yes/No) 
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responses. This output was edited by the research team so that each clinical 
question gave rise to distinct attributes and variables that could be studied in the 
planned conjoint analysis (column 3 in Table 4.6). Specifically, two revisions to the 
list of attributes were made. The attribute ‘primary problem’ was proposed by 
workshop attendees to contain stiffness. The research team opted to remove the 
word stiffness as a primary problem as stiffness is a strong diagnostic indicator for 
adhesive capsulitis (Page et al. 2014). Since establishing strong diagnostic signals 
was not the aim of the conjoint study, stiffness was removed. Pain elsewhere was 
removed from the attribute ‘neck involvement’ as there was consensus that the 
main attribute of interest was neck pain specifically, rather than pain elsewhere. 
Whilst neck pain in the context of shoulder pain could be understood as relevant 
pain elsewhere (Littlewood et al. 2012), pain elsewhere could also be understood 
as a sign of a multi-site pain presentation (Vergouw et al. 2011), other signs of 
which were suggested as included in the psychosocial complexity attribute. The 
research team felt that these two edits made the final list of attributes more distinct 
and suitable for a conjoint study. Table 4.6 summarises the above-discussed 
changes. 
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Table 4.6: Final 12 Patient Attributes of Relevance to Treatment Decision-Making for Shoulder Pain (Phase 3) 
No. Attribute Clinical Question Suggested During Phase 3 Final Wording Used in the Conjoint Study 
1 Otherwise 
fit & well 
Is the patient otherwise fit & well without significant co-morbidity 
(e.g., diabetes, unstable cardiovascular issues)? 
(i) Yes 
(ii) No 
As in Phase 3 
2 Positive 
Previous 
Treatment 
Response 
Did the patient have a positive treatment response for joint 
injection? 
(i) Yes 
(ii) No 
Edited to: 
(i) Previous positive treatment response to injection 
(ii) Previous positive treatment response to 
physiotherapy 
(iii) No previous treatment  
Did the patient have a positive treatment response for 
physiotherapy? 
(i) Yes 
(ii) No 
3 Improving Is the patient’s shoulder condition improving? 
(i) Yes 
(ii) No 
As in Phase 3 
4 Patient 
Treatment 
Preference 
Does the patient have a strong treatment preference for joint 
injection? 
(i) Yes 
(ii) No 
Edited to: 
(i) Patient treatment preference for injection 
(ii) Patient treatment preference for physiotherapy 
(iii) No patient treatment preference 
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Does the patient have a strong treatment preference for 
physiotherapy? 
(i) Yes 
(ii) No 
5 Functional 
Impact 
Is there significant interference with work or leisure? 
(i) Yes 
(ii) No 
As in Phase 3 
6 Sleep 
Disturbance 
Is there significant sleep disturbance due to the shoulder? 
(i) Yes 
(ii) No 
As in Phase 3 
7 Onset Traumatic onset? 
(i) Yes 
(ii) No 
As in Phase 3 
8 Overuse Over-use linked to sport, hobbies or work? 
(i) Yes 
(ii) No 
As in Phase 3 
9 Pain Severity What degree of pain does the patient report? 
(i) Mild 
(ii) Moderate 
(iii) Severe 
As in Phase 3 
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10 Primary 
Problem 
Is stiffness the predominant problem reported? 
(i) Yes 
(ii) No 
Removed by research team as stiffness is a strong diagnostic 
indicator for adhesive capsulitis.  
Is there significant instability and/or weakness? 
(i) Yes 
(ii) No 
As in Phase 3 
11 Psychosocial 
Complexity 
Does the patient have any psychosocial issues? 
(i) Yes 
(ii) No 
As in Phase 3 
12 Neck 
Involvement 
Does the patient have concomitant neck pain and/or pain 
elsewhere? 
(i) Yes 
(ii) No 
Edited to: 
(i) Also presents with neck pain 
(ii) Does not present with neck pain 
The research team removed ‘pain elsewhere’ in order to enable 
study of whether presence of neck pain specifically was an 
important factor in clinical decision-making. 
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4.9 Discussion 
This study used a three-phase method to gain consensus among clinicians 
regarding the patient attributes relevant to first-line treatment decision-making in 
patients with shoulder pain. Figure 4.2 provides an overview of the study process 
and Table 4.7 provides a visual summary of the categorization process that 
occurred during the three phases of the study culminating in the 12 patient 
attributes. Beginning with the 29 potential moderators identified by the previous 
review, clinicians initially suggested 53 patient attributes that were clinically 
relevant to differential first-line treatment decisions in patients with shoulder pain. 
Following the consensus process a final list of 12 attributes were agreed as highly 
relevant to this clinical decision, six of these patient attributes (previous positive 
treatment response, pain severity, patient treatment preference, functional impact, 
neck involvement and nature of primary problem) have been previously explored 
as potential predictors of treatment effect. In addition to the findings of the 
systematic review presented in the previous chapter, this study also identified six 
patient attributes that have not been previously suggested as potential moderating 
factors or examined in existing randomised controlled trials (general health status 
relating to diabetes and heart disease, traumatic onset, over-use, improving, 
psychosocial complexity, sleep disturbance).  
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Focus groups using modified Nominal Group Technique 
N=21 (UK-based Musculoskeletal Physiotherapists, GPs, Rheumatologists, Orthopaedic surgeons and clinical academics) 
Phase 1 
Moderators Suggested (n = 70) 
Research team conducted a 
categorization exercise (figure 4.1) 
Attributes excluded by research 
team (n = 8) Research team combined the list 
of 15 attributes into table 4.5 
Each group produced a list of 12 
attributes (Total n= 16) 
- 5 identical constructs 
- 5 similar constructs 
unique to each group 
- 6 constructs (3 unique to 
each group) 
Attributes excluded by 
participants (n = 3) 
Final attributes (n = 12) 
• Discussed vignettes from clinical practice  
• Suggested potential moderators 
•  Anonymous voting 
Workshop 1a 
Rheumatologist (1), GP (5), Physiotherapist (1), 
Orthopaedic surgeon (2) 
Workshop 1b 
Physiotherapist (13), Orthopaedic surgeon (1) 
• Discussed and edited the 
categories to best represent the 
attributes  
Workshop 2a 
GP (2), Physiotherapist (2) 
Workshop 2b 
Physiotherapist (7) 
• Finalised the wording of the 
clinical attributes  
Workshop 3 
Physiotherapist (2), GP (3), 
Rheumatologist (1) 
•  
Phase 2 Phase 1 
Figure 4.2: Overview of the Focus Groups using Nominal Group Technique 
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Table 4.7: Tracking of attributes across the study phases 
 
Attribute Name 
Phase 1 Phase 2 Phase 3 
Category Name 
Excluded 
Final Attributes Became Attribute on it’s own 
Brought forward to phase 3 
28 
Psychosocial complexity: Psychosocially 
burdened / Psychological problems 
Psychosocial 
complexity Brought forward to phase 3 Psychosocial Complexity 
29 Health literacy/understanding 
30 Motivation 
31 Patient Compliance 
32 Self-efficacy 
33 Pain elsewhere / isolated clinical problem 
49 Benefit/ Welfare Concerns 
53 
Socio-cultural issues (language or cultural 
difficulties) 
3 Compensation claim/ Litigation pending 
26 Over-use / Over-head activities / racquet sports Over-Use Brought forward to phase 3 Over-use linked to sport, hobbies or work 
22 Impact on Quality of Life 
Functional 
Impact Brought forward to phase 3 
Significant functional impact on work or 
leisure 12 Work Impact (Dysfunction/disability) 
13 Functional deficit (Dysfunction/disability) 
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14 Affected limb dominance 
40 
Sleep disturbance/problems sleeping Became Attribute on it’s 
own Sleep disturbance due to the shoulder 
18 
Previous treatment response (separately for 
each treatment) 
Previous 
Treatment 
Response 
Brought forward to phase 3 Previous treatment response 35 
Current response to analgesia/ Painkiller 
response 
50 Is analgesia already optimised? 
36 
Inadequate previous treatment / Incomplete 
previous physiotherapy 
51 
No. of previous injections Became Attribute on it’s 
own Excluded 
11 Symptom duration 
Trajectory Brought forward to phase 3 Improving 
45 Course of symptoms (improving/deteriorating) 
23 
Otherwise fit & well / Comorbidity (e.g., 
diabetes, RA) Otherwise Fit & 
Well Brought forward to phase 3 Otherwise Fit & Well 
47 Red flags/serious pathology 
46 
Active Inflammatory process 
 
Became Attribute on it’s 
own 
Inflammatory Process 
Excluded 
8 Pain location 
Pain Brought forward to phase 3 Pain severity 
9 Pain intensity 
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24 Pain severity 
44 Symptoms / pain frequency  
17 
Age Age Became Attribute on it’s own Excluded 
37 Muscle weakness 
Presentation 
Brought forward to phase 3 
Primary Presenting Problem 
Instability +/- weakness 20 Pain type (pain or stiffness) 
38 Instability / recurrent dislocation 
39 
History of injury: trauma or over-use Became Attribute on it’s 
own 
History of Injury 
Traumatic onset 
4 
No. of previous episodes Became Attribute on it’s 
own 
Episode type (first/not) 
Excluded 
16 Patient treatment preference 
Patient 
Treatment 
Preference 
Brought forward to phase 3 Patient Treatment Preference 
1 
Employment status/ Occupation/ self-
employment 
Became Attribute on it’s 
own 
Urgency of need of treatment 
Excluded 
 
19 Diagnosis 
Diagnosis 
Excluded 
 
Excluded 
 34 
Re-assurance re: diagnosis/ Diagnostic 
certainty 
52 Capsular pattern 
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15 Painful arc 
41 Response to physical test 
42 Imaging results 
7 
Neck involvement / neck range restriction Became Attribute on it’s 
own 
Neck involvement 
Neck involvement 
43 
Modifiable biomechanics Became Attribute on it’s 
own 
Symptoms indicative of a 
local shoulder pathology 
Excluded 
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Several authors have outlined strategies and tools intended to guide treatment 
decision-making for patients with shoulder pain (Carter et al. 2012; De Winter et al. 
1999; Lewis, 2009). However existing studies largely focus on use of diagnostic 
factors to guide diagnostic classification (Farmer, 2014) or prognostic factors to 
guide treatment decisions (Lewis, 2009; van Kampen et al. 2014) and often relate 
to the outcome of a single treatment only, for example physiotherapy (Chester et 
al. 2013). The shoulder diagnosis system defined by Farmer (2014) consists of 27 
questions and observations and provides an indication of probable diagnosis. Of 
the 12 patient attributes suggested by this study, just four are in common with 
Farmer (2014) (instability or weakness, pain severity, diabetes, type of onset). 
Farmer (2014) identified clinical variables from the literature that were used to 
diagnose shoulder pain alongside the expert opinion of the author (Farmer) and 
two additional experts. However, the processes were not described in detail, 
limiting an assessment of the scientific rigour and potential for bias. The attributes 
identified by this study were generated through broad insight gained from a large 
sample of multi-disciplinary clinicians involved in this study, which offered a 
diverse and generalisable list of patient attributes considered relevant to the 
treatment decision-making for shoulder pain.  
 
In line with Menendez et al. (2015) who identified psychosocial variables as being 
highly relevant to the prognosis of shoulder pain, this study suggests that the 
presence of psychosocial factors is considered by clinicians as relevant to their 
differential decision-making. Cho et al. (2013) described the association between 
psychosocial factors and shoulder pain, reporting that anxiety and depression 
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were highly prevalent in patients with shoulder pain for longer than three months. 
These results were supported by Wylie et al. (2016) who demonstrated that in 
patients with a complete tear in the rotator cuff, mental health had the strongest 
correlation with patient’s level of pain intensity. Furthermore, Chester et al. (2016) 
showed that psychological factors were associated with outcome of physiotherapy 
intervention for shoulder pain. Similarly, chronic shoulder pain is associated with 
sleep disturbance (Cho et al. 2013, Mulligan et al. 2015), although the role of sleep 
disturbance in moderating response to treatment is currently unknown. 
 
4.9.1 Strengths of the study 
A variety of shoulder pain clinicians from different disciplines accepted the 
invitation to take part in this consensus study confirming the importance of 
identifying factors that may help to optimally target first-line interventions to those 
patients likely to benefit most. As a result, output is likely to reflect the 
determinants required for clinical decision-making from a variety of relevant 
professional perspectives.	 Each phase of this study offered opportunity for the 
participants to discuss their unique experience and perspective on the challenges 
and potential routes forward for the field. Use of clinical case vignettes to elicit 
potential moderators appeared to resonate with the participants who were very 
engaged in contributing to the tasks required of them in the workshop. Patient 
vignettes in this context efficiently enabled participants to reflect on their own 
clinical practice and relate their clinical experiences to the research task in a time 
efficient manner.  
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A particular strength of this study was that the differences between generic 
prognostic factors and specific treatment moderators were explained throughout 
each consensus phase, ensuring that participants consistently considered the 
extent to which attributes inform their decisions between different treatments 
rather than there assessment of the probability of a favourable outcome in general. 
Feedback from participants indicated that they felt the process allowed their voices 
to be equally heard and that they gained a lot from the workshops, including the 
opportunity to examine their own approach to treatment decision-making from 
hearing the perspectives offered by other participants. Participants also valued 
that the definition of each potential attribute was clarified prior to the voting stage, 
which ensured that the participants understood clearly what the group meant by 
each attribute. Electronic voting using the classroom voting technology was a 
reliable and engaging means of enabling concealed/blind voting, as respondents 
were not able to influence or be influenced by each other’s voting preferences. 
 
4.9.2 Weaknesses of the study 
The purpose of this study was to identify the most relevant clinical attributes in 
differential first-line treatment decision-making for shoulder pain to inform the 
design of the conjoint analysis study presented in chapters 5-8. Participants were 
informed that the maximum number of clinical attributes that would be accepted in 
the final phase was 12, as the maximum number of attributes that is considered 
appropriate/feasible for inclusion in a conjoint analysis study (Carson et al. 1994; 
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Ryan et al. 2008). In an ideal world, investigators would have taken all attributes 
agreed by consensus forward into the decision analysis study to test their relative 
importance. However, the use of the conjoint analysis method restricted the 
number of attributes that could be carried forward to the next stage in order to 
generate valid and meaningful data. This may have resulted in the omission of a 
few potentially relevant attributes. However, the likelihood of this was reduced by 
the replication of each workshop phase with different professional groups, which 
also served to reflect the variety of perspectives offered by the different clinical 
backgrounds. 
 
As frequently noted, threat to representativeness of research findings exists 
because people who volunteer may have different or stronger opinions than those 
who do not volunteer. There is also a risk of a geographical selection bias due to 
the workshops taking place in a single location. This may have resulted in a 
participation barrier for clinicians who were not local or available on the workshop 
dates. To counteract this issue, clinicians who expressed an interest in taking part 
but were unable to attend, submitted their completed case vignettes to the 
workshop facilitator who included their ideas in the workshops in their absence.  
 
There is some potential for researcher bias in that one investigator initially 
conducted the categorisation exercise of the output of phase 1. In order to 
minimise any potential biases introduced in this step, the whole research team 
subsequently reviewed the analysis, with further iterations to the analysis made. 
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Revision of audio recordings confirmed that the group facilitator did not lead or 
steer any of the group’s discussion in any way and that similarities in output 
between groups are likely to be reflective of clinical practice. When participants 
struggled to express what they meant, the facilitator offered synonyms and 
examples to clarify attributes suggested by participants. 
 
4.10 Conclusions 
This chapter described the identification of patient attributes relevant to first-line 
treatment decision-making by clinicians for patients with shoulder pain, using focus 
groups with nominal group technique. Employing an iterative series of clinical 
consensus method groups, this study successfully identified 12 of the most salient 
attributes of patients with shoulder pain. The relative importance of each of these 
clinical attributes in differential decision-making is unknown and will be studied in a 
clinical decision analysis study. 
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CHAPTER 5: INTRODUCTION TO CONJOINT ANALYSIS  
 
5.1 Background 
The purpose of this PhD is to examine how treatment effect modifiers can be 
identified and used to underpin the development of an individualised or targeted 
approach to the management of shoulder pain. In the absence of such knowledge, 
clinicians continue to make decisions with their patients about selecting treatment 
for patients with shoulder pain. How exactly clinicians arrive at such individual 
treatment selection for patients with shoulder pain has not yet been explored. The 
rationale underpinning the clinical decision to manage individual patients with 
shoulder pain with education, advice and analgesia in primary care or whether to 
provide/refer them for steroid injection or physiotherapy is currently unknown.  
 
In chapter 4, a series of expert consensus workshops suggested a list of 12 
patient attributes thought to potentially moderate differential shoulder treatment 
response (table 4.6). There is merit and potential in using novel experimental 
approaches to quantitatively appraise clinical decision-making. Therefore the next 
logical step to identify any existing patterns and to develop understanding of how 
differential treatment recommendations are made. Therein, the experientially 
constructed clinical knowledge may be quantified, compared across professional 
groups and countries and the collective clinical opinion gained and quantified.  
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5.2 Study Aim 
Such knowledge has potential to inform the design of a future clinical decision tool 
for GPs and other first-line health professionals, which may facilitate better 
targeting of treatments for patients with shoulder pain. Therefore, this study aimed 
to identify the drivers of clinical decision-making for patients with shoulder pain.  
 
5.3 Rationale for Using Clinical Vignettes to Study Clinical Decision-Making 
 Clinical vignettes or hypothetical patients are often used in health and medical 
education to enable teaching and learning of common clinical patterns such as 
those that fit with diseases and disorders and are often used to study clinical 
decision-making (Converse et al. 2015). Vignettes allow researchers to 
experimentally manipulate the clinical attributes of interest and observe the effect 
on clinical decision-making in an isolated, distraction free environment (Veloski, 
2005). Therefore an experimental method of studying clinical treatment decisions 
when presented with a clinical pattern in the form of a hypothetical patient vignette 
was required.  
 
Vignettes have been used in existing research to study clinical decision-making for 
shoulder pain (Artus et al. 2017, Buchbinder et al. 2013b). The present study 
sought to quantify the impact of each of the patient attributes identified in chapter 4 
on differential treatment decision-making, not individually but when considered 
together in clinical patterns. Although a vignette study would allow researchers to 
identify associations between treatment choice and patient attributes, vignette 
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studies rely heavily on the composition of the vignette. Profiles of likely responder 
and non-responders to each of the three interventions of interest were not known 
at the outset of this study, therefore the most useful vignette composition to offer in 
a research survey were not clear. Since clinicians make clinical decisions on the 
basis of recognisable patterns of patient attributes, the composition of patient 
vignette offered for consideration was very important. Therefore instead of a 
vignette study, a method capable of studying the individual impact of each patient 
attribute when considered as part of a clinical pattern was required.  
 
Such a study would indicate based on clinician decision-making patterns, whether 
or not identified patient attributes are associated with specific treatment decisions. 
Specific differential treatment decisions of relevance to UK primary care include 
the decision to offer the patient with shoulder advice & analgesia or (i) refer the 
patient for assessment and management by a physiotherapist or (ii) provide the 
patient with a corticosteroid injection.  
 
 
5.4 Studying Decisions and Preferences using Discrete Choice Experiments 
Understanding how people make decisions relies on understanding individuals’ 
preferences for the ideal composition of a product, service or item under 
consideration. Two forms of preference exist, revealed preferences and stated 
preferences. Revealed preferences are based on real observed decisions and are 
conclusions from data drawn from the real choices, actions, behaviours of an 
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individual (Bridges et al. 2007).  Stated preferences are responses gained from 
individuals in experimental settings that reveal what an individual says they 
like/do/behave/choose. Stated preferences are elicited using rigorous scientific 
research methods (Bridges et al. that involve study of the choices or preferences 
that individuals exhibit. Revealed preferences could logically be assumed to 
provide accurate preference data since they are less prone to recall and social 
desirability bias. However, revealed preferences are highly situated in the physical, 
emotional and financial contexts in which the decisions occur (Bridges et al. 2007) 
and it is often not possible, practical, or ethical to experimentally study revealed 
preferences.   
 
Stated preference methods enable understanding and quantification of the relative 
importance of various attributes (Johnson et al. 2013). In experimental settings 
these studies, three synonymous terms are used to describe these studies: 
discrete choice experiments (DCE’s), stated choice experiments or stated 
preference experiments. In a DCE, respondents consider a series of hypothetical 
scenarios and indicate their decision based on each scenario (Ryan et al. 2008). 
Each scenario consists of specially chosen and highly relevant attributes of the 
decision (e.g., if studying how people choose to purchase a car, relevant attributes 
of the car might include it’s price, colour, number of doors, fuel economy, and 
other relevant features of a car). The experimental setting offered by stated 
preference research offers the benefits of focused attention on the experimental 
task itself, and reduction of environmental influences, allowing participants to 
respond to the questions exactly as they would like to, not how they feel that they 
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should or are encouraged to as per social or work roles or within the constraints of 
their current reality.  
 
5.5 Theoretical Background to Discrete Choice Experiments 
Underpinning discrete choice experiments are a series of theories and 
assumptions that are common across many aspects of economics. It is assumed 
under consumer theory that respondents are rational decision-makers. Originating 
in the field of mathematical psychology, utility theory concerns statistical modelling 
of choice behaviour, and importantly the determinants underlying a choice 
(Thurstone, 1994). Lancaster’s (1966) utility theory postulates that a consumer’s 
choice of a product, based on preferences for components of any given product 
choice, are ordinal and can be measured and ordered. The facet of utility theory 
that makes preferences measurable is that individuals have testable transitive 
preferences i.e.,  
“if A is preferred to B and B is preferred to C, then one can conclude that A is 
preferred to C” (Bridges et al. 2007, pg. 6). 
 
Random utility theory (McFadden, 1978) suggests that individuals innately, 
whether they realise it or not, hold a set of preferences or beliefs about what their 
ideal product (car/food/house/restaurant/book/credit card/concept being studied) 
looks like and that they place a value at the time of choice on all offered options 
based on the attributes comprising the object (Ryan et al. 2008). This utility is said 
to be random in the sense that at the general population level, it is an individually 
129 
 
constructed set of preferences, unique to the individual. Consumer theory 
suggests that consumers choose the product option that represents the maximum 
value or utility to them, i.e., meets the invisible list of ideals in their mind, whilst 
being balanced by the costs associated with that purchase (price, time, physical 
space etc.).  
 
These assumptions form the basis for the design and conduct of discrete choice 
experiments. Luce & Tukey (1964) proposed the concept of conjoint 
measurement, the measurement of the impact of attributes when presented 
together in bundles. When presented with a series of purchasing options 
comprising of the same attributes but different combinations of these attributes 
(bundles) i.e., different versions of the desired products, consumers assign value 
to each combination based on the composition of the bundles. In doing so, 
individuals make trade-offs to settle upon an ideal balance between costs and 
benefits of the product (Bridges et al. 2011). Therefore, gaining consumer 
responses/reactions to a number of different bundles can allow identification of the 
impact of each attribute on an individual’s decision-making. Marketers try to 
identify different types of shoppers based on how they make product selection 
decisions. This information is then used to guide how best to specify the minimum 
number of product versions that will best appeal to the maximum number of 
potential shoppers in the market. 
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5.6 Use of Discrete Choice Experiments in Health and Medical Research 
In contrast to how economists use DCE’s in marketing research, health 
economists use DCE’s to study how individuals, patients, medical professionals 
and funders differentiate between the costs and benefits involved in decisions 
about health and health care. Although considered a subset of DCE’s, the 
standard convention in the healthcare literature, although contentious (Louviere et 
al. 2010), is to call DCE’s conjoint analysis (Bridges et al. 2011). Studies using 
DCE’s and conjoint analysis in this way have seen increased application to a 
broad range of research involving decision-making in healthcare (Bridges et al. 
2008; Ryan & Farrar, 2000). However, a large proportion of these studies concern 
how patients, care-givers or health professionals weigh up decisions about single 
treatments (Bouma et al. 2001; Danishevski et al. 2007; Kee et al. 1998; 1997; 
MacCormick & Parry, 2006; Witt et al. 2009) or indicate the individual likelihood of 
choosing specific treatments (Timmermans et al. 1997).  
 
5.7 Conjoint Analysis to Study Determinants of Differential Decision-Making 
In contrast, use of conjoint analysis to study differential decision-making making 
between multiple treatment options by either patients or healthcare providers has 
less precedence. A review of medical decision-making studies that used DCE or 
conjoint analysis revealed that a variety of methods were used to study a range of 
different clinical decisions (Bachmann et al. 2008) with few studies assessing 
clinicians’ treatment decision-making. The authors are aware of just a few studies 
that have used a form of DCE to quantify the determinants of differential decision-
131 
 
making in this way (Caldon et al. 2007; de Bekker-Grob et al. 2013; Hifinger et al. 
2017; Langenhoff et al. 2007; McKinlay et al. 1997; Nathan et al. 2011). Table 5.1 
outlines four of the most common designs of DCE’s specifically in relation to how 
they could be used to study clinical decision-making by health care professionals. 
In order to study the determinants of differential decision-making, studies need to 
show respondents hypothetical clinical cases and collect data on treatment 
choices. Menu-based conjoint analysis can be used to study the determinants of 
differential decision-making in this way. 
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Table 5.1 Forms of conjoint analysis and how they relate to clinical decision-making studies 
Discrete Choice 
Experiment Type 
Task Format Question Format Output Relation to Identification of likely 
moderators of differential treatment 
response 
Conjoint Analysis View one hypothetical 
clinical case at a time 
Do you think that this 
patient is likely to 
respond well to 
treatment X?  
(Yes/No) 
Statistical weighting of each 
patient attribute that signifies 
respondents’ thinking on which 
patient is likely to respond well 
to treatment X.  
Statistically weighted profiles of 
likely best responder, where 
impact of each other attribute is 
accounted for in the analysis.  
Similar to a single treatment prognosis 
study, this study would provide insight into 
the clinical attributes that clinicians think 
predict response to treatment X. Even if 
repeated three times for different 
treatment options, this does not assist 
with differential treatment decision-making 
as the attributes would not necessarily 
discriminate between (expected) response 
to different treatment options. 
Choice based 
conjoint analysis 
View two or more 
hypothetical clinical 
cases at once 
Which of these patients 
would do you think 
would respond well to 
treatment X? 
(Choose a patient) 
Maximum difference 
scaling / best worst 
scaling 
View one hypothetical 
clinical case at a time 
Signal one aspect of the 
patient’s presentation 
makes you think that: 
(i) This patient is likely 
to respond to 
treatment X. 
(ii) This patient is not 
likely to respond to 
treatment X 
 
Statistical weighting of patient 
attributes on respondents 
thinking about the attributes that 
are involved in whether a patient 
responds to treatment X. 
In ranked list form, from most to 
least likely to influence 
response. 
Single treatment – as above. 
Even if repeated for many treatments, the 
data is in list form and not a profile. Does 
not help with identification of patient 
profiles or assist with identifying who will 
respond to specific treatment options 
differently. 
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Menu-based conjoint 
analysis 
View one hypothetical 
clinical case at a time 
Choose which of the 
three treatments you 
think that this patient is 
most likely to respond 
best to. 
Attributes are weighted 
statistically for their impact on 
likelihood that one treatment is 
chosen over another. Where 
Treatment A is kept as the 
constant, weighted profile data 
is gained on the patient most 
likely to be recommended to 
receive:  
(i) Treatment B versus A 
(ii) Treatment C versus A 
Multiple treatment options considered at 
once. Relates to differential treatment 
decision-making. Data quantifies strength 
of impact of each attribute on likelihood to 
choose different treatments. Provides 
quantified stated preference on clinical 
decision-making using the included 
attributes.  
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5.8 How Does Conjoint Analysis Work? 
The word conjoint means: ‘combining all or both people or things involved’ (OED, 
2016). In conjoint analysis, the item under consideration is deconstructed into 
attributes and levels so that the impact of each attribute and level on decision-
making can be quantified. In this thesis, the item under consideration is the patient 
with shoulder pain and the decision being studied is which treatment to 
recommend. Attributes refer to the patient attributes deemed relevant to decision-
making, as suggested by clinicians during the consensus workshops (chapter 4). 
Attributes and levels are systematically varied and combined to form hypothetical 
combinations and presented as a series of decision tasks (or patient vignettes in 
the case of deciding between shoulder pain treatments) that is relevant and 
meaningful to the respondents. Conjoint analysis focuses on the trade-offs that 
respondents make in response to each decision task (Bridges et al. 2008). The 
attributes and levels are the independent variables and the decisions made about 
the concept are the dependent variables. Based on responses over a series of 
decision tasks, statistical techniques such as regression analysis can be used to 
regress the independent variables on the dependent variables to determine the 
utility, value or impact of each attribute or level on decision-making at either an 
individual or group level (Bridges et al. 2008; Veldwijk et al. 2016). For example, 
Nathan et al (Nathan et al. 2011) used a conjoint analysis study to determine how 
seven specific attributes of patients with hepatocellular liver cancer were used by 
surgeons to decide on treatment. Respondents viewed ten case vignettes made 
up of various combinations of the attributes and indicated their preferred treatment 
from a choice of four treatment options. Multinomial logistic regression was used 
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to identify which of the seven patient attributes aligned with the decision to refer to 
each of the treatments.  
 
5.9 Role of Conjoint Analysis in this Thesis 
Conjoint analysis, a form of discrete choice experiment, is a robust experimental 
and quantitative methodology that can be applied to the study of clinical decision-
making. It offers advantages over Delphi studies and vignette studies namely; 
ability to present hypothetical patient profiles when the known best responder 
patient profile is unknown and the quantification of the impact of each attribute on 
decision-making, with the impact of every other attribute controlled for. The design 
and conduct of conjoint analysis studies require several methodological decisions 
in order to ensure valid results. These decisions are outlined in the context of a 
study of how clinicians choose treatment for patients with shoulder pain in chapter 
6.  
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CHAPTER 6: METHODOLOGY FOR CONJOINT ANALYSIS 
STUDY OF CLINICAL DECISION-MAKING FOR PATIENTS 
WITH SHOULDER PAIN 
 
6.1 Background 
Chapter 5 introduced the conjoint analysis method and outlined the relevance and 
benefits of using a conjoint analysis study to quantify the determinants of clinical 
decision-making. The rationale for the methodology used in the survey of clinical 
decision-making for shoulder pain is outlined below. The methodology is based on 
the checklist for good practice in conjoint analysis studies produced by the 
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 
(figure 6.1) (Bridges et al. 2011).  
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Figure 6.1: Checklist of conjoint analysis in healthcare (from Bridges et al. 2011) 
 
 
6.2 Aim 
This study aimed to identify the relative importance of patient attributes in the 
decision to refer to GP-led care, physiotherapy or steroid injection in hypothetical 
patients with a shoulder disorder.  
 
6.3 Research Question 
An online conjoint analysis study was designed to investigate clinical decision-
making of health and medical professionals who manage patients with shoulder 
disorders. Although there are accepted differences between what clinicians do and 
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what they say they do, conjoint analysis presents the opportunity to study clinical 
decision-making in a scientific and controlled manner using hypothetical yet 
realistic clinical scenarios that are meaningful to clinicians. Gaining insight into 
how clinicians’ trade-off potential combinations of the 12 clinical attributes 
identified in chapter 4 to make differential treatment decisions could aid 
development of a future first-line clinical decision tool. Conjoint analysis is well 
suited to quantifying trade-offs made by decision-makers in a clinical context 
(Bridges et al. 2011). 
 
6.4 Methods 
6.4.1 Attributes and Levels 
Inclusion of each attribute in a conjoint analysis study must be justified by a strong 
theoretical rationale. Attributes in this study were identified on the basis of a 
systematic review of the literature (chapter 2) and a series of mixed methods 
expert consensus workshops (chapter 4). This mixed methods work was 
undertaken specifically to identify the most parsimonious list of patient attributes 
perceived by clinicians as needed to make an informed differential treatment 
decision. Use of expert, clinical opinion and qualitative research is advised in order 
to identify the most salient clinical features so that the study design may be based 
on commonly considered and logical clinical information (Bridges et al. 2011; de 
Salis et al. 2013).  
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Clinicians involved in this developmental work were made aware that output from 
the work would be used in this conjoint analysis study and as such a number of 
conditions for the selection of attributes were stipulated: (i) relevance of attributes 
to the decision being studied, (ii) that attributes were mutually exclusive, (iii) that 
any level of an attribute must be theoretically combinable with any level of the 
other attributes and (iv) the final number of attributes is not infinite (Orme, 2002).  
 
6.4.1.1   Relevance of Attributes to the Decision 
As described in chapter 4 (workshops), the early lists of suggested moderators 
were very broad and included a wide range of clinical attributes of patients with 
shoulder pain. Consideration of the relevance of each attribute to the decision 
being studied was advised (Bridges et al. 2011), in this case relevance of 
attributes to differential treatment decision-making for shoulder pain. It is also 
suggested that attributes should be considered in the specific context of the 
decision being studied (Bridges et al. 2011). For this study, clinicians were asked 
to consider the common first-line treatment decision-making scenario: a patient 
presents to a clinician with shoulder pain, and the clinical history alone, as 
presented at that time, is used to guide first-line differential clinical decision-
making. 
 
6.4.1.2   Mutual Exclusivity of Attributes 
In conjoint analysis, best convergence of the statistical model occurs when 
attributes are not correlated with each other (Bridges et al. 2008; 2011). This was 
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difficult to apply to the context of a patient with shoulder pain where for example, 
the attribute of pain severity is likely to be highly correlated with levels of 
dysfunction, immobility and impact of pain on the affected individuals life, work and 
hobbies. Although correlation between attributes could not be avoided, the final 
attributes were selected on the basis that they each represented different clinical 
concepts. 
 
6.4.1.3   Theoretical Combinations of Attribute Levels 
Since this study concerns a patient with shoulder pain, as theorised under the 
expertise and pattern recognition frameworks (see chapter 3), certain common 
and naturally occurring patterns in patient attributes are likely to exist in the clinical 
presentation of patients with shoulder pain. Furthermore, there are likely to be 
some instances where a level of one attribute is theoretically but not logically 
combinable with a level of another attribute, e.g., although it is possible that a 
patient could have high pain intensity yet report low impact on sleep or no impact 
on work, hobbies or sport, this is not very likely or indeed logical. Where patients 
present with illogical clinical presentations in clinical practice, clinicians seek 
additional information for clarification.  Therefore possible instances such as these 
were viewed as a pragmatic limitation of the conjoint analysis method. Since this is 
the first conjoint analysis study in shoulder pain, how clinicians might overcome 
such illogical attribute combinations in an experimental setting was unknown. 
Conjoint analysis was deemed to have more benefits than downsides in 
addressing this research question. 
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6.4.2 Number of Final Attributes 
The number of attributes in a conjoint analysis study affects the complexity of the 
decision tasks that respondents are presented with, as each decision task (or 
patient vignette) will be a combination of multiple attributes. Conjoint analysis 
studies typically include three to seven attributes in a study, with most studies 
having six attributes and up to four attribute levels (Marshall et al. 2010). A study 
with a large number of attributes therefore demands a high degree of 
concentration and respondents often resort to simplification strategies (see section 
6.4.3, (Orme, 2002)). Although no exact ‘rules’ exist on the maximum number of 
attributes in a conjoint analysis study, researchers need to consider the impact of 
the number of attributes on the cognitive burden of completing the tasks for 
respondents. ‘Rules of thumb’ suggest that five to seven attributes is a reasonable 
number of attributes to include in a conjoint analysis study (Marshall et al. 2010). 
Six to eight attributes is commonly recommended to reduce potential 
measurement error due to inattention (Bachmann et al. 2008), although examples 
of successful studies with larger numbers of attributes exist (Bouma et al. 2001). In 
spite of the extensive preliminary work undertaken to reduce the list of attributes to 
be included in this study, it was agreed that 12 attributes should be included, even 
though this is remains a large number for a conjoint analysis study.  
 
6.4.3 Construction of Decision Tasks 
Decision tasks in a conjoint analysis study are the profiles that respondents view 
and are required to make decisions based on. Good task design is central to 
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designing an engaging conjoint analysis study that produces reliable data. Tasks 
may be presented using all of the attributes using full-profile methods or 
alternatively, tasks may be presented based on just some of the attributes by 
using partial-profile methods. Partial profile methods allow greater focus on the 
attributes shown however this does not often reflect reality and respondents may 
feel that they do not get a full sense of the object under consideration. Although 
full-profile methods generate more difficult decision tasks, this complexity reflects 
clinical reality hence, it is usual practice to offer full-profile methods in healthcare 
conjoint analysis studies (Bridges et al. 2011).  
 
It has been suggested that when respondents are asked to deal with decision 
tasks with greater than six attributes in a full-profile design they resort to 
simplification strategies or heuristics to manage the complex decisions presented, 
which can lead to over-estimation of importance of too few attributes (Orme, 
2002). A clinical heuristic from clinical practice may manifest in a conjoint analysis 
study where respondents may select a specific treatment option based on only 
one or two attributes, whilst effectively ignoring other attributes, an example in the 
context of this study could be the selection of corticosteroid injection every time a 
profile contained high pain intensity or sleep disturbance, regardless of other 
attributes. Whilst this is a valid concern, the purpose of this study was to identify 
these very heuristics that clinicians use to decide on treatments for specific 
patients with shoulder pain. Given that clinicians are accustomed to weighing up 
the many complex facets of each individual patient’s clinical presentation, it was 
considered unlikely that clinicians would employ inappropriately reductive 
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simplification tactics. Use of full-profile task in this study was undertaken accepting 
therefore that estimates might be deflated due to the selective inattention caused 
by the clinically realistic, yet complex decision task design. 
 
A number of possible conjoint analysis study designs, were considered to study 
the impact of the 12 attributes on differential decision-making for shoulder pain 
treatment. As outlined in table 5.1 (types of conjoint analysis), it is possible to 
show one or multiple hypothetical profiles at once and there are different questions 
that may be asked of respondents facing these profiles. In this study, one 
hypothetical patient profile was shown at a time in each decision task since this 
most closely replicated typical differential treatment decision-making scenarios 
encountered by clinicians during routine clinical practice. Conjoint analysis studies 
may allow respondents to opt out of decision tasks or respond by choosing a 
status quo response if they are uncertain of how best to respond to a specific task 
(Bridges et al. 2011). These options were not offered in this study, as clinical 
practice demands that patients are treated in spite of any clinical uncertainty.  
 
6.4.4 Experimental Design 
Experimental design involves systematically creating decision tasks using the 
attributes and levels to create hypothetical scenarios for respondents to view and 
respond to (Kinter et al. 2012). Experimental design involves a series of design 
decisions on: (i) full factorial or partial factorial design, (ii) use of orthogonal array, 
(iii) balancing design efficiency and statistical efficiency, (iv) blocked design, and 
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(v) dealing with implausible combinations. 
 
6.4.4.1   Full Factorial or Partial Factorial Design 
A full factorial design contains all possible combinations of attributes and levels, 
enabling estimation of all main effects and interactions (Ryan et al. 2008). To 
calculate the number of possible combinations of the attributes, attributes are 
grouped based on the number of levels in each attribute. For each group, the 
number of levels is risen to the power of number of attributes containing that 
number of levels. This number is then multiplied by the next level group to the 
power of the number of attributes with that number of levels. This study contains 
nine attributes with two levels each and three attributes with three levels each 
therefore, the calculation for number of possible combinations is: 2∧9 x 3∧3 
(alternatively denoted 2933) = 13824 possible combinations. As is the case with 
this study, a common disadvantage of a full factorial design is that the number of 
decision tasks is very large (Ryan et al. 2008). 
Since it would not be possible or sensible to ask that respondents respond to all 
13824 combinations of attributes, researchers typically select a smaller, or 
fractional subset of potential combinations to study (Ryan et al. 2008). A fractional 
factorial design offers this but at the cost of reduced capacity to study interactions 
between attributes, which is an accepted limitation of conducting conjoint analyses 
with large numbers of attributes (Ryan et al. 2008). In such circumstances, a main 
effects only design, not estimating all interactions between attributes, can be 
constructed using an orthogonal array.  
145 
 
 
6.4.4.2   Orthogonal Array 
An orthogonal array is a design matrix that indicates which attributes and levels 
should be grouped together into profiles whilst avoiding unnecessary repetition of 
attribute combinations, data redundancy, and allowing representation of the 
attributes and levels in an unbiased manner (Bridges et al. 2008; Kinter et al. 
2012). Thus, an orthogonal array is a very important stage in the design of an 
efficient experimental design (Kinter et al. 2012). A good experimental design 
reduces the number of tasks required of respondents so that respondent interest 
and focus are retained (Kinter et al. 2012). An orthogonal array can be applied to 
study main effects only where the number of decision tasks is mathematically 
defined and reduced compared to also studying interactions (Kinter et al. 2012; 
Louviere, 1988; Ryan & Gerard, 2003). A (2^9)(3^3) main effects orthogonal 
design identified from the SAS catalogue of orthogonal arrays (Kuhfeld, 2005) was 
applied to this study and 36 decision tasks were recommended.  
 
In a fractional factorial design such as this one, where not all possible 
combinations are used, the statistical efficiency of the experimental design is 
dependent on the degree of orthogonality (Kinter et al. 2012). Orthogonality relates 
to the degree to which correlation/co-linearity between the attributes has been 
removed within the experiment (Johnson et al. 2013). Therefore, having chosen 
attributes that are as independent of each other as possible and using an 
orthogonal array as a mathematically modeled method of designing the conjoint 
analysis study, researchers can be confident that the study will return efficient 
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estimation of respondents’ preferences with a low degree of measurement error 
(Hensher et al. 2005; Kinter et al. 2012). The final array used to inform the 
experimental design in this study was also visually examined for level balance, i.e., 
to ensure that each level was shown next to every other level a similar number of 
times (see appendix 6) (Johnson et al. 2013). Composition of the 36 decision 
tasks arising from orthogonal array may be found in appendix 7. 
 
6.4.4.3   Balancing Design Efficiency and Statistical Efficiency 
An optimal experimental design for a conjoint analysis study is one that accepts 
the inherent limitations that arise from balancing statistical efficiency and response 
efficiency (Johnson et al. 2013). Orthogonal designs achieve statistical efficiency 
when studying main effects only. However due to their complex design, decision 
tasks or including tasks that contain implausible combinations may negatively 
impact upon response efficiency (Johnson, 2008; Louviere et al. 2008). Response 
efficiency relates to the impact of cognitive effects such as simplifying heuristics, 
respondent fatigue, confusion or inattention on the degree of measurement error 
(Johnson et al. 2013). Response efficiency was achieved by reducing the number 
of decision tasks that each respondent was asked to complete using a blocked 
design. 
 
6.4.4.4   Blocked Design 
The number of decision tasks arising from the orthogonal array (n = 36) is a much 
more feasible number than the total number (n = 13824) of possible combinations. 
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However, undertaking 36 decision tasks could still take a considerable amount of 
time and effort, and response fatigue amongst respondents is likely to occur and 
impact upon response efficiency. A review of conjoint analysis studies showed that 
most contained the recommended maximum number of seven to sixteen decision 
tasks per respondent (Bridges et al. 2011; Coast et al. 2006; Marshall et al. 2010). 
Where the number of tasks exceeds this recommendation, the design can be 
partitioned into a set number of separate blocks of tasks to be presented to 
subgroups of respondents, to reduce the number of tasks shown to each 
respondent, therein reducing burden on respondents (Kinter et al. 2012). 
 
Therefore in order to minimize time and cognitive effort required of each 
respondent and to maximise chances of gaining high quality data, the 
experimental design was split into three blocks containing 12 decision tasks 
(Johnson et al. 2013). Prior to fielding the study, level balance was manually 
checked within each block of 12 tasks to ensure that each attribute level was 
shown an equal number of times. Any profiles that appeared to have similar 
combinations or obvious patterns in attribute levels were randomly allocated to 
different blocks. Respondents were randomly allocated one of three versions of 
the survey, each version containing 12 decision tasks consisting of hypothetical 
patient profiles with 12 attributes in each profile. Allocation to a block of tasks and 
within block randomisation of the tasks was conducted using randomisation 
sequences from Microsoft Excel. 
 
148 
 
6.4.4.5   Dealing with Implausible Combinations 
Implausible combinations of attributes can be a feature of statistically efficient 
orthogonal designs, since all attributes vary independently and randomly to 
produce a time-efficient subset of potential combinations of attributes and levels 
(Johnson et al. 2013). As discussed previously (section 6.4.4.3), there were a 
small number of implausible combinations in this study. It is possible to remove 
implausible combinations by either removing the affected tasks or to stipulate 
combinations of levels that are prohibited, however whilst these measures may 
improve response efficiency they would do so at the cost of reducing design 
efficiency, leading to imprecise estimation of or inability to calculation the impact of 
each attribute, therefore it is advised to use prohibitions very sparingly or not at all 
(Orme, 2002).  
 
Therefore implausible combinations were left in the design as removing them 
would have compromised design efficiency by interfering with the orthogonal 
design and potentially leading to imprecise estimation of or inability to calculate the 
impact of each attribute (Bridges et al. 2011). Since 12 attributes were being 
tested, which is a large number of attributes by conventional standards, it was 
anticipated that this would amount to a high respondent burden with some 
resultant loss of response efficiency. However, rather than remove tasks or use 
prohibitions to improve response efficiency, the study was run using a blocked, full 
factorial design so that statistical efficiency was retained. Therefore respondents 
were warned that implausible combinations may be present in some of the 
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hypothetical cases, and they were advised to respond as best they could, in spite 
of confusion or difficulty (Orme, 2002).  
 
6.4.5 Preference Elicitation 
Both the experimental design and framing of the decision task have potential to 
affect how respondents make decisions. The aims and future applications of the 
study were outlined and respondents were introduced to the tasks. To reduce the 
impact of professional habits, previous experiences, or beliefs, respondents were 
asked to consider only the clinical information in the hypothetical profiles when 
making their treatment choices and to consider all other, absent clinical 
information to be equal across profiles (Danishevski et al. 2007) (see instructions 
for survey completion, figure 6.2). 
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Figure 6.2: Screenshot of the first page of the survey, including a list of the patient 
attributes included in the study and instructions for completion 
 
 
Each decision task in this study was designed to replicate the routine clinical 
decision-making scenario that occurs when a patient with shoulder pain presents 
to a clinician in clinical practice and a decision on which treatment to recommend 
is needed (figure 6.3). It is accepted that in clinical practice, treatments for patients 
with shoulder pain are often offered as part of a multimodal intervention. The 
systematic review earlier in this thesis (chapter 2) identified very limited conclusive 
findings on moderators of treatment effect, yet the output of the clinical consensus 
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workshops (chapter 4) indicate that clinicians have clear ideas about how they use 
a broad range of information and their experiential knowledge to guide treatment 
decision-making. Whilst it makes sense in clinical practice to offer treatments in 
combination, especially where there is good evidence that the treatment shows 
some effect and is unlikely to be harmful, in this study, respondents were only 
permitted to recommend a single treatment in response to each hypothetical 
clinical case. A single treatment recommendation was requested in order to direct 
clinicians to really think about their decision-making strategies and to choose a 
treatment that was likely to work based on the information provided, rather than 
allowing respondents to choose their habitual, locally common, or departmentally 
preferred combination of treatments that usually work for many of their patients. 
Thus, the act of choosing between treatments enabled investigation of which 
clinical factors are most relevant in differential treatment decision-making.  
 
In order to maximise statistical efficiency, respondents were required to provide a 
response to all decision-making tasks. Lack of response was not permitted since it 
is logical that all presenting patients to a healthcare setting receive a treatment 
decision, even if that decision is just one-off delivery of advice and education. For 
the purposes of the survey, the scenario was defined as every hypothetical patient 
having unilateral shoulder pain. Three treatments options were available: (i) 
education, advice and pain relief, (ii) steroid injection and advice, (iii) 
physiotherapy. Each treatment was defined as per figure 6.3. When little is known 
a priori about how specific decisions are made, such as in this study, it is fair that 
the experimental design method assumes that respondents do not have a 
152 
 
favourite single treatment and that only the variability in the profiles presented to 
the respondent impacts upon the decision made, (Kinter et al. 2012). 
  
Figure 6.3: Example of a decision task 	
 
6.4.5.1 Assessing Validity through Decision Stability 
It is increasingly common to qualify validity of response data by collecting 
additional data on respondent’s level of confidence in responses to the decision 
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tasks (Bridges et al. 2011). The validated decisional conflict scale (O'Connor, 
1995) was originally designed to assess how comfortable and confident patients 
feel with their treatment decision to undergo influenza vaccination or breast cancer 
screening. This scale contains a range of questions about the determinants of 
such health decisions. In the context of assessing the validity of a survey designed 
to study clinical decision-making by health and medical professionals it was 
deemed more relevant to include a range of distinct questions to indicate 
respondents’ satisfaction with the process of taking part in the survey, how 
complete respondents felt the clinical case descriptions were, how likely clinicians 
were to stick with their decision if asked again and also how the survey instrument 
was perceived. Some questions from the original scale were not deemed relevant 
to differential treatment decision-making by health professionals and were 
therefore not used, whilst others were amended to meet this purpose.  
 
Since the wording and constructs of the validated scale were changed, the scored 
and scale elements of the scale are no longer valid. Therefore the modified 
decisional conflict questions will be used and reported separately using descriptive 
statistics.	The questions were posed to respondents after the decision tasks as a 
proxy measure for validity of the conjoint analysis data. Table 6.1 outlines the 
original decisional conflict scale and as well as the modified questions used in this 
study. 
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Table 6.1: Modified decisional conflict questions 
Validated Decisional Conflict Scale Modified Decisional Conflict Questions 
Response options: 
Strongly Agree, Agree, Neither Agree Or Disagree, Disagree & Strongly Disagree 
 
Original Question Wording Action taken for 
this study 
 
Question Wording Used 
1 I know which options are available to me. Re-worded 1 When I made the decisions, I felt that I did not know enough 
about the treatment alternatives  
2 I know the benefits of each option.  Not relevant to this study 
3 I know the risks and side effects of each option.  Re-worded 2 I believe that patients would fully understand the risks and 
benefits of the prescribed treatments 
4 I am clear about which benefits matter most to me.  Re-worded 3 I understood the patients’ views when I made these decisions 
5 I am clear about which risks and side effects matter most.  Not relevant to this study  
6 I am clear about which is more important to me (the 
benefits or the risks and side effects).  
Re-worded 4 When I made the decisions, it was hard to decide if the 
benefits of the treatment were more important than the risks 
7 I have enough support from others to make a choice.  Re-worded 5 All considerations that affected the decision were identified  
8 I am choosing without pressure from others.  Not relevant to this study 
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9 I have enough advice to make a choice.  Re-worded 6 I had trouble making the decisions because important 
information was unknown 
10 I am clear about the best choice for me.  Not relevant to this study 
11 I feel sure about what to choose.  Re-worded 7 I was unsure about which treatment would really be best for 
each patient 
12 This decision is easy for me to make.  Re-worded 8 The decisions were hard to make 
13 I feel I have made an informed choice  Not relevant to this study 
14 My decision shows what is important to me.  Not relevant to this study 
15 I expect to stick with my decision.  Re-worded 9 If asked again, I would expect to stick with my decisions 
16 I am satisfied with my decision.  Re-worded 10 I am satisfied with the decisions I have made 
 Additional 
question 
11 I am satisfied that the process (i.e., survey design) used to 
make the decisions was as good as it could be 
Additional 
question 
12 I believe that patients would comply with the prescribed 
treatment 
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6.4.6 Survey Instrument Design 
Conjoint analysis is a research methodology that morphs survey design with 
experimental features such as randomisation and inferential statistical analysis. As 
will be outlined in chapter 7, the Internet offers the potential to run complex survey 
designs driven by computer logic. In this study, the survey required individual 
respondents to be randomised to receive one of three versions of the survey and 
also the order of main survey questions were randomised to limit any potential 
learning or fatigue effects. Online survey delivery allowed seamless delivery of the 
necessary block randomisation and within block randomisation procedures. Online 
delivery also offered the advantage of providing respondents with prompts to 
minimise missing data through accidental data entry errors, e.g. when respondents 
accidently skip questions or follow the skip question pattern incorrectly which are 
not possible using a paper survey. Furthermore given that the source population 
for this study was unknown, the online survey allowed collection of demographic 
information on respondents who completed the survey as well as those who began 
the survey but did not complete it. 
 
As existing survey software was unable to host a survey using block 
randomisation, the survey instrument was custom designed by a computer 
programmer (Mr. Tim Smale, E-Learning Fellow, Keele University). Data was 
housed on a secure server at the University with Mr. Smale only having access to 
this data on the secure server. In addition to data on treatment recommendations 
and decision stability, demographic information was collected from respondents 
on:  professional background, years of clinical experience, proportion of clinical 
time spent treating patients with shoulder pain, country of clinical practice, 
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proportion of clinical practice that is Government/State funded, post-graduate 
training relevant to management of shoulder pain, and stated frequency of offering 
or referring for each treatment ((i) education, advice and analgesia, (ii) 
physiotherapy and advice, (iii) steroid injection). This data was used to 
characterise the sample and also to explore variability in differential treatment 
decision-making based on professional background and country of clinical 
practice. 
 
Attributes and levels were listed at the beginning of the survey. As these were 
gained from developmental work (chapter 4) with a variety of clinicians who were 
similar to those invited to take part in this study, an explanation of the meaning of 
each patient attribute was not deemed necessary as a pre-curser to the clinical 
decision tasks. Respondents were reassured that the survey was not a test and 
that there was no single correct response to any decision task. The issue of 
implausible combinations potentially being included in the hypothetical cases (as 
outlined above) was explained to respondents. 
 
Although evidence suggests that health professionals are more likely to complete 
web surveys in one sitting, in less time and during work hours (Chizawsky et al. 
2011), a  ‘save and return to survey later’ option was included in the survey 
instrument to enable busy clinicians to complete the survey in multiple sittings if 
required. A progress status bar was included at the bottom of every page of the 
survey to help motivate respondents to keep responding to the survey. Some 
conjoint analysis researchers advocate use ‘cheap talk’, positive motivational 
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statements throughout a conjoint analysis study to encourage completion (Bridges 
et al. 2011). This approach was not deemed appropriate for use with a 
professional audience since it could be considered time-wasting or insincere which 
may have the opposite to the desired effect. A paper version of the conjoint 
analysis study may be found in appendix 8. 
 
6.4.6.1   Piloting 
The survey was piloted on a mixed group of ten clinicians either in person or via 
telephone. Respondents gave real-time feedback on their understanding of 
instructions, questions and tasks as they worked through the survey. Respondents 
were invited to attempt to complete the survey incorrectly, skip questions and to 
attempt to ‘break the survey’ in any way so that the built-in error messages could 
be tested. The pilot indicated that perception of the survey design and fielding was 
positive and that planned error messages worked. Clinicians gave feedback that 
the original order of the attributes in the hypothetical clinical cases did not make 
clinical sense, and made reading each case more difficult. Attributes were 
therefore re-ordered as shown in figure 6.2, allowing the profile to be presented in 
a way that better aligns with the results of a clinical history as routinely conducted. 
 
 
6.4.7 Data Collection 
6.4.7.1   Consent 
As data collection and consent for this study was conducted entirely online, the 
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participant information sheet appeared on the first page of the survey. 
Respondents were required to indicate that they had read and understood the 
participant information sheet and met the inclusion criteria using a series of tick 
boxes (figure 6.4).  Entry to survey required that all boxes were ticked. Failure to 
tick all boxes resulted in respondents being shown a message that stated that this 
survey required only those who met the inclusion criteria to take part and thanked 
them for their interested in the survey. Respondents were advised that they could 
withdraw their consent to participate in the study either simply by closing the 
browser or at a later date, by emailing the lead researcher.  
 
The survey was open for data collection for a three-month period (17th March - 16th 
June 2015). The data collection plan including sample, recruitment, justification for 
mode of delivery and ethical approval will be outlined in detail in chapter 7.  
 
 160 
 
 
Figure 6.4: Consent process 
 
6.4.8 Statistical Analysis 
Only data from those who completed the 12 decision tasks was included in the 
analysis. A ‘save and return to the survey later’ option was built in to the survey. If 
respondents used this feature data was only analysed from those who managed to 
return to the survey later and completed the 12 decision tasks. Following data 
checking and cleaning, analysis included descriptive, statistical and thematic 
analyses to address the research aims. Descriptive statistics were used to 
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describe the characteristics of survey respondents. Demographic information was 
reported for: (i) those who completed the survey, (ii) those who started the survey 
and did not complete it (i.e., assumed withdrawal of consent) and (iii) those who 
started the survey, ran out of time and opted to save and return to the survey later. 
Demographic details provided by respondents were assessed to estimate 
sampling and response bias. 
 
A main effects model was run in this study to gain insight into the impact of patient 
attributes on treatment decisions (Kohn & Corrigan, 2000). Multinomial logistic 
regression analysis can be used to model an outcome with more than two 
categories using multiple predictors (Langenhoff et al. 2007). The treatment 
recommendation in the decision task (three outcome categories) was defined as 
the dependent variable while the 12 patient attributes were defined as the 
independent variables.  
 
In the stepped care model, GP-provided advice and analgesia is a common initial 
treatment approach. Therefore, recommendations for patients to receive either 
exercise and/or manual therapy or corticosteroid injection in this study was 
compared to advice and analgesia in order to ascertain which patient attributes 
drive alternative treatment decisions in patients with shoulder pain. Taking ‘advice 
and analgesia’ as the reference treatment category, odds ratios and associated 
95% confidence intervals were presented in order to highlight the effects of each 
attribute on treatment choice for either corticosteroid injection or exercise/manual 
therapy. Those intervals not containing the null value of 1 were considered to 
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reflect statistically significant results. 
 
Clustering is defined as the degree to which responses are similar within 
anticipated portions of the data. In this study, since individual respondents 
provided multiple responses and the study design was blocked (i.e., respondents 
provided data to one of three versions of the study), clustering was anticipated at 
both block and subject level. Descriptive statistics were generated for the 
demographics of the sample and to summarise the distribution of baseline 
variables across blocks (presented in chapter 8). In the event of the randomisation 
being considered to have been unsuccessful, due to failing to produce similar 
characteristics across each of the three blocks, models were to be run containing 
the nested term for both block and subject. If however, the randomisation 
procedure was considered to have been successful and resulted in similar 
demographics across the blocks, a block term for respondent would not be 
entered into the models.  
 
A term for subject was included in the model given that each respondent provided 
12 responses and data was expected to cluster at the level of the individual. 
Therefore, a random intercept model was used reflecting the hierarchical structure 
of the data with potential clustering of responses within respondents. This may 
also improve model convergence. Anticipated confounders likely to impact on 
patterns of clinical decision-making were controlled for (professional background, 
country of clinical practice and years of clinical experience). Sequential models 
were fitted to first assess the association of each individual attribute with treatment 
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decisions, and subsequently of all attributes (independent variables) with 
treatment decisions (dependent variable).  These are defined as: 
• Model 1: multinomial models including each individual attributes only 
• Model 2: including each individual attribute adjusted for the confounding 
variables  
• Model 3: including all attributes adjusted for confounding variables.  
 
Descriptive statistics were used to present data from the modified decisional 
stability questions to ascertain respondents’ perception of the process of 
completing the conjoint analysis study and it’s acceptability. Free text responses to 
the ‘any additional clinical information required to make this decision’ question 
were mapped against the results regarding potential treatment moderators derived 
from the systematic review and proposed during the workshops to inform judgment 
of whether all relevant clinical information was considered in the process of 
selecting attributes for the conjoint analysis study. 	
 
6.4.8.1   Sample Size 
Deciding on sample size for conjoint analysis in healthcare is challenging (Bridges 
et al. 2011) as a precise formula for estimation of sample size do not exist 
(Marshall et al. 2010). Estimates from previous studies or routinely collected data 
are not available for treatment preferences, treatment decision behaviour, and 
weighted relevance of each attribute in the decision to refer to each of the three 
treatments. In addition, it is not possible to perform an entirely accurate sample 
size calculation for a study that uses a hierarchical (random effects) multinomial 
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logistic model where the outcome is one of three response categories (personal 
communication with a statistician who posed this question to a panel of 
experienced statisticians at Keele University). Therefore, a pragmatic and cautious 
approach was applied.  
 
An event per variable approach can be applied as a rule of thumb to try and 
estimate the sample size required to derive a model that sufficiently discriminates 
between the three treatment recommendations. Typically, in binary logistic 
regression analysis, an event per variable rate of 10 is deemed sufficient for a 
stable regression-based statistical model (Hosmer et al. 2013; Peduzzi et al. 
1996). In the context of multinomial regression with three (rather than two) 
outcome categories, the analysis concerns two comparisons (here: injections 
versus advice & analgesics, and exercise/mobilisation versus advice & analgesics) 
and requires two regression coefficients to be estimated for each attribute. Based 
on these suggestions and what is feasible, a minimum sample size of 10 events 
(in each of the 3 treatment outcome categories) per variable was applied. 
 
Variations in decision-making on the basis of respondent characteristics can 
therefore be incorporated as confounders into statistical analysis (Bridges et al. 
2011). The number of variables in the model is based on the number of attributes 
and confounders being studied and how many levels each attribute or confounder 
has. The total number of dummy variables was estimated (table 6.2) and 25 
variables were entered into the model. Therefore the minimum number of 
responses required was (25X10X3)	 750. However, the figure 750 does not 
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represent a precise sample size estimate but a cautious minimum number of 
responses to decision tasks for this study on the basis of event per variable rate 
and number of response categories only. 
 
Table 6.2: Dummy variables for regression model 
Variable Number of Categories Number of Dummy Variables required 
Pain severity 3 2 
Onset 2 1 
Current Clinical Status 2 1 
Sleep Disturbance 2 1 
Functional and/or Work Status 2 1 
Neck Involvement 2 1 
Previous response to treatment 3 2 
General Health Status 2 1 
Psychosocial Issues  2 1 
Overuse due to Sport, Hobbies or Work 2 1 
Instability and/or Weakness 2 1 
Patient Treatment Preference 3 2 
Country of Clinical Practice 6 5 
Professional Background 5 4 
Year of Clinical Experience 1 1 
Total number of Dummy variables  25 
 
Clusters can be problematic in statistical models as data at aggregate level 
consists of multiple responses from individuals. Therefore the data from this 
sample is not as varied as a random sample without clustering would be, 
potentially reducing the impact of the sample size (Shackman, 2001). This loss of 
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variability caused by clustering is called the design effect, defined as the ratio of 
actual variance to the variance estimated as if in a random sample (Shackman, 
2001). Therefore where clustering is anticipated due to a design effect, the sample 
size needs to be adjusted to take this into account. In order to estimate the design 
effect, data from the first 100 respondents was analysed to ascertain the degree of 
clustering (the intra-class co-efficient). 
 
Preliminary analysis on data from the first 100 respondents revealed that the 
average cluster size was 12. This showed that each respondent provided 12 
responses, i.e., that the data did indeed cluster at the level of respondents as 
hypothesised. The intra-class co-efficient, determined using the variance term 
gained from a multinomial logistic regression model run on data received from the 
first 100 respondents, was calculated as 0.133. The design effect was thus 
estimated as 1 + (ICC * (cluster size - 1)) = 2.46. The number of responses 
needed to account for the design effect was calculated as (design effect X sample 
size estimate = 2.46 X 750) 1845.  Given that each respondent provides 12 
responses each, a recommended minimum number of respondents was calculated 
as (number of respondents needed/number of responses given by each 
respondent = 1845/12) 153.75, rounded up to 154 respondents.  
 
In comparison, an event per variable rate of 20 and multiplied by the number of 
response categories has been recommended for robust multinomial logistic 
regression (Biesheuvel et al. 2008; Hosmer et al. 2013; Pincus et al. 2011). On the 
basis of this and following the same calculation stages outlined above, this 
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amounted to a recommended sample size of 308. 
 
These sample size estimates take into consideration the event per variable rates 
of 10 and 20, the 12 patient attributes and three confounders, the three response 
categories, the expected clustering of data based on a preliminary analysis run on 
the first 100 participants, and the resulting design effect. Since the average 
sample size for conjoint analysis studies in health is 100-300 (Marshall et al. 
2010), it was felt that aiming to achieve complete data from 200 respondents 
represented the mid-way point between recommended sample size based on the 
event per variable rates of 10 and 20 and therefore set a safe minimum sample 
size to set for the study.   
 
6.5 Summary 
This chapter provided an overview of the methodological and design 
considerations involved in conducting a robust conjoint analysis study of clinical 
differential decision-making for patients with shoulder pain. The challenges of 
designing a conjoint analysis study that effectively balances both statistical and 
response efficiency have been explored and the final design constitutes a practical 
balance between the two. A strategy for the recruitment of a multidisciplinary and 
international sample of clinicians who manage patients with shoulder pain is 
outlined in the chapter 7.  
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CHAPTER 7: DEVELOPMENT OF A MULTI-MODAL 
RECRUITMENT STRATEGY USING SOCIAL MEDIA AND 
INTERNET-BASED METHODS TO RECRUIT A 
MULTIDISCIPLINARY SAMPLE OF CLINICIANS TO AN 
ONLINE, INTERNATIONAL RESEARCH STUDY 
 
 
7.1 Background 
In order to study the impact of each of the 12 patient attributes identified in chapter 
4 on differential first-line treatment decisions for patients with shoulder pain, a 
conjoint analysis study was conducted. The rationale and design of this online, 
international research survey was outlined in the previous chapter (6). This 
chapter is focused on the design of a novel multi-modal recruitment strategy to the 
online survey and includes description and discussion of the recruitment results. 
 
As previously discussed in chapter 3 (theoretical underpinning to workshops), first-
line management of shoulder pain is usually carried out by GPs, although in some 
places alternatives exist such as direct access physiotherapy, or musculoskeletal 
assessment/triage services where first-line treatment decisions are made. First 
contact professionals (i.e., GPs and physiotherapists in primary care roles) may 
have developed slightly different approaches to managing patients with shoulder 
pain compare to physiotherapists, who in turn may differ from specialist clinicians 
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(such as rheumatologists and orthopaedic surgeons) who typically see patients 
further along the clinical pathway. It could be hypothesised that for shoulder pain, 
where diagnosis is a challenge, management approaches may also be 
internationally diverse. To date, there has not been a study to explore the 
collective in first-line clinical decision-making for shoulder pain using a 
multidisciplinary and international sample of clinicians, including but not limited to 
GPs, physiotherapists, rheumatologists, and orthopaedic surgeons, also involving 
academic shoulder pain researchers. An international comparison of clinical 
decision-making for shoulder pain has not been conducted. Such a study would 
inform future research and/or the design of a widely applicable clinical decision 
tool to assist clinical decision-making for shoulder pain.  
 
The target population for the planned conjoint survey, investigating clinical 
decision-making for shoulder pain was therefore both international and involved 
clinicians who routinely manage patients with shoulder pain such as GPs, 
physiotherapists, rheumatologists, orthopaedic surgeons, other allied health 
professionals and researchers. To achieve a multidisciplinary and geographically 
inclusive sample from this population, careful consideration was given to a 
recruitment strategy that might prove effective for the needs of the study.  
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7.1.1 The Challenges of Recruiting Clinicians to Participate in Research 
Surveys 
To maximise generalisability and minimise recruitment bias, the source population 
should ideally replicate the target population intended for the future clinical tool as 
closely as possible. However, access to clinicians for research purposes can be 
challenging (Kellerman & Herold, 2001). Barriers to the engagement and 
recruitment of clinicians in research studies commonly include lack of time, lack of 
interest in the research question (Braithwaite, 2003; Kellerman & Herold, 2001; 
Rahman et al. 2011) and, the tension for clinicians between clinical practice and 
participating in a study that does not reflect clinical reality, due to the constraints 
and limitations of empirical scientific enquiry. For data protection reasons, 
researchers are typically granted limited access to national and international 
databases of clinicians in healthcare systems or professional societies 
(Braithwaite, 2003; Rahman et al. 2011). Therefore large-scale studies involving 
clinicians as research subjects are challenging.  
 
Despite some national professional registration bodies and professional interest 
societies such as those in the UK (Chartered Society of Physiotherapy (CSP), 
Royal College of General Practitioners (RCGP), British Society for Rheumatology 
(BSR), and British Orthopaedic Association (BOA)) having existing databases and 
mailing lists, member confidentiality precludes researchers having access to these 
databases and using these to recruit survey participants. Furthermore, accessing 
equivalent international mailing databases could prove difficult and a lengthy 
process. An alternative method of approaching clinicians by post or email is to use 
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commercial clinician databases such as the UK’s Binley’s databases. However, 
using such commercial databases internationally would be costly and would not 
give a specific list of clinicians interested in shoulder pain management.  
 
In addition, since this study was part of a PhD, a number of further practical issues 
required consideration: the study needed to recruit a sufficiently large sample 
within a relatively short period of time and at minimal cost. Given these challenges 
to the recruitment of a valid, representative and generalisable sample, a 
systematic framework to target this unfixed international population of relevant 
professionals was required. The opportunities and challenges of common and 
internet-mediated methods for recruitment are outlined in table 7.1. 
 
7.1.2 Using the Internet to Recruit Research Participants  
The Internet has progressed from being a resource that offered one-way 
interaction via Web 1.0 where information was received only, to an interactive 
medium via Web 2.0. Web 2.0 enables participation and interaction with online 
content. The Internet has changed from what once was a place for transaction and 
non-social communication to a social medium (Veletsianos, 2011), where users 
can interact socially and maintain and develop personal, social and professional 
connections. This change means that the Internet can be utilised in research 
studies for data collection but also has potential for use as a recruitment tool. 
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A variety of internet-mediated methods for attracting research participants are 
already in existence and include email invitations, Internet advertising, online 
message boards and more recently social media (Twitter, Facebook, LinkedIn, 
Google+) (Lane et al. 2015). Internet-based recruitment methods have been 
shown to be effective at reaching large, diverse pools of potential respondents 
aiding external validity whilst also reducing cost compared to traditional 
recruitment methods (Lane et al. 2015; Ryan, 2013). Furthermore there are many 
potential benefits of internet-based research, which include: being less costly to 
set up; recruit to and deliver in reduced time; lower risk of error in data entry 
compared to paper surveys; easier, quicker and more enjoyable to complete for 
respondents (perception of novelty); greater anonymity than paper surveys; 
increased pool of potential participants (increased generalisability); and 
researchers have control over the content, timing and initial targeting of online 
recruitment (Ahern, 2005).  
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Table 7.1 Advantages and disadvantages of survey recruitment methods 
Recruitment Method Advantages Disadvantages 
Word of mouth Low effort. Low cost. Fast. Narrow reach. Relies on access to population. Difficult to 
calculate response rate. 
Conferences & 
Networking events 
Access to engaged and relevant audience. More effort. Appropriateness of invitation depends on 
attendee demographics on that specific occasion. Difficult to 
calculate response rate. 
Postal flyers Personal delivery of invitation in physical form to relevant 
individuals. Possible to calculate response rate. 
Need access to postal or email address lists of relevant 
professionals. Moderate cost. Time intensive 
Notice boards Low cost. Low effort.  Narrow reach. Difficult to calculate response rate.   
Email invitations Low effort. Low cost. Quick and easy to forward. Possible 
to calculate response rate.  
Spam filters may block emails. Easy to ignore.  
Radio/Television Broad reach. Novelty.  High cost. High effort. Targeting of specific audience 
demographic or numbers difficult. Difficult to calculate 
response rate. 
Online message boards Low cost. Low effort. Novelty. Potentially wider reach. No guarantee on audience. Difficult to 
calculate response rate. 
Local/network/professional/
society 
mailing lists 
Access to large volume of relevant potential respondents. 
Possible to calculate response rate 
Access not guaranteed due to data protection policy of each 
organisation. Variable cost. Limited to information held on 
individuals. Potential for information being out of date.  
Commercial mailing lists Access to large volume of relevant potential respondents. 
Possible to calculate response rate. 
High cost. Each mailing list relevant to one country and one 
professional group only. Mailing lists often not specific to 
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clinical interest within professional group. 
Personal/professional 
networks 
Access to relevant potential respondents. 
Personal/professional connection may increase response 
rate. Low effort. Low cost. Fast. 
Reach limited only to those known to the researchers.  
Internet approaches (study 
adverts on professional 
society/interest websites) 
Moderate effort. Fast. Low cost. Likely to be viewed by 
relevant professionals. 
No control over impact of advert. 
Social media Low cost. Fast. Broad potential reach.  Uses existing 
personal/professional networks. Acceptable to approach 
those who are not in researcher’s network. Facilitates 
social sharing/snowballing. Crosses professional and 
geographical boundaries. 
Challenging to achieve good engagement. Relies on pre-
existence of a diverse and functioning social network. 
Multi-modal  
approach 
Cover broader demographic and geographical. Take 
advantages of existing networks as well as opportunities 
offered by Internet-mediated methods. 
More time, effort and cost required. Unable to calculate a 
response rate for entire approach.  
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In spite of the many studies that have shown that Internet-mediated research and 
recruitment are effective, concerns still prevail regarding the risk of selection bias 
in an internet-based study, as Internet mediated research is less likely than 
traditional recruitment methods to include certain sections of a population e.g., 
older people and those without access to the Internet (Frandsen et al. 2014). Early 
studies that employed Internet methods for recruitment and/or data collection 
reported that respondents were younger, more educated, predominantly white and 
were of a higher socioeconomic classification compared to paper-based surveys 
(Houston & Fiore, 1998). Whilst this is a valid research concern, a review by Ahern 
(2005) found numerous studies that report no differences in respondent 
characteristics between respondents when comparing Internet and traditional 
paper and pen research. As use of both Internet and social media continues to 
increase, the demographics of users expand to represent the general population 
more closely.  
 
Lack of access is reported to be a significant limitation of Internet-based studies 
and a greater issue than simply a lack of willingness to participate (Couper, 2007; 
Gjestland, 1996). Whilst this was probably a valid concern in 1996, some 20 years 
later a 2016 report on the use of media by UK adults by the communications 
regulator, Ofcom (2016) suggests that the use of the Internet, email and social 
media has increased substantially over the last 10 years with 87% of the UK 
population using the Internet at least once weekly. Time spent online by UK adults 
has almost doubled since 2005 and although the computer (desktop, laptop or 
 176 
notebook) is the primary Internet access device, two thirds of adults now use 
alternative devices including smart phones and tablets. It is estimated that 79% of 
UK adults who use the Internet, use email on a weekly basis on a range of 
devices. Increasing from 30% in 2005, in 2016 73% of UK adult Internet users 
have at least one social media account, of whom 65% access social media daily. 
Although younger people (aged 16-24 years) have traditionally been and remain 
the highest users of social media, adults in all other age categories shown 
markedly increasing use of social media (the last ten years have seen 68% 
increase in those of 35-44 years, 61% increase in those of 45-54 years, 41% in 
those of 55-64 years and 25% increase in those over 65 years) (Ofcom, 2015). 
Thus Ofcom Internet usage statistics demonstrate an ever-increasing uptake in 
internet and social media usage across age ranges which suggests that in the UK 
at least, previously reported differences in Internet access and uptake of Internet-
mediated research on the basis of age alone appear to be less stark than 
previously thought. 
 
As this study aimed to recruit qualified health professionals, it was assumed with a 
high degree of confidence that general utility of the Internet, email and social 
media would be high enough to warrant use of an Internet and social media 
recruitment strategy. Confirmation exists that health and medical professionals 
already use social media and online resources for the purposes of professional 
interaction and digital scholarship research, interaction and promotion of existing 
and current studies through the Internet (Thackeray et al. 2012; Ventola, 2014). 
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These developments are likely to lead to an increase in response rate to online 
research surveys compared with 20 or even five years ago. With the increased 
online population, the anticipated source population is likely to increase. Higher 
response rates may lead to obtaining a sample that better reflects the target 
population, reducing the risk of selection bias, as explained above. Furthermore, 
higher response rates may also increase precision of estimates drawn by any such 
study.  
 
7.1.3 Internet-mediated Recruitment Methods To Sample From A Known 
Source Population 
Using email to distribute invitations to participate in research to known pre-defined 
lists of health professionals and researchers is the modern equivalent of posting 
invitations to participate in research. Whilst other methodological possibilities for 
using the Internet to recruit individuals exist, these come with challenges such as; 
differentiating between known and unknown populations, and weighing the pros of 
access versus the cons of bias. Pre-existing groups on Internet forums or social 
media websites can share some of the same characteristics as a predefined 
mailing list in that they are easily located and the number of individuals in the 
group is quantifiable. Although it is difficult to estimate how many group members 
still use the online group at the time in which the research is conducted, this is also 
a consideration with traditional mailing lists.  
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7.1.4 Internet-Mediated Recruitment Methods To Sample From An Unknown 
Source Population  
Traditional recruitment methods include delivery of research invitations via word of 
mouth such as in person during conferences or shoulder-specific professional 
events. These methods are likely to capture a specific audience, but require 
orchestration and are time intensive. Therefore additional methods of interacting 
with and gaining input from relevant professionals were indicated, including 
internet-mediated snowballing methods using Internet and social media. For all 
these approaches, the source population is unknown, which means that a clear 
sampling frame cannot be defined, and response rates cannot be estimated. 
 
Social media can be defined as the various online platforms used as modes of 
connection with a wide variety of people. Recruitment to health and medical 
research studies via Internet and social media platforms is increasingly prevalent 
(Bull et al. 2013; Frandsen et al. 2014; Kapp et al. 2013; Ramo & Prochaska, 
2012) however, few studies of which we are aware, have used Internet and social 
media platforms to recruit clinicians as research participants.  Woodfield et al. 
(2013) describe social media as providing multiple channels for communicating 
with potential research participants. Success of an Internet-based recruitment 
strategy relies upon tailoring existing approaches to recruitment and the use of 
creative and engaging communication methods (Moloney et al. 2009). Much in the 
same way as traditional research relies on clarity, transparency and the reputation 
of the research team; social media creates the opportunity to rapidly build an 
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online network of relevant individuals. In the approach described as ‘networking 
the networks’ (Madia, 2011), the developed network may then act both as part of 
the sample and also assist with the recruitment approach.  
 
7.1.5 Multi-modal Recruitment Strategy 
Several studies on recruitment to online studies state that good uptake and 
response rate from the population of interest is obtained when multi-modal 
methods of study advertising and recruitment are applied (Frandsen et al. 2014; 
2016; Khatri, et al. 2015; Topolovec-Vranic & Natarajan, 2016). Having considered 
the alternatives, it was clear that a novel sampling and recruitment methodology to 
overcome the limitations of traditional survey recruitment methods was required 
and that this may involve using social media. Therefore, in order to overcome 
potential challenges of recruiting a broad, international group of clinicians and 
researchers, a hybrid approach to recruitment was considered that involved both 
traditional and internet-mediated methods. This hybrid approach sought to blend 
traditional offline methods inviting specific, predefined groups, with Internet-
mediated and social media-driven approaches, using snowball-sampling 
techniques. The approach is described in detail here, as despite the increasing 
use of social media as a research and recruitment tool, few studies have provided 
insight into the development of their social media strategy when Facebook or other 
forms of social media or Internet resources have been used as the primary 
recruitment method (Alessi & Martin, 2010). 
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Using social media is a cost effective means of efficiently engaging with and 
recruiting a diverse range of people in health research studies (Ryan, 2013). In the 
context of research, social media is a highly advantageous vehicle to facilitate 
social recruitment and to maximise the impact and distribution capacity of an 
existing professional network beyond solely those known personally to the 
researcher. Sharing the research invitation on social media facilitates snowball 
sampling. When an individual, group, society or business view the research 
invitation and opt to share or ‘re-tweet’ the research invitation, endorsement or 
support of the research invitation is implied (Temple & Brown, 2011). Such implied 
support indicates that the invitation was well received which enables the invitation 
to permeate another degree of social connection, therein delivering the invitation 
to individuals who the researcher would not have had connection with or direct 
access to otherwise. Child et al. (2014) refer to this social sharing as lateral 
communication that has a ‘multiplier effect’. In the context of online surveys, the 
snowball sampling approach, whereby invitation is sent to the researchers 
professional and personal network for redistribution is an efficient and valid 
approach to recruiting an unknown population (Benfield & Szlemko, 2006). 
Although Internet-mediated recruitment methods lend themselves more readily to 
this social sharing or snowball sampling method, the same principles apply to 
traditional recruitment methods of word of mouth, poster displays, and postal 
invitations as potential respondents are asked to share the research invitation with 
their professional network.  
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There are a number of potential challenges to the utility of a multi-modal 
recruitment strategy in addition to the known challenges from traditional survey 
recruitment methods, such as the differences between those who typically respond 
and those who do not (Couper, 2007). Coverage errors can occur where there is a 
mismatch between the target population and those actually sampled, for example, 
if some of those invited are not regular internet users (Couper et al. 2007). As a 
consequence, the multi-modal recruitment approach has been designed to try to 
take these limitations into consideration. An additional limitation is that open, 
unrestricted online surveys, have to accept the risk that respondents may not 
actually be who they say they are and even that computer programmes may have 
been used to create spam data or that respondents may have completed the 
survey multiple times to create a ‘ballot box stuffing’ effect (Couper, 2007). This 
chapter describes the development and operationalization of the hybrid 
recruitment strategy used to address these limitations and recruit to this online, 
international research survey. 
 182 
7.2 Methods 
 
7.2.1 Multimodal Recruitment Strategy 
Recruitment to this study occurred over a three-month period between 18.03.15 
and 18.06.15. Eligibility criteria for the survey were: being a qualified clinician 
(general practitioner, orthopaedic surgeon, rheumatologist, physiotherapist of 
other professional) who manages shoulder pain as part of their routine clinical 
practice or researcher/academic with an interest in the management of shoulder 
pain. The recruitment target was to collect complete data from 200 participants 
during this 13-week period. A multi-modal recruitment strategy was designed to 
maximise the networking potential of the study team and professional networks in 
a co-ordinated manner to distribute and spread the survey invitations as widely as 
possible across professional and geographical boundaries (table 7.2).  
 
Traditional recruitment methods in this study included: 
I. Flyers advertising the research survey with a web link were displayed in the 
Research Institute and University’s Physiotherapy & Medical Schools, and 
also sent to local and regional hospitals with physiotherapy and shoulder 
rehabilitation departments (n=120) 
II. In-person survey invitations were delivered during an invited guest talk at an 
international conference (n= 180) and research flyers distributed at a multi-
disciplinary shoulder rehabilitation training course in the UK (n=360) 
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III. Postal research flyer invitations were sent to professional networks (n=1000) 
including local, regional and national general practice doctors, 
rheumatologists, orthopaedic surgeons and physiotherapists known to the 
study team 
 
Internet-mediated snowball recruitment methods in this study included: 
I. Survey invitations were distributed to the professional network of the study 
team and Research Institute via e-mail 
II. Study adverts were placed on websites of relevant professional bodies and 
special interest groups (table 7.3) 
III. Study adverts distributed via the electronic/email newsletters of relevant 
professional societies/groups (table 7.3) 
IV. Study adverts placed on social networking websites (Twitter, Facebook, 
LinkedIn, and Google +) using a targeted social media strategy 
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Table 7.2: Overview of the Targeted Recruitment Strategy for the Conjoint Survey 
Method Professional Background Targeted Country Targeted 
General 
Practitioner 
Physiotherapist Orthopaedic 
Surgeon 
Rheumatologist Other relevant 
professional 
UK Non-UK 
In Person - Network 
 
- Network 
 
- Network 
 
- Network 
 
- Network 
 
- Yes 
 
Norway 
Sweden 
Denmark 
Displayed Flyer - N/A 
 
- Network - S.R.U. - Network - S.R.U. - N/A 
 
- Network 
 
- Yes 
 
- N/A 
 
Postal Flyer  - Network 
 
- Network - Shoulder 
Units 
- Network - Shoulder 
Units 
- Network 
 
- Network 
 
- Yes 
 
- N/A 
 
Twitter - Network - Societies - Individuals - Network - Societies - Individuals - Network - Societies - Individuals - Network - Societies - Individuals - N/A  - Yes  Worldwide 
Facebook - N/A 
 
- Network 
 
- N/A 
 
- N/A 
 
- N/A 
 
- Yes 
 
Worldwide 
LinkedIn - Network 
 
- Network 
 
- Network 
 
- Network 
 
- Network 
 
- Yes 
 
Worldwide 
Google+ - Network - Network - Network - Network - Network - Yes Worldwide 
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E-mail invitation 
from Study 
Team 
- Network - Network - Network - Network - Network - Yes 
 
Worldwide 
E-mail invitation 
via other party 
- Societies - Societies - Societies - Societies - Societies - Yes 
 
Worldwide 
Internet adverts - N/A - Network - Societies - N/A - N/A - N/A - Yes 
 
Worldwide 
Abbreviations: 
 
N/A = Not applicable 
Network = Professional Network of the Research Institute for Primary Care Sciences, Keele University 
Shoulder Units = Shoulder Rehabilitation Units in the National Health Service (NHS, UK) 
Societies = Professional Body/Society/Organisation relevant to professional background and clinical practice as a shoulder specialist 
Individuals = Relevant individuals with Twitter accounts identified via the Hootsuite computer application 
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Table 7.3: Additional recruitment measures used for the shoulder pain conjoint analysis study 
Parties Sharing Research 
Invitations on behalf of the 
Study Team 
Mode of 
Recruitment 
Relevance to Target 
Population Professional Background Targeted Country Targeted 
British Society of 
Rheumatology (BSR) Email mailing list Professional association Rheumatologists UK 
European Society for Elbow 
and Shoulder Rehabilitation 
(EUSSER) 
Email mailing List Professional Interest Group Physiotherapists & Shoulder Surgeons Europe 
Irish Society of Chartered 
Physiotherapists (ISCPT) Email mailing list Professional Body Physiotherapists Republic of Ireland 
British Orthopaedic 
Association Email mailing list Professional association Shoulder Surgeons UK 
Society for Orthopaedic 
Medicine (SOM) Email mailing list Professional Interest Group Physiotherapists International 
Primary Care Rheumatology 
Society Email mailing list Professional Interest Group Physiotherapists & Shoulder Surgeons UK 
European League Against 
Rheumatism (EULAR) Email mailing list Professional Interest Group Physiotherapists & Shoulder Surgeons Europe 
Physiospot Online study advert  Professional interest website Physiotherapists International 
Chartered Society of 
Physiotherapy (CSP) Online study advert  Professional Body Physiotherapist UK 
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The professional network of the study team consisted of the informal professional 
(clinical and research) email contacts of the study team members and a few 
departmental colleagues. Prior to this study, members of the team were not active 
professional social media users but set up social media accounts specifically for 
recruitment purposes for this study. Examples of individuals within this network 
include: members of national and international professional bodies, shoulder pain 
clinical interest groups, authors of randomised controlled trials in the field of 
shoulder pain conducted within the last 10 years, editors of journals that routinely 
publish research on shoulder pain, and clinicians working as clinical shoulder 
specialists.  When contacted, recipients were requested to distribute the invitation 
onwards through their individual networks i.e., snowball distribution of the survey 
invitation, where the initial distribution was targeted to those who met the eligibility 
criteria. The professional bodies and special clinical interest targeted for the 
survey (table 7.3) were relevant to the topic of the survey (clinical management of 
shoulder pain), but exact information regarding active membership of each of 
these groups was not known, as the study team did not have direct access to 
mailing lists.  
 
7.2.1.1   Targeted Social Media Strategy 
An effective social media recruitment strategy needed to be broad enough to 
target all relevant professionals with an interest in shoulder pain, both nationally 
and internationally. Generic invitations, personal invitations and group invitations 
were extended via social media networking sites. All invitations specifically 
included the request to share the invitation with further personal and professional 
networks. Generic invitations consisted of a brief outline of the study and who was 
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required to complete it. Study adverts were placed periodically on LinkedIn 
(LinkedIn, Co., California, USA) (figure 7.1) and Google+ (Google, Inc., California, 
USA) (eight times), and (figure 7.2). A specific profile page for the study named 
‘Physio Shoulder Researcher’ was set up on Facebook (Facebook, Inc., California, 
USA) (figure 7.3). Adverts were placed on the Facebook page (eight times). On 
each social media platform, visitors could re-post information or updates for others 
in their network to view, interact with or share. Tables 7.2 and 7.3 show the variety 
of over-lapping traditional and recruitment methods used to recruit individuals from 
each professional group. Figure 7.5 (in results section) shows the timing of 
delivery of each strand of the recruitment strategy.  
  
	
Figure 7.1: Example of Recruitment Post on LinkedIn website 
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Figure 7.2: Example of Recruitment Post on Google+ 
 
The social media website Twitter was extensively used to extend both individual 
personal and group invitations to participate in this research study (figure 7.4). 
Blogging is the term for creation and curating of online Internet content. Distinct 
from the other forms of social media listed above, Twitter is a form of micro-
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blogging, whereby the content of each post, message or ‘tweet’ is limited to 140 
characters. Twitter is a very fast and concise mode of communication and social 
networking and is therefore, an attractive recruitment method for delivering short, 
enticing messages to individuals, groups and professional bodies that meet the 
inclusion criteria.  
 
 
	
Figure 7.3: Example of Recruitment Post on Facebook 
 
 191 
	
Figure 7.4: Example of Recruitment Post on Twitter 
 
 
7.2.1.2   Optimisation of Twitter as a Recruitment Tool 
In total, 363 tweets were sent from the Twitter account of the researcher during the 
recruitment period.  The majority of tweets sent by the researcher contained a 
URL web link the study (www.keele.ac.uk/shoulder), requested for the invitation to 
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be shared, and used informal and friendly language to encourage interaction and 
participation. The computer application FollowerWonk was used in conjunction 
with the personal and professional networks of the research team, to identify 
individuals, societies, groups and organisations matching the inclusion criteria.  
 
Followerwonk was used to search the biographical information provided on Twitter 
users’ profiles for the keywords: shoulder, upper limb, physiotherapy, physical 
therapy, medicine, doctor, general practitioner, family medicine, rheumatologist, 
orthopaedic surgeon. A list of relevant accounts of relevant individuals, groups and 
societies with high ‘social capital’ was formed and these became the recruitment 
targets for this study (appendix 9). Followerwonk was also used to provide an 
indication of the most active times for the identified Twitter profiles. Tweets were 
sent to the recruitment targets as personalised, friendly yet professional 
invitations. On the basis of the identified most active times of Twitter profiles 
followed by and followers of the researcher (7am, 11a, 1am, 3pm, 4pm, 7pm, 9pm 
and, 11pm) social media posts were scheduled to be sent during these times 
using a computer application, Hootsuite (Hootsuite Media, Inc., Vancouver, 
Canada). Hootsuite was used in order to optimise time and resource management 
throughout the recruitment period and also to ensure that the research invitation 
featured regularly on the stream of tweets appearing on Twitter. 
 
In order to widen the international reach of the recruitment strategy, tweets were 
sent in multiple languages (Spanish, French, & Italian) to large international 
professional organisations including many large professional bodies. To make the 
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tweets impactful on the Twitter page, pictures of shoulders, a QR code for the 
study website and twitter hashtags #ShoulderResearch, #shoulder and #research 
were interchangeably used. Use of Twitter in the recruitment strategy evolved 
iteratively as the researcher monitored the level of interactions with tweets and 
amended the strategy as indicated. 
 
7.3   Results 
7.3.1 Observed Trends in Recruitment Modes of Access  
In total, the survey was accessed 2700 times by 2326 individuals during the three-
month survey recruitment period. Data was received from 1915 respondents. Data 
was categorized into complete data, partial data and unusable data. Complete 
data, defined as having provided an answer to every question on the survey was 
received from 387 individuals (20.2% of those who began the survey and 12.3% of 
those who accessed the survey). Partial data, defined as having completed at 
least all of the demographic data, was received from 178 individuals. Unusable 
data, defined as having started the survey but not completed the demographics 
questions, was received from 1350 individuals.  
 
Data from Google Analytics (http://www.google.com/analytics) (appendix 10) was 
used to determine how each respondent accessed the survey and also to explore 
the performance and impact of each of the recruitment methods (table 7.4). The 
greatest proportion of respondents accessed the survey via a direct internet 
address link (n=1029, 54%), most likely to have been gained from either a direct or 
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snowball circulated email from the researcher or from a postal flyer that was either 
individually received at a conference, via postal mail or seen displayed in a 
hospital or university setting. Internet-mediated and social media recruitment 
approaches accounted for 46% of the total survey data. Of these internet-
mediated approaches, Twitter accounted for 29% of the survey data with other 
approaches contributing smaller proportions. Over 30% of the complete and 
partially complete data (n=565) was received within the first week, 50% within four 
weeks and 75% within 6 weeks (table 7.5). The survey was closed after 13 weeks. 
 
Table 7.4: Respondents by survey access mode 
Access Route No. of Respondents % of Total Respondents  
Email or flyer 
(Direct webpage link) 
1029 54% 
Twitter 552 29% 
Facebook 100 10% 
Physiospot 72 4% 
CSP 52 3% 
Google 41 2% 
LinkedIn 1 <1% 
Other online sources 68 4% 
Total 1915 100% 
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Table 7.5: Response Rate over Time 
Week 
 
Responses Received % of Total Cumulative Total 
1 176 31% 31% 
2 53 9% 41% 
3 11 2% 42% 
4 44 8% 50% 
5 42 7% 58% 
6 29 5% 63% 
7 61 11% 74% 
8 41 7% 81% 
9 72 13% 94% 
10 12 2% 96% 
11 8 1% 97% 
12 9 2% 99% 
13 7 1% 100% 
 
 
Demographic details of those classified as complete responders and partial 
responders are presented in table 7.6. Data was received from 31 different 
countries, which were grouped according to similarities in model of healthcare 
provision.  Physiotherapists (66% of respondents) and professionals from UK & 
Republic of Ireland (64% of respondents) constituted the largest professional 
group and geographical region respectively of responders to the survey. Complete 
responders had more years of clinical experience (16.3 versus 13.1 Years), and 
more complete responders than partial responders reported that their primary 
clinical role was working in a state-funded healthcare system (100% versus 88%). 
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Table 7.6: Demographics of Complete and Partial Survey Responders 
 Total 
Responders 
(n=565) 
Complete 
Responders  
(n=387, %n) 
Partial 
Responders 
(n=178, %n) 
Professional Background 
Physiotherapist/ 
Physical Therapist  
371 255 (66%) 116 (66%) 
General Practitioner/ 
Family Doctor/ 
Primary Care Medical Physician 
75 60 (16%) 15 (8%) 
Rheumatologist  36 21 (5%) 15 (8%) 
Orthopaedic Surgeon  15 8 (2%)  7 (4%) 
Other relevant professionals 68  43 (11%) 25 (14%) 
Country of Clinical Practice 
UK & Republic of Ireland 352 263 (68%) 89 (50%) 
Netherlands, Norway, Sweden & Denmark 67 43 (11%) 24 (13%) 
Germany 3 2 (<1%) 1 (<1%) 
Australia & New Zealand 28 20 (5%) 8 (5%) 
USA & Canada 50 26 (7%) 24 (13%) 
Rest of World 65 33 (9%) 32 (18%) 
Years of clinical experience: 
Mean (std. dev.) 
565 16.3 (9.8) 13.1 (10) 
Primary clinical role in state-funded health 
system 
565 387 (100%) 157 (88%) 
 197 
The 363 recruitment tweets were viewed on average 1400 times per day over the 
first 60 days of recruitment with a total of over 85000 views over the three-month 
recruitment period. Tweets were shared in total 286 times via retweets, likes and 
on nine instances via email. Each tweet received on average 235 views. Of the 
85575 tweet views, the Internet address link was accessed in 0.0065% of views 
(563 times). 
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Figure 7.5: Recruitment Timeline 
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7.4   Discussion 
This chapter provided a detailed description of a multi-modal international 
recruitment strategy for an online survey involving a range of health professionals 
and researchers interested in the management of patients with shoulder pain. The 
recruitment strategy was considered successful as it exceeded the recruitment 
target of complete data from a multi-disciplinary and international sample of 240 
participants within the defined recruitment period, with 387 complete responses 
received. Respondent demographics (Table 7.6) indicate that the multi-modal 
recruitment strategy enabled recruitment of a sample from a large number of 
countries, professional disciplines, healthcare settings and ranging experience. 
Respondent demographics indicate that participants were similar to the intended 
target population, and that characteristics of complete responders were largely 
similar to partial responders.  
 
Given that recruitment used professional network-based snowball methods, it was 
not possible to calculate a response rate, however the survey access/completion 
rate was 20.2%. This access/completion rate is lower than the average 33% 
response rate in web surveys of the general public  (Shih & Fan, 2009). In 
comparison, response rate amongst health professionals appears to vary 
according to professional background with Bishop et al. (2008) reporting an 
average response rate of 38% in a postal cross-sectional population survey of 
clinicians  (22% for GPs and 55% for physiotherapists), and with physiotherapists 
also returning a higher response rate of 58% in a more recent postal survey 
(Bishop et al. 2016; Kellerman et al. 2001). However the access/completion rate in 
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this study is in line with the 21-26% average response rate observed in cross-
sectional postal surveys of GPs (Lane et al. 2015; Cottrell et al. 2015).  
 
7.4.1 Strengths of the Multimodal Strategy 
The main strengths of the multimodal strategy used were that barriers of 
geographical boundaries, international timelines, cost and time spent were 
minimised, with participants successfully recruited across international borders 
and professional backgrounds (table 7.6), in a short period of time and at minimal 
cost. Limited scope for international participation has been cited in the past as a 
weakness of web surveys (Lane et al. 2015; Ahern, 2005; Ryan 2013). However, 
using a multi-modal internet-mediated recruitment strategy, this study obtained 
response data from 31 different countries over a three-month period. The 
combination of multi-modal recruitment strategies delivered in parallel and in 
sequence resulted in a high level of engagement with the survey; with over 30% of 
survey data received within the first week (figure 7.5). This indicates that the multi-
modal research strategy delivered on its potential to rapidly engage and direct an 
unknown, professionally diverse and geographically spread target population to an 
online survey. Furthermore, the observation that nine individuals shared a tweet 
sent by the researcher via email indicates that the target population does indeed 
use multiple forms of communication including social media to collate and share 
information with peers. These emails represent multi-modal recruitment 
snowballing in action; an occurrence that itself generates momentum in sharing a 
research invitation with further, potentially untapped pockets of the target 
population. It cannot be known how many other such snowballs were generated 
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via the multi-modal approaches taken to recruitment in this survey, but this 
observation evidences the connectedness of everyday health and research 
professionals and also their willingness to participate in social sharing of research 
recruitment invitations. Collaboration and social interaction are inter-twined and 
social media is a current method of maximising the potential of the internet in a 
research capacity. 	
 
Use of internet-mediated and social media methods to recruit health professionals 
to research studies is relatively new (Ahern 2005; Khatri et al. 2015). Use of 
existing computer applications such as FollowerWonk and Hootsuite facilitated 
time-efficient identification of key individuals who were invited to act as new 
‘snowballs’ for recruitment of their professional network. One example from this 
study is the tweet sent to a physiotherapist with a clinical interest in shoulder pain, 
whose Twitter account had over 30,000 followers. Followerwonk identified this 
individual as a key recruitment target and this single tweet sent from the 
researchers account reached over 5000 individuals internationally with an interest 
in shoulder pain, a reach that would have been almost impossible relying on just 
the professional network of the study team and prior to the advent of social media. 
At least 46% of the respondent data can be directly attributed to recruitment using 
internet-mediated methods including social media. Use of Twitter to engage with 
and recruit health professionals and researchers in a research survey had little 
precedence at the time of designing the survey (early 2015), and use of a 
researcher’s personal Twitter account to recruit individuals to an international 
research survey was considered relatively novel. Since the lead researcher’s 
professional background and affiliations were clearly outlined on all internet 
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platforms employed, as well as in all of the recruitment material, it was intended 
that such transparency would make it easy to judge credibility of the researcher, 
the study team, and the study itself. 
 
Use of ‘broadcast’ methods as recruitment tool has been previously outlined (Lane 
et al. 2015; Ofcom 2016), whereby researchers pay social media companies to 
display study adverts on the timeline/live feed of individuals who meet the 
inclusion criteria. Weaknesses of broadcasting approaches include cost per 
individual, the degree to which ‘adverts’ are ignored or mistrusted on otherwise 
free to use social media platforms, and that broadcasting relies on an individual 
being online during a specific time-period that the researcher has paid the platform 
to broadcast within. In comparison, peer-led, socially shared, snowballing methods 
amongst clinical and research colleagues such as those outlined in this study were 
hypothesised by the study team to have greater credibility and impact as a 
recruitment strategy, and has the advantage of being cost-free. This targeted 
approach also has the advantage of being specifically targeted to individuals likely 
to meet survey inclusion criteria. This may have helped to increase the response 
rate as well as generate a powerful snowballing recruitment effect amongst other 
professionals who were unknown to the study team or perhaps not included in the 
international professional societies targeted. However, it is accepted that 
individuals, societies or groups may have been missed as the strategy relied on 
individuals including their specific professional interests and social media 
biography. 
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Although the online survey was provided exclusively in English, the recruitment 
strategy included a number of steps intended to specifically include and invite 
international participation. These included contacts with relevant professional 
bodies, societies and organisations across the world, and tweets translated by 
native speakers into Spanish, French and Italian. The online nature of the study 
also enabled participants to respond in a time that best suited them and the ‘save 
and return later’ facility enabled busy clinicians and researchers to fit in completing 
the survey between tasks or duties. Use of a web survey over a paper survey in 
this study facilitated immediate receipt of responses to a secure database.  
 
Given high degree of interaction in the form of retweets and ‘likes’, it is clear that 
health professionals and researchers have adopted Twitter as a platform for 
engagement on professional issues. Furthermore, it is also clear that such 
individuals are happy to be contacted for research purposes via this medium. It is 
therefore unsurprising that recruitment to more recent surveys of health 
professionals has begun to include Internet-mediated and social media 
approaches (Frandsen et al. 2016). A particular strength of the social media 
aspect of the strategy is that respondents felt able to contact the researcher 
directly to express interest in the topic, ask more about the study, the researcher’s 
PhD and how the research will inform clinical practice. 
 
Further strengths of the study include that data was anonymously gathered from 
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respondents. The research team strived to collect only the necessary information 
required to characterise but not identify the sample. The online nature of the study 
also enabled participants to respond in a time that best suited them and the ‘save 
and return later’ facility enabled busy clinicians to fit in completing the survey 
between tasks or duties. Use of a web survey over a paper survey in this study 
enabled immediate receipt of responses to a secure database without delays due 
to post or manual data entry (Ilieva et al.2002). This enabled the research team to 
run preliminary statistical analysis to determine the variability of the characteristics 
of the sample obtained from the source population in order to inform a sample size 
target (see section 6.4.8.1).  
 
7.4.2 Weaknesses of the Multimodal Strategy 
Recruitment, retention and representativeness are as much a challenge in an 
internet-mediated research study as in any other research. A significant obstacle 
for this study was in defining a strategy to attract and recruit an unknown 
population. There is an unavoidable degree of self-selection bias in any survey, 
where certain individuals are more likely to respond to surveys than others 
(Frandsen et al. 2014; van Horn et al. 2009). However in the case of an unknown 
population, it is more difficult to assess the risk of bias.  
 
A criticism of using social media as a recruitment tool for research studies is that 
respondents recruited via social media tend to be younger than those from more 
traditional recruitment methods (Frandsen et al. 2014; Houston & Fiore, 1998). 
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However, data on number of years experience was collected and shows that 
respondents who provided complete data had more years of clinical experience on 
average (mean 16.3 (SD 9.8) years) than those who provided incomplete data 
(mean 13.1 (SD 10.0) years).  
 
Response rate is difficult, if not impossible, to calculate for this survey as 
recruitment happened in person, via postal invitation, via email and online using 
planned internet-mediated approaches. The difficulty with response rate 
calculation in this context lies in the lack of methodology used to track what 
happens to research invitations once they are placed online. Whilst the Google 
Analytics data provided insight into how each of the social media platforms and 
professional websites on which an advert was placed performed, one and the 
same web link was used to allow access to the survey website. Therefore it was 
not possible to see how the different recruitment routes compared in terms of 
achieving survey participation. The Twitter metrics showed how often each tweet 
was shared and on certain websites (PhysioSpot and Chartered Society of 
Physiotherapy websites) how often the webpage containing the recruitment 
invitation was shared. However, this study did not include a data capture method 
that could inform the researchers about the exact access route to the survey taken 
by each individual responder, making it impossible to gain insight into the access 
to completion rates across different recruitment or social media routes. For 
example, it may be possible that some social media platforms generated lower 
traffic to the survey than others, but were more successful in generating complete 
versus incomplete survey data. Future online surveys should include a question to 
assess how participants heard about and accessed the survey, which will enable 
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analysis of the impact of each recruitment method on generation of: (i) traffic to the 
survey and (ii) complete response data. Also, future researchers could consider 
stratifying recruitment methods over time, using one method alone for a defined 
period before moving on to the next. Whilst this would have the disadvantage of 
potentially limiting the accumulation of online presence and visibility during a 
defined period, it would allow researchers to quantify how many respondents 
came from each method and whether different recruitment methods attract 
respondents with different characteristics.  
 
The sample obtained is unbalanced by geography (64% from the UK & Republic of 
Ireland) and professional background (66% of sample were physiotherapists). In 
spite of advertising the study in other languages, the survey was conducted 
exclusively in English due to known issues with translation and loss of culturally 
imbued meaning (Aherm, 2005; Harkness et al. 2003), and several recruitment 
approaches specifically targeted organisations (Table 7.3) or potential participants 
(e.g. distribution of flyers) in the UK. Response to the survey from GPs, 
orthopaedic surgeons and rheumatologists was low, with physiotherapists 
providing 66% of responses. The strong contribution from physiotherapists may be 
explained in part by the lead researcher’s professional background. Steps taken to 
address this potential bias included specifically identifying and targeting national 
and international professional interest groups for non-physiotherapists as outlined 
in table 7.3 and targeting recruitment flyers to GPs with a special interest in 
musculoskeletal conditions and shoulder and upper limb orthopaedic surgeons 
and rheumatologists known to the study team. Potential reasons for low response 
rate may include perception that the research area is not of relevance to the 
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physician’s clinical practice, that they are already too busy, or simply that they do 
not participate in research surveys (van Geest et al. 2007). Impact of participation 
incentives for physicians to boost response rates have been not been shown to be 
effective amongst GPs (Kellerman et al. 2001; Cottrell et al. 2015; Kaner et al. 
1998) and were therefore not used in this study. However since it is traditionally 
difficult to achieve high response rates amongst physicians (Couper et al. 2007; 
Gjestland, 1996; Grava-Gubins et al. 2008), further research is indicated to 
improve participation and response rates amongst clinicians in research surveys, 
including the potential for using a multi-modal recruitment strategy in conjunction 
with commercially available databases of clinicians, accepting the cost implications 
of such an approach.  
 
A further challenge for the use of internet-mediated research in general is gaining 
complete data. Analytic data from Twitter and some of the professional Internet 
websites indicated that it is relatively easy to encourage potential respondents to 
click on the survey web address. Data from this study shows that the survey 
website was accessed 2700 times, with 1916 respondents submitting some data 
but complete data only being received from 387 individuals. Precise reasons for 
providing incomplete data are not clear, but since the survey was fielded only in 
English individuals who accessed the survey but were not fluent in the English 
language may have opted to leave the survey without providing complete data. A 
more extensive discussion of the potential reasons for incomplete data is 
presented in chapter 8.   
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Similar challenges in retaining respondents’ levels of interest and engagement to 
the end of the survey have previously been reported (Lane et al. 2015; Thackeray 
et al. 2012; Ventola, 2014; Kapp et al. 2013). Respondent anonymity and the 
physical distance from the researcher may be a factor as individuals are less likely 
to feel an obligation to the researcher to complete the survey. The same challenge 
may occur in paper-based surveys, however with paper-based studies people 
decide to either complete it or not to respond at all, resulting in fewer partially 
completed surveys. Despite the large proportion of incomplete data, the 
demographic information provided indicated that respondents who provided 
complete data were largely similar to those providing incomplete data, and 
representative of the target population.  
 
A common concern about the use of web-based surveys is that respondents are 
anonymous and that the authenticity of data often cannot be confirmed (Lane et al. 
2015; Ahern, 2005; Ryan 2013; Frandsen et al. 2014; Ramo & Prochaska, 2012; 
Bull et al. 2012; Kapp et al. 2013). Although it was possible to retake the survey, 
all data were screened for total completion times less than five minutes. No such 
responses were found, indicating that on balance, the data is likely to be 
legitimate, given the expected completion time of 15 minutes. An additional 
limitation is that open, unrestricted online surveys have to accept the risk that 
respondents may not actually be who they say they are and even that computer 
programmes may have been used to create spam data or that respondents may 
have completed the survey multiple times to create a ‘ballot box stuffing’ effect 
(Couper et al. 2007; Frandsen et al. 2016; Khatri et al. 2015).  
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7.4.3 Ethical Considerations 
The research team considered the ethical issues surrounding the use of a 
multimodal and Internet-mediated recruitment strategy. Specifically with regard to 
using social media to contact potential respondents, the important distinction 
between public and private use of social media was considered. Use of social 
media as a recruitment tool raises some potential considerations about 
respondent’s privacy and right to anonymity (McKee, 2013).  Specific details 
pertinent to the acquisition of ethical approval for the study included anonymity 
and security of the data provided. To maintain respondents’ anonymity, 
demographic questions were kept to the minimum required to characterize the 
sample (professional background, number of years experience, relevant post-
graduate training, country of clinical practice), and Internet protocol (IP) addresses 
were not collected in order to protect respondents’ anonymity. Data was stored on 
the physically and electronically secure, restricted access Keele University server, 
which is routinely backed up and which was accessible only by the study team. 
 
Ethical approval was gained from the University ethical approval panel for this 
online, international, survey of healthcare professionals (ERP 324) (appendices 11 
and 12). The survey consisted of non-identifiable demographic questions, 
questions about frequency of use of a number of common treatments not 
concerning patients, and asked for respondent’s choice of treatment suggestions 
in response to a series of hypothetical clinical cases. Questions were not specific 
to NHS setting although some respondents were likely to be NHS employees; 
therefore relevant checks were carried out with a local NHS Research Ethics 
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Committee (NREC) who recommended that specific approval from the NHS was 
not required and that approval from the University ethical approval panel would 
suffice. 
 
Guidance on the ethical issues involved in conducting Internet-mediated research 
from the British Psychological Society (BPS, 2013) indicates that participants in a 
study might come from a number of countries. As the research survey was open to 
any person meeting the inclusion criteria, from any country, it was made clear in 
the participant information sheet that the study adhered to Keele University’s 
Research Ethics Policy. Therefore the ethical approval granted by Keele University 
was considered by the ethical review panel to constitute sufficient approval to 
conduct an international study. 
 
7.5 Conclusion 
Using a multi-modal traditional and Internet-mediated recruitment strategy was 
successful in recruiting a professionally diverse international sample of health and 
research professionals with an interest in clinical management of shoulder pain. A 
social media strategy involved identification of most relevant societies, 
organisations and individuals and sending of targeted research invitations were via 
social media (Twitter, Facebook, Google+ and LinkedIn) and traditional methods. 
Of the 565 respondents who provided data in response to this survey, social 
media accounted for 46%, indicating that clinicians were happy to be contacted 
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and recruited to the research survey via social media and internet-mediated 
methods as well as traditional methods.  
 
Social media can be used as an effective, time and resource efficient online 
survey recruitment and engagement tool. In order to maximise the potential of 
social media as a recruitment tool, dedicated preparation and pre-planning is 
required. Consideration of ethical issues related to Internet-mediated research is 
advised. Employment of social media can be a time consuming task, therefore 
computer applications which help to optimise development of a target list and 
automate the scheduled delivery of social media posts is highly beneficial. 
Researchers can therefore consider using a multi-modal research strategy to 
recruit health professionals to future online studies. Whilst acknowledging 
limitations of the method, this approach offers a pragmatic, easy to use strategy 
that can be used in future studies. A multi-modal survey recruitment proforma has 
been developed to assist future researchers achieve the potential offered by these 
methods (appendix 13). 
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CHAPTER 8: WHAT INFLUENCES TREATMENT 
DECISION-MAKING IN PRIMARY CARE FOR PATIENTS 
WITH SHOULDER PAIN? A MULTI-DISCIPLINARY, 
INTERNATIONAL CONJOINT ANALYSIS STUDY  
 
8.1 Background Summary 
In order to derive a robust, evidence-based set of hypotheses of candidate 
moderators to inform a future treatment decision-making strategy, a choice-based 
conjoint analysis study was designed to identify which patient attributes influenced 
decision-making for selecting treatment in primary care for patients presenting with 
shoulder pain, (full methodology outlined in chapter 6). This study was conducted 
using an online survey targeting an international sample of healthcare practitioners 
and shoulder pain experts. Chapter 7 outlined the development, operationalization 
and appraisal of a multi-modal recruitment strategy for a conjoint analysis study.  
In response to 12 hypothetical patient cases, respondents were asked to choose 
their optimal recommended first-line treatment option from either: (i) advice and 
analgesia, (ii) exercise and/or manual therapy delivered by a physiotherapist, or 
(iii) steroid injection. 
 
8.2 Brief Summary of Statistical Analysis 
Descriptive statistics were generated for the demographics of the sample and to 
summarise the distribution of baseline variables across blocks (table 8.1). Three 
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main multinomial statistical models were: (i) separate models for each individual 
attribute, (ii) separate models for each individual attribute adjusting for 
confounders and, (iii) multivariable model including all attributes adjusted for the 
confounding variables. Taking the treatment ‘advice and analgesia’ as the 
reference category, odds ratios and associated 95% confidence intervals were 
presented in order to highlight the association between patient attributes and 
treatment choice. Those intervals not containing the null value of 1 will be 
highlighted as being statistically significant.	Responses to the modified decisional 
conflict questions were summarised using descriptive statistics. Responses to the 
open-ended questions about absence of relevant clinical information were 
summarised and compared to the suggested patient attributes obtained during the 
clinical consensus workshops (chapter 4).	
	
8.3 Results 
As described in chapter 7 (recruitment chapter), the survey was accessed 2700 
times by 2326 individuals over a three-month survey recruitment period (March – 
June 2015). The survey was started 1915 times, although 1350 individuals failed 
to complete all the questions. There were 565 respondents who completed all the 
demographic questions, of whom 387 individuals completed every question on the 
survey (20.2% of those who began the survey and 12.3% of those who accessed 
the survey) and 178 individuals provided partial data. Demographics of responders 
are shown in table 8.1. This shows that the randomisation procedure worked and 
produced similar respondent characteristics across the three blocks. A model 
containing nested terms for both block and subject was initially considered. 
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However when executed, the model containing the term for block accounted for 
only neglible overall variability and the parameter estimates remained unchanged 
with it removed. Therefore, a block term for respondent was not entered into the 
models.  
 
Table 8.1: Respondent demographics by block 
 Block 1 
n=123 (33%) 
Block 2 
n=129 (35%) 
Block 3 
n=122 (32%) 
Total 
n=374 (100%) 
Country of Clinical Practice (n,%) 
UK & ROI 83 (67%) 87 (67%) 82 (67%) 252 (67%) 
Netherlands, 
Norway, Sweden & 
Denmark 
18 (15%) 12 (9%) 13 (11%) 43 (1%) 
Australia &  
New Zealand 
5 (4%) 8 (6%) 7 (6%) 20 (5%) 
Germany 1 (1%) 0 (0%) 1 (1%) 2 (1%) 
USA & Canada 4  (3%) 11 (9%) 10 (8%) 25 (7%) 
Rest of World 12 (10%) 10 (8%) 9 (7%) 31 (8%) 
Professional Background (n, %) 
Physiotherapist 79 (64%) 86 (67%) 79 (65%) 244 (65%) 
General Practitioner 23 (19%) 22 (17%) 15 (13%) 60 (16%) 
Rheumatologist 7 (6%) 4 (3%) 10 (8%) 21 (6%) 
Orthopaedic 
Surgeon 
4 (3%) 1 (1%) 2 (2%) 7 (2%) 
Other 10 (8%) 15 (12%) 16 (13%) 41 (11%) 
Years of Clinical 
Experience (Mean, 
SD) 
16.6 (10.6) 15.5 (9.2) 16.8 (9.7)  
Percentage of 
clinical practice 
funded by state 
73.6 (38.7) 70.8 (40.0) 70.0 (40.4)  
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Results of the multinomial logistic regression depicting the odds of health 
professionals choosing corticosteroid injection over advice and analgesia and the 
odds of choosing physiotherapy above advice and analgesia, are shown in tables 
8.2 and 8.3 respectively.  Comparison of univariable models unadjusted and 
adjusted for confounders (Models 1 and 2, tables 8.2 and 8.3) shows that 
estimation of associations between the patient attributes and treatment decisions 
were very similar with the addition of confounders compared to without. Compared 
to the adjusted univariable model, estimates from the multivariable model do vary 
in magnitude and direction, indicating that some attributes may be interrelated. In 
addition to confounders, the multivariable model takes into account all other 
patient attributes, more completely representing how patterns of patient attributes 
affect decisions rather than attributes in isolation. Since clinicians make decisions 
using patterns of patient attributes and were presented with patterns of attributes 
in the decision task, the multivariable model represents clinical decision-making 
more accurately than the univariable model, and will be summarized here. 
 
From the multivariable model, eleven of the 12 patient attributes studies were 
significantly associated with treatment choice at the level of p < 0.05 for either 
injection or exercise/mobilisation (pain severity, onset, sleep disturbance, current 
clinical status, functional and/or work impact, neck involvement, previous response 
to treatment, general health status, overuse (linked to sport, hobbies or work), 
instability and/or weakness, patient treatment preference). The presence of 
psychosocial issues was the only attribute that was not significantly associated 
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with treatment choice, with the association with treatment decisions being very 
weak (OR (95% C.I.) corticosteroid injection (0.97 (0.75, 1.27) and physiotherapy 
(0.96 (0.79, 1.16)).  
 
8.3.1 Multivariable Associations for Recommending a Corticosteroid 
Injection: 
Multivariable multinomial logistic regression analysis revealed that respondents 
were more likely to recommend corticosteroid injection rather than advice and 
analgesia when a patient presented as: condition not improving (OR 2.81 (2.16, 
3.65)), previous positive treatment response (steroid injection (2.79 (2.07, 3.76)), 
physiotherapy (1.61 (1.16, 2.23)), patient treatment preference for injection (2.41 
(1.82, 3.19) but not for physiotherapy), moderate or high pain severity (1.66 (1.19, 
2.31) and 1.79 (1.29, 2.47) respectively), significant instability and/or weakness 
(1.74 (1.30, 2.32)),or sleep disturbance (1.49 (1.14, 1.94)).  
 
8.3.2 Multivariable Associations for Not Recommending a Corticosteroid 
Injection: 
Multivariable analysis revealed that respondents were less likely to recommend 
corticosteroid injection over advice and analgesia when patients presented with 
traumatic onset or unstable diabetes and/or cardiac issues (traumatic onset (0.55 
(0.42, 0.71)), unstable diabetes and/or cardiac issues (0.72 (0.56, 0.94)). 
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Table 8.2: Results of statistic models showing likelihood of recommending 'corticosteroid 
injection' over 'advice and analgesia' 
Variables 
 
  Model 1(*)    Model 2(†) Model 3(+) 
 
OR (95% CI)   OR (95%CI) OR (95% CI) 
Pain Severity 
Low 1 1 1 
Moderate 2.11(1.58,2.82) 2.11(1.58,2.86) 1.66(1.19,2.31) 
High 2.23(1.67,2.97) 2.27(1.70,3.03)  1.79(1.29,2.47) 
Onset 
Non-Traumatic 
onset 1 1 1 
Traumatic onset 0.53(0.43,0.66)  0.53(0.43,0.66) 0.55(0.42,0.71) 
Current Clinical 
Status 
 Condition 
Improving 1 1 1 
Condition not 
Improving 3.19(2.54,4.03)  3.14(2.49,3.95) 2.81(2.16,3.65) 
Sleep Disturbance 
None 1 1 1 
Sleep disturbance 1.24(0.99,1.57) 1.25(1.00,1.57)  1.49(1.14,1.94) 
Functional and/or 
Work Status 
No Impact 1 1 1 
Significant Impact 
on activities/work 1.19(0.95,1.48)  1.20(0.96,1.49) 1.61(1.25,2.08) 
Neck Involvement 
None 1 1 1 
Also presents with 
neck pain 0.74(0.59,0.93)  0.74(0.59,0.92) 0.92(0.71,1.19) 
Previous response 
to treatment 
No previous 
treatment 1 1 1 
Previous positive 
response to steroid 
injection 
2.53(1.96,3.27) 2.49(1.93,3.22) 2.79(2.07,3.76) 
Previous positive 
response to 
physiotherapy 
1.23(0.91,1.65)  1.21(0.89,1.62) 1.61(1.16,2.23) 
General Health 
Status 
Otherwise fit & well 1 1 1 
Unstable diabetes 
and/or cardiac 
issues 
0.86(0.69,1.07)  0.86(0.69,1.07) 0.72(0.56,0.94) 
Psychosocial 
Issues 
None 1 1 1 
Psychosocial issues 
present 0.60(0.48,0.75)  0.61(0.49,0.76) 0.97(0.75,1.27) 
Overuse due to None 1 1 1 
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Sport, Hobbies or 
Work 
Over-use linked to 
sport, hobbies or 
work 
0.99(0.79,1.25)  1.01(0.80,1.27) 1.06(0.81,1.39) 
Instability and/or 
Weakness 
None 1 1 1 
Significant 
Instability  1.65(1.30,2.09)  1.66(1.31,2.10) 1.74(1.30,2.32) 
Patient Treatment 
Preference 
None 1 1 1 
Preference for 
Injection 2.77(2.15,3.56) 2.79(2.17,3.60) 2.41(1.82,3.19) 
Preference for 
Physiotherapy 1.15(0.82,1.62) 1.13(0.80,1.59) 1.00(0.69,1.46) 
(*) Attribute Entered Only  
(†)  Attribute plus confounders  
(+)  All Attributes plus confounders (professional background, country of clinical practice and years 
of clinical experience) 
OR=Odds Ratio, CI = Confidence Interval, Shaded cells highlight p <0.05 
 
8.3.3 Multivariable Associations for Recommending Physiotherapy: 
The multivariable multinomial logistic regression analysis indicated that clinicians 
were more likely to recommend physiotherapy rather than advice and analgesia 
when the patient presented with: patient treatment preference for physiotherapy 
(OR 2.77 (2.16, 3.55), but not for injection), previous positive treatment response 
(physiotherapy (2.22 (1.76, 2.80)), corticosteroid injection (1.44 (1.14, 1.81)), 
significant instability and/or weakness (2.05 (1.64, 2.57)), not improving (1.90 
(1.55, 2.33)), neck pain (1.47 (1.21, 1.80)), or overuse due to work, sport or 
hobbies (1.34 (1.09, 1.66)).  
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8.3.4 Multivariable Associations for Not Recommending Physiotherapy: 
Presence of sleep disturbance and high pain were significant predictors of being 
less likely to recommend corticosteroid injection over advice and analgesia (sleep 
disturbance (OR 0.66 (0.54, 0.81)), high pain (0.71 (0.55, 0.89); association not 
significant for moderate pain)).  
 
Table 8.3: Results of statistic models showing likelihood of recommending 'physiotherapy 
treatment’ over 'advice and analgesia' 
Variables 
 
  Model 1(*)    Model 2(†) Model 3(+) 
 
OR (95% CI)   OR (95%CI) OR (95% CI) 
Pain Severity 
Low 1 1 1 
Moderate 1.04(0.84,1.29) 1.04(0.84,1.29) 0.98(0.77,1.26) 
High 0.77(0.62,0.96) 0.76(0.62,0.95)  0.71(0.55,0.89) 
Onset 
Non-Traumatic 
onset 1 1 1 
Traumatic onset 0.82(0.69,0.97)  0.82(0.69,0.98) 0.83(0.68,1.01) 
Current 
Clinical Status 
 Condition 
Improving 1 1 1 
Condition not 
Improving 1.89(1.57,2.26)  1.88(1.57,2.26) 1.90(1.55,2.33) 
Sleep 
Disturbance 
None 1 1 1 
Sleep 
disturbance 0.74(0.63,0.88) 0.73(0.61,0.87)  0.66(0.54,0.81) 
Functional 
and/or Work 
Status 
No Impact 1 1 1 
Significant 
Impact on 
activities/work 
0.99(0.84,1.18)  0.99(0.84,1.18) 1.12(0.92,1.37) 
Neck 
Involvement 
None 1 1 1 
Also presents 
with neck pain 1.34(1.13,1.60)  1.36(1.14,1.62) 1.47(1.21,1.80) 
Previous 
response to 
No previous 
treatment 1 1 1 
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treatment Previous 
positive 
response to 
steroid injection 
1.37(1.11,1.68) 1.35(1.10,1.66) 1.44(1.14,1.81) 
Previous 
positive 
response to 
physiotherapy 
1.94(1.57,2.41)  1.96(1.57,2.43) 2.22(1.76,2.80) 
General Health 
Status 
Otherwise fit & 
well 1 1 1 
Unstable 
diabetes and/or 
cardiac issues 
0.97(0.82,1.15)  0.97(0.82,1.16) 0.95(0.78,1.17) 
Psychosocial 
Issues 
None 1 1 1 
Psychosocial 
issues present 1.03(0.86,1.23)  1.04(0.87,1.24) 0.96(0.79,1.16) 
Overuse due 
to Sport, 
Hobbies or 
Work 
None 1 1 1 
Over-use linked 
to sport, 
hobbies or work 
1.16(0.97,1.39)  1.17(0.98,1.40) 1.34(1.09,1.66) 
Instability 
and/or 
Weakness 
None 1 1 1 
Significant 
Instability  2.18(1.80,2.65)  2.14(1.76,2.59) 2.05(1.64,2.57) 
Patient 
Treatment 
Preference 
None 1 1 1 
Preference for 
Injection 1.11(0.91,1.36) 1.10(0.90,1.35) 0.99(0.79,1.23) 
Preference for 
Physiotherapy 2.66(2.11,3.36) 2.67(2.110,3.37) 2.77(2.16,3.55) 
(*) Attribute Entered Only  
(†)  Attribute plus confounders (professional background, country of clinical practice and years of 
clinical experience) 
(+)  All Attributes plus confounders  
OR=Odds Ratio, CI = Confidence Interval, Shaded cells highlight p <0.05 
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8.3.5 Modified Decisional Conflict Questions 
Summary of data related to respondent perception of task complexity and 
completeness of the hypothetical clinical cases are shown in table 8.4. If asked 
again, 68% or respondents expressed that they would not expect to stick with their 
recommended treatment decisions and 66% of respondents reported feeling 
unsatisfied with their treatment decisions. Over half (51%) of respondents stated 
that it was clear which treatment would be best for each patient and half (50%) of 
respondents reported not having trouble making their treatment decisions 
compared with 25% who did and 25% who neither had nor had not trouble making 
their treatment decisions. Responses to open (free-text) questions regarding 
important information related to the hypothetical patient (question 5) and any other 
considerations that affected the decision (question 7) were collected. Respondents 
indicated 12 additional factors that had not been included in this conjoint analysis 
study (table 8.5). These factors were mainly greater depth of information in the 12 
patient attributes included in the conjoint analysis and additional patient medical 
history. The most commonly suggested of these factors including; aggravating and 
easing factors and full diabetes and cardiac history.      
 222 
Table 8.4: Modified Decisional Conflict Responses 
Question Strongly 
Agree 
Agree 
 
Neither 
Agree or 
Disagree 
Disagree 
 
Strongly 
Disagree 
n=374, %n 
1 The decisions were hard to make 24 6% 99 26% 82 22% 143 38% 26 7% 
2 I was unsure about which treatment would really 
be best for each patient 
23 6% 114 30% 82 22% 144 39% 10 3% 
3 It was clear which treatment would be best for 
each patient 
21 6% 169 45% 86 23% 84 22% 14 4% 
4 When I made the decisions, I felt that I did not 
know enough about the treatment alternatives 
34 9% 134 36% 59 16% 114 30% 33 9% 
5 I had trouble making the decisions because 
important information was unknown 
13 3% 83 22% 92 25% 133 36% 53 14% 
6 When I made the decisions, it was hard to decide if 
the benefits of the treatment were more important 
that the risks. 
30 8% 136 4% 100 27% 98 26% 10 3% 
7 All considerations that affected the decision were 
identified  
26 7% 141 38% 114 30% 83 22% 10 3% 
8 I am satisfied with the decisions I have made 3 1% 36 10% 86 23% 221 59% 28 7% 
9 I am satisfied that the process used to make the 
decisions was as good as it could be 
22 6% 82 22% 98 26% 151 40% 21 6% 
10 If asked again, I would expect to stick with my 
decisions. 
1 0% 18 5% 100 27% 225 60% 30 8% 
n = Total Sample (374) 
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Table 8.5: Free-text responses to modified Decisional Conflict Questions on missing clinical 
information (with frequency of responses) 	
Attribute Frequency NEW 
Discussed in 
preparatory 
work 
Accepted 
limitation 
of study 
Included in 
conjoint 
analysis 
Objective 
findings 72  X   
Combination of 
treatment 44   X  
Age 43  X   
Imaging results 42  X   
Symptom 
duration 36  X   
Diagnosis 30  X   
Injury 
mechanism 27  X   
Shoulder range 
of Movement 20  X   
Already tried 
analgesics 16  X   
Type of 
work/hobbies 15  X   
Pain 
mechanism 8  X   
Specific muscle 
weakness 8  X   
Past medical 
history 8  X  X 
Previous 
physiotherapy  8  X   
What sort of 
psychosocial 
issues 
7  X   
Patient goals 7  X   
Aggravating / 7 X    
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Attribute Frequency NEW 
Discussed in 
preparatory 
work 
Accepted 
limitation 
of study 
Included in 
conjoint 
analysis 
easing factors 
Red flags 6  X   
Contradictory 
information 6    X 
Treatment 
expectation 6  X   
Full diabetes 
information 6 X    
Social history 6  X   
Full cardiac 
information 5 X    
Movement 
pattern 5  X   
Inflammatory 
condition 5  X   
Referred pain 4  X  X 
Patient 
perspective 4 X    
Could patient 
tolerate 
physiotherapy 
3  X   
Gender 3  X   
JL shoulder 
symptom 
modification 
procedure 
3  X   
Neurological or 
Bobath 
examination 
4  X   
(Severity, 
Irritability, 
Nature) SIN 
factors 
2  X   
Cleared by 
orthopaedics  2 X    
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Attribute Frequency NEW 
Discussed in 
preparatory 
work 
Accepted 
limitation 
of study 
Included in 
conjoint 
analysis 
Contra-
indications for 
shoulder 
injection 
2  X   
Drug history 2 X    
Time since last 
injection 3 X    
Understanding 
of treatment  2  X   
Posture 2  X   
Previous 
shoulder 
problems 
2  X   
Lying on side 2  X   
Patient training 
age/ fitness 
level 
2  X   
Physiotherapy 
waiting time  2  X   
Extent of 
positive 
response to 
injection 
2 X    
Driving impact 1  X   
Could patient 
tolerate 
injection 
1  X   
Whether patient 
knows proper 
sleep position 
1 X    
Dressing impact 1 X    
Self 
management to 
date 
1  X   
Patient 1  X   
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Attribute Frequency NEW 
Discussed in 
preparatory 
work 
Accepted 
limitation 
of study 
Included in 
conjoint 
analysis 
awareness 
Injection 
location 1 X    
Insurance 
limitations 1 X    
Time 
constraints 1  X   
Inflammatory 
condition 1  X   
Pain location 1  X   
Coping 
strategies 1  X   
Patients main 
complaint 1  X   
Dominant arm 1  X   
Period symptom 
free between 
treatments 
1  X   
Sleep loss 
distress 1  X   
Patient 
treatment 
preference 
1     
How many 
previous 
injections 
1  X   
Evidence of 
spinal protective 
behaviour 
1  X   
Reason for 
preferences 1 X    
Patient 
treatment 
preference 
    X 
Progression of 1    X 
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Attribute Frequency NEW 
Discussed in 
preparatory 
work 
Accepted 
limitation 
of study 
Included in 
conjoint 
analysis 
symptomology 
Patient 
motivation for 
self-help 
1    X 
Pain levels 5    X 
Neck exam 
findings 5    X 
Degree of 
impairment  1    X 
Work impact 1    X 
Function 1    X 
Yellow flags 2    X 
 
8.4 Discussion 
8.4.1 Main Findings 
Twelve patient attributes were suggested in the mixed methods study by a range 
of experienced shoulder clinicians as being highly relevant to first-line treatment 
decision-making for shoulder pain for the three treatments in question. Using a 
conjoint analysis study and hierarchical multinomial logistic regression to analyse 
the results, this study provides insight into the association of these 12 patient 
attributes with differential first-line treatment decision-making. Figure 8.1 provides 
a visual overview of results of the multivariable model showing the independent 
association of each patient attribute with the likelihood of recommending 
corticosteroid injection or physiotherapy treatment. The single most important 
patient attribute that influenced healthcare practitioners’ decision to recommend 
corticosteroid injection was current clinical status, i.e., whether the patient was 
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improving, or not ((OR, 95%) (2.81 (2.16, 3.65). The decision to recommend 
physiotherapy over advice and analgesia was influenced by three additional 
factors: preference for physiotherapy (2.77 (2.16, 3.56)), previous positive 
response to physiotherapy (2.22 (1.76, 2.80)) and significant instability and/or 
weakness (2.05 (1.64, 2.57)).  
 
Some commonalities in the determinants of recommending either corticosteroid or 
physiotherapy treatments include: being more likely to recommend a treatment 
when the patient was not improving, patient preference for the treatment or had a 
previous positive response to the treatment previously. In contrast, results indicate 
that the patient attributes: traumatic onset, pain severity and sleep disturbance 
guide differential treatment decision-making. Traumatic onset was significantly 
associated with the likelihood to recommend corticosteroid injection (0.55 (0.42, 
0.71)), but not physiotherapy (0.83 (0.68, 1.01)). This is a clinically intuitive finding 
as evidence that corticosteroid injection may pre-dispose to rotator cuff tear is 
increasingly accepted and (recent) trauma may be considered a contra-indication 
for injection by many healthcare providers (Mohamadi et al. 2016).  
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Figure 8.1: Results overview 
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Pain severity impacted upon respondents’ likelihood to refer to either corticosteroid 
injection or physiotherapy treatment; high or moderate pain was associated with 
greater likelihood to refer a patient for corticosteroid injection (1.79 (1.29, 2.47) 
and 1.66 (1.19, 2.31), respectively) with high pain being associated with lower 
likelihood of referring a patient for physiotherapy treatment (0.71 (0.55, 0.89)). This 
indicates that there may be a perception amongst respondents that adequate pain 
relief is an important first-line treatment goal and that physiotherapy is more likely 
to be effective in patients with lower or better-controlled pain. This in spite of 
suggestion that exercising the shoulder through some pain is not as detrimental to 
recovery as previously thought, in fact may incur some benefit (Littlewood et al. 
2014; Smith et al. 2017). 
 
Similarly, sleep disturbance prompted greater likelihood of referral for 
corticosteroid injection and less likelihood for referral for physiotherapy treatment 
than advice and analgesia (corticosteroid injection: 1.49 (1.14, 1.94), 
physiotherapy treatment: 0.71 (0.55, 0.89)). The co-occurrence of musculoskeletal 
pain and sleep disturbance in patients with shoulder pain (Cho et al. 2013; 
Mulligan et al. 2015) as well as in the general population has been reported (Baker 
et al. 2017). Therefore the finding that sleep disturbance prompts similar treatment 
decisions to high pain indicates that sleep disturbance is perceived as indicative of 
high pain, which are both logical targets for pain reduction and are therefore 
important clinical drivers of decision-making. Free text responses regarding clinical 
information considered missing by survey respondents also indicated that 
clinicians preferred to further ascertain information about whether the sleep 
disturbance was due to the painful shoulder or not, the degree of distress causes 
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by the sleep disturbance, whether the pain was at rest, (Kempf & Kongsted, 2012) 
or when lying on the affected side, and whether the patient had identified a sleep 
posture that reduced their pain. Therefore, future research should investigate 
sleep in more detail as a potential moderator of treatment effect for corticosteroid 
injection and physiotherapy treatment. 
 
Although the attribute ‘general health’ (with levels (i) unstable diabetes and/or 
cardiac issues and (ii) otherwise fit and well), reduced the likelihood of 
respondents recommending corticosteroid injection over advice and analgesia 
(0.72 (0.56, 0.94)), respondents indicated in free text responses that a much more 
complete clinical picture on both diabetes and cardiac issues was preferred before 
a confident treatment decision could be made. Furthermore, free text responses 
suggested that respondents hold a range of views on the relevance of diabetes 
when considering corticosteroid injection: diabetes being a contraindication, a 
clinical scenario to be managed cautiously, or an unimportant patient factor. One 
NHS guideline for example, includes the recommendation that diabetes is treated 
as a caution to be dealt with by informing patient of potential risk of elevated blood 
sugar level (Harris, 2017) However, this recommendation represents the clinical 
opinion of the guideline authors only and therefore further research is indicated to 
determine the relevance and patient safety implications of diabetes in differential 
treatment decision-making for shoulder pain. 
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8.4.2 Role of Diagnosis in Treatment Decision-Making 
Presence of significant instability and/or weakness increased the likelihood that 
healthcare professionals recommended physiotherapy over advice and analgesia 
(2.05 (1.64, 2.57)) and also corticosteroid injection over advice and analgesia 
(1.74 (1.30, 2.23)). Free text responses on attributes perceived as missing in the 
hypothetical patient cases suggest that respondents consider instability and 
weakness to be potentially indicative of distinct shoulder pathologies. 
Respondents also suggested in free-text responses that knowing a patient’s 
diagnosis or imaging results can prevent potential known harms of corticosteroid 
injection such as tissue degradation.  
 
This indicates respondents perceive diagnosis as being strongly intertwined with 
treatment decision-making, although it is increasingly accepted that establishing a 
confident clinical diagnosis is a challenge (McFarland et al. 2010; Mitchell, et al. 
2005; Smidt & Green, 2003). The observed reasoning amongst respondents that a 
diagnosis is necessary before making a treatment recommendation, is likely to 
represent the standard approaches to treatment planning learned by clinicians 
during both under and post-graduate specialist training. As discussed in chapters 
1 and 3, such systematic data collection to inform judgement of diagnosis is 
commonplace in clinical practice, where the clinician seeks to prove or disprove 
competing diagnostic hypotheses during the objective examination in order to 
make reasoned and justifiable treatment plans for patients. This clinical framework 
is advocated in the British Orthopaedic Association (BOA) and British Elbow and 
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Shoulder Surgery Society (BESS) guideline on management of subacromial pain, 
which states: 
“Making the correct diagnosis is very important and will ensure an efficient and 
optimum treatment experience for the patient” (Kulkarni et al. 2015, pg. 136). 
However as Raynor et al. (2015) showed, although specific patient features are 
associated with specific diagnoses, diagnostic labels do not seem to be predictive 
of outcome. Therefore the value of pursuing diagnosis for the purposes of 
informing treatment decision-making for shoulder pain requires further 
investigation. 
 
8.4.3 Relevance of Psychosocial Issues in Shoulder Pain 
The presence or absence of psychosocial issues was the only patient attribute that 
was not significantly associated with treatment choice for shoulder pain over and 
beyond the other attributes in the model. Free text responses in this study suggest 
that respondents desired further information on aspects of likely patient 
adherence, understanding of treatments, yellow flags, patient motivation for self-
help, carer role, work information, impact on work and information on sport and 
hobbies, much of which would inform a clinical judgement on the psychosocial 
complexity of the patient’s shoulder problem. Furthermore, some respondents 
indicated they were unclear about the meaning, extent and relevance of the 
attribute psychosocial issues. This suggests that the attribute psychosocial issues 
was considered too broad and lack the detail respondents required to include it as 
part of decision-making. Rich evidence exists in the field of low back pain that 
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psychosocial issues are important prognostic factors that can guide clinical 
management (Hill et al. 2011) and there are studies that demonstrate psychosocial 
issues are associated with the extent of shoulder disability and symptom intensity 
(Chester et al. 2016; Menendez et al. 2015), but the evidence as yet is limited. It 
may be that respondents and/or clinicians managing patients with shoulder pain 
do not yet associate psychosocial issues, psychological distress or social issues 
with poor prognosis in patients with shoulder pain. Also the role of these factors as 
a moderator of treatment effect is currently unclear (van der Windt et al. 2007).	
 
8.4.4 Respondent Perceptions of Conjoint Analysis Method to Study Clinical 
Decision-Making 
Since the conjoint analysis method had not, prior to this study, been used to study 
clinician decision-making in musculoskeletal pain using a multi-disciplinary and 
international sample of clinicians and researchers, gaining an insight into how the 
method was received as a research study was valuable. This was ascertained 
using the modified decisional conflict questions (table 8.4). Responses provided 
insight into respondent perception of task complexity and completeness of the 
hypothetical clinical cases, indicated mixed perception of difficulty in undertaking 
the conjoint analysis tasks.  
 
Whilst the majority of respondents indicated that the hypothetical clinical cases did 
contain all of the necessary clinical information upon which to base a treatment 
recommendation, many respondents were not satisfied with the decision they 
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made and did not expect to stick to them if asked again. Approximately half of 
respondents were clear about which treatment would really be best for each 
patient (51% versus 26% unclear and 23% unsure) with 50% of respondents 
reporting not having trouble making decisions due to important information being 
missing compared with 25% who had trouble and 25% who were unsure. A 
greater proportion of respondents also reported feeling that all considerations that 
affected the decision were identified (45% compared with 25% who disagreed and 
30% who were unsure).  
 
In spite of many respondents reporting that they could make the treatment 
decisions based on the presented information, the majority of respondents (66%) 
reported feeling unsatisfied with their decisions. There was mixed contentment 
about the process for making decisions in the survey with 46% reporting that the 
process was not as good as it could have been, 36% feeling unsure and 28% 
feeling content with the process. Free text responses to this question suggest that 
clinicians did not find it easy to apply their extensive clinical knowledge and skill to 
a fixed and purposively designed clinical decision experiment as it did not fully 
replicate their usual clinical practice.  
 
Main reasons provided for how the experimental task differed from clinical practice 
included the inability to select multiple treatments at once and lack of objective 
assessment information. Respondents reported that they felt that treatments for 
shoulder pain were not mutually exclusive and in clinical practice were often 
offered in various combinations. They indicated that in specific clinical situations, 
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the order of treatment in these combinations depended on whether pain relief was 
the primary objective ahead of beginning physiotherapy treatment (i.e., 
recommending injection first) or whether physiotherapy had failed and an injection 
was then indicated. 
 
8.4.5 Strengths of Study 
It is noteworthy that in spite of the free text data suggesting that respondents did 
not feel comfortable, confident or enjoy completing the survey and that the 
hypothetical patient cases were too short and lacked detail, the statistical model 
converged and clinically sensible patterns in decision-making emerged. The study 
demonstrated that it is possible and productive to combine individual level data to 
form a group of expert opinions from which the signals of differential decision-
making can be drawn out from the noise of individuality by using a robust conjoint 
analysis study design and appropriate statistical model for analysis. The analysis 
gave rise to logical clinical patterns that can be used in future research to further 
explore the potential explanatory power of moderators of treatment effect as 
drivers for treatment decision-making.  
 
High level of engagement with the study (1915 potential respondents accessed the 
survey online) indicates that research concerning differential treatment decision-
making appears to be a clinical question/approach that is of interest and relevance 
to professionals managing patients with shoulder disorders. To the authors’ 
knowledge this is the first study of its kind to recruit a multidisciplinary and 
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international sample of clinicians and researchers with special interest in the 
management of shoulder pain for the purposes of understanding how clinicians 
use patient information to guide clinical decision-making. A strength of conjoint 
analysis is that the final output of the study represents not the opinion of one 
single professional, professional group or set of individuals from a particular 
geographical region, but is the sum of the combined experience and knowledge of 
the entire sample. 
 
8.4.6 Weaknesses of Study 
Potential risks of bias in a conjoint analysis study may arise from framing effects 
(question and/or attribute wording), ordering (of attributes or decision tasks) 
effects, sampling issues and any other features of the study that respondents 
protest against (Rakotonarivo, Schaafsma, & Hockley, 2016). As previously 
outlined (in chapter 6), pilot work was conducted to ensure that the decision task, 
attribute wording and order of attributes made sense to the relevant clinical 
audience. A fractional factorial design with random allocation of a limited number 
of decision tasks to respondents (chapter 6) also helped to reduce the impact of 
respondent fatigue and inattention. Issues around sampling have been previously 
been discussed in detail (chapter 7).  
 
Whilst two thirds of respondents reported being unsatisfied with the survey 
research experience, it must be highlighted that protests against features of 
conjoint analysis studies are very common and are reported in up to 90% of 
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conjoint analysis studies (Rakotonarivo et al. 2016). The nature of the tradeoff 
faced by researchers in the design of a conjoint study between construct validity 
(i.e., how closely the study replicates reality being constructed), content validity 
(whether descriptions of attributes make logical sense), and experimental design 
(with a limitation of an orthogonal array design being the presence of occasional 
illogical combinations of patient attributes), means that the resultant survey 
experience may feel somewhat unreflective of reality, restrictive and lacking in 
clinical depth. Unavoidable weaknesses of using vignette-based methods to study 
clinical decision-making therefore exist, specifically the loss of real-world patient-
clinician interaction and clinical observation is likely to impact on the decision-
making processes used by healthcare practitioners (Lutfey et al. 2008).  
 
When using an orthogonal array to design a conjoint analysis study there is a risk 
of generating vignettes with illogical combinations of patient attributes (see 
6.4.4.5). Free text response data from respondents suggested that this occurred in 
two of the 36 clinical cases included in the study. It cannot be known how these 
reportedly confusing clinical case descriptions impacted on the clinical decision-
making of respondents who viewed them, or how respondents managed to 
overcome the challenges that this presented i.e., whether respondents ignored the 
nonsense attribute or focused on their preferred clinical attributes when making 
their treatment decision. Further research is indicated to explore the impact of this 
on decision-making.  
 
In addition to recognising that conjoint analysis studies are most often cognitively 
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demanding and challenging for respondents to complete, the potential for over or 
under-estimation of associations of patient attributes with treatment choices due to 
the hypothetical bias exists (Orme, 2014). A blocked design was used to limit the 
number of hypothetical clinical cases that each respondent was asked to consider 
in the survey. Each respondent viewed and made treatment recommendations for 
12 clinical cases. However feedback was received that indicated that respondents 
felt that the survey was tedious, boring, long and repetitious. This feedback aligns 
with previously reported high degree of cognitive burden imposed on respondents 
during a conjoint analysis study (Orme, 2014; Johnson et al. 2013).  
 
Hypothetical bias and respondent inattention can arise because respondents are 
not making ‘real life’ decisions with tangible consequences, i.e., impacting 
positively or negatively on whether a patient improves or not (Orme, 2014; 
Johnson et al. 2013). Whilst this is likely to be a potential issue in some studies, 
respondent feedback highlighted areas of the study that did not match with clinical 
practice indicating that they had tried to employ their usual thinking in the survey 
but were not fully able due to limitations imposed upon them by the survey design.	
 
The unavoidable bias in this study is due to the hypothetical nature of conjoint 
analysis data. Since the purpose of the study was to understand which factors 
drive treatment decision-making by clinicians, an area where little evidence exists 
for subgrouping, a benchmark for identifying the ‘correct answer’ does not exist. 
Furthermore, Bateman et al. (2002) also state that there is no way to assess the 
level of potential discrepancy between results of a conjoint analysis study and 
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reality. Therefore although the emergent response profiles appeared to be logical 
(from the perspectives of the candidate, supervisory team and a selection of local 
shoulder clinicians), there is potential with conjoint analysis that due to the 
hypothetical nature of the study respondents may have made treatment decisions 
that do not reflect their usual clinical practice.  
 
Respondents indicated in free text responses a degree of dissatisfaction with the 
dichotomisation and perceived over-simplification of the patient attributes included 
in hypothetical clinical cases. It is accepted that real-life patients in clinical practice 
are not merely a combination of simple dichotomised patient attributes and that the 
actual patterns that exist in clinical practice are indeed much more complex. The 
decision to dichotomise the patient attributes for inclusion in this study was made 
in collaboration with a variety of experienced clinical professionals with expertise in 
the management of shoulder pain (chapter 4). It is also accepted that the 
reductionist approach taken to the description of clinical attributes for this study 
limits the external validity of the findings since the descriptions used in the study 
may not match those used in real clinical practice. However, use of additional 
and/or more richly detailed patient attribute descriptions would have increased the 
complexity of the study, potentially necessitating a larger sample size, and the risk 
of respondents misunderstanding the meaning of the patient attributes and time 
taken to respond to each hypothetical case.  
 
Current statistical guidance for analysing associations between dichotomised 
patient attributes and outcome questions the practice of dichotomising variables 
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given the likelihood that important data with explanatory or predictive performance 
will be lost (Riley et al. 2013; Vergouw et al. 2010). This challenge is not unique to 
this study and Vergouw (2010) summarised exactly this tension between the 
preference of researchers for increased data points and the preference of clinical 
tool users (clinicians) for simple, quick and easy to use tools. Therefore, whilst it is 
accepted that some statistical power may have been lost through the reductionist 
approach taken to the patient attribute descriptions, the pragmatic and endpoint 
focused goal of informing a future simple, easy-to-use clinical decision aid guided 
final study design decisions. 
 
Table 8.5 (pg. 218) contains a further 12 patient attributes suggested as being 
highly relevant to differential treatment decision-making by survey respondents but 
that were not included in the study. Of note is the low frequency of which each of 
the 12 new attributes was suggested (maximum seven times, minimum by just one 
respondent). This suggests that attributes included in this study and those 
considered in the preparatory research (chapter 4), mirror the general perception 
of the respondents. Of these 12 attributes, the request for full diabetes information, 
full cardiac information and full drug history represents a request for a fully 
comprehensive clinical assessment. For the purposes of a brief clinical decision 
tool, such detailed questions are not feasible, and when used in routine practice, 
additional information can always be collected on attributes that give raise to 
concern. Therefore, it is accepted that the necessary brevity of a decision tool 
limits the depth of clinical information that can be obtained using the tool alone. 
The suggestion by respondents to consider aggravating/easing factors among the 
patient attributes did not arise from previous research, but warrants further 
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attention as a potential moderator of treatment effect as aggravating and easing 
factors may provide valuable insights into the mechanisms through which a 
treatment might achieve its effect, i.e. a mediator of treatment effect could 
potentially also moderate response to specific treatments. Time since last injection 
and extent of previous response to injection are also new suggestions that warrant 
further investigation in future research.  
 
8.5 Conclusion 
This study quantified the impact of the 12 patient attributes for differential decision-
making for shoulder pain. In spite of respondent burden, the pragmatic limitations 
of the design (single treatment options and being forced to make treatment 
recommendations on the basis of limited and pre-specified patient attributes), and 
the hypothetical nature of the clinical cases, respondents still managed to 
complete the survey and provide meaningful responses so that the statistical 
model converged and clear conclusions could be drawn. This preliminary work to 
identify the patient attributes of relevance to clinical decision-making appears to 
have generated novel and informative data in the identification of highly relevant, if 
not some of the most salient patient attributes in differential treatment decision-
making.  
 
Caution is always advised in interpreting and implementing findings of an empirical 
study but especially in the context of a conjoint analysis study since findings are 
born of hypothetical scenarios and responses driven by respondents’ unique, 
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professional perspectives. Surowiecki’s book ‘The Wisdom of The Crowds: Why 
the Many Are Smarter Than the Few’ (2004) outlined many examples from fields 
of science, law, psychology, computing and politics of how each member of a 
crowd contributes their experiential knowledge, so that the aggregate response is 
often more accurate than the response of any one individual.  Conjoint analysis 
was used in this study to deliver the collective wisdom of clinicians on the 
composition of patient profiles of likely good response to specific primary care 
treatments.  
 
Limiting the number of attributes to be included in the conjoint analysis study to 12 
was a pragmatic decision made on the basis of the implications of the complexity 
of conjoint analysis studies with large numbers of attributes, namely increased 
sample size and elevated respondent cognitive burden. The processes undertaken 
(systematic review and expert consensus workshops using focus groups with 
nominal group technique) to arrive at the final 12 patient attributes included in the 
conjoint analysis study were robust, methodologically sound and therefore the final 
data represented the clinical experience of relevant healthcare professionals and 
researchers.  
 
Eleven of the 12 patient attributes studied were identified by clinicians as highly 
relevant to making decisions in the management of shoulder pain and were found 
to influence differential treatment decision-making. The presence or absence of 
psychosocial issues was the only patient attribute studied that was not significantly 
independently associated with differential treatment choice, over and beyond the 
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other attributes in the model. This conjoint analysis study enabled investigation of 
the stated clinical decision-making behaviour in a large number of professionals in 
a highly time and cost-efficient manner, whilst avoiding the practical, ethical or 
financial challenges of clinical observation methods or medical record reviews 
(Lutfey et al. 2008). Robust design and statistical analysis of the conjoint analysis 
method allow confidence in the findings of the study.  
 
It seems that the challenging conjoint analysis questions forced respondents to 
consciously employ their clinical simplification strategies and clinical heuristics, 
which are reflected by the results. The study suggests that logical patterns in 
clinical decision-making exist among experienced clinicians who frequently 
manage the care of patients with shoulder pain. It is a logical assumption that 
clinicians chose the treatment they believed was most likely to result in the best 
outcome for each patient. Therefore the observed pattern represents clinician’s 
perception of likely best responders to physiotherapy and corticosteroid injection 
as well as profiles of patents that they do not believe should receive steroid 
injection or physiotherapy. However, this study has not provided evidence as to 
whether these patterns contain moderators of treatment effect that be used to 
identify patients most likely to respond to particular treatments.  Future studies 
should assess whether these patient attributes are indeed moderators of treatment 
effect, ideally using data from a randomised controlled trial using appropriate 
methodology and sample size, or by using data from multiple existing trials 
providing relevant data on both patient attributes and treatment effects.  
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CHAPTER 9: THESIS SUMMARY AND DISCUSSION 
 
As current clinical guidelines do not assist clinicians with optimal treatment 
selection for patients with shoulder pain, the central aim of this thesis was to 
identify (combinations of) patient attributes that help clinicians decide between 
different treatments in primary care, using existing trial evidence and clinical 
expertise/opinion. At the outset of the thesis, the distinction between prognostic 
factors and moderators of treatment effect and potential utility in informing 
treatment selection had not been discussed within the shoulder pain literature (see 
systematic review, chapter 2). Whilst prognostic research to identify the prognosis 
of shoulder patients was available, there was little research on the moderators of 
the effect of specific treatments or how to choose between treatments for patients 
with shoulder pain. This thesis, therefore, aimed to use appropriate methodologies 
to differentiate between prognostic factors and moderators of treatment effect for 
patients with musculoskeletal shoulder pain. Studies constituting this thesis were 
strongly underpinned by clinical expertise to inform the identification of statistically 
and clinically relevant candidate moderators and therein, the foundations for a 
future model of stratified care for shoulder pain. In this final chapter, an overview 
of thesis findings and applications of the research to date will be presented, 
followed by a critical reflection on the merits and limitations of the methodologies 
employed in this thesis. Applications of findings from the thesis to date will be 
discussed. Finally, this chapter will conclude with the research and clinical 
implications of this thesis. 
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9.1 Summary of Thesis Findings 
9.1.1 Systematic Review 
In chapter 2, a systematic review was undertaken to identify potential moderators 
of treatment effect in patients with shoulder pain and to assess the quality of the 
current evidence. The review focused on identifying randomised controlled trials of 
adults with musculoskeletal shoulder pain that studied any of the three commonly 
used primary care interventions of interest; (i) advice and analgesia, (ii) 
physiotherapy treatment (manual therapy and/or exercise) and (iii) corticosteroid 
injections. Twenty-two studies were included in the review and assessed using the 
Cochrane risk of bias tool (Cochrane, 2011) and the Pincus criteria for assessment 
of methodological quality of moderation analysis (Pincus et al. 2011). Although 
numerous factors were considered or proposed in the 14 studies as potential 
moderators of treatment effect, the review identified just seven trials (based on 
data from six trials) that had conducted either a full moderation analysis or 
subgroup analyses where interactions were tested. Within these seven trials, 13 
patient attributes were specifically examined using processes that could be 
considered to be a form of moderation analysis. Of these, only ‘presence of painful 
arc’ was identified as a moderator treatment effect with confirmatory level 
evidence. All other potential moderators had insufficient or exploratory level 
evidence, highlighting common methodological issues in the current conduct of 
moderation analysis in this field. This review concluded that existing evidence of 
moderation of treatment effect for shoulder pain was limited. The review also 
highlighted that the conduct of appropriate, high quality moderation analysis is 
challenging. The requirement of moderation analysis to utilise large sample sizes 
to test identified pre-specified moderation hypotheses means that at the time of 
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conducting the systematic review moderators of treatment effect had not been 
identified with confidence. 
 
The conclusion of this review gave rise to much consideration of the logical next 
steps to advance this field. At this juncture, I, as a musculoskeletal physiotherapist 
with experience of managing patients with shoulder pain, along with my 
supervisory team who also had the benefit of relevant clinical and epidemiological 
insight, felt that the list of 29 potential moderators (13 potential moderators and 16 
additional un-tested suggestions) identified from the systematic review was both 
overlong as well as incomplete, in that some potentially relevant patient attributes 
appeared to be missing (e.g., psychological attributes such as anxiety, depression, 
psychosocial determinants of health and well-being including work-load and sport 
participation, chronic widespread pain, multi-site pain, employment status, 
analgesic medication and education). Therefore, given that the review conclusions 
were based solely on the clinical factors that had already been studied as potential 
moderators in randomised controlled trials, the logical next step was to ascertain a 
more complete picture of the patient attributes that are likely to be potential 
moderators of treatment effect prior to conducting future, a priori defined 
moderation analyses.  
 
A number of research and methodological options were considered at this time. An 
option could have been a purposive randomised controlled trial of the common 
primary care interventions of interest, in which to conduct a full-scale moderation 
analysis, but this was not feasible within the remit of this PhD. Additional concerns 
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arose that such a moderation analysis, based on an incomplete yet large list of 
potential moderators could represent a data-driven approach that is likely to 
produce spurious findings due to the large number of interactions being 
investigated, as well as risking the omission of potentially relevant genuine 
moderators of treatment effect. 
 
Instead, it was considered that the identification of a highly clinically relevant yet 
short, parsimonius list of potential moderators of treatment effect was likely to be 
of greater benefit to future researchers and clinicians alike. Since first-line 
clinicians make treatment decisions with patients with shoulder pain on a daily 
basis, it was deemed logical and appropriate to next draw upon the knowledge 
and clinical skills of relevant healthcare professionals to populate a list of potential 
moderators of treatment effect and progress the field. Therefore, chapter 3 
outlined the rationale for studying clinical decision-making and its relevance to the 
identification of moderators of treatment effect. 
 
9.1.2 Clinical Consensus Studies 
Chapter 3 outlined the theoretical models of clinical decision-making in the context 
of first-line treatment decision-making for shoulder pain. In the absence of recent 
national guidance (e.g. from NICE) to support primary care treatment decision-
making for shoulder pain, little was known at the outset of the thesis about how 
clinicians chose treatments for patients with shoulder pain or indeed which patient 
attributes were deemed most important to guide differential treatment selection. 
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Instead, it was considered likely that clinicians have developed and follow series of 
individual and experientially constructed clinical heuristics or cognitive shortcuts 
that enable them to make recommendations for treatment selection on the basis of 
prior clinical knowledge and clinical experience. The design of a series of studies 
to explore these decision-making processes in order to understand and identify the 
patient attributes that drive decision-making was indicated. Chapter 3 outlined this 
theoretical basis for studying decision-making in order to identify potential 
moderators of treatment effect. 
 
Although it is accepted that expert opinion constitutes the lowest form of evidence 
in the hierarchy of evidence (Sackett et al. 1997) as chapter 3 outlined, experts do 
not often make uninformed decisions. Rather, ranges of decision-making 
strategies are employed in conjunction with reflection on current evidence, as well 
as clinical experience to systematically arrive at a sound and logical clinical 
diagnosis and treatment decision. Since two of the main studies in this thesis 
made use of expert opinion, potential for scientific critique of this method was 
accepted.  
 
“There are in fact two things, science and opinion; 
the former begets knowledge, the latter ignorance.” 
- Hippocrates (460-377 BCE) 
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This thesis presented a good opportunity to expand on this presumed dichotomy 
by utilising a hybrid approach to study the largely qualitative entity of clinical 
decision-making using scientific and rigorous quantitative research methods. 
Therefore, it was conceived that opportunity and value existed in the conduct of 
sound mixed method research to inform identification of the constructs and 
decision-making strategies of relevant professionals. The high degree of external 
validity gained from drawing upon the knowledge and skills of a variety of 
experienced multidisciplinary healthcare professionals outweighed any concern 
about the potential for qualitative or mixed methods to result in highly individual, 
unrepresentative or professionally biased data. Chapter 4 outlines the various 
(mostly qualitative) options that were considered as potential appropriate 
methodologies for studying the nature, content and processes of clinical decision-
making for shoulder pain. An opportunity existed in this thesis to employ and 
develop methodologies to study clinical decision-making for shoulder pain in a way 
that would yield insightful and novel data and also in a way that had not previously 
been conducted.  
 
Chapter 4 outlines a series of focus groups using nominal group technique and 
consensus workshops that aimed to obtain the clinical breadth of patient attributes 
considered pertinent to differential treatment response. Focus group and workshop 
participants consisted of a professionally diverse group of 21 UK-based healthcare 
professionals and researchers with experience and interest in the management of 
patients with shoulder pain who convened on six dates to participate in a series of 
focus groups. In the focus groups, clinicians suggested 63 patient attributes 
considered relevant to differential decision-making for shoulder pain, of which 53 
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were voted as important. The same participants reorganised the attributes into 13 
parent attributes in focus group two. In workshop three participants agreed upon 
simple clinical questions to describe the information contained in each of the 
parent attributes. Output from this series of focus groups consisted of 12 clinical 
questions with defined categorical response options that were deemed highly 
relevant to differential treatment decision-making for shoulder pain. 
 
Of these 12 clinical attributes, six had not been previously studied as potential 
moderators of treatment effect or examined in existing randomised controlled trials 
(general health status relating to diabetes and heart disease, traumatic onset, 
overuse, current clinical status, psychosocial complexity, sleep disturbance). The 
output from chapter 4 represented insight into the clinical attributes considered 
highly relevant to differential treatment decision-making by clinicians and provided 
new direction to the next phase of investigating decisions between three 
commonly used first-line treatments for shoulder pain and thereby identify potential 
moderators of treatment effect. 
 
9.1.3 Introduction to Conjoint Analysis 
At the outset of chapter 5, the relative importance of the 12 patient attributes in 
differential decision-making for shoulder pain was not known. The next phase of 
the thesis sought to develop understanding of how these patient attributes are 
valued by clinicians to arrive at treatment decisions. Chapter 5 outlined a variety of 
methods that have previously been used to study clinical decision-making and also 
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to provide the rationale for and the merit of using a novel experimental approach to 
develop understanding of differential treatment decision-making for patients with 
shoulder pain. An overview of the conjoint analysis methodology and specifically 
it’s potential to quantify the influence of each of the attributes on specific 
differential treatment decisions was provided.  
 
Particular challenges encountered in the design phase of the conjoint study 
(chapter 6) included determination of the optimum balance between statistical 
efficiency and response efficiency. Statistical efficiency was assured through the 
use of an orthogonal design and response efficiency was achieved through use of 
blocking with random allocation of tasks to limit the number of decision tasks 
required of each respondent. Much consideration was given during the design 
phase of the study to the likely impact that potential illogical combinations of 
clinical attributes arising from the orthogonal array could have on response 
efficiency. The final design represented the perceived optimal balance between 
obtaining sound data and designing the conjoint analysis study in a way to best 
represent the clinical reality. Achieving both aims at once, in one study is accepted 
to be difficult (Marshall et al. 2010). Therefore, the final study design represented a 
trade-off between these two aims. Particular strengths of the study include 
navigating sample size calculation for our study type where no known convention 
exists and designing the custom-built survey platform to host the randomisation 
and data collection features required for the survey. These aspects of the thesis 
were conceptually driven by the PhD student, and supported technically by a 
statistician and an IT specialist, respectively. 
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9.1.4 Multimodal Recruitment Strategy for the Conjoint Study 
The target population for the conjoint analysis study was an international and 
multidisciplinary population of medical, health and research practitioners with an 
interest in the clinical management of shoulder pain, either clinical or research.  As 
outlined in chapter (7), numerous challenges exist in recruiting clinicians for the 
purposes of survey research, namely lack of access to complete registries of 
shoulder specialist clinicians as well as the time and cost inefficiencies associated 
with using some of the traditional methods of recruitment. Therefore, it was 
deemed necessary to develop an alternative, novel recruitment strategy that 
involved both traditional and Internet mediated methods of recruitment. Chapter 7 
outlined the background, rationale and appraisal of the final recruitment strategy, 
surmising that on balance, the multi-modal strategy developed was successful as 
it delivered complete data from enough respondents to meet the minimum sample 
size within the defined recruitment period and at almost zero material cost.  
 
9.1.5 Conjoint Analysis Study of Clinical Decision-Making 
As outlined in chapter 8, complete survey data was received from 387 
respondents and partially complete data was received an additional 178 
respondents. The statistical analysis depicted the odds of respondents choosing 
either corticosteroid injection or physiotherapy above advice and analgesia for 
each attribute. The conjoint analysis indicated that logical patterns of decision-
making exist using the 12 attributes studied. Specific patient attributes were 
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associated with either increased or decreased likelihood of respondents choosing 
corticosteroid or physiotherapy above advice analogies. The results suggest that 
clinicians do indeed use patient attributes to guide differential treatment decision-
making for patients of shoulder pain and that different patient profiles exist that 
respondents considered to be more and less likely to respond to the specific 
interventions.  
 
Since the design of the conjoint analysis was relatively complex as well as novel, it 
was deemed pertinent to ascertain a measure of acceptability and completeness 
of the survey as an experimental representation of the clinical decision-making 
process. Data were therefore gained on respondent perception of task complexity 
and completeness of the hypothetical clinical cases. The results indicated that 
respondents found completing the conjoint analysis tasks difficult. Although the 
study was piloted in a small group of respondents similar to the intended target 
population for the study (chapter 6), the small-scale pilot did not identify frustration 
with either the illogical attribute combinations or the limited response options 
offered in the study. Free text response data indicated that respondents to the 
actual survey felt that a number of relevant patient attributes were missing from 
the study. When the attributes suggested as being relevant by respondents were 
compared to the attributes that fed into the design of the conjoint analysis study, 
the majority of items suggested were similar to those considered during the 
developmental work, lending credence to the developmental study design 
methods. Of the twelve clinical factors newly suggested by the responders, nine 
were not deemed relevant to a brief clinical tool or not applicable to an NHS 
context. However, three had not previously considered in the developmental work 
 255 
for this study and warrant investigation in future research: aggravating/easing 
factors, time since last injection, and extent of previous response to corticosteroid 
injection. These are worthy of investigation in future research. 
 
The primary strength of the conjoint analysis study was that it enabled 
quantification of the impact of specific patient attributes on differential treatment 
decision-making. A large sample size was achieved facilitating convergence of the 
statistical model and emergence of clinically sensible patterns of decision-making 
for shoulder pain. The high degree of engagement with the study from a range of 
relevant professionals internationally indicated that the research question was of 
relevance to clinicians. In addition, the conjoint analysis methods facilitated 
consolidation of data received from individual respondents into patterns of clinical 
decision-making that represent the input from the multitude of professional 
disciplines relevant to management shoulder pain. The weaknesses of any 
conjoint analysis study are the hypothetical nature of the study, the limited and 
tightly defined question formats and response options required to achieve testable 
hypotheses, and that only specific attributes can be offered for consideration and 
quantified during the study. In spite of these limitations, respondents managed to 
provide meaningful data that constitutes a list of clinically relevant candidate 
moderators of treatment effect and profiles of likely responders to each 
intervention. These patient attributes and profiles warrant further investigation in 
future research to determine their moderating effect on the actual outcomes of 
treatments received by patients with shoulder pain. 
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9.2 Originality of This Thesis 
This thesis has several original elements and combines insights from a variety of 
methodological fields. Consideration of moderators of treatment effect for 
musculoskeletal conditions has less precedence than in fields such as 
cardiovascular and cancer research. This thesis therefore represents a 
methodological step forward for the field of musculoskeletal pain management.  
 
Investigation of clinical decision-making and the use of the conjoint analysis 
method are not new, however application of the conjoint analysis methodology to 
study differential treatment decision-making by clinicians is relatively new. This 
thesis utilised menu-based conjoint analysis, a form of conjoint analysis more 
regularly applied in the field of marketing to study the determinants of differential 
decision-making when choosing between three potentially viable treatment options 
(most often consumer choices surrounding food and products). Specifically, there 
was no precedence for the use of the experimental design of the conjoint analysis 
in a clinical decision scenario with a large number of patient attributes and three 
treatment options. Also, since no known convention existed to determine 
appropriate sample size and statistical analysis approaches steps taken during 
this thesis constituted methodological steps forward in the practical application of 
conjoint analysis in empirical research. The use of a multidisciplinary and 
international sample of researchers and clinicians for the conjoint analysis study is 
also novel and provides results of the study with good external validity. 
Specifically, the development of a multimodal recruitment strategy to identify, invite 
and recruit this multidisciplinary sample to participate in the conjoint analysis study 
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represents new recruitment methodology development and innovative use of 
information communication technologies (a proforma for use in other studies may 
be found in appendix 13). 
 
9.3 Critical Reflection of Methods Used 
In spite of using robust systematic review methods and review tools (Cochrane 
Risk of Bias tool and the Pincus tool for assessment of moderators), conclusions 
drawn from the systematic review are limited by the extent of patient attributes 
included in each study and also the statistical analysis conducted in existing trials 
of interventions for shoulder pain. Therefore, the review does not present data or a 
conclusion on every possible moderator of treatment effect or a clear-cut set of 
patient attributes that differentially moderate response to commonly used 
treatments for musculoskeletal shoulder pain in primary care, but rather a 
summary of the current application of moderation and subgroup analysis in studies 
concerning the management of patients with shoulder pain. Nonetheless, the 
review was valuable as it identified the methodological and clinical gaps in 
moderation analysis in this field, which informed the next steps taken in this thesis. 
 
The clinical consensus focus groups and workshops aimed to develop a list of the 
most relevant patient attributes to differential treatment decision-making for 
patients with shoulder pain. Although conducted with sound clinical consensus 
methods, concern existed about the maximum number of attributes that the 
planned conjoint analysis study could manage. This forced the application of the 
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limit of 12 patient attributes, an upper limit reasoned on the basis of previous 
conjoint analysis studies (outlined in chapter 5). In spite of achieving consensus 
agreement on the final 12 most salient patient attributes, it is possible that some 
informative data may have been lost to the conjoint survey due to the potential for 
omission of highly relevant patient attributes from the final list or by virtue of the 
way in which final combinations of patient information were grouped together into 
parent attributes by the participating clinicians.  Also, since the expert consensus 
workshops were conducted on a single site in the UK, some geographical bias 
might have existed. Steps were taken to counteract each of these issues but they 
may have persisted nonetheless. Future expert clinical consensus research could 
incorporate either multiple geographical locations nationally or internationally or 
target a pre-existing and well-attended international conference as an opportunity 
to engage relevant international clinicians in the consensus research exercise.  
 
Although the recruitment strategy employed for the conjoint analysis study was 
deemed successful as it managed to recruit the target number of responders 
providing a complete set of response data, methodological reflections were made 
on how the recruitment strategy could be improved for future research studies. 
Specifically, future use of the recruitment strategy should include a single question 
related to mode of entry to the survey. Also different web addresses could be used 
for specific strands of the recruitment strategy, which could inform analysis on the 
impact of each strand of the recruitment strategy. 
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The conjoint study was fielded from the UK and was also open to international 
clinicians. The recruitment strategy was based on a convenience snowball 
sampling method that drew upon the professional network of the PhD student and 
supervisory team. In spite of the multimodal recruitment strategy (chapter 7), the 
final sample was unbalanced both by professional background and by country of 
clinical practice (64% of sample were from the UK & Republic of Ireland and 66% 
were physiotherapists). It is anticipated that this was in part due to the increased 
likelihood that physiotherapists may be more interested in a research survey that 
relates to referral to physiotherapist-led interventions (amongst other treatment 
decisions) than other professionals. The sample imbalance is also likely to be due 
to the strong physiotherapy research network the Research Institute has 
developed and the professional background in physiotherapy of both the PhD 
student and supervisor (Dr. Jonathan Hill), meaning that invitations were more 
likely to be well received by respondents who shared this professional 
background. Access to and recruitment of medically trained professionals to 
research surveys has been shown to be challenging (Cottrell et al. 2015). Further 
research is required on the optimal way to engage and recruit medically trained 
health professionals, especially to multidisciplinary research. Future research 
aiming to recruit a balanced international and multidisciplinary sample should 
consider identifying recruitment champions in each country of interest and in each 
professional background interest to ensure optimal professional credibility and 
visibility. 
 
Data from Google Analytics showed that the survey website was accessed 2700 
times, indicating that it was relatively easy to encourage potential respondents to 
 260 
click on the survey web address. However, of the 2700 times the survey was 
accessed, 1916 respondents submitted some data but complete data was 
received from only 387 individuals. Precise reasons for respondents providing 
incomplete data are unclear, but since the survey was fielded only in English, it is 
possible that individuals who accessed the survey but not fluent in the English 
language may have opted to leave the survey without providing complete data. 
Offering the survey exclusively in the English language created an obvious 
geographical and language bias. However this avoided the significant, recognised 
challenges associated with assuring translation validity, internal consistency and 
face validity in a translated survey (Litwin & Fink, 1995). Future surveys that aim to 
recruit an international sample should consider translating the survey and 
recruitment materials into the languages spoken in the countries of interest, as 
well as conducting the necessary piloting to ensure consistency across 
translations.  
 
The pragmatic decision in the design of the conjoint survey to limit the number of 
treatment choices for each hypothetical scenario to just one and preclude 
selecting a combination of treatment choices resulted in both methodological and 
practical strengths and limitations. It was hypothesised that respondents might opt 
to select both physiotherapy and corticosteroid injection as a combined treatment 
as their first line treatment decision. Free text responses provided by survey 
responders indicated that respondents were frustrated by the lack of option to 
combine treatments and reported that the survey did not accurately depict clinical 
reality. Future conjoint analysis studies should take this valid criticism into account 
and offer the option to select both single and combined treatments considered 
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most likely to achieve positive treatment effect to enable analysis of the impact of 
patient attributes on clinicians’ decision between routinely available treatment 
options.  
 
The multi-modal recruitment strategy developed in this thesis has been 
successfully applied by another research team in a separate study (Salt et al. 
2018). Salt et al operationalised the strategy and recruited 529 physiotherapists 
(492 of whom were eligible for inclusion in analysis) to a survey on the use of 
suprascapular nerve blocks in patients with persistent shoulder pain. In 
comparison to the sample obtained in the conjoint study in this thesis, where 
complete data was received from 387 clinicians, 255 of whom were 
physiotherapists, Salt et al’s recruitment appears to have been more successful. It 
is thought that the comparatively larger sample size achieved by Salt et al is due 
their survey being much more conventional (i.e., similar to other previous surveys 
of treatment options used in everyday clinical practice), and comparatively shorter 
and easier to complete. In contrast, the conjoint survey in this thesis was, to the 
best of author’s knowledge, the first conjoint analysis study to have been 
conducted on clinical decision-making in musculoskeletal pain, therefore clinicians 
will not have been familiar with the format and limitations of the study type. The 
conjoint survey was also longer, required responses to 12 cognitively demanding 
hypothetical, clinical decision-making scenarios, and also included a series of 
decision stability questions whereby respondents had to reflect upon decisions 
made. Furthermore responses to the decision stability questions revealed, as 
previously discussed in this thesis, that the conjoint study format was perceived by 
respondents to be challenging and reductive. These limitations have been 
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reflected on throughout the thesis and on balance, it is felt that they do not strongly 
affect the validity of the findings of this thesis. 
 
9.4 This Thesis’ Impacts on Future Primary Management of Shoulder Pain  
At the very outset of conceptualising this thesis, how a PhD thesis could contribute 
to the future development of a model for stratified care for shoulder pain was 
considered. As demonstrated with a systematic review (chapter 2), the research 
field of shoulder pain is relatively young, therefore this thesis aimed to make a 
conceptual as well as methodological step towards the development of a model for 
stratified care shoulder pain, through the identification of clinically valid candidate 
moderators of treatment effect.  
 
Given the methodological challenges encountered in moderation analysis and the 
quantitative study of clinical decision-making, the output of this thesis represents a 
logical and sequential series of steps undertaken to develop knowledge on 
moderators of treatment effect for shoulder pain in the face of the current lack of 
data from RCTs and methodological barriers. The future of shoulder pain 
management in primary care could logically be based on an evidence-based 
model of stratified care underpinned by moderators of treatment effect. Further 
research involving testing of the candidate moderators identified in this thesis 
including those additional moderators suggested by clinicians in the conjoint 
analysis study in existing trial data datasets or in a new trial is required before any 
such model can be confidently proposed. 
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9.5 Relevance of the Thesis Findings for Practice 
Although this thesis has no immediate or direct implications for clinical practice, 
the underpinning of the thesis highlights the importance of differentiating between 
generic prognostic factors and moderators of treatment effect, therein offering 
potential learning opportunities for all clinicians who engage in differential 
treatment decision-making, irrespective of the clinical presentation being 
addressed. Extending understanding of this important methodological distinction is 
likely to assist clinicians in everyday clinical practice in using the available 
evidence to inform sound differential clinical treatment decisions. 
 
Confirmation is first needed from appropriate trials or large cohorts about the 
impact of the candidate moderators suggested by this thesis. However, the 
existing survey format has potential for further future development for on-going 
research as well as an education tool for clinicians if the candidate moderators are 
indeed found to moderate treatment effect. If in the future, the conjoint analysis 
study methods could be scaled up sufficiently and include the range of treatment 
choices suggested by respondents to the survey (i.e., combinations of 
conservative treatments and also the option to refer to secondary care specialists), 
this could enable longer-term data collection and also include other currently un-
explored potential moderators (such as imaging findings, genetic biomarkers, 
metabolic factors or inflammatory markers). Longitudinal data collection could also 
be used in place of surveys of current practice to investigate changes in opinion 
and decision-making over time, and analyse the impact of new guidelines, seminal 
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trials, new interventions, models of care or other significant drivers of clinical 
behaviour change on clinical attitudes, beliefs and decision-making behaviour. 
Since not formally addressed in this thesis, examination of differences in treatment 
decision-making across countries and between professionals could be also be pre-
specified and modeled in future data collection using an appropriate recruitment 
strategy.  
 
The survey also has development potential to as act as an educational resource 
for clinicians, if it was possible in the future to format the survey so that clinicians 
could complete the survey and compare their results with the results of members 
of their profession as well as in the international multidisciplinary sample as a 
whole. If in the future this could be supported by data from a large cohort study or 
trial about the usual clinical course of patients with shoulder pain who present with 
specific attributes (prognosis) or patterns of symptoms, a summary of the 
clinicians current decision-making strategies could be compared with data on how 
each clinical factor affects prognosis, and which patterns of patient attributes are 
considered by expert clinicians to be associated with positive or negative response 
to specific treatments.  
 
This could also, if successful, become integrated into a computer application for 
use by patients and clinicians to inform treatment decisions. In clinical practice, a 
patient’s characteristics could be entered into the application that would then use 
the data already gained from international and multidisciplinary professionals to 
indicate how other clinicians would manage a similar patient. This information 
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could also be combined with insights gained from the forthcoming individual 
patient data meta-analysis planned as part of the Prognostic and Diagnostic 
Assessment of Shoulder Pain (PANDA-S) programme of research (outlined in 
section 9.8) to provide predicted likely response statistics based on similar patients 
in previous research studies. A simple and clinically useful output of this would be 
predicted treatment response statistics for each of the treatments being 
considered.  
 
9.6 Implications for Research 
The next step from this thesis is to investigate the predictive performance and 
clinical utility of the candidate moderators of treatment effect of interventions for 
shoulder pain identified in this thesis. Once their predictive performance in clearly 
defined patient groups has been established, a model of stratified care can be 
defined. Within the forthcoming PANDA–S research programme, due to begin at 
Keele University in 2018, the predictive performance of candidate moderators, 
including those suggested by this thesis will be investigated. This will inform the 
design of a model of stratified primary care for shoulder pain, in which optimal 
diagnostic and prognostic information will be used to target shoulder pain 
interventions to patient subgroups likely to benefit most or experience least harm.   
 
Additional future research could also include analysis of the impact of the multi-
modal recruitment strategy that has been applied so far in other studies involving 
clinicians or other specific target groups. A systematic review of such studies could 
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inform reflection on the application of the strategy and the comparative strengths 
and opportunities for strategic development of its component streams. Such a 
review could guide its future iteration and development for use in other studies. 
Although broadcast recruitment methods (adverts placed on social media website, 
programmed by the social media company to appear on the timeline of individuals 
who match the demographics of the source population) have been used 
successfully to recruit patients to research on sensitive topics (Frandsen et al. 
2014; Lane et al. 2015), the impact of additional potential social media-based 
recruitment streams in the recruitment of clinicians to a research survey is 
unknown. Therefore, future research could also investigate the cost-effectiveness 
of such advertisements for a study on Facebook, Twitter, LinkedIn etc., compared 
to the low cost recruitment strategy developed in this thesis. 
 
A weakness of the conjoint analysis that has been discussed in this thesis is the 
request for additional treatment response options and the option of multiple 
treatment combinations, for example corticosteroid injection and referral to 
physiotherapy. Additional insights could also be gained if respondents were asked 
to indicate their first single treatment recommendation (as in this study) and also 
recommend a combination of treatments if they felt it was indicated. Future 
application of conjoint analysis in the field of treatment decision-making for 
shoulder pain in primary care could, in addition to the three primary care 
treatments of interest, include the option to refer for further assessment by an 
advanced practice musculoskeletal physiotherapist or refer to an orthopaedic 
surgeon. This clinical consensus could be used as a basis for future intervention 
studies.  
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Of greatest relevance to future research is the replicable sequential approach to 
investigating clinical decision-making that has value in its potential future 
application to progress other clinical areas where diagnosis and clinical decision-
making are currently unclear or rely on ‘clinical instinct’ or ‘gut feeling’ outlined in 
this thesis. As discussed throughout this thesis, within shoulder pain, areas of 
clinical uncertainty currently are likely to include: (i) which patients are likely to 
benefit from surgical repair of rotator cuff tears, (ii) the role of ultrasound imaging 
in diagnosis of shoulder pain, (iii) the implications of diagnosis for treatment 
decision-making in shoulder pain and, beyond the remit of this thesis but of clinical 
relevance to clinicians who manage shoulder pain, (iv) early recognition of patients 
who have suffered a dislocation who are likely to repeatedly dislocate and 
therefore require surgical management. Development of the above potential 
research ideas into a clinically informative mix of clinical expertise-driven decision 
support and treatment success probability estimates obtained from data collected 
in similar ‘real’ patients could have meaningful potential to improve decision-
making and outcome for many patients. 
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9.7 Applications/Output from this Thesis 
 
1) Output from the thesis has been incorporated in a research programme led 
by Keele University recently funded by the National Institute for Health 
Research (NIHR) and Arthritis Research UK entitled ‘Prognostic and 
Diagnostic Assessment of Shoulder Pain (PANDA-S)’. This programme of 
research will test the candidate moderators identified in this thesis, 
alongside other candidate predictors, using an individual patient data (IPD) 
meta-analysis of existing trial data. A cohort study will provide a context to 
examine the profiles of likely best responders as identified in the IPD meta-
analysis. Finally, a model of stratified care for shoulder pain will be 
developed, partly based on confirmed treatment moderators, and tested in 
a randomised controlled trial that will compare the clinical and cost-
effectiveness of using the stratified care model with usual care for shoulder 
pain. 
 
2) The approaches used in this thesis to identify relevant patient attributes in a 
clinically uncertain decision context and also quantify their impact on 
decision-making inspired a portion of a recently EU Horizon 2020-funded 
research project entitled ‘Personalised Prognostic Models to Improve Well-
being and Return to Work After Neck and Low Back Pain – Back-Up’ led by 
the Instituto de Biomechanica in Valencia (Spain), in which Keele 
researchers (Hill, van der Windt and Wynn-Jones) are co-applicants. For 
one of the work-packages, the Back-Up programme will draw upon 
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procedures developed and methodological insights gained during this thesis 
and design a multimodal recruitment strategy to recruit a multi-disciplinary, 
international sample of clinicians to a conjoint analysis study investigating 
clinical decision-making in the management of spinal pain across Europe. 
 
3) The multi-modal recruitment strategy developed for the conjoint analysis 
study appears to have appeal as a pragmatic survey recruitment 
methodology. I have been invited to apply the methodology in two separate 
studies to date:  
a. Dr. Emma Salt (Research Intern, Keele University) et al’s (in 
preparation for publication) online survey of current clinical utility of 
suprascapular nerve blocks (SSNBs) amongst specialist 
physiotherapists, achieving 529 respondents in six weeks. 
b. Mr Ahmad Almari’s (PhD candidate, Sheffield Hallam University) 
online survey of UK-based physiotherapist’s management on neck 
pain, achieving in excess of 2100 respondents in four weeks (in 
progress). 
 
4) Dr. Elizabeth Cottrell (Academic GP, Keele University) has included a 
conjoint analysis study as part of a proposed research project to determine 
the optimal clinical explanation of osteoarthritis for GPs to give in order to 
inform, equip and inspire patients to partake in evidence-based 
management approaches (exercise and weight management). Practical 
knowledge and insights gained during my PhD regarding the challenges of 
conjoint analysis study design, likelihood of and measures available to 
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counteract respondent burden and on necessary preliminary studies have 
been applied to this research question.  
 
9.8 Final Conclusion 
This thesis used a variety of quantitative and qualitative methods to systematically 
and empirically draw upon multidisciplinary clinical expertise in order to derive a 
list of candidate moderators of the effect of commonly used first-line treatments for 
shoulder pain. The series of studies contained within this thesis forms a logical 
sequence of progressive research that that provided novel and rich data regarding 
decision-making processes in clinicians responsible for the management of 
patients with shoulder pain. Although based on hypothetical decision-making and 
accepting limitations in terms of question format and sample balance, the conjoint 
analysis study offered new, novel and quantified insights into how 12 specific 
patient attributes drive differential decision-making for shoulder pain (pain severity, 
onset, clinical status, sleep impact, work/sport/hobby impact, neck involvement, 
previous treatment response, general health status, psychosocial issues, overuse, 
instability and/or weakness and patient treatment preference). The profiles of likely 
responders and non-responders to the three specific treatments derived from the 
conjoint survey also make logical and clinical sense, therefore strengthening the 
potential of these candidate moderators as predictors of differential treatment 
effect.  
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Methods developed during this thesis may have potential for research application 
in other clinical presentations that require co-ordinated, evidence-based 
healthcare intervention and where hypotheses exist that specific subgroups of 
patients are likely to respond differently to specific interventions. The next 
research steps arising from this thesis are the testing of the predictive 
performance of the candidate moderators suggested by this thesis using data from 
RCTs and if genuine evidence of moderation of treatment effect is found, this 
would indicate the design and impact evaluation of a resultant clinical decision tool 
for primary care management of shoulder pain.  
 
 
 
 
 
 		 	
 272 
REFERENCES 
AAOS (2009). The Treatment of Glenohumeral Joint Osteoarthritis: Guideline and 
Evidence Report. American Academy of Orthopedic Surgeons (AAOS). pp. 1-
201. 
 
Abdulla, S. Y., Southerst, D., Côté, P., Shearer, H. M., Sutton, D., Randhawa, K., 
et al. (2015). Manual Therapy. Manual Therapy, 20(5), 646–656. 
http://doi.org/10.1016/j.math.2015.03.013 
 
Ahern, N. R. (2005). Using the Internet to conduct research. Nurse Researcher, 
13(2), 55–70. http://doi.org/10.7748/nr2005.10.13.2.55.c5968 
 
Alessi, E. J., & Martin, J. I. (2010). Conducting an internet-based survey: Benefits, 
pitfalls, and lessons learned. Social Work Research, 34(2), 122-128. 
http://doi.org/10.1093/swr/34.2.122.  
 
Arslan, S., & Celiker, R. (2001). Comparison of the efficacy of local corticosteroid 
injection and physical therapy for the treatment of adhesive capsulitis. 
Rheumatol Int. 21(1), 20-3. 
 
 Artus, M., van der Windt, D.A., Afolabi, E.K., Buchbinder, R., Chesterton, L.S., 
Hall, A., et al. (2017). Management of shoulder pain by UK general 
practitioners (GPs): a national survey. BMJ Open, 7(6), e015711. 
http://doi.org/10.1136/bmjopen-2016-015711 
 
Ashby, D., & Smith, A.F. (2000). Evidence-based medicine as Bayesian decision-
making. Statistics in Medicine, 19(23), 3291–3305. 
 
Austin, P.C., & Steyerberg, E.W. (2017). Events per variable (EPV) and the 
relative performance of different strategies for estimating the out-of-sample 
validity of logistic regression models. Statistical Methods in Medical Research, 
130, 096228021455897. http://doi.org/10.1214/07-STS242 
 
Bachmann, L.M., Mühleisen, A., Bock, A., Riet, ter, G., Held, U., & Kessels, A.G. 
(2008). Vignette studies of medical choice and judgement to study caregivers' 
medical decision behaviour: systematic review. BMC Medical Research 
Methodology, 8(1), 50. http://doi.org/10.1186/1471-2288-8-50 
 
Baker, S., McBeth, J., Chew-Graham, C.A., Wilkie, R. (2017). Musculoskeletal 
pain and co-morbid insomnia in adults; a population study of the prevalence 
and impact on restricted social participation. BMC Family Pract 18(1); 1–9. doi: 
10.1186/s12875-017-0593-5 
 
Banning, M. (2008). A review of clinical decision making: models and current 
research. Journal of Clinical Nursing, 17(2), 187–195. 
http://doi.org/10.1111/j.1365-2702.2006.01791.x 
 
Baron, R.M., & Kenny, D.A. (1986). The moderator-mediator variable distinction in 
 273 
social psychological research: conceptual, strategic, and statistical 
considerations. Journal of Personality and Social Psychology, 51(6), 1173–
1182. 
 
Bateman, I.J., Carson, R.T., Day, B., Hanemann, M., Hanley, N., Hett, T., Jones-
Lee, M., Loomes, G., Mourato, S., Ozdemirog lu, E., Pearce, D.W., Sugden, 
R., Swanson, J. (2002). Economic Valuation with Stated Preferences 
Techniques: A Manual. Cheltenham: Edward Elgar. 
 
Beaton, D.E., & Richards, R.R. (1996). Measuring function of the shoulder. A 
cross-sectional comparison of five questionnaires. The Journal of Bone and 
Joint Surgery. American Volume, 78(6), 882–890. 
 
Benfield, A.J., & Szlemko, J.W. (2006). Internet-based data collection: Promises 
and realities. Journal of Research Practice, 2(2), D1. Retrieved from 
http://jrp.icaap.org/index.php/jrp/article/view/30/51 
 
Bennell, K., Wee, E., Coburn, S., Green, S., Harris, A., Staples, M., Forbes, A., 
Buchbinder R. (2010). Efficacy of standardised manual therapy and home 
exercise programme for chronic rotator cuff disease: randomised placebo 
controlled trial [with consumer summary]. BMJ, 340:C2756. 
http://doi.org/10.1136/bmj.c2756 
 
Benner, P. (1984). From Novice to Expert: Excellence and Power in Clinical 
Nursing Practice. Menlo Park, California: Addison-Wesley Publishing. 
 
Benner, P., & Tanner, C.A. (1987). How expert nurses use intuition. American 
Journal of Nursing, 87(1), 23–34. 
 
Biesheuvel, C.J., Vergouwe, Y., Steyerberg, E.W., Grobbee, D.E., & Moons, 
K.G.M. (2008). Polytomous logistic regression analysis could be applied more 
often in diagnostic research. Journal of Clinical Epidemiology, 61(2), 125–134. 
http://doi.org/10.1016/j.jclinepi.2007.03.002 
 
Bishop, A., Holden, M.A., Ogollah, R.O., Foster, N.E., & Ease Back Study Team 
(2016). Current management of pregnancy-related low back pain: a national 
cross-sectional survey of UK physiotherapists. Physiotherapy, 102(1), 78–85. 
http://doi.org/10.1016/j.physio.2015.02.003 
 
Bishop, F.L., & Lewith, G.T. (2008). A Review of Psychosocial Predictors of 
Treatment Outcomes: What Factors Might Determine the Clinical Success of 
Acupuncture for Pain? Journal of Acupuncture and Meridian Studies, 1(1), 1–
12. http://doi.org/10.1016/S2005-2901(09)60001-7 
 
BPS (2013). Ethics Guidelines for Internet-Mediated Research (pp. 1–28). The 
British Psychological Society (BPS). Retrieved from 
http://www.bps.org.uk/publications/policy-and- guidelines/research-guidelines-
policy- documents/research-guidelines-poli: 03.03.15 
 
Blanchard, V., Barr, S., & Cerisola, F.L. (2010). The effectiveness of corticosteroid 
 274 
injections compared with physiotherapeutic interventions for adhesive 
capsulitis: A systematic review. Physiotherapy, 96(2): 95-107. http://doi: 
10.1016/j.physio.2009.09.003. 
 
Blangsted, A.K., Sogaard, K., Hansen, E.A., Hannerz, H., & Sjogaard, G. (2008). 
One-year randomized controlled trial with different physical-activity programs 
to reduce musculoskeletal symptoms in the neck and shoulders among office 
workers. Scandinavian Journal of Work, Environment & Health 2008 
Feb;34(1):55-65. 
 
Bot, S.D.M., van der Waal, J.M., Terwee, C.B., van der Windt, D.A.W.M., 
Scholten, R.J.P.M., Bouter, L.M., & Dekker, J. (2005). Predictors of outcome in 
neck and shoulder symptoms: a cohort study in general practice. Spine, 
30(16), E459–70. 
 
Bouma, B.J., van der Meulen, J.H., van den Brink, R.B., Arnold, A.E., Smidts, A., 
Teunter, L.H., Lie, K.I., Tijssen, J.G. (2001). Variability in treatment advice for 
elderly patients with aortic stenosis: a nationwide survey in The Netherlands. 
Heart (British Cardiac Society), 85(2), 196–201. 
 
Braithwaite, D. (2003). Using the Internet to conduct surveys of health 
professionals: a valid alternative? Family Practice, 20(5), 545–551. 
http://doi.org/10.1093/fampra/cmg509 
 
Bridges, J.F.P., Hauber, A.B., Marshall, D., Lloyd, A., Prosser, L.A., Regier, D.A., 
Johnson, R., Mauskopf, J. (2011). Conjoint Analysis Applications in Health—a 
Checklist: A Report of the ISPOR Good Research Practices for Conjoint 
Analysis Task Force. Value in Health, 14(4), 403–413. 
http://doi.org/10.1016/j.jval.2010.11.013 
 
Bridges, J.F.P., Onukwugha, E., Johnson, R., & Hauber, A.B. (2007). Patient 
Preference Methods A Patient Centered Evaluation Paradigm. ISPOR 
Connections, (13), 4–7. As accessed from: 
https://www.ispor.org/news/articles/Dec07/Bridgesetal2007-
Patientpreferencemethods.pdf on 17.04.14.  
 
Bridges, J.F.P., Kinter, E.T., Kidane, L., & Heinzen, R.R. (2008). Things are 
looking up since we started listening to patients. Patient, 1;1(4):273-82. 
http://doi: 10.2165/01312067-200801040-00009 
 
Bron, C., de Gast, A., Dommerholt, J., Stegenga, B., Wensing, M., & Oostendorp, 
R.A.B. (2011). Treatment of myofascial trigger points in patients with chronic 
shoulder pain: a randomized, controlled trial. BMC Medicine 2011 Jan 
24;9(8):Epub. http://dx.doi.org/10.1186/1741-7015-9-8 
 
Brookes, S.T., Whitely, E., Egger, M., Smith, G.D., Mulheran, P.A., & Peters, T.J. 
(2004). Subgroup analyses in randomized trials: risks of subgroup-specific 
analyses. Journal of Clinical Epidemiology, 57(3), 229–236. 
http://doi.org/10.1016/j.jclinepi.2003.08.009 
 
 275 
Brookes, S.T., Whitley, E., Peters, T.J., Mulheran, P.A., Egger, M., & Smith, G.D. 
(2001). Subgroup analyses in randomised controlled trials: quantifying the 
risks of false-positives and false-negatives. Health Technology Assessment 
(Winchester, England), 5(33), 1–56.  
 
Buchbinder, R., Green, S., & Youd, J.M. (2013a). Corticosteroid injections for 
shoulder pain. Cochrane Database Systematic Review, (1), CD004016. 
http://doi.org/10.1002/14651858.CD004016 
 
Buchbinder, R., Staples, M.P., Shanahan, E.M., & Roos Juliana, F. (2013b). 
General Practitioner Management of Shoulder Pain in Comparison with 
Rheumatologist Expectation of Care and Best Evidence: An Australian 
National Survey. PLoS ONE, 8(4), e61243. 
http://doi.org/10.1371/journal.pone.0061243.s002 
 
Bull, S.S., Levine, D., Schmiege, S., & Santelli, J. (2013). Recruitment and 
retention of youth for research using social media: Experiences from the 
Just/Us study. Vulnerable Children & Youth Studies, 8(2), 171–181. 
http://doi.org/10.1080/17450128.2012.748238 
 
Cadogan, A., Laslett, M., Hing, W., McNair, P., & Taylor, S. (2012). Clinical 
predictors of a positive response to guided diagnostic block into the 
subacromial bursa. J Rehabil Med, 44(10), 877–84. 
 
Cadogan, A., McNair, P., Laslett, M., & Hing, W. (2013). Shoulder pain in primary 
care: diagnostic accuracy of clinical examination tests for non-traumatic 
acromioclavicular joint pain. BMC Musculoskeletal Disorders, 14, 156. 
http://doi.org/10.1186/1471-2474-14-156 
 
Caldon, L.J.M., Walters, S.J., Ratcliffe, J., & Reed, M.W.R. (2007). What 
influences clinicians’ operative preferences for women with breast cancer? An 
application of the discrete choice experiment. European Journal of Cancer, 
43(11), 1662–1669. http://doi.org/10.1016/j.ejca.2007.04.021 
 
Canivet, C., Östergren, P.O., Choi, B., Nilsson, P., Sillén, U.A., Moghadassi, M., 
Karasek, R., Isacsson, S.O. (2008). Sleeping problems as a risk factor for 
subsequent musculoskeletal pain and the role of job strain: Results from a 
one-year follow-up of the Malmö shoulder neck study cohort. International 
Journal of Behavioral Medicine, 15(4), 254–262. 
http://doi.org/10.1080/10705500802365466 
 
Carette, S., Moffet, H., Tardif, J., Bessette, L., Morin, F., Frémont, P., Bykerk, V., 
Thorne, C., Bensen, W., Blanchette, C. (2003). Intraarticular corticosteroids, 
supervised physiotherapy, or a combination of the two in the treatment of 
adhesive capsulitis of the shoulder: a placebo-controlled trial. Arthritis Rheum. 
48(3), 829-38. 
 
Carr, A., & Rees, J. (2012). Pathway Guidelines for Subacromial Shoulder Pain 
(pp. 1–16). British Elbow and Shoulder Society. As accessed from: 
http://www.bess.org.uk/media/Research%20Committee/National%20Guideline
 276 
s/Subacromial%20Shoulder%20Pain.pdf on 17.19.14 
 
Carson, R.T., Louviere, J.J., Anderson, D.A., Arabie, P., Bunch, D.S., Hensher, 
D.A., Johnson, R.M., Kuhfeld, W.F., Steinberg, D., Swait, J., Timmerman, H., 
Wiley, J.B. (1994). Experimental analysis of choice. Marketing Letters, 5(4), 
351–367. 
 
Carter, T., Hall, H., McIntosh, G., Murphy, J., MacDougall, J., & Boyle, C. (2012). 
Intertester reliability of a classification system for shoulder pain. Physiotherapy, 
98(1), 40–46. http://doi.org/10.1016/j.physio.2010.12.003 
 
Chester, R., Jerosch-Herold, C., Lewis, J., & Shepstone, L. (2016). Psychological 
factors are associated with the outcome of physiotherapy for people with 
shoulder pain: a multicentre longitudinal cohort study. British Journal of Sports 
Medicine, pii: bjsports-2016-096084. http://doi: 10.1136/bjsports-2016-096084 
 
Chester, R., Shepstone, L., Daniell, H., Sweeting, D., Lewis, J., & Jerosch-Herold, 
C. (2013). Predicting response to physiotherapy treatment for musculoskeletal 
shoulder pain: a systematic review. BMC Musculoskeletal Disorders, 14(1), 1–
1. http://doi.org/10.1186/1471-2474-14-203 
 
Child, R.J.H., Mentes, J.C., Pavlish, C., & Phillips, L.R. (2014). Using Facebook 
and participant information clips to recruit emergency nurses for research. 
Nurse Res, 21(6), 16–21. http://doi.org/10.7748/nr.21.6.16.e1246 
 
Chizawsky, L.L.K., Estabrooks, C.A., & Sales, A.E. (2011). The feasibility of Web-
based surveys as a data collection tool: a process evaluation. Applied Nursing 
Research, 24(1), 37–44. http://doi.org/10.1016/j.apnr.2009.03.006 
 
Cho, C.H., Jung, S.W., Park, J.Y., Song, K.S., Yu, K.I. (2013). Is shoulder pain for 
three months or longer correlated with depression, anxiety, and sleep 
disturbance? J Shoulder Elbow Surg, 22(2), 222–228.  
 http://doi: 10.1016/j.jse.2012.04.001 
 
Cioffi, J., & Markham, R. (1997). Clinical decision-making by midwives: managing 
case complexity. Journal of Advanced Nursing, 25(2), 265–272. 
 
Coast, J., Flynn, T.N., Salisbury, C., Louviere, J., & Peters, T.J. (2006). 
Maximising responses to discrete choice experiments: a randomised trial. 
Applied Health Economics and Health Policy, 5(4), 249–260. 
 
Cochrane. (2011). Cochrane Handbook for Systematic Reviews of Interventions 
Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. 
Available from www.cochrane-handbook.org. Wiley-Blackwell. 
 
Coggon, D., Ntani, G., Palmer, K.T., Felli, V.E., Harari, R., Barrero, L.H., Felknor, 
S.A., Gimeno, D., Cattrell, A., Vargas-Prada, S., Bonzini, M, Solidaki, 
E., Merisalu, E., Habib, R.R., Sadeghian, F., Masood, K.M, Warnakulasuriya, 
S.S., Matsudaira, K., Nyantumbu, B., Sim, M.R., Harcombe, H., Cox, 
K., Marziale, M.H., Sarquis, L.M., Harari, F., Freire, R., Harari, N., Monroy, 
 277 
M.V., Quintana, L.A., Rojas, M., Salazar, Vega, E.J., Harris, E.C., Serra, 
C., Martinez, J.M., Delclos, G., Benavides, F.G., Carugno, M., Ferrario, 
M.M., Pesatori, A.C., Chatzi, L., Bitsios, P., Kogevinas, M., Oha, K., Sirk, 
T., Sadeghian, A., Peiris-John, R.J., Sathiakumar, N., Wickremasinghe, 
A.R., Yoshimura, N., Kelsall, H.L., Hoe, V.C., Urquhart, D.M., Derrett, 
S., McBride, D., Herbison, P., Gray, A. (2013). Patterns of multisite pain and 
associations with risk factors. Pain, 154(9), 1769–1777. 
http://doi.org/10.1016/j.pain.2013.05.039 
 
Converse, L., Barrett, K., Rich, E., & Reschovsky, J. (2015). Methods of Observing 
Variations in Physicians’ Decisions: The Opportunities of Clinical Vignettes. 
Journal of General Internal Medicine, 30(S3), 586–594. 
http://doi.org/10.1007/s11606-015-3365-8 
 
Cottrell, E., Roddy, E., Rathod, T., Thomas, E., Porcheret, M., & Foster, N.E. 
(2015). Maximising response from GPs to questionnaire surveys: do length or 
incentives make a difference? BMC Medical Research Methodology, 15(1), 3. 
http://doi.org/10.1186/1471-2296-15-136 
 
Couper, M.P. (2007). Issues of Representation in eHealth Research (with a Focus 
on Web Surveys). American Journal of Preventative Medicine, 32(5), S83–
S89. http://doi.org/10.1016/j.amepre.2007.01.017 
 
Couper, M.P., Kapteyn, A., Schonlau, M., & Winter, J. (2007). Noncoverage and 
nonresponse in an Internet survey. Social Science Research, 36(1), 131–148. 
http://doi.org/10.1016/j.ssresearch.2005.10.002 
 
Crawshaw, D.P., Helliwell, P.S., Hensor, E.M.A., Hay, E.M., Aldous, S.J., & 
Conaghan, P.G. (2010). Exercise therapy after corticosteroid injection for 
moderate to severe shoulder pain: large pragmatic randomised trial. BMJ, 
340:c3037. https://doi.org/10.1136/bmj.c3037  
Croft, P., Pope, D., & Silman, A. (1996). The clinical course of shoulder pain: 
prospective cohort study in primary care. Primary Care Rheumatology Society 
Shoulder Study Group. BMJ: British Medical Journal, 313(7057), 601. 
Croft, P., Altman, D.G., Deeks, J.J., Dunn, K.M., Hay, A.D., Hemingway, H., 
LeResche, L., Peat, G., Perel, P., Petersen, S.E., Riley, R.D., Roberts, I., 
Sharpe, M., Stevens, R.J., van der Windt, D.A., von Korff, M., Timmis, A.. 
(2015). The science of clinical practice: disease diagnosis or patient 
prognosis? Evidence about “what is likely to happen” should shape clinical 
practice. BMC Medicine 13, 20. http://doi.org/10.1186/s12916-014-0265-4 
Danishevski, K., Mckee, M., Sassi, F., & Maltcev, V. (2007). The decision to 
perform Caesarean section in Russia. International Journal for Quality in 
Health Care, 20(2), 88–94. http://doi.org/10.1093/intqhc/mzm070 
 
de Bekker-Grob, E.W., Bliemer, M. C. J., Donkers, B., Essink-Bot, M-L., Korfage, I. 
K., Roobol, M. J., Gnagma, C.H., Steyerberg, E.W. (2013) Men's preferences 
for prostate cancer screening: a discrete choice experiment. British Journal of 
Cancer, 109, 633-640. doi: 10.1038/bjc.2013.5. 
 278 
 
de Salis, I., Whiting, P., Sterne, J.A.C., & Hay, A.D. (2013). Using qualitative 
research to inform development of a diagnostic algorithm for UTI in children. 
Family Practice, 30(3), 325–331. http://doi.org/10.1093/fampra/cms076 
 
De Winter A.F, Jans, M.P., Scholten, R.J., Deville, W., van Schaardenburg, D., & 
Bouter, L.M. (1999). Diagnostic classification of shoulder disorders: 
interobserver agreement and determinants of disagreement. Annals of the 
Rheumatic Diseases, 58(5), 272–277. 
 
Delbecq, A.L. (1971). A Group Process Model for Problem Identification and 
Program Planning. The Journal of Applied Behavioral Science, 7(4), 466–492. 
http://doi.org/10.1177/002188637100700404. 
 
Dickens, V.A., Williams, J.L., & Bhamra, M.S. (2005). Role of physiotherapy in the 
treatment of subacromial impingement syndrome: a prospective study. 
Physiotherapy;91(3):159-164. http://doi.org/10.1016/j.physio.2004.10.008. 
 
Diercks, R.L., & Stevens, M. (2004). Gentle thawing of the frozen shoulder: a 
prospective study of supervised neglect versus intensive physical therapy in 
seventy-seven patients with frozen shoulder syndrome followed up for two 
years. Journal of Shoulder and Elbow Surgery; 13(5):499-502. 
http://doi.org/10.1016/j.jse.2004.03.002 
 
Dinant G.J.G.,, Buntinx F.F., Butler C.C. The necessary shift from diagnostic to 
prognostic research. BMC Family Practice. (2007); 8:53. 
http://doi:10.1186/1471-2296-8-53. 
 
Dong, W., Goost, H., Lin, X.B., Burger, C., Paul, C., Wang, Z.L., Zhang, T.Y., 
Jiang, Z.C., Welle, K., Kabir, K. (2015). Treatments for Shoulder Impingement 
Syndrome. Medicine, 94(10), e510. 
http://doi.org/10.1097/MD.0000000000000510. 
 
Dorresteijn, J.A.N., Visseren, F.L.J., Ridker, P.M., Wassink, A.M.J., Paynter, N.P., 
Steyerberg, E.W., van der Fraaf, Y., Cook, N.R. (2011). Estimating treatment 
effects for individual patients based on the results of randomised clinical trials. 
BMJ (Clinical Research Ed.), 343, d5888–d5888. 
http://doi.org/10.1136/bmj.d5888 
 
Dreyfus, S. E. (2004). The Five-Stage Model of Adult Skill Acquisition. Bulletin of 
Science, Technology and Society, 24(3), 177–181. 
http://doi.org/10.1177/0270467604264992 
 
Elstein, A.S., Schwartz, A., & Schwarz, A. (2002). Clinical problem solving and 
diagnostic decision making: selective review of the cognitive literature. Bmj, 
324(7339), 729–732. http://doi.org/10.1136/bmj.324.7339.729 
 
Elstein, A.S., Shulman, L.S., & Sprafka, S.A. (2008). Medical problem solving: a 
ten-year retrosepctive. Evaluation and the Health Professions, 13, 5–38. 
 
 279 
Engebretsen, K., & Soberg L,H. (2010). Exercise therapy alone and exercise 
therapy after corticosteroid injection are equally effective after 12 weeks for 
moderate to severe shoulder pain. Journal of Physiotherapy, 56(4), 278–278. 
 
Engebretsen, K., Grotle, M., Bautz-Holter, E., Ekeberg, O.M., & Brox, J.I. (2010). 
Predictors of Shoulder Pain and Disability Index (SPADI) and work status after 
1 year in patients with subacromial shoulder pain. BMC Musculoskeletal 
Disorders, 11(1), 218. http://doi.org/10.1186/1471-2474-11-218 
 
Engebretsen, K., Grotle, M., Bautz-Holter, E., Sandvik, L., Juel, N.G., Ekeberg, 
O.M., & Brox, J.I. (2009). Radial extracorporeal shockwave treatment 
compared with supervised exercises in patients with subacromial pain 
syndrome: single blind randomised study. Bmj, 339(sep15 1), b3360–b3360. 
http://doi.org/10.1136/bmj.b3360 
 
Ensor, K.L., Kwon, Y.W., DiBeneditto, M.R., Zuckerman, J.D., & Rokito, A.S. 
(2013). The rising incidence of rotator cuff repairs. Journal of Shoulder and 
Elbow Surgery, 22(12), 1628–1632. http://doi.org/10.1016/j.jse.2013.01.006 
 
Feleus, A., Bierma-Zeinstra, S.M.A., Miedema, H.S., Verhagen, A.P., Nauta, A.P., 
Burdorf, A., Verhaar, J.A., Koes, B.W. (2007). Prognostic indicators for non-
recovery of non-traumatic complaints at arm, neck and shoulder in general 
practice--6 months follow-up. Rheumatology, 46(1), 169–176. 
http://doi.org/10.1093/rheumatology/kel164 
 
Farmer, N. (2014). An update and further testing of a knowledge-based diagnostic 
clinical decision support system for musculoskeletal disorders of the shoulder 
for use in a primary care setting. J Eval Clin Pract. 2014 Oct;20(5):589-95. 
http://doi: 10.1111/jep.12153 
Foster, N.E., Hill, J.C., O’Sullivan, P., & Hancock, M. (2013). Stratified models of 
care. Best Practice & Research Clinical Rheumatology, 27(5), 649–661. 
http://doi.org/10.1016/j.berh.2013.10.005 
Frandsen, M., Thow, M., & Ferguson, S.G. (2016). The Effectiveness Of Social 
Media (Facebook) Compared With More Traditional Advertising Methods for 
Recruiting Eligible Participants To Health Research Studies: A Randomized, 
Controlled Clinical Trial. JMIR Res Protoc, 5(3), e161. http://doi: 
10.2196/resprot.5747. 
 
Frandsen, M., Walters, J., & Ferguson, S. G. (2014). Exploring the Viability of 
Using Online Social Media Advertising as a Recruitment Method for Smoking 
Cessation Clinical Trials, 16(2), 247–251. http://doi.org/10.1093/ntr/ntt157 
 
Fritz, J. M. (2009). Clinical Prediction Rules in Physical Therapy: Coming of Age? 
Journal of Orthopaedic and Sports Physical Therapy, 39(3), 159–161. 
http://doi.org/10.2519/jospt.2009.0110 
 
Gartsman, G.M., Brinker, M.R., Khan, M., & Karahan, M. (1998). Self-assessment 
of general health status in patients with five common shoulder conditions. 
Journal of Shoulder and Elbow Surgery, 7(3), 228–237. 
 280 
 
Geraets, J.J., Goossens, M.E., de Groot, I.J., de Bruijn, C.P., De Bie R.A, Dinant, 
G.J., van der Heijden, G., van den Heuvel, W.J. (2005). Effectiveness of a 
graded exercise therapy program for patients with chronic shoulder 
complaints. Australian Journal of Physiotherapy 2005;51(2):87-94. 
http://doi.org/10.1016/S0004-9514(05)70037-4 
 
Geraets, J., Goossens, M., de Bruijn, C.P.C., de Groot, I.J.M., Koke, A.J.S., Pelt, 
R., et al. (2006). Cost-effectiveness of a graded exercise therapy program for 
patients with chronic shoulder complaints. International Journal of Technology 
Assessment in Health Care, 22(1):76-83. 
 
Gialanella, B., & Prometti, P. (2011). Effects of corticosteroids injection in rotator 
cuff tears. Pain Med.,12(10):1559-65. http://doi: 10.1111/j.1526-
4637.2011.01238.x. 
 
Gismervik, S.Ø., Drogset, J.O., Granviken, F., Rø, M., & Leivseth, G. (2017). 
Physical examination tests of the shoulder: a systematic review and meta-
analysis of diagnostic test performance. BMC Musculoskeletal Disorders, 1–9. 
http://doi.org/10.1186/s12891-017-1400-0 
 
Gjestland, L. (1996). Net? Not yet. Marketing Research, 8(1), 26-29. 
 
Glaser, B. G., Strauss, A. L. (1967) The discovery of grounded theory: Strategies 
for qualitative research. New York, NY: Routledge. ISBN: 9781351522168. 
 
Gooberman-Hill, R., Woolhead, G., MacKichan, F., Ayis, S., Williams, S., & 
Dieppe, P. (2007). Assessing chronic joint pain: Lessons from a focus group 
study. Arthritis & Rheumatism, 57(4), 666–671. 
http://doi.org/10.1002/art.22681 
 
Good, I.J. (1983). Good Thinking: The Foundations of Probability and Its 
Applications. Minneapolis, MN: University of Minnesota Press. 
 
Grava-Gubins, I., & Scott, S. (2008). Effects of various methodologic strategies: 
survey response rates among Canadian physicians and physicians-in-training. 
Can Fam Physician,54(10):1424-30. 
 
Green, S, Buchbinder, R, Hetrick, S.E. (2003) Physiotherapy interventions for 
shoulder pain. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: 
CD004258. DOI: 10.1002/14651858.CD004258. 
 
Greving, K., Dorrestijn, O., Winters, J.C., Groenhof, F., Van Der Meer, K., 
Stevens, M., & Diercks, R. L. (2012). Incidence, prevalence, and consultation 
rates of shoulder complaints in general practice. Scandinavian Journal of 
Rheumatology, 41(2), 150–155. http://doi.org/10.3109/03009742.2011.605390 
 
Guest, G., Macqueen, K., & Namey, E. (2012). Applied Thematic Analysis. Sage, 
London. IBN:10.4135/9781483384436.  
 
 281 
Gurung, T., Ellard, D. R., Mistry, D., Patel, S., & Underwood, M. (2015). Identifying 
potential moderators for response response to treatment in low back pain: A 
systematic review. Physiotherapy, 101(3):243-51.  
http://doi: 10.1016/j.physio.2015.01.006 
 
Hanchard, N., Cummins, J., & Jeffries, C. (2004). Evidence-based clinical 
guidelines for the diagnosis, assessment and physiotherapy management of 
shoulder impingement syndrome. The Chartered Society of Physiotherapy. As 
accessed: http://www.csp.org.uk/publications/evidence-based-clinical-
guidelines-diagnosis-assessment-physiotherapy-management-should 
19.02.14. 
 
Hancock, M., Herbert, R.D., & Maher, C.G. (2009). A Guide to Interpretation of 
Studies Investigating Subgroups of Responders to Physical Therapy 
Interventions. Physical Therapy, 89(7), 698–704. 
http://doi.org/10.2522/ptj.20080351 
 
Harkness, J.A., Van De Vijver, F.J.R., & Mohler, P.P.H. (2003). Cross-Cultural 
Survey Methods. John Wiley & Sons. 
 
Harris, M. (2017, January 2). Protocol for Injection of Intra-articular, Peri-articular 
or Soft Tissue Corticosteroid. Southern Health NHS Foundation Trust. As 
accessed: 
http://www.southernhealth.nhs.uk/_resources/assets/inline/full/0/42387.pdf on 
01.04.17. 
 
Hay, E.M., Thomas, E., Paterson, S.M., Dziedzic, K., & Croft, P.R. (2003). A 
pragmatic randomised controlled trial of local corticosteroid injection and 
physiotherapy for the treatment of new episodes of unilateral shoulder pain in 
primary care. Annals of the Rheumatic Diseases, 62(5), 394–399. 
 
He, G., Cerin, E., Huang, W.Y., & Wong, S.H. (2014). Understanding 
Neighborhood Environment Related to Hong Kong Children’s Physical Activity: 
A Qualitative Study Using Nominal Group Technique. PLoS ONE, 9(9), 
e106578. http://doi.org/10.1371/journal.pone.0106578.t003 
 
Hebert, J.J., & Fritz, J.M. (2012). Clinical decision rules, spinal pain classification 
and prediction of treatment outcome: A discussion of recent reports in the 
rehabilitation literature. Chiropractic & Manual Therapies, 20(1), 19. 
http://doi.org/10.1186/2045-709X-20-19 
 
Hegedus, E.J., Goode, A.P., Cook, C.E., Michener, L., Myer, C.A., Myer, D.M., & 
Wright, A.A. (2012). Which physical examination tests provide clinicians with 
the most value when examining the shoulder? Update of a systematic review 
with meta-analysis of individual tests. British Journal of Sports Medicine, 
46(14), 964–978. http://doi.org/10.1136/bjsports-2012-091066 
 
Hemingway, H., Croft, P., Perel, P., Hayden, J.A., Abrams, K., Timmis, A., Briggs, 
A., Udamyan, R., Moons, K.G.M., Steyerberg, E.W., Roberts, I., Schroter, S., 
Altman, D.G., Rile, R.R. (2013). Prognosis research strategy (PROGRESS) 1: 
 282 
A framework for researching clinical outcomes. BMJ, 346(1), e5595–e5595. 
http://doi.org/10.1136/bmj.e5595 
 
Hensher, D.A., Rose, J.M., & Greene, W.H. (2005). Applied Choice Analysis. 
Cambridge University Press. http://doi.org/10.1007/9781316136232 
Hifinger, M., Hiligsmann, M., Ramiro, S., Watson, V., Severens, J.L., Fautrel, B., 
Uhlig, T., van Vollenhoven, R., Jacques, P., Detert, J., Canas da Silva, J., 
Scire, C.A., Berghea, F., Carmona, L., Pentek, M., Keat, A., Boonen, A. (2016) 
In uence of disease activity on RA treatment choices in countries with 
restricted access to expensive, innovative drugs: a discrete choice experiment 
among rheumatologists. Annals of Rheumatic Diseases, 76(1), 126-132. 
http://doi:10.1136/ rmdopen-2017-000453. 
Higgins, J.P.T., Altman, D.G., Gøtzsche, P.C., Juni, P., Moher, D., Oxman, A.D., , 
J., Schulz, K.F., Weeks, L., Sterne,  J.A.C.,Cochrnae Bias Methods Group, 
Cochrane Statistical Methods Group. (2011). The Cochrane Collaboration's 
tool for assessing risk of bias in randomised trials. BMJ (Clinical Research 
Ed.), 343(2), d5928–d5928. http://doi.org/10.1136/bmj.d5928 
Hill, J.C., & Fritz, J.M. (2011). Psychosocial influences on low back pain, disability, 
and response to treatment. Physical Therapy, 91(5), 712–721. 
http://doi.org/10.2522/ptj.20100280 
 
Hill, J.C., Dunn, K.M., Lewis, M., Mullis, R., Main, C.J., Foster, N.E., & Hay, E.M. 
(2008). A primary care back pain screening tool: Identifying patient subgroups 
for initial treatment. Arthritis & Rheumatism, 59(5), 632–641. 
http://doi.org/10.1002/art.23563 
 
Hill, J.C., Whitehurst, D.G.T., Lewis, M., Stirling, B., Dunn, K.M., Foster, N.E., 
Konstantinou, K., Main, C.J., Mason, E., Somerville, S., Sowden, G., Vohora, 
K., Hay, E.M. (2011). Comparison of stratified primary care management for 
low back pain with current best practice (STarT Back): a randomised controlled 
trial. The Lancet, 378(9802), 1560–1571. http://doi.org/10.1016/S0140-
6736(11)60937-9 
 
Hingorani, A.D., Windt, D.A.W.M., Riley, R.D., Abrams, K., Moons, K.G.M., 
Steyerberg, E.W., Schroter, S., Sauerbrei, W., Altman, D.G., Hemingway, H. 
(2013). Prognosis research strategy (PROGRESS) 4: Stratified medicine 
research. BMJ, 346(1), e5793–e5793. http://doi.org/10.1136/bmj.e5793 
 
Hoare, B.J., Wallen, M.A., Imms, C., Villanueva, E., Rawicki, H.B., & Carey, L. 
(2010). Botulinum toxin A as an adjunct to treatment in the management of the 
upper limb in children with spastic cerebral palsy (UPDATE). Cochrane 
Database Systematic Review, 20;(1):CD003469. http://doi: 
10.1002/14651858.CD003469.pub4. 
 
Hosmer, D.W., Lemeshow, S., & Studivant, R.X. (2013). Applied Logistic 
Regression (3rd ed.). John Wiley & Sons. 
 
 283 
Houston, J.D., & Fiore, D.C. (1998). Online medical surveys: using the Internet as 
a research tool. MD Comput, 15(2), 116–120. 
Hsu, J.K., Thibodeau, R., Wong, S.J., Zukiwsky, D., Cecile, S., & Walton, D.M. 
(2011). A “Wii” bit of fun: The effects of adding Nintendo Wii Bowling to a 
standard exercise regimen for residents of long-term care with upper extremity 
dysfunction. Physiotherapy Theory and Practice, 27(3):185-193. 
http://doi.org/10.3109/09593985.2010.483267 
 
Ilieva, J., Baron, S., & Healey, N.M. (2002). On-line surveys in international 
marketing research: pros and cons. International Journal of Market Research, 
44(3), 361–367.  
 
Judge, A., Murphy, R.J., Maxwell, R., Arden, N.K., Carr, A.J. (2014) Temporal 
trends and geographical variation in the use of subacromial decompression 
and rotator cuff repair of the shoulder in England. Bone Joint Journal, 
96(1):70-4. http://doi: 10.1302/0301-620X.96B1.32556. 
Johal, P., Martin, D., Broadhurst, N. Managing shoulder pain in general practice - 
assessment, imaging and referral. (2008). Managing shoulder pain in general 
practice - assessment, imaging and referral. Aust Fam Physician, 37(4), 263–
265.  
 
Johnson, R.F. (2006). Measuring conjoint stated preferences for pharmaceuticals: 
a brief introduction. RTI Health Solutions, Research Triangle Park. 
 
Johnson, R.F., Lancsar, E., Marshall, D., Kilambi, V., Mühlbacher, A., Regier, D. 
A., Bresnahan, B.W., Kanninen, B,. Bridges, J.F. (2013). Constructing 
Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR 
Conjoint Analysis Experimental Design Good Research Practices Task Force. 
Value in Health, 16(1), 3–13. http://doi.org/10.1016/j.jval.2012.08.2223 
 
Jones, J., & Hunter, D. (1995). Qualitative Research: Consensus methods for 
medical and health services research. BMJ (Clinical Research Ed.), 
311(7001), 376–380. http://doi.org/10.1136/bmj.311.7001.376 
 
Jordan, K.P., Kadam, U.T., Hayward, R., Porcheret, M., Young, C., & Croft, P. 
(2010). Annual consultation prevalence of regional musculoskeletal problems 
in primary care: an observational study. BMC Musculoskeletal Disorders, 
11(1), 144. http://doi.org/10.1186/1471-2474-11-144 
 
Joseph, G.M., Patel, V.L. (1990). Domain knowledge and hypothesis genenation 
in diagnostic reasoning. Med Dec Making, 10(1):31-46. 
http://doi/abs/10.1177/0272989X9001000107 
 
Kahneman, D. (2003). A perspective on judgment and choice: Mapping bounded 
rationality. American Psychologist, 58(9), 697–720. 
http://doi.org/10.1037/0003-066X.58.9.697 
 
Kaner, E.F., Haighton, C.A., & McAvoy, B.R. (1998). 'So much post, so busy with 
practice--so, no time!‘: a telephone survey of general practitioners’ reasons for 
 284 
not participating in postal questionnaire surveys. British Journal of General 
Practice, 48, 1067–1069.  
 
Kapp, J.M., Peters, C., & Oliver, D.P. (2013). Research Recruitment Using 
Facebook Advertising: Big Potential, Big Challenges, J Cancer Ed, 28(1), 134–
137. http://doi.org/10.1007/s13187-012-0443-z 
Kee, F., McDonald, P., Kirwan, J.R., Patterson, C.C., & Love, A.H.G. (1998). 
Urgency and priority for cardiac surgery: a clinical judgment analysis. BMJ 
(Clinical Research Ed.), 316(7135), 925–929. 
http://doi.org/10.1136/bmj.316.7135.925 
 
Kee, F., McDonald, P., Kirwan, J.R., Patterson, C.C., & Love, G. (1997). The 
stated and tacit impact of demographic and lifestyle factors on prioritization 
decisions for cardiac surgery. QJM: Monthly Journal of the Association of 
Physicians, 90(2), 117–123. http://doi.org/10.1093/qjmed/90.2.117 
 
Kellerman, S.E., & Herold, J. (2001). Physician response to surveys. A review of 
the literature. Am J Prev Med, 20(1), 61–67.  
 
Kempf, B., Kongsted, A.(2012). Association Between the Side of Unilateral 
Shoulder Pain and Preferred Sleeping Position: A Cross-Sectional Study of 83 
Danish Patients. J Maipulative Physiol Ther, 35(5), 407–412. http://doi: 
10.1016/j.jmpt.2012.04.015 
 
Kennedy, C.A., Haines, T., & Beaton, D.E. (2006a). Eight predictive factors 
associated with response patterns during physiotherapy for soft tissue 
shoulder disorders were identified. Journal of Clinical Epidemiology, 59(5), 
485–496. http://doi.org/10.1016/j.jclinepi.2005.09.003 
 
Kennedy, C.A., Manno, M., Hogg-Johnson, S., Haines, T., Hurley, L., McKenzie, 
D., & Beaton, D.E. (2006b). Prognosis in soft tissue disorders of the shoulder: 
predicting both change in disability and level of disability after treatment. 
Physical Therapy, 86(7), 1013–32– discussion 1033–7. 
 
Khatri, C., Chapman, S.J., Glasbey, J., Kelly, M., Nepogodiev, D., Bhangu, A., 
Fitzgerald, J.E., & Committee (2015). Social Media and Internet Driven Study 
Recruitment: Evaluating a New Model for Promoting Collaborator Engagement 
and Participation. PLoS ONE, 10(3), e0118899. 
http://doi.org/10.1371/journal.pone.0118899 
 
Kinter, E.T., Prior, T.J., Carswell, C.I., & Bridges, J. (2012). A comparison of two 
experimental design approaches in applying conjoint analysis in patient-
centered outcomes research. Patient, 5(4):279-94. http://doi: 
10.2165/11641100-000000000-00000. 
 
Kohn, L.T., & Corrigan, J.M. (2000). To Err Is Human: Building a Safer Health 
System. (Committee on Quality of Health Care in America, Institute of 
Medicine, Ed.) (pp. 1–312). Washington, D.C.: National Academies Press. 
http://doi.org/10.17226/9728 
 285 
 
Kraemer, H.C., Wilson, G.T., Fairburn, C.G., & Agras, W.S. (2002). Mediators and 
moderators of treatment effects in randomized clinical trials. Archives of 
General Psychiatry, 59(10), 877–883. 
 
Kraemer, H.C., Kiernan, M., Essex, M., & Kupfer, D.J. (2008). How and why 
criteria defining moderators and mediators differ between the Baron & Kenny 
and MacArthur approaches. Health Psychology, 27(2, Suppl), S101–S108. 
http://doi.org/10.1037/0278-6133.27.2(Suppl.).S101. 
 
Kuhfeld, W.F. (2005). Orthogonal Array Lists (pp. 1–55). SAS Institute. As from 
http://support.sas.com/ techsup/technote/ts723.html on 13.03.13. 
 
Kuijpers, T., van der Windt, D.A.W.M., Boeke, A.J.P., Twisk, J.W.R., Vergouwe, 
Y., Bouter, L.M., & van der Heijden, G.J.M.G. (2006a). Clinical prediction rules 
for the prognosis of shoulder pain in general practice. Pain, 120(3), 276–285. 
http://doi.org/10.1016/j.pain.2005.11.004 
 
Kuijpers, T., van der Windt, D.A.W.M., van der Heijden, G.J.M.G., & Bouter, L.M. 
(2004). Systematic review of prognostic cohort studies on shoulder disorders. 
Pain, 109(3), 420–431. http://doi.org/10.1016/j.pain.2004.02.017 
 
Kuijpers, T., van der Windt, D.A., van der Heijden, G.J., Twisk, J.W., Vergouwe, 
Y., & Bouter, L.M. (2006b). A prediction rule for shoulder pain related sick 
leave: a prospective cohort study. BMC Musculoskeletal Disorders, 7(1), 97. 
http://doi.org/10.1186/1471-2474-7-97 
 
Kulkarni, R., Gibson, J., Brownson, P., Thomas, M., Rangan, A., Carr, A.J., & 
Rees, J.L. (2015). BESS/BOA Patient Care Pathways: Subacromial shoulder 
pain. Shoulder & Elbow, 7(2), 135–143. 
http://doi.org/10.1177/1758573215576456 
 
Lancaster, K.J. (1966). A New Approach to Consumer Theory. Journal of Political 
Economy, 74(2), 132–157. 
 
Lane, T.S., Armin, J., & Gordon, J.S. (2015). Online Recruitment Methods for 
Web-Based and Mobile Health Studies: A Review of the Literature. J Med 
Internet Res, 17(7), e183. http://doi: 10.2196/jmir.4359. 
Langenhoff, B.S., Krabbe, P.F.M., & Ruers, T.J.M. (2007). Computer-based 
decision making in medicine: A model for surgery of colorectal liver 
metastases. European Journal of Surgical Oncology (EJSO), 33, S111–S117. 
http://doi.org/10.1016/j.ejso.2007.09.023 
Laupacis, A., Sekar, N., & Stiell, I.G. (1997). Clinical prediction rules. A review and 
suggested modifications of methodological standards. JAMA: the Journal of 
the American Medical Association, 277(6), 488–494. 
 
LeBlanc, M., & Fitzgerald, S. (2000). Research design and methodology section: 
Logistic regression for school psychologists. School Psychology Quarterly, 
15(3), 344–358. 
 286 
 
Lewis, J.S. (2009). Rotator cuff tendinopathy/subacromial impingement syndrome: 
is it time for a new method of assessment? British Journal of Sports Medicine, 
43(4), 259–264. http://doi.org/10.1136/bjsm.2008.052183 
 
Liesdek, C., van der Windt, D.A., Koes, B.W., & Bouter, L.M. (1997). Soft-tissue 
disorders of the shoulder: a study of inter-observer agreement between 
general practitioners and physiotherapists and an overview of 
physiotherapeutic treatment. Physiotherapy, 83(1), 12–17. 
 
Linstone, H.A. & Turoff, M. (2002). The Delphi Method: Techniques and 
Applications (18 ed.). Reading, Mass.: Addison-Wesley Pub. Co., Advanced 
Book Program. 
 
List, D. (2001) The consensus group technique in social research. Field Methods, 
13(3): 277-290. https://doi.org/10.1177/1525822X0101300304 
 
Littlewood, C. (2012) Contractile dysfunction of the shoulder (rotator cuff 
tendinopathy): an overview. J Man Manip Ther. 20(4): 209–213.  
 https://doi:  10.1179/2042618612Y.0000000005 
 
Littlewood, C., Ashton, J., Chance-Larsen, K., May, S., & Ben Sturrock. (2012). 
Exercise for rotator cuff tendinopathy: a systematic review. Physiotherapy, 
98(2), 101–109. http://doi.org/10.1016/j.physio.2011.08.002 
 
Littlewood, C., Malliaras, P., Mawson, S., Walters, S.J. (2014). Self-managed 
loaded exercise versus usual physiotherapy treatment for rotator cuff 
tendinopathy: a pilot randomised controlled trial. Physiotherapy, 100(1), 54–60. 
http://doi: 10.1016/j.physio.2013.06.001 
 
Litwin, M.S., & Fink, A. (1995). How To Measure Survey Reliability and Validity. 
The Survey Kit. (7 ed.). Thousand Oaks, California: Sage. 
 
Lo, Y.P., Hsu, Y.C., & Chan, K.M. (1990). Epidemiology of shoulder impingement 
in upper arm sports events. British Journal of Sports Medicine, 24(3), 173–177. 
 
Louviere, J.J. (1988). Conjoint Analysis Modelling of Stated Preferences. Journal 
of Transport Economics and Policy, 22(1), 93–119. 
 
Louviere, J.J., Flynn, T., & Carson, R.T. (2010). Discrete Choice Experiments Are 
Not Conjoint Analysis. Journal of Choice Modelling, 3(3), 57–72. 
 
Louviere, J.J., Islam, T., Wasi, N., Street, D., & Burgess, L. (2008). Designing 
Discrete Choice Experiments: Do Optimal Designs Come at a Price? Journal 
of Consumer Research, 35(2), 360–375. http://doi.org/10.1086/586913 
 
Luce, R.D., & Tukey, J.W. (1964). Simultaneous conjoint measurement: A new 
type of fundamental measurement. Journal of Mathematical Psychology, 1(1), 
1–27. 
 
 287 
MacCormick, A.D., & Parry, B.R. (2006). Judgment Analysis of Surgeons' 
Prioritization of Patients for Elective General Surgery. Medical Decision 
Making, 26(3), 255–264. http://doi.org/10.1177/0272989X06288680 
 
Madia, S.A. (2011). Best practices for using social media as a recruitment 
strategy, 10(6), 19–24. http://doi.org/10.1108/14754391111172788 
 
Magarey, M.E., Jones, M.A., Cook, C.E., Hayes, M.G. (2016). Does physiotherapy 
diagnosis of shoulder pathology compare to arthroscopic findings? Br J Sports 
Med, 50(18), 1151–1157. http://doi.org/10.1136/bjsports-2012-091492 
 
Mansell, G., Kamper, S.J., & Kent, P. (2013). Best Practice & Research Clinical 
Rheumatology. Best Practice & Research Clinical Rheumatology, 27(5), 685–
697. http://doi.org/10.1016/j.berh.2013.10.001 
 
Marshall, D., Bridges, J.F.P., Hauber, B., Cameron, R., Donnalley, L., Fyie, K., & 
Johnson, F.R. (2010). Conjoint Analysis Applications in Health - How are 
Studies being Designed and Reported?: An Update on Current Practice in the 
Published Literature between 2005 and 2008. The Patient, 3(4), 249–256. 
http://doi.org/10.2165/11539650-000000000-00000 
 
May, S., Greasley, A., Reeve, S., & Withers, S. (2008). Expert therapists use 
specific clinical reasoning processes in the assessment and management of 
patients with shoulder pain: a qualitative study. Australian Journal of 
Physiotherapy, 54(4), 261–266. 
 
McFadden, D. (1978). Modelling the Choice of Residential Location. In Spacial 
Interaction Theory and Planning Models (pp. 75–96).  Amsterdam: North 
Holland Pub. 
 
McFarland, E.G., Garzon-Muvdi, J., Jia, X., Desai, P., & Petersen, S.A. (2010). 
Clinical and diagnostic tests for shoulder disorders: a critical review. British 
Journal of Sports Medicine, 44(5), 328–332. 
http://doi.org/10.1136/bjsm.2009.067314 
 
McGinn, T.G., Guyatt, G.H., Wyer, P.C., Naylor, C.D., Stiell, I.G., & Richardson, 
W.S. (2000). Users' guides to the medical literature: XXII: how to use articles 
about clinical decision rules. Evidence-Based Medicine Working Group. JAMA: 
the Journal of the American Medical Association, 284(1), 79–84. 
 
McKee, R. (2013). Ethical issues in using social media for health and health care 
research. Health Policy, 110(2-3), 298–301. 
http://doi.org/10.1016/j.healthpol.2013.02.006 
 
McKinlay, J.B., Burns, R.B., Durante, R., Feldman, H.A., Freund, K.M., Harrow, B. 
S., Irish, J.T., Kasten, L.E., Moskowitz, M.A. (1997). Patient, physician and 
presentational influences on clinical decision making for breast cancer: results 
from a factorial experiment. Journal of Evaluation in Clinical Practice, 3(1), 23–
57. 
 
 288 
Menendez, M.E., Baker, D.K., Oladeji, L.O., Fryberger, C.T., McGwin, G., & 
Ponce, B.A. (2015). Psychological Distress Is Associated with Greater 
Perceived Disability and Pain in Patients Presenting to a Shoulder Clinic. The 
Journal of Bone and Joint Surgery. American Volume, 97(24), 1999–2003. 
http://doi.org/10.2106/JBJS.O.00387 
 
Miles, C.L., Pincus, T., Carnes, D., Homer, K.E., Taylor, S.J.C., Bremner, S.A., 
Rahman, A., Underwood, M. (2012). Review: Can we identify how 
programmes aimed at promoting self-management in musculoskeletal pain 
work and who benefits? A systematic review of sub-group analysis within 
RCTs. European Journal of Pain, 15(8), 775.e1–775.e11. 
http://doi.org/10.1016/j.ejpain.2011.01.016 
 
Miller-Spoto M., Gombotto, S.P. (2014) Diagnostic labels assigned to patients with 
orthopedic conditions and the influence of the label on selection of 
interventions: a qualitative study of orthopaedic clinical specialists. Phys Ther, 
94(6):776-91. http://doi:10.2522/ptj.20130244 
Miranda, H., Punnett, L., Viikari-Juntura, E., Heliovaara, M., & Knekt, P. (2008). 
Physical work and chronic shoulder disorder. Results of a prospective 
population-based study. Annals of the Rheumatic Diseases, 67(2), 218–223. 
http://doi.org/10.1136/ard.2007.069419 
 
Mitchell, C., Adebajo, A., Hay, E.M., & Carr, A. (2005). Shoulder pain: diagnosis 
and management in primary care. BMJ, 331(7525), 1124–1128. 
http://doi.org/10.1136/bmj.331.7525.1124 
 
Mohamadi, A., Chan, J.J., Claessen, F.M., Ring, D., Chen, N.C. (2016). 
Corticosteroid Injections Give Small and Transient Pain Relief in Rotator Cuff 
Tendinosis: A Meta-analysis. Clin Orthop Relat Res, 475(1), 232–243. 
http://doi: 10.1007/s11999-016-5002-1 
 
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting 
items for systematic reviews and meta-analyses: the PRISMA statement. 
PLoS Medicine, 6(7), e1000097–e1000097. 
http://doi.org/10.1371/journal.pmed.1000097 
 
Moloney, M.F., Aycock, D.M., Cotsonis, G.A., Myerburg, S., Farino, C., & Lentz, 
M. (2009). An Internet-Based Migraine Headache Diary: Issues in Internet-
Based Research, 49(5), 673–686. http://doi.org/10.1111/j.1526-
4610.2009.01399.x 
 
Mulligan, E.P., Brunette, M., Shirley, Z., Khazzam, M. (2015). Sleep quality and 
nocturnal pain in patients with shoulder disorders. J Shoulder Elbow Surg, 
24(9), 1452–1457. http://doi: 10.1016/j.jse.2015.02.013 
 
Murphy RJ, Carr AJ. (2010) Shoulder pain. Systematic review 1107. BMJ 
Clinical Evidence. As accessed: 
http://www.clinicalevidence.com/x/systematic-review/1107/overview.html. 
on 26.09.14.  
 289 
Nathan, H., Bridges, J.F.P., Schulick, R.D., Cameron, A.M., Hirose, K., Edil, B.H., 
Wolfgang, C.L., Segev, D.L., Choti, M.A., Pawlik, T.M. (2011). Understanding 
surgical decision making in early hepatocellular carcinoma. Journal of Clinical 
Oncology, 29(6), 619–625. http://doi.org/10.1200/JCO.2010.30.8650 
 
NICE. (2017). Osteoporosis: assessing the risk of fragility fracture (CG146) 1–14. 
National Institute for Health and Care Excellence (NICE). As accessed: 
https://www.nice.org.uk/guidance/cg146 on 27.03.15. 
 
Nicholson, R.A., Hursey, K.G., & Nash, J.M. (2005). Moderators and mediators of 
behavioral treatment for headache. Headache: the Journal of Head and Face 
Pain, 45(5), 513–519. 
 
O'Connor, A. (1995). Validation of a Decisional Conflict Scale. Medical Decision 
Making, 15, 25–30. 
 
Ofcom. (2015) Adults’ media use and attitudes (pp. 1–197). The Office of 
Communications (Ofcom). As accessed:     
https://www.ofcom.org.uk/__data/assets/pdf_file/0014/82112/2015_adults_me
dia_use_and_attitudes_report.pdf on 03.07.15. 
 
Ofcom. (2016). Adult's media use and attitudes, 1–203. The Office of 
Communications (Ofcom). As accessed: 
https://www.ofcom.org.uk/__data/assets/pdf_file/0026/80828/2016-adults-
media-use-and-attitudes.pdf on 05.04.16. 
 
Orme, B. (2002). Formulating Attributes and Levels in Conjoint Analysis. Sequin, 
WA.: Sawtooth Software, Inc. As accessed: 
https://www.sawtoothsoftware.com/download/techpap/formatt.pdf on 14.02.14 
 
Orme, B.K. (2014). Getting Started With Conjoint Analysis. Strategies for Product 
Design and Pricing Research (3rd ed.). Glendale: Research Publishers LLC. 
ISBN: 9780972729741 
 
Ostergren, P.O., Hanson, A.B.S., Balogh, I., Ektor-Andersen, J., Isacsson, S.O., 
Malmo Shoulder Neck Study Group. (2005). Incidence of shoulder and neck 
pain in a working population: effect modification between mechanical and 
psychosocial exposures at work? Results from a one year follow up of the 
Malmo shoulder and neck study cohort. Journal of Epidemiology & Community 
Health, 59(9), 721–728. http://doi.org/10.1136/jech.2005.034801 
 
OED (2016) Oxford English Dictionary Online. 
https://en.oxforddictionaries.com/definition/conjoint). As accessed on 03.08.16 
 
Page, M.J., Green, S., Kramer, S., Johnston, R.V., McBain, B., Chau, M., & 
Buchbinder, R. (2014). Manual therapy and exercise for adhesive capsulitis 
(frozen shoulder). Cochrane Database of Systematic Reviews, (8), 225. 
http://doi.org/10.1002/14651858.CD011275 
 
Pajareya, K., Chadchavalpanichaya, N., Painmanakit, S., Kaidwan, C., Puttaruksa, 
 290 
P., & Wongsaranuchit, Y. (2004). Effectiveness of physical therapy for patients 
with adhesive capsulitis: a randomized controlled trial. Chotmaihet Thangphaet 
[Journal of the Medical Association of Thailand],87(5):473-480. 
 
Patel, S., Hossain, F.S., Colaco, H.B., El-Husseiny, M., Lee, M.H. (2010). The 
accuracy of primary care teams in diagnosing disorders of the shoulder, J Eval 
Clin Pract. 17(1), 118–122. http://doi.org/10.1093/rheumatology/kep008 
 
Peduzzi, P., Concato, J., Kemper, E., Holford, T. R., & Feinstein, A. R. (1996). A 
simulation study of the number of events per variable in logistic regression 
analysis. Journal of Clinical Epidemiology, 49(12), 1373–1379. 
Pelaccia, T., Tardif, J., Triby, E., & Charlin, B. (2011). An analysis of clinical 
reasoning through a recent and comprehensive approach: the dual-process 
theory. Medical Education Online, 16(0), 223. 
http://doi.org/10.1056/NEJMra054782 
 
Perry, J., & Linsley, S. (2006). The use of the nominal group technique as an 
evaluative tool in the teaching and summative assessment of the inter-
personal skills of student mental health nurses. Nurse Education Today, 26(4), 
346–353. http://doi.org/10.1016/j.nedt.2005.11.004 
 
Peters, D., Davies, P., & Pietroni, P. (1994). Musculoskeletal clinic in general 
practice: study of one year's referrals. British Journal of General Practice, 
44(378), 25–29. 
 
Petri, M., Dobrow, R., Neiman, R., Whiting-O'Keefe, Q., & Seaman, W.E. (1987). 
Randomized, double- blind, placebo- controlled study of the treatment of the 
painful shoulder. Arthritis Care & Research, 30(9), 1040–1045. 
 
Pincus, T., Miles, C., Froud, R., Underwood, M., Carnes, D., & Taylor, S.J. (2011). 
Methodological criteria for the assessment of moderators in systematic reviews 
of randomised controlled trials: a consensus study. BMC Medical Research 
Methodology, 11(1), 14. http://doi.org/10.1186/1471-2288-11-14 
 
Pope, D.P., Croft, P.R., Pritchard, C.M., & Silman, A.J. (1997). Prevalence of 
shoulder pain in the community: the influence of case definition. Annals of the 
Rheumatic Diseases, 56(5), 308–312. 
 
Priestman, T.J., & Baum, M. (1976). Evaluation of quality of life in patients 
receiving treatment for advanced breast cancer. Lancet, 1(7965), 899–900. 
 
Rahman, S., Majumder, A., Shaban, S., Rahman, N., Ahmed, S.M., Abdulrahman, 
K., & Dsouza. (2011). Physician participation in clinical research and trials: 
issues and approaches. Advances in Medical Education and Practice, 85. 
http://doi.org/10.2147/AMEP.S14103 
 
Rakotonarivo, O.S., Schaafsma, M., & Hockley, N. (2016). A systematic review of 
the reliability and validity of discrete choice experiments in valuing non-market 
environmental goods. Journal of Environmental Management, 183(1), 98–109. 
http://doi.org/10.1016/j.jenvman.2016.08.032 
 291 
Ramo, D.E., & Prochaska, J.J. (2012). Broad Reach and Targeted Recruitment 
Using Facebook for an Online Survey of Young Adult Substance Use. J Med 
Internet Res, 14(1), e28. http://doi.org/10.2196/jmir.1878 
 
Rankin, G., Rushton, A., Olver, P., & Moore, A. (2012). Chartered Society of 
Physiotherapy's identification of national research priorities for physiotherapy 
using a modified Delphi technique. Physiotherapy, 98(3), 260–272. 
http://doi.org/10.1016/j.physio.2012.03.002 
 
Raynor, M.B., Kuhn, J.E. (2015). Utility of features of the patient's history in the 
diagnosis of atraumatic shoulder pain: a systematic review. J Shoulder Elbow 
Surg, 25(4); 1–7. http://doi: 10.1016/j.jse.2015.09.023 
 
Reilly, B.M., & Evans, A.T. (2006). Translating clinical research into clinical 
practice: impact of using prediction rules to make decisions. Annals of Internal 
Medicine, 144(3), 201–209. 
 
Riley, R.D., Hayden, J.A., Steyerberg, E.W., Moons, K.G.M., Abrams, K., Kyzas, 
P.A., Malats, N., Briggs, A., Schroter, S., Altamna, D.G., Hemingway, H. 
(2013). Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor 
Research. PLoS Medicine, 10(2), e1001380. 
http://doi.org/10.1371/journal.pmed.1001380.s002 
 
Riley, R.D., Lambert, P.C., & Abo-Zaid, G. (2010). Meta-analysis of individual 
participant data: rationale, conduct, and reporting. BMJ (Clinical Research 
Ed.), 340(1), c221–c221. http://doi.org/10.1136/bmj.c221 
 
Rothwell, P.M. (2005). Subgroup analysis in randomised controlled trials: 
importance, indications, and interpretation. The Lancet, 365(9454), 176–186. 
 
Ryan, G.S. (2013). Online social networks for patient involvement and recruitment 
in clinical research. Nurse Res, 21(1), 35–39. 
http://doi.org/10.7748/nr2013.09.21.1.35.e302 
 
Ryan, M., & Farrar, S. (2000). Using conjoint analysis to elicit preferences for 
health care. British Medical Journal, 320(7248), 1530–1533. 
 
Ryan, M., & Gerard, K. (2003). Using discrete choice experiments to value health 
care programmes: current practice and future research reflections. Applied 
Health Economics and Health Policy, 2(1), 55–64. 
 
Ryan, M., Gerard, K., & Amaya-Amaya, M. (2008). Using Discrete Choice 
Experiments to Value Health and Health Care. (M. Ryan, K. Gerard, & M. 
Amaya-Amaya, Eds.) (1st ed.). Dordrecht: Springer Netherlands. 
http://doi.org/10.1007/978-1-4020-5753-3 
 
Ryans, I., Montgomery, A., Galway, R., Kernohan, W. G., & McKane, R. (2005). A 
randomized controlled trial of intra-articular triamcinolone and/or physiotherapy 
in shoulder capsulitis. Rheumatology (Oxford), 44(4), 529-35. 
 
 292 
Ryösä, A., Laimi, K., Äärimaa, V., Lehtimäki, K., Kukkonen, J., & Saltychev, M. 
(2016). Surgery or conservative treatment for rotator cuff tear: a meta-analysis. 
Disability & Rehabilitation, 39(14), 1357–1363. 
http://doi.org/10.1136/bmj.39465.451748.AD 
 
Sackett, D.L., Richardson, W.S., Rosenberg, W., & Haynes, R.B. (1997). 
Evidence-Based Medicine—How to Practice and Teach EBM (2nd ed.). New 
York: Churchill Livingstone. 
 
Saulle, M., & Gellhorn, A.C. (2017). Approach to the diagnosis of shoulder pain 
using physical exam and ultrasound: an evidence-based approach. Curr Phys 
Med Rehabil Rep, 1–11. http://doi.org/10.1007/s40141-017-0149-6 
 
Schneider, G.M., Jull, G., Thomas, K., & Salo, P. (2012). Screening of patients 
suitable for diagnostic cervical facet joint blocks: A role for physiotherapists. 
Manual Therapy, 17(2), 180–183. http://doi.org/10.1016/j.math.2011.11.004 
 
Shackman, G. (2001). Sample size and design effect (pp. 1–7). Presented at the 
Albany Chapter of American Statistical Association. As accessed from: 
http://faculty.smu.edu/slstokes/stat6380/deff%20doc.pdf on 01.02.15 
 
Shih, T.H., & Fan, X. (2009). Comparing response rates in e-mail and paper 
surveys: A meta-analysis. Educational Research Review, 4(1), 26–40. 
http://doi.org/10.1016/j.edurev.2008.01.003 
 
Sim, J., & Wright, C. (2000). Research in Health Care. Concepts, Methods and 
Designs. Cheltenham: Nelson Thornes. 
 
Sleight, P. (2000). Debate: Subgroup analyses in clinical trials: fun to look at-but 
don't believe them! Current Controlled Trials in Cardiovascular Medicine, 1, 
25–27. 
 
Smidt, N., & Green, S. (2003). Is the diagnosis important for the treatment of 
patients with shoulder complaints? The Lancet, 362(9399), 1867–1868. 
http://doi.org/10.1016/S0140-6736(03)14997-5 
 
Smith, B.E., Hendtrick, P., Smith, T.O., Bateman, M., Moffattm F., Rathleff, M.S., 
Selfe, J., Logan, P. (2017). Should exercises be painful in the management of 
chronic musculoskeletal pain? A systematic review and meta-analysis. Br J 
Sports Med, Published Online First: 08 June 2017. doi: 10.1136/bjsports-2016-
097383 
 
Song, A., Higgins, L.D., Newman, J., & Jain, N.B. (2014). Glenohumeral 
corticosteroid injections in adhesive capsulitis: a systematic search and review. 
The Journal of Injury, Function, and Rehabilitation, 6(12), 1143–56. 
 
Steyerberg, E.W., Moons, K.G.M., van der Windt, D.A., Hayden, J.A., Perel, P., 
Schroter, S., Riley, R.D., Hemingway, H., Altman, D.G. (2013). Prognosis 
Research Strategy (PROGRESS) 3: Prognostic Model Research. PLoS 
Medicine, 10(2), e1001381. http://doi.org/10.1371/journal.pmed.1001381.s002 
 293 
 
Sun, X., Briel, M., Busse, J.W., You, J.J., Akl, E.A., Mejza, F., Bala, M.M., Bassler, 
D., Mertz, D., Diaz-Granados, N., Vandvik, P.O., Malage, G., Srinathan, S.K., 
Dahm, P., Johnston, B.C., Alonso-Coello, P., Hassouneh, B., Truoung, J., 
Dattani, N.D., Heels-Ansdell, D., Bhatnagar, N., Altman, D.G., Guyatt, G.H. 
(2011). The influence of study characteristics on reporting of subgroup 
analyses in randomised controlled trials: systematic review. BMJ, 342, d1569. 
 
Sun, X., Briel, M., Busse, J. W., You, J. J., Akl, E. A., Mejza, F., Bala, M.M., 
Bassler, D., Mertz, D., Diaz-Granados, Vandvik, P.O., Srinathan, S.K., Dahm, 
P., Johnston, B.C., Alonso-Coello, P., Hassouneh, B., Walter, S.D., Heels-
Ansdell, D., Bhatnagar, N., Altman, D.G., Guyatt, G.H. (2012). Credibility of 
claims of subgroup effects in randomised controlled trials: systematic review. 
BMJ (Clinical Research Ed.), 344(mar15 1), e1553–e1553. 
http://doi.org/10.1136/bmj.e1553 
 
Sun, X., Briel, M., Walter, S.D., & Guyatt, G.H. (2010). Is a subgroup effect 
believable? Updating criteria to evaluate the credibility of subgroup analyses. 
Bmj, 340(mar30 3), c117–c117. http://doi.org/10.1136/bmj.c117 
 
Sundstrup, E., Jakobsen, M.D., Brandr, M. Aagaard, P., Andersen, L.L. (2016). 
Associations between biopsychosocial factors and chronic upper limb pain 
among slaughterhouse workers: cross sectional study. BMC Musculoskelet 
Disord. 17:104. http: doi: 10.1186/s12891-016-0953-7. 
 
Surowiecki, J. (2004). The Wisdom of Crowds. Why the Many Are Smarter Than 
the Few. London: Abacus. 
 
Tanner, C.A., Padrick, K.P., Westfall, U.E., & Putzier, D.J. (1987). Diagnostic 
reasoning strategies of nurses and nursing students. Nurs Res, 36(6); 358–
363. 
 
Temple, E., & Brown, R.F. (2011). A Comparison of Internet-Based Participant 
Recruitment Methods: Engaging the Hidden Population of Cannabis Users in 
Research, 7(2), D2. 
 
Thackeray, R., Neiger, B.L., Smith, A.K., & Van Wagenen, S.B. (2012). Adoption 
and use of social media among public health departments, 12(1), 242. 
http://doi.org/10.1186/1471-2458-12-242 
 
Thomas, E., Croft, P.R., Paterson, S.M., Dziedzic, K., & Hay, E.M. (2004). What 
influences participants' treatment preference and can it influence outcome? 
Results from a primary care-based randomised trial for shoulder pain [with 
consumer summary]. British Journal of General Practice,54(499):93-96. 
 
Thompson, C., & Dowding, D. (2002). Clinical Decision Making and Judgement in 
Nursing. (D. Dowding, Ed.) (1st ed.). Edinburgh: Churchill Livingstone. 
 
Thompson, C., Cullum, N. McCaughan, D., Sheldon, T., Raynor, P. (2004). 
Nurses, information use, and clinical decision making—the real world potential 
 294 
for evidence-based decisions in nursing, Evidence-Based Nursing 2004;7:68-
72. 
 
Thurstone, L.L. (1994). A law of comparative judgment. Psychological Review. 
 
Timmermans, D., Gooszen, A. W., & Geelkerken, R. H. (1997). Analysis of the 
variety in surgeons' decision strategies for the management of left colonic 
emergencies. Medical Care. 35(7):701-13. 
 
Topolovec-Vranic, J., & Natarajan, K. (2016). The Use of Social Media in 
Recruitment for Medical Research Studies: A Scoping Review. J Med Internet 
Res, 18(11), e286. http://doi.org/10.2196/jmir.5698 
 
Turner, J.A., Holtzman, S., & Mancl, L. (2007). Mediators, moderators, and 
predictors of therapeutic change in cognitive–behavioral therapy for chronic 
pain. Pain, 127(3), 276–286. http://doi.org/10.1016/j.pain.2006.09.005 
 
Underwood, M.R., Morton, V., Farrin A, on behalf of the UK BEAM trial team. 
(2007). Do baseline characteristics predict response to treatment for low back 
pain? Secondary analysis of the UK BEAM dataset [ISRCTN32683578]. 
Rheumatology, 46(8), 1297–1302. 
http://doi.org/10.1093/rheumatology/kem113 
 
Urwin, M., Symmons, D., Allison, T., Brammah, T., Busby, H., Roxby, M., 
Simmons, A., Williams, G. (1998). Estimating the burden of musculoskeletal 
disorders in the community: the comparative prevalence of symptoms at 
different anatomical sites, and the relation to social deprivation. Annals of the 
Rheumatic Diseases, 57(11), 649–655. 
 
van der Heijden, G.J.M.G., van der Windt, D.A.W.M., & De Winter A.F. (1997). 
Physiotherapy for patients with soft tissue shoulder disorders: A systematic 
review of randomised clinical trials. BMJ, 5;315(7099):25-30. 
 
van der Windt, D.A., Koes, B.W., Boeke, A.J., Deville, W., De Jong, B.A., & 
Bouter, L.M. (1996). Shoulder disorders in general practice: prognostic 
indicators of outcome. British Journal of General Practice, 46(410), 519–523. 
 
van der Windt, D.A., Koes, B.W., Deville, W., Boeke, A.J.P., De Jong, B.A., & 
Bouter, L.M. (1998). Effectiveness of corticosteroid injections versus 
physiotherapy for treatment of painful stiff shoulder in primary care: 
randomised trial [with consumer summary]. BMJ 1998 Nov 7;317(7168):1292-
1296. 
 
van der Windt, D.A., Koes, B.W., van Aarst, M., Heemskerk, M.A., & Bouter, L.M. 
(2000). Practical aspects of conducting a pragmatic randomised trial in primary 
care: patient recruitment and outcome assessment. Br J Gen Pract, 
50(454):371-4. 
van der Windt, D.A., Kuijpers, T., Jellema, P., van der Heijden, G.J., Bouter, L.M. 
(2007). Do psychological factors predict outcome in both low-back pain and 
 295 
shoulder pain? Ann Rheum Dis. 66(3), 313–319. 
http://doi.org/10.1136/ard.2006.053553 
Van Geest, J.B., Johnson, T.P., & Welch, V.L. (2007). Methodologies for 
Improving Response Rates in Surveys of Physicians: A Systematic Review. 
Eval Health Prof, 30(4), 303–321. http://doi.org/10.1177/0163278707307899 
Van Horn, P.S., Green, K.E., & Martinussen, M. (2009). Survey Response Rates 
and Survey Administration in Counseling and Clinical Psychology: A Meta-
Analysis. Educational and Pschological Measurement, 69(3), 389–403. 
http://doi.org/10.1177/0013164408324462 
 
van Kampen, D.A., van den Berg, T., van der Woude, H.J., Castelein, R.M., 
Scholtes, V.A., Terwee, C.B. Willems, W.J. (2014). The diagnostic value of the 
combination of patient characteristics, history, and clinical shoulder tests for 
the diagnosis of rotator cuff tear. J Orthop Surg Res, 7(9);70 doi: 
10.1186/s13018-014-0070-y 
 
Veldwijk, J., Determann, D., Lambooij, M.S., van Til, J.A., Korfage, I.J., de Bekker-
Grob, E.W., & de Wit, G.A. (2016). Exploring how individuals complete the 
choice tasks in a discrete choice experiment: an interview study. BMC Medical 
Research Methodology, 1–11. http://doi.org/10.1186/s12874-016-0140-4 
 
Veletsianos, G. (2011). Higher education scholars' participation and practices on 
Twitter. Journal of Computer-Assisted Learning, 28(4), 336–349. 
http://doi.org/10.1111/j.1365-2729.2011.00449.x 
 
Veloski, J. (2005). Clinical Vignette-Based Surveys: A Tool for Assessing 
Physician Practice Variation. American Journal of Medical Quality, 20(3), 151–
157. http://doi.org/10.1177/1062860605274520 
 
Ventola, C.L. (2014). Social media and health care professionals: benefits, risks, 
and best practices. Pharmacy & Therapeutics, 39(7), 491–520.  
 
Vergouw, D., Heymans, M.W., de Vet, H.C., van der Windt, D.A., & van der Horst, 
H.E. (2011). Prediction of persistent shoulder pain in general practice: 
Comparing clinical consensus from a Delphi procedure with a statistical 
scoring system. BMC Family Practice, 12(1), 63. http://doi.org/10.1186/1471-
2296-12-63. 
 
Vergouw, D., Heymans, M.W., Peat, G.M., Kuijpers, T., Croft, P.R., de Vet, H.C., 
van der Horst, H.E., van der Windt, D.A. (2010). The search for stable 
prognostic models in multiple imputed data sets. BMC Medical Research 
Methodology, 10(1), 81. http://doi.org/10.1186/1471-2288-10-81 
 
Virta, L., Joranger, P., Brox, J.I., & Eriksson, R. (2012). Costs of shoulder pain and 
resource use in primary health care: a cost-of-illness study in Sweden. BMC 
Musculoskeletal Disorders, 13(1), 17. http://doi.org/10.1186/1471-2474-13-17 
 
Westman, A., Linton, S.J., Öhrvik, J., Wahlén, P., & Leppert, J. (2012). Do 
psychosocial factors predict disability and health at a 3-year follow-up for 
 296 
patients with non-acute musculoskeletal pain? A validation of the Örebro 
Musculoskeletal Pain Screening Questionnaire. European Journal of Pain, 
12(5), 641–649. http://doi.org/10.1016/j.ejpain.2007.10.007 
 
Winters, J.C., Jorritsma, W., Groenier, K.H., Sobel, J.S., Meyboom-de Jong, B., & 
Arendzen, H.J. (1999a). Treatment of shoulder complaints in general practice: 
long term results of a randomised, single blind study comparing physiotherapy, 
manipulation, and corticosteroid injection. BMJ 1999 May 22;318(7195):1395-
1396. 
 
Winters, J. C., Sobel, J. S., Groenier, K. H., Arendzen, J. H., & Meyboom-de Jong, 
B. (1999b). The long-term course of shoulder complaints: a prospective study 
in general practice. Rheumatology (Oxford, England), 38(2), 160–163. 
 
Witt, J., Scott, A., & Osborne, R.H. (2009). Designing choice experiments with 
many attributes. An application to setting priorities for orthopaedic waiting lists. 
Health Economics, 18(6), 681–696. http://doi.org/10.1002/hec.1396 
 
Woodfield, K., Morriell, G., Metzler, K., Blank, G., Salmons, J., Finnegan, J., & 
Lucraft, M. (2013). New social media, new social research: Developing a 
network to explore the issues faced by researchers negotiating the new 
research landscape of online social media platforms (pp. 1–26). National 
Centre for Research Methods (NCRM) Networks for Methodological 
Innovation. 
 
Wylie, J.D., Suter, T., Potter, M.Q., Granger, E.K., Tashjian, R.Z. (2016). Mental 
Health Has a Stronger Association with Patient-Reported Shoulder Pain and 
Function Than Tear Size in Patients with Full-Thickness Rotator Cuff Tears. J 
Bone Joint Surg Am, 98(4), 251–256. http://doi.org/10.2106/JBJS.O.00444 
 
Yang, J.L., Jan, M.H., Chang, C.W., & Lin, J.J. (2012a). Effectiveness of the end-
range mobilization and scapular mobilization approach in a subgroup of 
subjects with frozen shoulder syndrome: a randomized control trial. Manual 
Therapy, 17(1): 47-52. http://doi.org/10.1016/j.math.2011.08.006 
 
Yang, J.L., Chen, S.Y., Hsieh, C.L., & Lin, J.J. (2012b). Effects and predictors of 
shoulder muscle massage for patients with posterior shoulder tightness. BMC 
Musculoskeletal Disorders, 13, 46. http://doi.org/10.1186/1471-2474-13-46 
 
Zheng, X., Simpson, J.A., van der Windt, D.A.W.M., & Elliott, A.M. (2005). Data 
from a study of effectiveness suggested potential prognostic factors related to 
the patterns of shoulder pain. Journal of Clinical Epidemiology, 58(8), 823–
830. http://doi.org/10.1016/j.jclinepi.2005.01.011 
  
APPENDICES
  
Appendix 1: Data Extraction, Risk of Bias & Methodological Appraisal Form 
  
  
Systematic review data extraction form 
 
 
Data Extraction 
 
Author: 
 
Year: 
 
Journal: 
 
 
Setting  
Country  
No. of 
Participants: 
 Participants 
completed: 
 
Selection 
Criteria 
 
 
 
Intention to 
Treat 
Analysis 
performed: 
Yes 
No  
Unclear 
Interventions 
Studied 
 
Control 
Group 
 
Duration of 
Treatment 
 
Frequency of 
Treatment 
 
Follow-up  
Periods 
 
  
Outcome  
Measures 
 
 
Cochrane Risk of Bias Tool 
 
Bias 
Domain 
Source of 
Bias 
Judgement 
Yes = low 
risk of bias, 
No = high 
risk of bias, 
Unclear = 
insufficient 
information 
to assess 
Description 
Selection 
Bias 
Adequate 
sequence 
generation
? 
  
Allocation 
concealm
ent? 
  
Performan
ce Bias 
Blinding 
(Patient-
reported 
outcomes)
? 
  
Attrition 
Bias 
Incomplet
e outcome 
data 
addressed
? (Short-
term 
outcomes 
(2-6 wks)) 
  
Incomplet
e outcome 
data 
addressed
? (Longer-
term 
outcomes 
 
  
(>6 wks)) 
Reporting 
Bias 
Free of 
selective 
reporting? 
  
Other 
Bias 
Free of 
other 
bias? 
  
 
Methodological criteria for the assessment of Moderators 
Pincus et al (2011) 
 
Rationale 
(1) A priori 
hypothesis 
Yes=1 (2) Theory driven and/or evidence driven 
Yes=1, No=0 
 
No=0 
Method    
 
Moderation 
analysis: 
Equal distribution of 
moderators at baseline 
Yes 
No  
(3) Moderators measured 
prior to randomisation 
Yes=1  
No=0  
Power 
Power analysis of 
moderator effect 
reported: 
Y
e
s 
A priori (Optimal) 
Post-hoc Using a priori effect size (Correct) 
Observed effect (Incorrect) 
N
o 
 
Adequate sample 
size for 
moderation 
Yes (at least 4 times the required sample size for main 
treatment effect in the lowest sub-group for the moderator 
factor) 
  
analysis   
 
If no, were 
there at 
least 20 
people in 
the smallest 
sub-group 
of the 
moderator? 
Yes  
 
 
Have authors 
employed 
analysis to 
compensate 
for insufficient 
power (i. e. 
boot-
strapping 
techniques?) 
 
Yes 
No No  
Correction for multiple comparisons 
Was the 
regression 
significant at P < 
0.05? 
 
Yes 
Or, (if more than three 
comparisons) corrected or 
significance adjusted to P < 
0.01? 
 
Yes 
No No  
Did the authors 
explore residual 
variances of 
interactions if 
carrying out 
multiple two-way 
interactions? 
Yes 
 
 
 
 
No  
Measurement validity & measurement error 
(4i) Was 
measurement of 
baseline and 
process factors 
reliable and valid 
(from published 
information) in 
target population? 
Yes=1 
 
No=0 
(4)ii Is there 
evidence that the 
measurement 
error of the 
instrument is 
Yes=1 
 
 
  
likely to be 
sufficiently small 
to detect the 
differences 
between sub- 
groups that are 
likely to be 
important? 
No=0 
Did the authors 
comment on 
measurement 
validity in 
reference to 
construct validity, 
face validity etc? 
Yes 
 
 
No  
 
 
Analysis 
(5) Contains an 
explicit test of the 
interaction 
between 
moderator and 
treatment (e.g. 
regression)? 
Yes=1  
 
No=0 
Was there 
adjustment for 
other baseline 
factors? 
Yes 
 
 
No  
 
 
Is there an explicit 
presentation of the 
differences in 
outcome between 
baseline sub-
groups (e.g. 
standardised 
mean difference 
between groups, 
Cohen’s d)? 
Yes 
 
No 
  
 
Results 
Clinical plausibility of results 
Are differences 
between 
subgroups 
clinically 
plausible? 
Yes  
 
 
No 
 
 
Were results of 
sub-group 
analysis reported 
even when 
magnitude of the 
difference was too 
small to support 
differing 
recommendations 
for different 
groups? 
Yes  
 
No 
 
TOTAL SCORE FOR PINCUS TOOL (max 
5): 
 
Confirmatory Evidence (All 5 items): 
 
Exploratory Evidence (Final 3 items): 
__ / 5 
 
Yes/No 
 
Yes/No 
  
  
Appendix 2: Guidance notes for reviewers for completion of data extraction, 
risk of bias assessment and methodological appraisal of included articles 
  
  
Shoulder Moderation Systematic Review Guidance Notes 
 
In order to ensure uniform and complete information and data extraction for the 
purposes of risk of bias and methodological appraisal, please follow the below 
notes for guidance on how to complete the form. 
 
 
Criteria Guidance Notes 
 
Data Extraction 
 
Author Surname of first author 
Year Year of publication 
Journal Title of journal 
Setting E.g., Primary Care, Secondary Care, Tertiary 
etc. 
Country Country 
No. of Participants No. of participants recruited 
Participants completed: No. of participants completed  
Selection criteria Define selection/inclusion criteria 
Intention to Treat 
Analysis performed 
Yes/No/Unclear. Copy and paste any further info 
here 
Interventions studied List interventions studied including who delivered 
it, duration of intervention 
Control Group Describe what happened to control group (e.g., 
waiting list, placebo/sham, routine intervention) 
Duration of Treatment No. of consecutive weeks treatment was 
delivered over 
Frequency of Treatment Weekly, monthly etc. 
Follow-up Periods When were the data collection time-points (list in 
weeks) 
Outcome Measures List all outcome measures, indicate which 
outcome measures were tested with relation to 
  
moderation analysis 
 
Cochrane Risk of Bias Tool 
 
Domain Description Required 
Review Authors 
Judgement – Assess 
as low, unclear or 
high risk of bias) 
*Assessments should 
be made for each 
main outcome or class 
of outcomes. 
Answer the bolded 
question “yes, 
unclear, or no”, where 
Yes = low risk of bias, 
No = high risk of bias, 
Unclear = insufficient 
information to assess 
whether an important 
risk of bias exists; or 
insufficient rationale or 
evidence that an 
identified problem will 
introduce bias  
Adequate sequence 
generation? 
Describe the method 
used to generate the 
allocation sequence in 
sufficient detail to allow 
an assessment of 
whether it should 
produce comparable 
groups 
Was the allocation 
sequence adequately 
generated? 
Selection bias (biased 
allocation to 
interventions) due to 
inadequate generation 
of a randomised 
sequence 
Adequate 
concealment? 
Describe the method 
used to conceal the 
allocation sequence in 
sufficient detail to 
determine whether 
intervention allocations 
could have been 
foreseen before or during 
Was allocation 
adequately 
concealed? 
Selection bias (biased 
allocation to 
interventions) due to 
inadequate 
concealment of 
  
enrolment allocations before 
assignment 
Blinding (Patient-
reported outcomes)? 
Describe all measures 
used, if any, to blind 
outcome assessment 
from knowledge of which 
intervention a participant 
received. Provide any 
information relating to 
whether the intended 
blinding was effective 
 
Was knowledge of 
the allocated 
intervention 
adequately 
prevented during the 
study? 
Detection bias due to 
knowledge of the 
allocated interventions 
by outcome 
assessment 
Incomplete outcome 
data addressed? 
(Short-term outcomes 
(<2 weeks), Medium 
term (2-24 weeks) Long 
term (>24 weeks) 
Describe the 
completeness of 
outcome data for each 
main outcome, including 
attrition and exclusions 
from the analysis. State 
whether attrition and 
exclusions were 
reported, the numbers in 
each intervention group 
(compared with total 
randomised participants), 
reasons for attrition or 
exclusions where 
reported, and any 
reinclusions in analyses 
for the review 
Were incomplete 
outcome data 
adequately 
addressed? 
Attrition bias due to 
amount, nature, or 
handling of incomplete 
outcome data 
 
Free of selective 
reporting? 
State how selective 
outcome reporting was 
examined and what was 
found 
Are reports of the 
study free of 
suggestion of 
selective outcome 
reporting? 
Reporting bias due to 
selective outcome 
reporting 
Free of otbias? State any important 
concerns about bias not 
covered in the other 
domains in the tool 
 
Was the study 
apparently free of 
other problems that 
could put it at a high 
risk of bias? 
Bias due to problems 
  
not covered elsewhere 
 
Pincus Tool 
 
Criteria Judge yes or no 
Criteria for a 
judgement of ‘yes’ 
Scoring 
(NS = not scored) 
Yes = 1 
No = 0 
(1) A priori hypothesis Mention of explicit 
hypothesis planned in 
protocol stating which 
sub-groups will be 
tested for which 
outcome 
 
Yes = 1 
No = 0 
(2) Clinical and/or 
theory-based hypothesis 
A clinical and/or 
theoretical hypothesis 
provided 
Yes = 1 
No = 0 
Method Describe analysis 
content and analysis 
method in as full detail 
as paper allows 
NS 
Equal distribution of 
moderators at baseline 
Ideally, a-priori 
stratification in design 
NS 
(3) Moderators measured 
prior to randomisation 
Report what/wasn’t was 
measured prior to 
randomisation 
Yes = 1 
No = 0 
Power analysis of 
moderator effect 
Sufficient power to 
detect small/moderate 
effects in moderator 
analysis has been 
defined as at least four 
times that of the main 
effect 
NS 
Adequate sample size 
for moderation analysis 
Yes = At least 4 fold the 
required sample size for 
main treatment effect in 
the lowest sub-group 
NS 
  
for the moderator factor 
If no, were there at 
least 20 people in the 
smallest sub-group of 
the moderator? 
Have authors employed 
analysis to compensate 
for insufficient power? 
i.e., any boot-strapping 
techniques 
NS 
Was the regression 
significant at P < 0.05? 
P < 0.05 or (if more 
than three 
comparisons) corrected 
or significance adjusted 
to P < 0.01) 
NS 
Did the authors explore 
residual variances of 
interactions if carrying 
out multiple two-way 
interactions? 
Residual variances 
explored to assess 
statistical reliability prior 
to making a statement 
about relative 
importance of factors. 
NS 
(4i) Was measurement of 
baseline and process 
factors reliable and valid 
(from published 
information) in target 
population? 
Supporting references 
provided or reliability 
and validity well 
established in the field 
Yes for one or both = 
1 
No = 0 
(4ii) Is there evidence 
that the measurement 
error of the instrument is 
likely to be sufficiently 
small to detect the 
differences between 
sub- groups that are 
likely to be important? 
Estimates of reliability 
of measures should be 
reported 
 
Did the authors 
comment on 
measurement validity in 
reference to construct 
validity, face validity? 
Construct validity and 
face validity etc 
 
NS 
Contains an explicit test 
of the interaction 
between moderator and 
treatment? 
e.g. regression or path 
analysis using 
regression, structural 
equation modelling etc 
Yes = 1 
No = 0 
  
Was there adjustment 
for other baseline 
factors? 
Report any adjustments 
made or expected 
NS 
(5) Is there an explicit 
presentation of the 
differences in outcome 
between baseline sub-
groups? 
e.g. standardised 
mean difference 
between groups, 
Cohen’s d 
 
 
Are differences between 
subgroups clinically 
plausible? 
Selection of 
characteristics should 
be motivated by 
biological and clinical 
hypotheses, ideally 
supported by evidence 
from sources other than 
the included studies 
NS 
Were results of sub-
group analysis reported 
even when magnitude of 
the difference was too 
small to support 
differing 
recommendations for 
different groups? 
i.e., where the 
magnitude of a 
difference between 
subgroups will not 
result in different 
recommendations for 
different subgroups 
NS 
TOTAL SCORE FOR PINCUS TOOL (max 5): 
 
Confirmatory Evidence (All five items): 
 
Exploratory Evidence (Final three items): 
X / 5 
 
Yes/No 
 
Yes/No 
 
 
  
  
Appendix 3: Ethical approval documents for consensus workshops 
 
  
  
ETHICAL REVIEW PANEL	
Application Form (Staff and PGR Students) 
 
 
• To be completed for every research project involving human participants/subjects;   
• The form must be authorised by your Research Institute Director / (or for applicants who 
are members of RI Social Sciences the application can be signed off by your Research 
Centre Head)/Supervisor /Head of School as appropriate 
• Both an electronic copy & hard copy of all documentation must be provided. 
 
APPROVAL MUST BE OBTAINED BEFORE potential participants are approached to take part in 
any research. 
 
Information regarding the completion of the ethical review panel application form: 
Section A – To be completed by all applicants.  
Section B – To be completed by applicants who have already obtained Ethics Approval from a separate 
committee. 
Section C – To be completed by applicants requiring approval from a University Ethical Review Panel 
Section D – To be completed by all applicants. 
 
Further information regarding the completion of the application can be found in Section E (at the 
end of this document) 
 
SECTION A (to be completed by all applicants)  
 
Project Title:  
 
Musculoskeletal Shoulder Disorders: Which Treatment for Whom? 
Proposed start date:  
 
1st February 2015 
Proposed end date for ‘field 
work’ (eg interviews): 
31th October 2015 
Name of Researcher 
(applicant): 
Cliona McRobert 
Status:  POSTGRADUATE RESEARCH STUDENT  
  
 
Research Institute or School if 
not in an Research Institute 
Primary Care Sciences 
Keele Email address: c.j.mcrobert@keele.ac.uk 
Correspondence address: Arthritis Research UK Primary Care Centre 
Primary Care Sciences 
Keele University 
Staffordshire, ST5 5BG 
Keele Telephone number: 
 
01782 734889 
 
 
SECTION B (to be completed by applicants who have already obtained ethics approval from a 
separate committee) 
 
Has your project already been approved by an ethics committee? (for example, an 
NHS research ethics committee)  
 
If YES the following documentation should be sent directly to the Chair of the University 
Research Ethics Committee, C/O Nicola Leighton, University Research Ethics 
Committee Administrator, Research & Enterprise Services, Dorothy Hodgkin Building, e-
mail n.leighton@keele.ac.uk, telephone 01782 733306 
 
NO  
 
A completed and signed hard copy of this application form 
(please complete Sections A, B and D) and an electronic 
copy should also be e-mailed to n.leighton@keele.ac.uk 
 
 
Signed hard copy:  
 
Electronic copy:  
N/A 
N/A 
Evidence of prior ethics approval from the hosting 
institution. 
 
Copy of approval 
document: 
N/A 
 
  
SECTION C (to be completed by applicants who have NOT already obtained ethics approval from a 
separate committee)                                                                                                                                                                         
If your project requires approval by a University Ethical Review Panel (ERP).   
 
The following documentation should be forwarded to Nicola Leighton, Research & Enterprise 
Services, Dorothy Hodgkin Building, telephone 01782 733306.  An electronic copy of the 
application form and all necessary documentation should also be e-mailed to 
uso.erps@keele.ac.uk   An application cannot be considered until a signed copy is received and 
accompanied by an electronic copy.  
       
A completed and signed hard copy of this application form 
(please complete Sections A, C and D) and an electronic 
copy should also be e-mailed to uso.erps@keele.ac.uk 
 
Signed copy attached:  
 
Electronic copy: 
 
YES  
 
YES  
A hard copy of the summary document attached to this form, NO MORE THAN two 
sides of A4  
It may help the review of your project if you include a diagram to clearly explain the 
project (eg what activities will undertaken, by whom and when) 
 
An electronic copy of the summary document 
Please ensure that the version number and date is clearly stated in footer of the 
summary document (approval may be delayed if these details are not included) 
 
YES  
 
 
 
YES  
And, if (and only if) they are appropriate given the study’s design and approaches; 
A letter of invitation for participants  
Please ensure that the version number and date is clearly stated in the footer of 
the letter (approval may be delayed if these details are not included) 
 
YES  
(including 
combined 
participant 
information 
sheet)  
An information sheet which should normally include the following sections:  
o Why the participant has been chosen;  
o What will happen to participants if they take part 
o A discussion of the possible disadvantages, risks and benefits of taking part 
o The procedures for ensuring confidentially and anonymity (if appropriate) 
o The proposed use of the research findings 
o Contact details of the principal investigator plus details of additional support 
agencies (if 
  Necessary) 
YES 
(Combined 
with 
invitation 
letter)  
  
o Version number and date is clearly stated in the footer of the information 
sheet  (approval may be delayed if these details are not included) 
 
 
A template for a participant information sheet is available from the Research & 
Enterprise Services website via the following link  
http://www.keele.ac.uk/researchsupport/researchgovernance/researchethics/ 
 
A copy of the participant consent form/s; 
Please ensure that the version number and date is clearly stated in the footer of 
the consent form (approval may be delayed if these details are not included) 
 
Templates for consent forms are available from the Research & Enterprise Services 
website via the following link 
http://www.keele.ac.uk/researchsupport/researchgovernance/researchethics/ 
 
Health professionals will decide if they wish to participate after reading the combined 
invitation letter and participant information sheet. Consent to participate is implied by 
clicking next on the first page of the online survey and proceeding to provide responses 
to the questions. PLEASE NOTE: there is only one online survey to be completed for 
this study.  
 
 
NO  
Copies of any questionnaire, interview schedules or topic guides. 
Please ensure that the version number and date is clearly stated in the footer of 
these documents (approval may be delayed if these details are not included) 
 
YES  
 
  
(PARTICIPANTS’ CONSENTS) 
 
1.  Will the researchers inform participants of all aspects of the research that 
might reasonably be expected to influence willingness to participate and in 
particular, any negative consequences that might occur? 
 
If YES, please give details:  
Participants will be provided with a combined letter of invitation and participant 
information sheet detailing why they have been chosen to participate, the purpose of the 
study, anticipated length of time taken to complete the survey, what is expected of them, 
the possible disadvantages of taking part and their right to withdraw from the survey at 
any point. Other than the use of their time, no negative consequences or harm to 
respondents associated with taking part are anticipated.  
 
The survey does not have an actual 'escape survey' button but respondents may 
choose to close the internet browser window at any point in order to escape the 
survey. In the event of a respondent not providing responses to the 12 patient cases, 
this will be understood as having dropped out from the study. As the planned statistical 
analysis relies upon complete data i.e., responses to all 12 patient cases, only data from 
respondents who have provided responses to all 12 patient cases will be analysed. The 
number of participants starting the survey but dropping out at any point will be recorded. 
 
If NO, please explain: 
 
 
2.  Will all participants be provided with a written information sheet and be 
provided with an opportunity to provide (or withhold) written consent?   
 
If YES, please ensure that these documents are attached (see above).   
This study is an online survey. The combined participant invitation and information sheet 
will be available via a hyperlink on the first page of the online survey. Page 1 of the 
survey states that by clicking the ‘next’ button that they are indicating that they have 
read the combined participant invite and information sheet and that they imply their 
consent to take part in the survey. 
 
If NO, please explain why written consent &/or information is not appropriate for this 
study. 
 
YES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
YES 
 
 
 
 
 
 
  
 
3.  Is consent being sought for the dataset collected to be used for future 
research projects?  
Results from this survey will inform the design of a future individual patient data analysis 
study which seeks to assess the validity of the result of this survey. The actual data from 
this survey will not be used in this future study. 
 
4.  What are the exclusion/inclusion criteria for this study (i.e. who will be allowed 
to / not allowed to participate)? 
 
Inclusion: Health or medical practitioners, clinical academics or academics (including 
but not limited to physiotherapists, general practitioners (GPs), rheumatologists and 
orthopaedic surgeons) who: 
(i) Clinically manage or have a clinical or research interest in patients with 
musculoskeletal shoulder disorders as part of their normal clinical practice 
(ii) Practice in a country where healthcare services are government, state or 
national insurance funded  
(iii) Can read and write English 
 
Exclusion: Individuals who: 
(i) Are not practicing health or medical practitioners, clinical academics or 
academics 
(ii) Practice in a country where healthcare is predominantly privately funded 
(iii) Have no clinical or academic interest in musculoskeletal shoulder disorders 
(iv) Do not read or write English 
 
5.  Please explain briefly (and in ‘lay’ terms) why you plan to use these particular 
criteria? 
The purpose of the survey is to assess how clinicians from across the world make 
treatment decisions in the care for patients with shoulder pain in the context of publicly 
funded healthcare systems such as the NHS in the U.K. In privately-funded and 
capitalist ideated healthcare systems patient preference/choice exerts a greater 
influence on treatment decision-making processes. Therefore we aim to include 
respondents who practice in a healthcare setting similar to the U.K. i.e., publicly funded 
where the patient is a partner in the decision, not a consumer of healthcare.  
 
 
 
 
 
 
NO 
 
 
 
6. Will people who are vulnerable be allowed to take part in this study?  For these 
purposes, vulnerable participants are those whose abilities to protect their own interests 
are impaired or reduced in comparison to the population as a whole.  Vulnerability may 
arise from personal characteristics (such as mental or physical impairment) or from 
social context and disadvantage (e.g. lack of power, education, or resources).  
Prospective participants, who are at high risk of consenting under duress, or as a result 
of manipulation or coercion, should also be considered as vulnerable.  All children and 
NO 
 
 
 
  
adults who lack mental capacity are presumed to be vulnerable. 
 
If NO, please outline the rationale for excluding them:  
Participants will be health professionals and/or academics with a special interest in 
shoulder disorders.   
 
 
If YES, what special arrangements (if any) are in place to protect vulnerable 
participants’ interests? 
 
7. Does the research activity proposed require a Disclosure & Barring Scheme 
(DBS) disclosure?  (information concerning activities which require DBS checks are 
required can be accessed via https://www.gov.uk/government/publications/dbs-check-
eligible-positions-guidance and 
http://www.keele.ac.uk/hr/policiesandprocedures/crbsafeguarding/ If you are unsure 
whether a DBS disclosure is required please contact Human Resources or Nicola 
Leighton prior to submission of this application form.  If you answer YES please 
complete the relevant section below.   If you answer no please go to question 8. 
 
STAFF ONLY 
7a   Have you (and other individuals who will be working on the research project) had a 
DBS 
       disclosure initiated by Keele University? 
 
 
7b   If you have answered YES to question 7a please contact Human Resources to 
obtain a 
       confirmation note indicating that a DBS disclosure has been previously initiated by 
Keele and that it  
       was satisfactory.  Is the confirmation note attached to this form? 
 
       If you have answered NO to question 7a please contact Human Resources 
immediately to arrange  
       for a DBS disclosure to be applied for.  You will still be able to apply for ethical 
approval in parallel  
       to applying for a DBS disclosure.  However, your project will not be approved by the 
ERP until you  
       have forwarded the confirmation note from Human Resources indicating that a DBS 
disclosure has  
       been undertaken and is satisfactory.       Has Human Resources been contacted 
about this?  
 
 
 
 
HOME/EU STUDENTS ONLY 
7c   Have you (and other individuals who will be working on the research project) had a 
DBS  
       Disclosure (or equivalent) initiated by Keele University? 
 
 
 
 
 
 
 
 
 
 
 
 
NO 
 
 
 
 
 
 
 
 
N/A 
 
 
 
N/A 
 
 
 
N/A 
 
  
 
7d   If you have answered YES to question 7c please contact the Admissions Officer, 
Admissions to  
       obtain a confirmation note indicating that a DBS disclosure (or equivalent) has been 
previously  
       initiated by Keele and that it was satisfactory.  Is the confirmation note attached to 
this form? 
 
 
       If you have answered NO to question 7c please contact the Admissions Officer 
       immediately to arrange for a DBS disclosure (or equivalent) to be applied for.  You 
will still be able        
       to apply for ethical approval in parallel to applying for a DBS disclosure.  However, 
your project will  
       not be approved by the ERP until you have forwarded the confirmation note from 
Nicola Leighton 
       indicating that a DBS disclosure has been undertaken and is satisfactory.   I confirm 
the  
       Admissions Officer has been contacted and a DBS disclosure (or equivalent) has 
been initiated. 
 
I have contacted the Home/EU Admissions Officer, and was informed that a CRB 
disclosure is not required for this project, as I am not dealing with patients, minors 
or vulnerable adults but healthcare practitioners only 
 
 
INTERNATIONALSTUDENTS ONLY  
Please contact Nicola Leighton on 01782 733306 or e-mail n.leighton@keele.ac.uk 
before completing this section 
 
7e   Have you (and other individuals who will be working on the research project) had a 
DBS 
       Disclosure (or equivalent) initiated by Keele University? 
 
 
7f   If you have answered YES to question 7e please contact the appropriate person 
(as advised by  
      Nicola Leighton) to obtain a confirmation note indicating that a DBS disclosure (or 
equivalent) has  
      been previously initiated by Keele and that it was satisfactory.  Is the confirmation 
note attached to  
      this form.    
 
       If you have answered NO to question 7e please contact the appropriate person (as 
advised by  
       Nicola Leighton) immediately to arrange for a DBS disclosure (or equivalent) to be 
applied for.  You  
       will still be able  to apply for ethical approval in parallel to applying for a DBS 
disclosure.  However,  
       your project will not be approved by the ERP until you have forwarded the 
confirmation note from  
       Human Resources indicating that DBS disclosure has been undertaken and is 
satisfactory.   I  
       confirm the relevant person has been contacted and a DBS disclosure (or 
equivalent) has been  
       initiated. 
 
 
 
 
 
 
 
 
 
NO  
 
 
 
 
N/A 
 
 
 
 
 
 
 
 
 
 
8. Will the study involve participants who are unable to give valid (informed) NO 
  
consent (e.g. children and adults lacking mental capacity)? 
 
If YES, what procedures will be in place to ensure that informed consent is obtained, 
where appropriate, from third parties (e.g. parents or carers)?  And what procedures will 
be in place (if any) to give the participants an opportunity to have their objections 
recognised and respected? 
 
 
 
9.  Does the investigation involve observing participants unawares? 
 
If YES, what efforts will be made to respect their privacy, values and well-being?    
 
NO 
 
10.  Will the confidentiality of participants be maintained? 
 
If NOT, please give rationale: 
 
If YES, how? 
 
Any information provided by a respondent during the course of the research will be kept 
strictly confidential. Respondents will not be asked to provide information that could be 
used to identify them. Demographic data collected will be limited to profession, 
postgraduate training specific to musculoskeletal shoulder disorders, country of clinical 
practice, percentage of clinical time funded by government/state and privately funded, 
and frequency of referral/recommendation to three commonly used treatments. This 
survey will be hosted by Keele University on a secure password protected and backed 
up server. Once the sample size has been met and data collection has been completed, 
the link to the survey will be disabled and the survey will no longer be available for 
access online. All data will be maintained in an anonymous form that cannot be linked 
with any respondent. A separate password protected database (accessible only by Tim 
Smale, software programmer and the research team) will be maintained for respondents 
who email the student to indicate that they would like to receive notification of results. 
Individuals populating this database will receive two sets of results, results of the survey 
and results of a further study that will assess the validity of the results. This database 
will be destroyed after the second results email has been sent. Data will be stored on 
the secure University server, which is password protected with only designated 
members of the research team and survey development team authorised to access it. 
All research staff work to robust data security procedures and have explicit duties of 
confidentiality, equivalent to the duty placed on NHS staff, written into their employment 
contracts, in line with the Data Protection Act (1998) and the NHS Research 
Governance Framework.  
YES 
 
  
 
11. Will participants require any support to take part in the research (eg. disability 
support, interpreter)? 
 
If YES, what sort of support is required and how will it be delivered? 
 
NO 
 
 
 
(PROCEDURES) 
 
12.  Does the research involve people being investigated for a condition or 
disorder which has received medical, psychiatric, clinical psychological or similar 
attention? 
 
If YES, please give details: 
 
NO 
 
13.  Are drugs, placebos or other substances (eg food substances, vitamins) to be 
administered to participants or will the study involve invasive, intrusive or 
potentially harmful procedures of any kind? 
 
If YES, please give details and justify: 
 
NO 
 
 
14.  Will blood or other bodily fluids/tissues (including hair, nails and sebum) be 
obtained from   
       participants? 
 
If YES, please give details and justify: 
NO 
 
 
15.		Is pain or more than mild discomfort likely to result from the study? 
 
If YES, please give details and justify: 
 
NO 
 
	
  
 (RESEARCH PROCESS) 
 
16.  Will participants receive any reimbursements or other payments 
 
If YES, please give details: 
 
NO 
 
17.  Does the research involve the analysis of data participants will not realise 
would be used by you for research purposes (e.g. confidential criminal, medical 
or financial records)? 
 
If YES, please give rationale: 
 
NO 
 
18.  Does the research involve the possible disclosure of confidential information 
to other participants (e.g. in focus groups)? 
 
If YES, please explain how this will be handled: 
 
 
NO 
 
19.  Will the researchers de-brief participants to ensure that they understand the 
nature of the research and to monitor possible misconceptions or negative 
effects? 
 
IF YES, how will this be done? 
Participants will be provided with links to the combined participant invite and information 
sheet and consent at the beginning of each survey. Opportunity will be provided for 
participants to contact the student or the students’ lead supervisor and the university’s 
Research Governance Officer in the event of any misunderstandings or misconceptions. 
 
If NO, please explain why not: 
 
 
YES  
20.  Are there any other ethical issues that you think might be raised by the 
research? 
NO 
 
  
 
If YES, please give details: 
 
 
(Health & Safety) 
 
21.  Does the project have any health & safety implications for the researcher? 
 
 
If YES, please outline the arrangements which are in place to manage these risks: 
 
 
 
 
 
NO 
 
FOR STAFF ONLY 
 
22.  Does your research involve travel overseas? 
 
 
 
If YES,  
Have you consulted the Foreign and Commonwealth Office website for guidance/travel 
advice? 
http://www.fco.gov.uk/en/travel-and-living-abroad/ 
 
 
Have you completed and submitted the risk assessment form?  Available from 
http://www.keele.ac.uk/finance/insurance/travelinsurance/travellingoverseas-
policyriskassessment/ 
 
 
 
 
N/A 
 
 
 
N/A 
 
 
 
N/A 
 
 
 
  
 
 
FOR STUDENTS ONLY 
 
23.  Will any research take place outside the UK? 
This is an online survey that will be completed by respondents internationally. The 
researcher does not need to travel in order to obtain the data. 
 
 
If YES 
For home students - have you consulted the Foreign and Commonwealth Office website 
for guidance/travel advice?   http://www.fco.gov.uk/en/travel-and-living-abroad/ 
 
 
For international students - have you also sought advice/guidance from the Foreign 
Office (or equivalent body) of your country? 
 
 
For all students - will you be visiting any areas for which particular risks have been 
identified or for which the advice given is not to travel to this area? 
 
 
If YES 
(a) Please give details 
 
 
(b) Please outline the arrangements in place to manage these risks. 
 
 
 
24.  What insurance arrangements are in place?   (Please contact Alan Slater on 
01782 733525 to ascertain if you will be covered by University Insurance) 
 
 
NO 
 
 
 
 
 
N/A 
 
 
 
N/A 
 
 
 
 
N/A 
 
 
 
 
 
 
 
 
 
 
  
N/A 
 
 
 
  
SECTION D (to be completed by all applicants) 
 
Please complete the checklist below to indicate the version number and date of any supporting 
documents included with this application. 
 
Document(s) Version Number Date 
Summary document V1.0 16.12.14 
Combined participant invitation 
letter and information sheet  
V1.0 16.12.14 
Questionnaire(s) (paper copy) V1.0 16.12.14 
Consent Form(s) N/A N/A 
Consent Form(s) for use of quotes N/A N/A 
Interview Topic Guide(s) N/A N/A 
   
 
Signatures  
 
Principal Investigator / Research 
Student:  
 
I understand that I must comply with 
the University’s regulations and 
other applicable codes of ethics at 
all times. 
 
 
 
 
 
Cliona McRobert 
Research Student 
 
Signatures 
 
 
The following permissions must be obtained before 
this form is submitted: 
 
- for staff who are members of a research 
institute, the signature of your Research 
Institute Director (or, for RI Social Sciences, 
Research Centre Head); 
- for staff who are NOT members of a 
research institute, the signature of your Head 
of School (of, if not in a School, other line 
manager) 
- for postgraduate research students, the 
signature of your lead supervisor. 
 
I have read this application and confirm that:- 
• The academic and/or scientific quality of the 
application is satisfactory. 
  
16/12/14 
 
 
 
 
 
 
 
 
 
 
Professor Danielle van der Windt 
Lead supervisor 
 
16/12/2014 
• Arrangements are in place for the management and 
governance of this project 
 
 
……………………………………………………………………..    
Research Institute Director / Research Centre Head / 
Supervisor / Head of School / Other Line Manager 
 
………………………… 
Date     
 
 
 
*please delete as appropriate 
 
Please ensure when submitting your application that you have provided a hard copy and e-
mailed a copy of all the documentation to Hannah Reidy, ERP Administrator, Research & 
Enterprise Services, Dorothy Hodgkin Building, Keele, e-mail uso.erps@keele.ac.uk 
 
Applicants who have already obtained ethics approval from a separate committee should forward 
documentation to  
Nicola Leighton, University Research Ethics Committee Administrator, Research & Enterprise 
Services, Dorothy Hodgkin Building, e-mail n.leighton@keele.ac.uk, telephone 01782 733306. 
 
Applications which require approval by an University Ethical Review Panel should forward 
documentation to Nicola Leighton, Research & Enterprise Services, Dorothy Hodgkin Building, e-
mail uso.erps@keele.ac.uk, telephone 01782 733306. 
 
Please note that it is your responsibility to follow the University’s Code of good research practice 
http://www.keele.ac.uk/researchsupport/researchgovernance/ and any relevant academic or 
professional guidelines in the conduct of your study. This includes providing appropriate 
information sheets and consent forms, and ensuring confidentiality in the storage and use 
of data. Any significant change in the question, design or conduct over the course of the research 
  
should be notified to the Research Institute Director/Supervisor and may require a new application 
for ethics approval.  
 
This form was developed from the Ethics application forms used within Humanities and Social 
Sciences with kind permission from the HUMSS Research Ethics Committee.  
  
SECTION E 
 
Information regarding the completion of the ethical review panel application form 
Section A – To be completed by all applicants.  
Section B – To be completed by applicants who have already obtained Ethics Approval from a separate 
committee. 
Section C – To be completed by applicants requiring approval from a University Ethical Review Panel 
Section D – To be completed by all applicants. 
 
PLEASE NOTE:  Ethics Approval for Research Projects 
All projects involving human research participants/subjects and/or data about identifiable individuals, 
need to be approved by an ethics committee before the fieldwork for projects can commence.  The 
University has established Ethical Review Panels to review proposed research projects to be 
undertaken by staff and postgraduate research students.  The information below provides more details 
about the role of these panels and the documents that need to be submitted to support the review 
process. 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
- - - - - - - - - - - -  
1. If your project has already been approved by a recognised ethics committee (for example, an NHS 
research ethics committee), the following documentation should be sent directly to the Chair of the 
University Research Ethics Committee, C/o Nicola Leighton, University Research Ethics Committee 
Administrator, Research & Enterprise Services, Dorothy Hodgkin Building, e-mail 
n.leighton@keele.ac.uk, telephone 01782 733306. 
• A completed and signed ethical review application form (Sections A, B and D) accompanied by 
an electronic copy; 
• Evidence of prior ethics approval from the hosting institution. 
 
  
2. If your project requires approval by a University Ethical Review Panel, the following documentation 
should be sent directly to Nicola Leighton, Research & Enterprise Services, Dorothy Hodgkin 
Building, e-mail uso.erps@keele.ac.uk, telephone 01782 733306 
• A completed and signed ethical review application form (Sections A, C and D) accompanied by 
an electronic copy of the application form and relevant documentation.  An application  cannot 
be considered until a signed copy is received and also by an electronic copy; 
• A summary document, NO MORE THAN two sides of A4 paper; 
  And, if they are applicable given the study’s design and approaches, 
• A letter of invitation for participants; 
• An information sheet which should normally include following sections: invitation paragraph; the 
purpose of the study; why the participant has been chosen; what will happen to participants if 
they take part; a discussion of the possible disadvantages, risks and benefits of taking part; the 
procedures for ensuring confidentiality and anonymity, if any; the proposed use of the research 
findings; and contact details of the principal investigator plus details of additional support 
agencies (if necessary); 
• A copy of the participant consent form; 
  
• Copies of any questionnaire, interview schedules or topic guides. 
 
  
3. The review will be undertaken at the next available ethical review panel meeting.  Please access 
http://www.keele.ac.uk/researchsupport/researchgovernance/researchethics/ for a list of meeting 
dates and submission deadlines.  Following the review process you will be informed of the panel’s 
decision which will be either: 
• Study approved; 
• Study approved subject to clarification of issues, modification of design or provision of additional 
information which will be itemised in the letter of response; 
• Study rejected with supporting reasons. 
 
4. If ethical approval is not granted, applicants have the right of appeal to the University’s Research 
Ethics Committee. 
 
5.    Correspondence informing applicants of the outcome of the panel’s decision will be copied to the 
relevant Research  
       Administrators.  It is the responsibility of applicants to keep their respective Institutes informed of 
their research activities  
       for the purposes of research governance.		
  
  
                      
 
Letter of Invitation 
 
22nd January 2013 
 
Dear Professional Colleague, 
 
Musculoskeletal Shoulder Disorders: Which Treatment for Whom? 
 
As a musculoskeletal physiotherapist and current PhD student at the Arthritis Research UK Primary 
Care Centre at Keele University, I am currently researching the predictors of response to commonly 
used clinical treatments for musculoskeletal shoulder conditions.  
 
As you know, musculoskeletal shoulder disorders are common and cause considerable reductions in 
social and work functional and quality of life. Achieving consistently successful outcomes for patients 
with shoulder disorders has proven difficult to achieve with over 70% of primary care patients still report 
pain after 6 weeks and 50% still report pain after 6 months. Although prognostic studies been able to 
identify some of the characteristics predicting who will improve or not improve over time, i.e., the 
predictors of outcome irrespective of treatment, currently, very little is known about predicting which 
patients are likely to respond to commonly used treatment such as: (i) education, advice and pain relief, 
(ii) physiotherapy treatment or (iii) joint injection. These sorts of predictors are known as ‘treatment 
moderators’ and are useful for helping to subgroup patients to better target treatment based on an 
individual patient’s clinical profile, an approach often termed ‘stratified care’. 
 
The aim of my PhD is to address our current gap in knowledge and evidence 
regarding stratified care for musculoskeletal shoulder disorders. A systematic review 
has been conducted to identify the clinical factors already known to be ‘treatment 
moderators’. The next stage of the research plan is to gain consensus from clinical 
experts on the clinical factors which are felt to be useful for identifying patients who are 
likely to respond positively to these commonly used treatments and so, inform a future 
clinical decision-aid tool.  
 
I am writing to ask you, as an expert clinician in musculoskeletal shoulder disorders, if 
you would like to be involved with this research. Your involvement would require your 
attendance at two (or if unavailable for both, either of the) 2-hour evening consensus 
workshops, which are to begin in Keele in April 2013, and 10 minutes homework 
between workshops 1 and 2 (received via email). Further information about the study 
and what you will be required to do can be found in the enclosed information sheet.  
	
  
 
If you would like to be involved in this research or would like further information, please 
contact me at c.j.mcrobert@keele.ac.uk or on the telephone number below.  
 
Best wishes and kind regards, 
 
Cliona McRobert, Principal Investigator; Danielle van der Windt, Academic Supervisor 
 
e-mail: c.j.mcrobert@keele.ac.uk or telephone: 01782 734889 
e-mail: d.van.der.windt@keele.ac.uk or telephone: 01782 734830  
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Participant Information Sheet  
 
Study Title:  Musculoskeletal Shoulder Disorders: Which Treatment for 
Whom? 
 
Invitation 
You are being invited to consider taking part in the research study: Musculoskeletal Disorders: 
Which Treatment for Whom? This project is being undertaken by Cliona McRobert, a 
physiotherapist and PhD student within the Arthritis Research UK Primary Care Centre at 
Keele University who is under the academic supervision of Prof. Danielle van der Windt, Prof. 
Elaine Hay and Dr. Jonathan Hill. Before you decide whether or not you wish to take part, it is 
important for you to understand why this research is being done and what it will involve. 
Please take time to read this information carefully and ask us if there is anything that is unclear 
of if you would like more information. 
 
Aims of Research 
This study aims to progress existing knowledge on how patient attributes (e.g., pain, disability, 
age and gender) influence the clinical effectiveness of three commonly used treatment 
options: (i) advice & pain relief, (ii) physiotherapy, and (iii) joint injection in patients with 
shoulder disorders. Using the knowledge and experience of expert shoulder clinicians, we aim 
to identify the patient attributes agreed to potentially predict the response to specific treatment 
(i.e., moderators of clinical outcome) in musculoskeletal shoulder disorders, agreed levels of 
each patient attribute (e.g., patient-reported pain measured on a visual analogue scale may be 
understood in the three clinically sensible cut-offs: VAS 0-3, VAS 4-6, VAS 7-10) and agreed 
profiles of likely responders to individual treatments. This new information will be used to 
design an online survey of international expert shoulder clinicians in order to create patient 
profiles of likely optimal responders to these three commonly used treatments and later, inform 
a future clinical decision-aid tool.  
 
Why have I been invited to participate? 
You have been invited to take part because you have a recognised expertise or special 
interest in the assessment and treatment of musculoskeletal shoulder disorders. 
  
 
Do I have to take part? 
It is up to you to decide whether or not you take part.  If you decide to take part, you will be 
asked to attend two (or if unavailable for both, either of the) 2-hour consensus workshops,  
which we plan to organise outside your working hours in the evening, and do around 10 
minutes of homework between workshops 1 and 2, which will involve reading through the 
results of workshop 1 which will be sent to you. If you decided to take part, copies of the 
consent forms will be available for you to complete at each workshop. You will be free to 
withdraw at any time and without giving a reason. This decision will not affect you or your 
rights in any way.  You will be provided with a light meal and refreshments at each workshop.  
Any travel expenses that you incur as a result of your attendance at Keele for these 
workshops will also be reimbursed.   
 
What will happen if I take part? 
If you would like to take part please respond to this e-mail or contact Cliona McRobert at 
c.j.mcrobert@keele.ac.uk or leave a message at the telephone number below.  The principal 
investigator will then be in touch to arrange dates for you to attend two (or if unavailable for 
both, either of the) 2-hour consensus workshops at Keele where you will be asked to identify, 
discuss, and prioritise patient attributes which are felt to moderate the outcome of commonly 
used treatments in musculoskeletal shoulder disorders. 
 
What are the possible benefits (if any) of taking part? 
There are no direct benefits to you taking part in this study. However, we are hoping that the 
data collected from you and other expert clinicians will contribute to the improvement of 
treatment of musculoskeletal shoulder disorders in primary care. The results of the consensus 
workshops will be written up and submitted to peer-reviewed scientific journals and to relevant 
conferences. Your contribution will be acknowledged in the publication. 
 
What are the possible disadvantages of taking part? 
There are no major disadvantages to taking part other than attending the nominal group 
consensus workshops will take up to 4 hours of your time if you decide to attend both of the 2 
hour workshops (excluding travel), and you will be required to read through the results of 
workshop 1 prior to attendance at workshop 2, which should take no more than 10 minutes of 
your time.   
 
How will information about me be used? 
Information regarding your professional position, duration in clinical practice, age, gender, 
post-graduate qualification, and geographical region in which you work will recorded and 
  
combined with similar information from all other group members. Descriptive statistics will later 
be used to summarise and describe the make-up of the group of expert clinicians involved in 
each consensus workshop. All data collected during the consensus workshops will be audio-
recorded, analysed and reported anonymously.  
  
Who will have access to information about me? 
The use of any information that identifies you during the course of the research will be kept 
strictly confidential.  This information will be kept in a secure place (locked filing cupboard or 
password protected computer) and only people involved in the study or authorised individuals 
will have access to it. 
 
What happens when the research stops? 
Data obtained from each workshop will be analysed and participants will be notified of the 
results.   The output of the consensus workshops will be submitted for publication in a peer 
reviewed scientific journal and presented at a relevant conference. The output of the 
workshops will inform the design of an online survey of international expert clinicians. You will 
also be most welcome to partake in this online survey on international expert clinicians. 
Results from this survey will be subjected to further statistical analysis in order to identify 
predictors of treatment response in primary care patients with shoulder disorders, and define 
clinical profiles of patients who are likely to respond well to specific treatments. This work will 
then inform the design of future interventions studies.     
 
Who is funding and organising the research? 
Cliona McRobert is supported by the Arthritis Research UK Primary Care Centre at Keele 
University and is funded by NHS R&D funding for new Medical Schools. 
 
Who has reviewed this research? 
This study including the PhD as a whole in which this study is nested has undergone 
independent peer review by academic members of the Arthritis Research UK (ARUK) Primary 
Care Centre at Keele Univeristy. The scientific quality of this study has therefore been 
approved as part of the PhD development phase. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you may wish to speak to the researcher 
who will do her best to answer your questions. You should contact Cliona McRobert on 
c.j.mcrobert@keele.ac.uk. Alternatively, if you do not wish to contact the researcher you may 
contact Danielle van de Windt on danielle.van.der.windt@keele.ac.uk. If you remain unhappy 
about the research and/or wish to raise a complaint about any aspect of the way that you have 
  
been appraoched or treated during the course of the study, please write to Nicola Leighton 
who is the University’s contact for complaints regarding research at the following address: 
 
Nicola Leighton 
Research Governance Officer 
Research & Enterprise Building 
Dorothy Hodgkin Building 
Keele University 
ST5 5BG 
E-mail: n.leighton@keele.ac.uk 
 
 
Contact for further information 
If you would like any further information please contact: 
Cliona McRobert  e-mail: c.j.mcrobert@keele.ac.uk or telephone: 01782 734889 
Danielle van der Windt  e-mail: d.van.der.windt@keele.ac.uk or telephone: 01782 734830 
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CONSENT FORM 
Title of Project:  Musculoskeletal Shoulder Disorders: Which Treatment for 
Whom? 
Name and Contact Details of Principal Investigator: 
Cliona McRobert 
Arthritis Research UK Primary Care Centre, Primary Care Sciences 
Keele University 
Staffordshire, ST5 5BG 
Tel:  01782 734889 
Email: c.j.mcrobert@keele.ac.uk 
 
Please tick box if you agree with the statement 
I confirm that I have read and understand the information sheet for the above study and 
have had the opportunity to ask questions 
 
 
I understand that my participation is voluntary and that I am free to withdraw at any time  
I agree to take part in this study  
I understand that data collected about me during this study will be anonymised before 
submission for publication.  
I agree to the consensus workshop being audio recorded  
I agree to allow the dataset collected to be used for future research projects  
I agree to be contacted about possible participation in future research projects  
I agree for any quotes to be used anonymously  
I do not agree for any quotes to be used, even if anonymised  
I agree to keep the issues discussed in the workshop confidential and in particular, to 
avoid identifying any participant in relation to individual comments made during the 
session 
 
__________________ 
Name of participant 
____________ 
Date 
______________ 
Signature 
________________ 
Researcher 
____________ 
Date 
_____________ 
Signature 
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PARTICIPANT DESCRIPTIVES FORM 
 
 
Title of Project:  Musculoskeletal Shoulder Disorders: Which Treatment for 
Whom? 
Name and Contact Details of Principal Investigator: 
Cliona McRobert 
Arthritis Research UK Primary Care Centre, Primary Care Sciences 
Keele University 
Staffordshire, ST5 5BG 
Tel:  01782 734889 
Email: c.j.mcrobert@keele.ac.uk 
 
Please complete this table to help create an anonymous summary of this workshop’s 
participants. Please note that this data collection sheet will not be linked to your consent 
form.  
Clinical Speciality 
 
Are you currently 
involved in the clinical 
management of 
shoulder disorders? 
Yes No 
Which clinical 
management options 
do you routinely use 
for shoulder disorders? 
 
Education & Advice 
Pain Relief 
Physiotherapy  
Joint Injections  
Other 
(please specify) ……………………………………………………. 
Duration in clinical 
practice 
 
  
 
  
Post-graduate 
Qualifications 
 
Age  Gender Male Female 
Region in which you 
practice 
(Please circle) 
 
East East Midlands London North East 
North West Northern Ireland Scotland South East 
South West Wales West Midlands Yorkshire &  
The Humber 
  
Appendix 4: Ethical approval for consensus workshops 
  
              
Research and Enterprise Services, Keele University, Staffordshire, ST5 5BG, UK 
Telephone: + 44 (0)1782 734466   Fax: + 44 (0)1782 733740 
 
RESEARCH AND ENTERPRISE SERVICES 
 
 
7th November 2013 
 
Cliona McRobert 
Arthritis Research UK Primary Care Centre 
Primary Care 
David Weatherall Building 
Keele University 
 
Dear Cliona, 
 
Re: ‘Musculoskeletal shoulder treatments: Which treatment for whom?’ 
 
Thank you for submitting your application to amend study for review. 
 
I am pleased to inform you that your application has been approved by the Ethics Review Panel. 
 
The following documents have been reviewed and approved by the panel as follows: 
 
Document Version Date 
Summary Proposal 2 29/10/2013 
Supporting Documents 2 29/10/2013 
 
If the fieldwork goes beyond the date stated in your application you must notify the Ethical Review 
Panel via the ERP administrator at uso.erps@keele.ac.uk stating ERP2 in the subject line of the e-
mail. 
 
If there are any other amendments to your study you must submit an ‘application to amend study’ 
form to the ERP administrator stating ERP2 in the subject line of the e-mail.  This form is available via 
http://www.keele.ac.uk/researchsupport/researchethics/ 
 
If you have any queries, please do not hesitate to contact me via the ERP administrator on 
uso.erps@keele.ac.uk   stating ERP2 in the subject line of the e-mail. 
 
Yours sincerely 
 
Dr Bernadette Bartlam 
Chair – Ethical Review Panel 
 
CC  RI Manager 
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Psychosocial com
plexity 
 
-
Psychosocial com
plexity  
-
H
ealth literacy	
-
M
otivation	
-
C
om
pliance	
-
Self-efficacy	
-
Pain elsew
here	
-
Benefit/w
elfare concerns	
-
Socio-cultural issues	
-
Litigation pending	
-
R
eassurance re: diagnosis	
Previous treatm
ent response 
-
Previous response to corticosteroid 
injection 
-
Previous response to physiotherapy	
-
Previous response to education, advice 
and analgesia	
-
C
urrent response to analgesia	
-
Is analgesia already optim
ised?	
-
Incom
plete physiotherapy	
-
N
o. of previous injections	
Presentation 
-
W
eakness 
-
Pain : Stiffness 
-
Instability 
-
H
istory of injury 
-
N
o. of previous episodes 
Trajectory 
-
Sym
ptom
 duration 
-
Sym
ptom
 course 
D
iagnosis 
-
C
apsular pattern 
-
Painful arc 
-
R
esponse to physical 
test 
-
Im
aging results 
-
N
eck involvem
ent 
O
ver-use 
-
H
istory of overuse 
-
R
acket sports 
O
therw
ise Fit & W
ell 
-
O
therw
ise fit and 
w
ell 
-
C
om
orbidity 
(diabetes) 
-
Active 
inflam
m
atory 
process 
-
R
ed flags 
Functional Im
pact 
-
Im
pact on Q
uality of Life 
-
Im
pact on w
ork 
-
Im
pact on Sleep 
-
Functional deficit 
-
Affected lim
b dom
inance 
Patient treatm
ent preference 
-
Prefer corticosteroid injection 
-
Prefer physiotherapy	
-
Prefer education, advice and 
analgesia	
-
Em
ploym
ent Status	
Pain 
-
Pain location 
-
Pain intensity 
-
Pain severity 
-
Pain frequency 
-
Pain type 
A
ge 
-
Age 
Appendix 5: Edited results of categorisation exercise (Phase 1) 
  
Appendix 6: Orthogonal array for the conjoint analysis study 
  
  
1 Patient 
Attribute 1 1 Level 2 
Attribute 2 2 Level 2 
Attribute 3 Level 2 
Attribute 4 Level 1 
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Attribute 7 Level 1 
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Attribute 10 Level 1 
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Attribute 10 2 
Attribute 11 3 
Attribute 12 2 
  Choose one 
Treatment 1   
Treatment 2   
Treatment 3   
  21 Patient 
Attribute 1 2 
Attribute 2 2 
Attribute 3 2 
Attribute 4 1 
Attribute 5 1 
Attribute 6 1 
Attribute 7 2 
Attribute 8 2 
Attribute 9 2 
Attribute 10 2 
Attribute 11 2 
Attribute 12 3 
  Choose one 
Treatment 1   
  
Treatment 2   
Treatment 3   
  22 Patient 
Attribute 1 1 
Attribute 2 2 
Attribute 3 2 
Attribute 4 2 
Attribute 5 2 
Attribute 6 2 
Attribute 7 2 
Attribute 8 1 
Attribute 9 1 
Attribute 10 1 
Attribute 11 2 
Attribute 12 1 
  Choose one 
Treatment 1   
Treatment 2   
Treatment 3   
  23 Patient 
Attribute 1 2 
Attribute 2 1 
Attribute 3 2 
Attribute 4 2 
Attribute 5 2 
Attribute 6 1 
Attribute 7 1 
Attribute 8 2 
Attribute 9 1 
Attribute 10 1 
Attribute 11 3 
Attribute 12 3 
  Choose one 
Treatment 1   
Treatment 2   
Treatment 3   
  24 Patient 
Attribute 1 1 
Attribute 2 2 
Attribute 3 1 
Attribute 4 2 
Attribute 5 1 
Attribute 6 1 
Attribute 7 2 
  
Attribute 8 2 
Attribute 9 1 
Attribute 10 1 
Attribute 11 1 
Attribute 12 1 
  Choose one 
Treatment 1   
Treatment 2   
Treatment 3   
  25 Patient 
Attribute 1 2 
Attribute 2 1 
Attribute 3 1 
Attribute 4 2 
Attribute 5 1 
Attribute 6 2 
Attribute 7 2 
Attribute 8 1 
Attribute 9 2 
Attribute 10 2 
Attribute 11 1 
Attribute 12 2 
  Choose one 
Treatment 1   
Treatment 2   
Treatment 3   
  26 Patient 
Attribute 1 1 
Attribute 2 1 
Attribute 3 1 
Attribute 4 1 
Attribute 5 1 
Attribute 6 1 
Attribute 7 1 
Attribute 8 1 
Attribute 9 1 
Attribute 10 3 
Attribute 11 3 
Attribute 12 2 
  Choose one 
Treatment 1   
Treatment 2   
Treatment 3   
  
  
27 Patient 
Attribute 1 2 
Attribute 2 1 
Attribute 3 1 
Attribute 4 2 
Attribute 5 1 
Attribute 6 2 
Attribute 7 2 
Attribute 8 1 
Attribute 9 2 
Attribute 10 3 
Attribute 11 2 
Attribute 12 3 
  Choose one 
Treatment 1   
Treatment 2   
Treatment 3   
  28 Patient 
Attribute 1 1 
Attribute 2 2 
Attribute 3 1 
Attribute 4 1 
Attribute 5 2 
Attribute 6 2 
Attribute 7 1 
Attribute 8 2 
Attribute 9 2 
Attribute 10 3 
Attribute 11 1 
Attribute 12 2 
  Choose one 
Treatment 1   
Treatment 2   
Treatment 3   
  29 Patient 
Attribute 1 1 
Attribute 2 2 
Attribute 3 1 
Attribute 4 1 
Attribute 5 2 
Attribute 6 2 
Attribute 7 1 
Attribute 8 2 
Attribute 9 2 
Attribute 10 1 
  
Attribute 11 2 
Attribute 12 3 
  Choose one 
Treatment 1   
Treatment 2   
Treatment 3   
  30 Patient 
Attribute 1 1 
Attribute 2 1 
Attribute 3 2 
Attribute 4 1 
Attribute 5 2 
Attribute 6 1 
Attribute 7 2 
Attribute 8 1 
Attribute 9 2 
Attribute 10 3 
Attribute 11 3 
Attribute 12 3 
  Choose one 
Treatment 1   
Treatment 2   
Treatment 3   
  31 Patient 
Attribute 1 1 
Attribute 2 1 
Attribute 3 2 
Attribute 4 1 
Attribute 5 2 
Attribute 6 1 
Attribute 7 2 
Attribute 8 1 
Attribute 9 2 
Attribute 10 1 
Attribute 11 1 
Attribute 12 1 
  Choose one 
Treatment 1   
Treatment 2   
Treatment 3   
  32 Patient 
Attribute 1 2 
Attribute 2 1 
Attribute 3 1 
  
Attribute 4 1 
Attribute 5 2 
Attribute 6 2 
Attribute 7 2 
Attribute 8 2 
Attribute 9 1 
Attribute 10 2 
Attribute 11 3 
Attribute 12 3 
  Choose one 
Treatment 1   
Treatment 2   
Treatment 3   
  33 Patient 
Attribute 1 1 
Attribute 2 2 
Attribute 3 1 
Attribute 4 1 
Attribute 5 2 
Attribute 6 2 
Attribute 7 1 
Attribute 8 2 
Attribute 9 2 
Attribute 10 2 
Attribute 11 3 
Attribute 12 1 
  Choose one 
Treatment 1   
Treatment 2   
Treatment 3   
  34 Patient 
Attribute 1 2 
Attribute 2 1 
Attribute 3 1 
Attribute 4 1 
Attribute 5 2 
Attribute 6 2 
Attribute 7 2 
Attribute 8 2 
Attribute 9 1 
Attribute 10 1 
Attribute 11 2 
Attribute 12 2 
  Choose one 
Treatment 1   
  
Treatment 2   
Treatment 3   
  35 Patient 
Attribute 1 2 
Attribute 2 2 
Attribute 3 2 
Attribute 4 1 
Attribute 5 1 
Attribute 6 2 
Attribute 7 1 
Attribute 8 1 
Attribute 9 1 
Attribute 10 3 
Attribute 11 1 
Attribute 12 2 
  Choose one 
Treatment 1   
Treatment 2   
Treatment 3   
  36 Patient 
Attribute 1 2 
Attribute 2 2 
Attribute 3 2 
Attribute 4 1 
Attribute 5 1 
Attribute 6 1 
Attribute 7 2 
Attribute 8 2 
Attribute 9 2 
Attribute 10 3 
Attribute 11 3 
Attribute 12 1 
  Choose one 
Treatment 1   
Treatment 2   
Treatment 3   
  
  
Appendix 7: Decision tasks for the conjoint analysis study 
  
  
1 Patient 
 General health status Unstable diabetes and/or cardiac issues 2 
Current Clinical Status Condition not improving 2 
Functional and/or work impact No significant impact on work/activities 2 
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Traumatic onset 1 
Over-use linked to work, sport, or hobbies No over-use 2 
Instability and/or weakness Significant instability and/or weakness 1 
Psychosocial issues Psychosocial issues 1 
Neck involvement Con-comittant neck pain 1 
Previous response to treatment No previous physiotherapy or steroid injection 1 
Patient treatment preference Patient treatment preference for steroid injection 2 
Pain Severity High pain 3 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   2 Patient 
 General health status Otherwise fit & well 1 
Current Clinical Status Condition improving 1 
Functional and/or work impact Significant impact on activities/work 1 
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Traumatic onset 1 
Over-use linked to work, sport, or hobbies Over-use linked to work, sport or hobbies 1 
Instability and/or weakness Significant instability and/or weakness 1 
Psychosocial issues Psychosocial issues 1 
  
Neck involvement Con-comittant neck pain 1 
Previous response to treatment Previous positive response to steroid injection 2 
Patient treatment preference Patient treatment preference for steroid injection 2 
Pain Severity Low pain 1 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   3 Patient 
 General health status Unstable diabetes and/or cardiac issues 2 
Current Clinical Status Condition not improving 2 
Functional and/or work impact Significant impact on activities/work 1 
Sleep Disturbance No significant sleep disturbance due to shoulder 2 
Onset Non-traumatic onset 2 
Over-use linked to work, sport, or hobbies Over-use linked to work, sport or hobbies 1 
Instability and/or weakness Significant instability and/or weakness 1 
Psychosocial issues Psychosocial issues 1 
Neck involvement No neck pain 2 
Previous response to treatment Previous positive response to steroid injection 2 
Patient treatment preference No patient treatment preference 1 
Pain Severity High pain 3 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   4 Patient 
 
  
General health status Unstable diabetes and/or cardiac issues 2 
Current Clinical Status Condition improving 1 
Functional and/or work impact No significant impact on work/activities 2 
Sleep Disturbance No significant sleep disturbance due to shoulder 2 
Onset Non-traumatic onset 2 
Over-use linked to work, sport, or hobbies Over-use linked to work, sport or hobbies 1 
Instability and/or weakness Significant instability and/or weakness 1 
Psychosocial issues No psychosocial issues 2 
Neck involvement Con-comittant neck pain 1 
Previous response to treatment Previous positive response to physiotherapy  3 
Patient treatment preference Patient treatment preference for steroid injection 2 
Pain Severity Moderate pain 2 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   5 Patient 
 General health status Otherwise fit & well 1 
Current Clinical Status Condition not improving 2 
Functional and/or work impact Significant impact on activities/work 1 
Sleep Disturbance No significant sleep disturbance due to shoulder 2 
Onset Traumatic onset 1 
Over-use linked to work, sport, or hobbies Over-use linked to work, sport or hobbies 1 
Instability and/or weakness No significant instability or weakness 2 
Psychosocial issues No psychosocial issues 2 
Neck involvement Con-comittant neck pain 1 
  
Previous response to treatment Previous positive response to steroid injection 2 
Patient treatment preference Patient treatment preference for steroid injection 2 
Pain Severity Moderate pain 2 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   6 Patient 
 General health status Unstable diabetes and/or cardiac issues 2 
Current Clinical Status Condition not improving 2 
Functional and/or work impact Significant impact on activities/work 1 
Sleep Disturbance No significant sleep disturbance due to shoulder 2 
Onset Non-traumatic onset 2 
Over-use linked to work, sport, or hobbies Over-use linked to work, sport or hobbies 1 
Instability and/or weakness Significant instability and/or weakness 1 
Psychosocial issues Psychosocial issues 1 
Neck involvement No neck pain 2 
Previous response to treatment Previous positive response to physiotherapy  3 
Patient treatment preference Patient treatment preference for steroid injection 2 
Pain Severity Low pain 1 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   7 Patient 
 General health status Otherwise fit & well 1 
  
Current Clinical Status Condition improving 1 
Functional and/or work impact No significant impact on work/activities 2 
Sleep Disturbance No significant sleep disturbance due to shoulder 2 
Onset Traumatic onset 1 
Over-use linked to work, sport, or hobbies No over-use 2 
Instability and/or weakness Significant instability and/or weakness 1 
Psychosocial issues No psychosocial issues 2 
Neck involvement No neck pain 2 
Previous response to treatment Previous positive response to physiotherapy  3 
Patient treatment preference Patient treatment preference for steroid injection 2 
Pain Severity Low pain 1 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   8 Patient 
 General health status Unstable diabetes and/or cardiac issues 2 
Current Clinical Status Condition improving 1 
Functional and/or work impact Significant impact on activities/work 1 
Sleep Disturbance No significant sleep disturbance due to shoulder 2 
Onset Traumatic onset 1 
Over-use linked to work, sport, or hobbies No over-use 2 
Instability and/or weakness No significant instability or weakness 2 
Psychosocial issues Psychosocial issues 1 
Neck involvement No neck pain 2 
Previous response to treatment No previous physiotherapy or steroid injection 1 
  
Patient treatment preference Patient treatment preference for physiotherapy 3 
Pain Severity Low pain 1 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   9 Patient 
 General health status Otherwise fit & well 1 
Current Clinical Status Condition improving 1 
Functional and/or work impact Significant impact on activities/work 1 
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Traumatic onset 1 
Over-use linked to work, sport, or hobbies Over-use linked to work, sport or hobbies 1 
Instability and/or weakness Significant instability and/or weakness 1 
Psychosocial issues Psychosocial issues 1 
Neck involvement Con-comittant neck pain 1 
Previous response to treatment No previous physiotherapy or steroid injection 1 
Patient treatment preference No patient treatment preference 1 
Pain Severity Low pain 1 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   10 Patient 
 General health status Unstable diabetes and/or cardiac issues 2 
Current Clinical Status Condition not improving 2 
  
Functional and/or work impact No significant impact on work/activities 2 
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Traumatic onset 1 
Over-use linked to work, sport, or hobbies No over-use 2 
Instability and/or weakness Significant instability and/or weakness 1 
Psychosocial issues Psychosocial issues 1 
Neck involvement Con-comittant neck pain 1 
Previous response to treatment Previous positive response to steroid injection 2 
Patient treatment preference Patient treatment preference for physiotherapy 3 
Pain Severity Low pain 1 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   11 Patient 
 General health status Otherwise fit & well 1 
Current Clinical Status Condition improving 1 
Functional and/or work impact No significant impact on work/activities 2 
Sleep Disturbance No significant sleep disturbance due to shoulder 2 
Onset Traumatic onset 1 
Over-use linked to work, sport, or hobbies No over-use 2 
Instability and/or weakness Significant instability and/or weakness 1 
Psychosocial issues No psychosocial issues 2 
Neck involvement No neck pain 2 
Previous response to treatment No previous physiotherapy or steroid injection 1 
Patient treatment preference Patient treatment preference for physiotherapy 3 
  
Pain Severity Moderate pain 2 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   12 Patient 
 General health status Unstable diabetes and/or cardiac issues 2 
Current Clinical Status Condition improving 1 
Functional and/or work impact Significant impact on activities/work 1 
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Non-traumatic onset 2 
Over-use linked to work, sport, or hobbies No over-use 2 
Instability and/or weakness No significant instability or weakness 2 
Psychosocial issues No psychosocial issues 2 
Neck involvement Con-comittant neck pain 1 
Previous response to treatment Previous positive response to physiotherapy  3 
Patient treatment preference No patient treatment preference 1 
Pain Severity Low pain 1 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   13 Patient 
 General health status Unstable diabetes and/or cardiac issues 2 
Current Clinical Status Condition not improving 2 
Functional and/or work impact No significant impact on work/activities 2 
  
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Traumatic onset 1 
Over-use linked to work, sport, or hobbies Over-use linked to work, sport or hobbies 1 
Instability and/or weakness No significant instability or weakness 2 
Psychosocial issues No psychosocial issues 2 
Neck involvement No neck pain 2 
Previous response to treatment No previous physiotherapy or steroid injection 1 
Patient treatment preference No patient treatment preference 1 
Pain Severity Moderate pain 2 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   14 Patient 
 General health status Otherwise fit & well 1 
Current Clinical Status Condition improving 1 
Functional and/or work impact No significant impact on work/activities 2 
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Non-traumatic onset 2 
Over-use linked to work, sport, or hobbies Over-use linked to work, sport or hobbies 1 
Instability and/or weakness No significant instability or weakness 2 
Psychosocial issues Psychosocial issues 1 
Neck involvement No neck pain 2 
Previous response to treatment Previous positive response to steroid injection 2 
Patient treatment preference Patient treatment preference for steroid injection 2 
Pain Severity Moderate pain 2 
  
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   15 Patient 
 General health status Unstable diabetes and/or cardiac issues 2 
Current Clinical Status Condition not improving 2 
Functional and/or work impact Significant impact on activities/work 1 
Sleep Disturbance No significant sleep disturbance due to shoulder 2 
Onset Non-traumatic onset 2 
Over-use linked to work, sport, or hobbies Over-use linked to work, sport or hobbies 1 
Instability and/or weakness Significant instability and/or weakness 1 
Psychosocial issues Psychosocial issues 1 
Neck involvement No neck pain 2 
Previous response to treatment No previous physiotherapy or steroid injection 1 
Patient treatment preference Patient treatment preference for physiotherapy 3 
Pain Severity Moderate pain 2 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   16 Patient 
 General health status Unstable diabetes and/or cardiac issues 2 
Current Clinical Status Condition not improving 2 
Functional and/or work impact No significant impact on work/activities 2 
Sleep Disturbance No significant sleep disturbance due to shoulder 2 
  
Onset Non-traumatic onset 2 
Over-use linked to work, sport, or hobbies No over-use 2 
Instability and/or weakness No significant instability or weakness 2 
Psychosocial issues No psychosocial issues 2 
Neck involvement No neck pain 2 
Previous response to treatment Previous positive response to steroid injection 2 
Patient treatment preference Patient treatment preference for steroid injection 2 
Pain Severity Moderate pain 2 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   17 Patient 
 General health status Otherwise fit & well 1 
Current Clinical Status Condition improving 1 
Functional and/or work impact Significant impact on activities/work 1 
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Traumatic onset 1 
Over-use linked to work, sport, or hobbies Over-use linked to work, sport or hobbies 1 
Instability and/or weakness Significant instability and/or weakness 1 
Psychosocial issues Psychosocial issues 1 
Neck involvement Con-comittant neck pain 1 
Previous response to treatment No previous physiotherapy or steroid injection 1 
Patient treatment preference No patient treatment preference 1 
Pain Severity High pain 3 
  Choose one 
 
  
Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   18 Patient 
 General health status Otherwise fit & well 1 
Current Clinical Status Condition not improving 2 
Functional and/or work impact No significant impact on work/activities 2 
Sleep Disturbance No significant sleep disturbance due to shoulder 2 
Onset Non-traumatic onset 2 
Over-use linked to work, sport, or hobbies No over-use 2 
Instability and/or weakness No significant instability or weakness 2 
Psychosocial issues Psychosocial issues 1 
Neck involvement Con-comittant neck pain 1 
Previous response to treatment Previous positive response to physiotherapy  3 
Patient treatment preference No patient treatment preference 1 
Pain Severity High pain 3 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   19 Patient 
 General health status Otherwise fit & well 1 
Current Clinical Status Condition improving 1 
Functional and/or work impact No significant impact on work/activities 2 
Sleep Disturbance No significant sleep disturbance due to shoulder 2 
Onset Traumatic onset 1 
  
Over-use linked to work, sport, or hobbies No over-use 2 
Instability and/or weakness Significant instability and/or weakness 1 
Psychosocial issues No psychosocial issues 2 
Neck involvement No neck pain 2 
Previous response to treatment Previous positive response to steroid injection 2 
Patient treatment preference No patient treatment preference 1 
Pain Severity High pain 3 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   20 Patient 
 General health status Otherwise fit & well 1 
Current Clinical Status Condition not improving 2 
Functional and/or work impact No significant impact on work/activities 2 
Sleep Disturbance No significant sleep disturbance due to shoulder 2 
Onset Non-traumatic onset 2 
Over-use linked to work, sport, or hobbies No over-use 2 
Instability and/or weakness No significant instability or weakness 2 
Psychosocial issues Psychosocial issues 1 
Neck involvement Con-comittant neck pain 1 
Previous response to treatment Previous positive response to steroid injection 2 
Patient treatment preference Patient treatment preference for physiotherapy 3 
Pain Severity Moderate pain 2 
  Choose one 
 Physiotherapy   
 
  
Steroid Injection   
 Education, Advice & Pain Relief   
 
   21 Patient 
 General health status Unstable diabetes and/or cardiac issues 2 
Current Clinical Status Condition not improving 2 
Functional and/or work impact No significant impact on work/activities 2 
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Traumatic onset 1 
Over-use linked to work, sport, or hobbies Over-use linked to work, sport or hobbies 1 
Instability and/or weakness No significant instability or weakness 2 
Psychosocial issues No psychosocial issues 2 
Neck involvement No neck pain 2 
Previous response to treatment Previous positive response to steroid injection 2 
Patient treatment preference Patient treatment preference for steroid injection 2 
Pain Severity High pain 3 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   22 Patient 
 General health status Otherwise fit & well 1 
Current Clinical Status Condition not improving 2 
Functional and/or work impact No significant impact on work/activities 2 
Sleep Disturbance No significant sleep disturbance due to shoulder 2 
Onset Non-traumatic onset 2 
Over-use linked to work, sport, or hobbies No over-use 2 
  
Instability and/or weakness No significant instability or weakness 2 
Psychosocial issues Psychosocial issues 1 
Neck involvement Con-comittant neck pain 1 
Previous response to treatment No previous physiotherapy or steroid injection 1 
Patient treatment preference Patient treatment preference for steroid injection 2 
Pain Severity Low pain 1 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   23 Patient 
 General health status Unstable diabetes and/or cardiac issues 2 
Current Clinical Status Condition improving 1 
Functional and/or work impact No significant impact on work/activities 2 
Sleep Disturbance No significant sleep disturbance due to shoulder 2 
Onset Non-traumatic onset 2 
Over-use linked to work, sport, or hobbies Over-use linked to work, sport or hobbies 1 
Instability and/or weakness Significant instability and/or weakness 1 
Psychosocial issues No significant instability or weakness 2 
Neck involvement Con-comittant neck pain 1 
Previous response to treatment No previous physiotherapy or steroid injection 1 
Patient treatment preference Patient treatment preference for physiotherapy 3 
Pain Severity High pain 3 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 
  
Education, Advice & Pain Relief   
 
   24 Patient 
 General health status Otherwise fit & well 1 
Current Clinical Status Condition not improving 2 
Functional and/or work impact Significant impact on activities/work 1 
Sleep Disturbance No significant sleep disturbance due to shoulder 2 
Onset Traumatic onset 1 
Over-use linked to work, sport, or hobbies Over-use linked to work, sport or hobbies 1 
Instability and/or weakness No significant instability or weakness 2 
Psychosocial issues No psychosocial issues 2 
Neck involvement Con-comittant neck pain 1 
Previous response to treatment No previous physiotherapy or steroid injection 1 
Patient treatment preference No patient treatment preference 1 
Pain Severity Low pain 1 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   25 Patient 
 General health status Unstable diabetes and/or cardiac issues 2 
Current Clinical Status Condition improving 1 
Functional and/or work impact Significant impact on activities/work 1 
Sleep Disturbance No significant sleep disturbance due to shoulder 2 
Onset Traumatic onset 1 
Over-use linked to work, sport, or hobbies No over-use 2 
Instability and/or weakness No significant instability or weakness 2 
  
Psychosocial issues Psychosocial issues 1 
Neck involvement No neck pain 2 
Previous response to treatment Previous positive response to steroid injection 2 
Patient treatment preference No patient treatment preference 1 
Pain Severity Moderate pain 2 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   26 Patient 
 General health status Otherwise fit & well 1 
Current Clinical Status Condition improving 1 
Functional and/or work impact Significant impact on activities/work 1 
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Traumatic onset 1 
Over-use linked to work, sport, or hobbies Over-use linked to work, sport or hobbies 1 
Instability and/or weakness Significant instability and/or weakness 1 
Psychosocial issues Psychosocial issues 1 
Neck involvement Con-comittant neck pain 1 
Previous response to treatment Previous positive response to physiotherapy  3 
Patient treatment preference Patient treatment preference for physiotherapy 3 
Pain Severity Moderate pain 2 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   
  
27 Patient 
 General health status Unstable diabetes and/or cardiac issues 2 
Current Clinical Status Condition improving 1 
Functional and/or work impact Significant impact on activities/work 1 
Sleep Disturbance No significant sleep disturbance due to shoulder 2 
Onset Traumatic onset 1 
Over-use linked to work, sport, or hobbies No over-use 2 
Instability and/or weakness No significant instability or weakness 2 
Psychosocial issues Psychosocial issues 1 
Neck involvement No neck pain 2 
Previous response to treatment Previous positive response to physiotherapy  3 
Patient treatment preference Patient treatment preference for steroid injection 2 
Pain Severity High pain 3 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   28 Patient 
 General health status Otherwise fit & well 1 
Current Clinical Status Condition not improving 2 
Functional and/or work impact Significant impact on activities/work 1 
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Non-traumatic onset 2 
Over-use linked to work, sport, or hobbies No over-use 2 
Instability and/or weakness Significant instability and/or weakness 1 
Psychosocial issues No psychosocial issues 2 
  
Neck involvement No neck pain 2 
Previous response to treatment Previous positive response to physiotherapy  3 
Patient treatment preference No patient treatment preference 1 
Pain Severity Moderate pain 2 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   29 Patient 
 General health status Otherwise fit & well 1 
Current Clinical Status Condition not improving 2 
Functional and/or work impact Significant impact on activities/work 1 
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Non-traumatic onset 2 
Over-use linked to work, sport, or hobbies No over-use 2 
Instability and/or weakness Significant instability and/or weakness 1 
Psychosocial issues No psychosocial issues 2 
Neck involvement No neck pain 2 
Previous response to treatment No previous physiotherapy or steroid injection 1 
Patient treatment preference Patient treatment preference for steroid injection 2 
Pain Severity High pain 3 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   30 Patient 
 
  
General health status Otherwise fit & well 1 
Current Clinical Status Condition improving 1 
Functional and/or work impact No significant impact on work/activities 2 
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Non-traumatic onset 2 
Over-use linked to work, sport, or hobbies Over-use linked to work, sport or hobbies 1 
Instability and/or weakness No significant instability or weakness 2 
Psychosocial issues Psychosocial issues 1 
Neck involvement No neck pain 2 
Previous response to treatment Previous positive response to physiotherapy  3 
Patient treatment preference Patient treatment preference for physiotherapy 3 
Pain Severity High pain 3 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   31 Patient 
 General health status Otherwise fit & well 1 
Current Clinical Status Condition improving 1 
Functional and/or work impact No significant impact on work/activities 2 
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Non-traumatic onset 2 
Over-use linked to work, sport, or hobbies Over-use linked to work, sport or hobbies 1 
Instability and/or weakness No significant instability or weakness 2 
Psychosocial issues Psychosocial issues 1 
Neck involvement No neck pain 2 
  
Previous response to treatment No previous physiotherapy or steroid injection 1 
Patient treatment preference No patient treatment preference 1 
Pain Severity Low pain 1 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   32 Patient 
 General health status Unstable diabetes and/or cardiac issues 2 
Current Clinical Status Condition improving 1 
Functional and/or work impact Significant impact on activities/work 1 
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Non-traumatic onset 2 
Over-use linked to work, sport, or hobbies No over-use 2 
Instability and/or weakness No significant instability or weakness 2 
Psychosocial issues No psychosocial issues 2 
Neck involvement Con-comittant neck pain 1 
Previous response to treatment Previous positive response to steroid injection 2 
Patient treatment preference Patient treatment preference for physiotherapy 3 
Pain Severity High pain 3 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   33 Patient 
 General health status Otherwise fit & well 1 
  
Current Clinical Status Condition not improving 2 
Functional and/or work impact Significant impact on activities/work 1 
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Non-traumatic onset 2 
Over-use linked to work, sport, or hobbies No over-use 2 
Instability and/or weakness Significant instability and/or weakness 1 
Psychosocial issues No psychosocial issues 2 
Neck involvement No neck pain 2 
Previous response to treatment Previous positive response to steroid injection 2 
Patient treatment preference Patient treatment preference for physiotherapy 3 
Pain Severity Low pain 1 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   34 Patient 
 General health status Unstable diabetes and/or cardiac issues 2 
Current Clinical Status Condition improving 1 
Functional and/or work impact Significant impact on activities/work 1 
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Non-traumatic onset 2 
Over-use linked to work, sport, or hobbies No over-use 2 
Instability and/or weakness No significant instability or weakness 2 
Psychosocial issues No psychosocial issues 2 
Neck involvement Con-comittant neck pain 1 
Previous response to treatment No previous physiotherapy or steroid injection 1 
  
Patient treatment preference Patient treatment preference for steroid injection 2 
Pain Severity Moderate pain 2 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   35 Patient 
 General health status Unstable diabetes and/or cardiac issues 2 
Current Clinical Status Condition not improving 2 
Functional and/or work impact No significant impact on work/activities 2 
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Traumatic onset 1 
Over-use linked to work, sport, or hobbies No over-use 2 
Instability and/or weakness Significant instability and/or weakness 1 
Psychosocial issues Psychosocial issues 1 
Neck involvement Con-comittant neck pain 1 
Previous response to treatment Previous positive response to physiotherapy  3 
Patient treatment preference No patient treatment preference 1 
Pain Severity Moderate pain 2 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
   36 Patient 
 General health status Unstable diabetes and/or cardiac issues 2 
Current Clinical Status Condition not improving 2 
  
Functional and/or work impact No significant impact on work/activities 2 
Sleep Disturbance Significant sleep disturbance due to shoulder 1 
Onset Traumatic onset 1 
Over-use linked to work, sport, or hobbies Over-use linked to work, sport or hobbies 1 
Instability and/or weakness No significant instability or weakness 2 
Psychosocial issues No psychosocial issues 2 
Neck involvement No neck pain 2 
Previous response to treatment Previous positive response to physiotherapy  3 
Patient treatment preference Patient treatment preference for physiotherapy 3 
Pain Severity Low pain 1 
  Choose one 
 Physiotherapy   
 Steroid Injection   
 Education, Advice & Pain Relief   
 
    
 
  
 
 
 
 
 
 
Appendix 8: Paper version of the conjoint analysis study 
 
Cliona McRobert, Survey Paper Version V2.0 – 30.01.15 
 
 
1 
Page 1 Welcome 
Thank you for joining this survey. 
We are seeking the views of clinicians who treat or are involved in the care of 
patients with musculoskeletal shoulder disorders as part of their practice. 
This survey should take no more than 20 minutes of your time to complete. 
Please read the participant information sheet by clicking here (electronic link to 
participant invitation & information sheet) (may be found as a separate document) 
If you have any questions about this survey or the study in general, you can email 
Cliona McRobert at c.j.mcrobert@keele.ac.uk. 
Instructions for completing this survey 
When completing this survey, please remember that there are no ‘correct’ or 
‘incorrect’ answers.  
Please try to provide answers that most accurately reflect your usual clinical practice.  
Please do not consult any literature or other resources while completing this survey.  
This survey has been designed by Cliona McRobert, a musculoskeletal 
physiotherapist and PhD student at the Arthritis Research UK Primary Care Centre 
at Keele University, UK, along with Prof. Danielle van der Windt, Prof. Elaine Hay 
and Dr. Jonathan Hill of Keele University and Prof. John F.P. Bridges of Johns 
Hopkins University Bloomberg School of Public Health, US. 
Survey web page design and database programming conducted by Tim Smale, 
Keele University. 
Inclusion Criteria & Consent 
I	am	a	qualified	health	or	medical	practitioners,	clinical	academic	or	academic	(including	but	not	
limited	to	physiotherapists,	general	practitioners	(GPs),	rheumatologists	and	orthopaedic	surgeons)	
who	(INSERT	TICK	BOX)	
I	clinically	manage	or	have	a	clinical	or	research	interest	in	patients	with	musculoskeletal	shoulder	
disorders	as	part	of	their	normal	clinical	practice	(INSERT	TICK	BOX)	
I	can	read	and	write	English	(INSERT	TICK	BOX)	
I	have	read	the	information	sheet,	understand	the	instructions	and	I	consent	to	taking	part	in	the	
survey	(INSERT	TICK	BOX)	
 
Cliona McRobert, Survey Paper Version V2.0 – 30.01.15 
 
 
2 
 
 
Page 2 Unique Identifier Number 
 
Please find below your unique identifier number. This number relates to your responses 
in this survey. Please write it down, take a screen shot or enter your email address 
below to receive an automated email containing your unique identifier number.  
----(unique identifier number here)---- 
Enter your email address here to receive an email containing your unique identifier 
number (Box for email address) 
Please use this number if you are unable to complete the survey all in one sitting and 
would like to save your responses and return to complete the survey later. You may do 
this at any time by pressing the ‘Save responses and return to survey later’ button. 
If you decide after completing the survey that you wish to withdraw from the study, 
please contact the lead researcher at c.j.mcrobert@keele.ac.uk quoting your unique 
identifier number and your responses will be removed from the database.  
 
Page 3 Please tell us about you... 
 
This information will in no way identify you or your responses. 
All responses are strictly confidential. 
 
Please select your professional background: 
Physiotherapist/Physical Therapist 
General Practitioner/Family Doctor/ Primary Care Medical Physician 
Rheumatologist 
Orthopaedic Surgeon 
Other (please state below) 
……………………………………….. 
 
Have you completed any post-graduate training specific to the management of 
musculoskeletal shoulder disorders? 
Yes - Please detail below  
Cliona McRobert, Survey Paper Version V2.0 – 30.01.15 
 
 
3 
No 
………………………………………. 
 
In which country do you practice clinically? 
United Kingdom 
Republic of Ireland 
The Netherlands 
Australia 
New Zealand 
Norway 
Sweden 
USA 
Canada 
Other (please state below) 
…………………………………….. 
How many years clinical experience do you have? 
… years 
 
What percentage of your current clinical work is funded by the 
state/government/complulsory health insurance? (Examples of state/government 
funded healthcare include: UK - National Health Service (NHS) and Republic of 
Ireland- Health Service Executive (HSE) and examples of compulsory health 
insurance funded healthcare systems include the Netherlands, Germany and 
Switzerland) 
…% 
 
What percentage of your current clinical role involves treating patients with 
musculoskeletal shoulder disorders? 
…% 
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Please estimate the proportion of patients with shoulder pain that you 
provide/recommend/refer to each of the below treatments: 
…% 
 
 
Pain medication prescription & advice (radio check boxes for each response) 
All patients  
Most patients  
Some patients  
Few patients  
No patients  
 
Steroid injection & advice (radio check boxes for each response) 
All patients  
Most patients  
Some patients  
Few patients  
No patients  
 
Physiotherapy (radio check boxes for each response) 
All patients  
Most patients  
Some patients  
Few patients  
No patients 
 
Save	responses	now	and	return	to	survey	later 
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Page 4 Study Background 
 
The next pages will present 12 hypothetical patient profiles. 
 
These profiles contain 12 patient attributes suggested by research on UK shoulder clinicians 
as highly relevant to treatment decision-making: 
•General health status 
•Previous response to treatment 
•Current clinical status (improving or not) 
•Patient treatment preference 
•Functional and/or work impact 
•Sleep disturbance 
•Traumatic onset 
•Over-use linked to sport, hobbies or work 
•Instability and/or weakness 
•Psychosocial issues 
•Neck involvement 
•Pain severity 
 
Imagine that all three treatment options are available to each patient. 
 
Of the three treatment approaches below, select a treatment recommendation that you feel is 
the single most clinically effective and cost effective treatment for each patient. 
•Pain medication prescription & advice (Prescription of pain and/or anti-inflammatory 
medication & general advice) 
•Steroid injection & advice (Steroid injection dosage and technique tailored to patient need & 
advice) 
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•Physiotherapy (Assessment by an appropriately skilled physiotherapy/physical therapy 
practitioner followed by a course of evidence-based exercise and/or manual therapies) 
 
These hypothetical patient profiles may not always make perfect clinical sense as they have 
been created using systematically varied combinations of patient attributes. Try to use your 
best clinical judgement to make a treatment recommendation for each of the profiles. 
 
This survey has been designed using conjoint analysis, therefore only the patient attributes 
being studied by the research team have been included in the patient profiles. The tasks you 
will see replicate clinical decision scenarios but are not designed to be a complete case 
history. We would appreciate if you answered the questions in this survey using solely the 
information provided. Please assume that ALL other clinical information is EQUAL across 
the profiles. If you feel strongly that a relevant clinical detail is missing, please write it down 
as we would like you to share it with us at the end of the survey. 
 
Before you begin, please be assured that this is not a test of your clinical knowledge and that 
we sincerely appreciate your valuable input into this research. 
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Page 5  Pick a Treatment 
Patient 1 
Imagine that this patient with a unilateral musculoskeletal shoulder disorder presents 
to you in clinical practice. 
Here is their case description: 
•Non-traumatic onset 
•Condition not improving 
•Moderate pain severity 
•Significant sleep disturbance due to shoulder 
•Significant impact on activities/work 
•No psychosocial issues identified 
•No over-use linked to sport hobbies or work 
•No neck pain 
•Significant instability and/or weakness 
•No patient treatment preference 
•Otherwise fit & well 
•Previous positive response to physiotherapy  
 
Imagine that all three of these treatment options are available. 
Please make a treatment recommendation for this patient (radio check boxes by 
each response): 
 
Pain medication prescription & advice (Prescription of pain and/or anti-inflammatory 
medication & general advice)  
Steroid injection & advice (Steroid injection dosage and technique tailored to patient 
need & advice)  
Physiotherapy (Assessment by an appropriately skilled physiotherapy/physical 
therapy practitioner followed by a course of evidence-based exercise and/or manual 
therapies) 
Cliona McRobert, Survey Paper Version V2.0 – 30.01.15 
 
 
8 
Please remember that these hypothetical patient profiles may not always make 
perfect clinical sense as they have been created using systematically varied 
combinations of patient attributes. Try to use your best clinical judgment to select 
your treatment recommendation for each of the profiles. 
 
 
 
 
 
(Each respondent will view 12 randomly ordered clinical cases. Each case will be 
presented in this way with only the clinical attributes varying between cases) 
 
Page 16  Final Questions  
 
Considering the clinical decisions you have just made in the previous tasks, please 
answer the following questions: 
(presented in a table format with 5 response options across the top from left to right: 
Strongly Agree, Agree, Neither Agree Or Disagree, Disagree & Strongly Disagree) 
 
1 - The decisions were hard to make       
2 - I was unsure about which treatment would really be best for each patient       
3 - It was clear which treatment would be best for each patient       
4 - When I made the decisions, I felt that I did not know enough about the treatment 
alternatives       
5 - I had trouble making the decisions because important information was unknown       
6 - When I made the decisions, it was hard to decide if the benefits of the treatment 
were more important than the risks       
7 - All considerations that affected the decision were identified       
8 - I understood the patients’ views when I made these decisions       
Save	responses	now	and	return	to	survey	later 
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9 - I believe that patients would fully understand the risks and benefits of the 
prescribed treatments       
10 - I believe that patients would comply with the prescribed treatment       
11 - I am satisfied with the decisions I have made       
12 - I am satisfied that the process (i.e., survey design) used to make the decisions 
was as good as it could be       
13 - If asked again, I would expect to stick with my decisions       
 
 
Page 16  Your responses have been submitted 
 
Thank you for your time. 
If you have any questions about this survey, the study in general or would like to 
hear about the results, you can email Cliona McRobert at c.j.mcrobert@keele.ac.uk. 
 
Your responses are extremely valuable to us. We are looking for an international 
sample of physiotherapists/physical therapists, general practitioners/family doctors, 
rheumatologists and orthopaedic surgeons. Do you know any other clinicians who 
might be able to help with this survey? Please distribute this survey widely. 
 
Tweet about this survey (link out to twitter with suggested tweet): 
“Shoulder clinicians required for brief online international research survey: 
http://goo.gl/Zo4K7X #shoulders #StratifiedCare PLS RT” 
Facebook share and Google+ share options also. 
Save	responses	now	and	return	to	survey	later 
Appendix 9: Twitter targetted recruitment list 
Social Media Strategy 
 
A) Twitter 
 
Used application called Followerwonk, to access google analytics. 
Analysis 1: cliona311 // analyse people I follow 
 
 
Send tweet to the people I follow with Highest Social Authority (According to Follower 
Wonk): 
Adam Meakins 
AM Cunningham 
RCGP 
MelloJonny 
DocAndrewMurray 
physiotalk 
Dr Ridge DPT 
Greg Lehman 
Steve Nawoor 
Dr John Orchard 
Neil O'Connell 
APA Physio 
theCSP 
NSRiazat 
gerardgreenphy 
rogerKerry 
Richard56 
ArthritisResearch UK 
Sport Injury Matt 
PhysioCan 
NakedPhysio 
Peter Gettings 
Emma Stokes 
Chris Littlewood 
Paula Woods 
Prof Gill Cook 
Ciaran O Sullivan 
MACP 
Dr Pete Malliaras 
ShoulderDoc UK 
myOrthoDoc 
ISPC 
WCPT 
FysioNederland 
JeremyLewis 
PhysioNZ 
OntarioPT 
Shoulderarth 
 
Scheduled tweet TIMES using hootsuite: 
7am, 11a, 1am, 3pm, 4pm, 7pm, 9pm, 11pm 
 
Analysis 2: cliona311 // analyse people who follow me 
 
Highest Social Influence 
Adam Meakins 
thecsp 
joe mcveigh 
physiowizzio 
pain physio 
derek griffin 
Paula Woods 
Physiopedia 
physiotalk 
 
People I know: 
Peter O'Sullivan 
 
 
Most active times for followers of: 
7am, 12:00, 2pm, 8pm 
 
Tweet wording: 
1) Launching PhD survey on how clinicians choose shoulder 
treatments. www.keele.ac.uk/shoulder Would appreciate your 
support @AdamMeakins  PLS RT 
2) Do you 1st line manage patients with shoulder problems? International 
online survey live now: http://bit.ly/1DP4LQe Please share! #shoulder 
3) How do you choose treatment for patients with shoulder disorders? 
International online survey: http://bit.ly/1DP4LQe PLS RT! #shoulder 
4) Launching international survey of shoulder clinicians. How do you 
choose first line treatments? http://bit.ly/1DP4LQe PLS RT! #shoulder 
5) Hi @thecsp Launching international survey of interest to shoulder 
clinicians. How do we choose treatments? http://bit.ly/1DP4LQe PLS RT!  
6) Have you seen this @thecsp? International survey of shoulder clinicians. 
How do you pick 1st line treatments http://bit.ly/1DP4LQe PLS RT!  
7) Would be brilliant if you shared this far and wide! International shoulder 
survey:how do we choose treatments? http://bit.ly/1DP4LQe 
8) This will make you think. International shoulder survey for 
clinicians/academics: how do we pick 1st line 
treatments? http://bit.ly/1DP4LQe 
9) Shoulder clinicians, get your cogs turning here. International shoulder 
survey: how do we pick 1st line treatments? http://bit.ly/1DP4LQe 
10) Interested in shoulders-Get your thinking caps on! International 
shoulder survey: how do we pick 1st line 
treatments? http://bit.ly/1DP4LQe 
11) Doc, my shoulder hurts! How do health/medical professionals choose 
1st line treatment for people with #shoulder pain? http://bit.ly/1DP4LQe 
 	
 Appendix 10: Google Analytics drill-down 
 	
Go to this reportapps.nur ­ https://apps.nur.keele.ac.uk
Live server
Mar 18, 2015 ­ May 20, 2015Content Drilldown
ALL » PAGE PATH LEVEL 1: /sur141013/
Page path level 2 Source
Explorer
Pageviews
Unique
Pageviews
Avg. Time on Page
Bounce Rate % Exit
11,448
% of Total:
47.98% (23,860)
5,226
% of Total:
53.38% (9,791)
00:00:50
Avg for View:
00:01:13 (­31.59%)
56.65%
Avg for View:
33.50% (69.08%)
15.58%
Avg for View:
16.53% (­5.70%)
1. / (direct) 2,097 (18.32%) 1,820 (34.83%) 00:01:03 54.90% 39.34%
2. / BHPR enews 4 (0.03%) 4 (0.08%) 00:00:00 100.00% 100.00%
3. / BSR e­newsletter recipients 1 (0.01%) 1 (0.02%) 00:00:00 100.00% 100.00%
4. / csp.org.uk 78 (0.68%) 66 (1.26%) 00:01:10 45.45% 29.49%
5. / exchange14.net.addenbrookes.nhs.uk 2 (0.02%) 2 (0.04%) 00:00:15 0.00% 0.00%
6. / facebook.com 25 (0.22%) 17 (0.33%) 00:00:49 30.00% 40.00%
7. / flipboard.com 2 (0.02%) 2 (0.04%) 00:00:00 100.00% 100.00%
8. / google 8 (0.07%) 8 (0.15%) 00:00:43 40.00% 25.00%
9. / keele.ac.uk 9 (0.08%) 3 (0.06%) 00:01:35 0.00% 0.00%
10. / linkedin.com 1 (0.01%) 1 (0.02%) 00:00:00 100.00% 100.00%
11. / m.facebook.com 78 (0.68%) 41 (0.78%) 00:01:16 63.89% 44.87%
12. / mail.google.com 3 (0.03%) 3 (0.06%) 00:00:03 100.00% 66.67%
13. / physiospot.com 15 (0.13%) 12 (0.23%) 00:01:40 50.00% 26.67%
14. / rightrelevance.com 1 (0.01%) 1 (0.02%) 00:00:00 100.00% 100.00%
15. / t.co 370 (3.23%) 339 (6.49%) 00:00:52 70.26% 55.95%
16. / twitter.com 3 (0.03%) 3 (0.06%) 00:00:15 50.00% 33.33%
17. / uk­mg42.mail.yahoo.com 3 (0.03%) 3 (0.06%) 00:00:22 50.00% 33.33%
18. /a1.aspx (direct) 1,335 (11.66%) 135 (2.58%) 00:00:39 100.00% 2.02%
19. /a1.aspx csp.org.uk 48 (0.42%) 4 (0.08%) 00:00:40 0.00% 0.00%
20. /a1.aspx keele.ac.uk 2 (0.02%) 1 (0.02%) 00:00:08 0.00% 50.00%
21. /a1.aspx physiospot.com 4 (0.03%) 1 (0.02%) 00:01:22 0.00% 25.00%
22. /a1.aspx t.co 137 (1.20%) 15 (0.29%) 00:00:30 0.00% 2.19%
 Pageviews
Mar 22 Apr 5 Apr 19 May 3
500
1,000
All Sessions
47.98%
23. /a1.aspx uk­mg42.mail.yahoo.com 13 (0.11%) 1 (0.02%) 00:01:16 0.00% 0.00%
24. /a2.aspx (direct) 1,252 (10.94%) 125 (2.39%) 00:00:39 50.00% 1.52%
25. /a2.aspx csp.org.uk 102 (0.89%) 9 (0.17%) 00:00:45 0.00% 0.98%
26. /a2.aspx dub128.mail.live.com 12 (0.10%) 1 (0.02%) 00:00:33 0.00% 0.00%
27. /a2.aspx exchange14.net.addenbrookes.nhs.uk 12 (0.10%) 1 (0.02%) 00:00:24 0.00% 0.00%
28. /a2.aspx facebook.com 12 (0.10%) 1 (0.02%) 00:00:24 0.00% 0.00%
29. /a2.aspx google 13 (0.11%) 1 (0.02%) 00:00:23 0.00% 0.00%
30. /a2.aspx m.facebook.com 12 (0.10%) 1 (0.02%) 00:00:32 0.00% 0.00%
31. /a2.aspx physiospot.com 16 (0.14%) 2 (0.04%) 00:00:32 0.00% 6.25%
32. /a2.aspx t.co 142 (1.24%) 16 (0.31%) 00:00:35 100.00% 2.82%
33. /a2.aspx web.nhs.net 11 (0.10%) 1 (0.02%) 00:00:59 0.00% 0.00%
34. /a3.aspx (direct) 1,292 (11.29%) 125 (2.39%) 00:00:36 0.00% 1.08%
35. /a3.aspx csp.org.uk 50 (0.44%) 5 (0.10%) 00:00:32 0.00% 2.00%
36. /a3.aspx dub130.mail.live.com 12 (0.10%) 1 (0.02%) 00:00:33 0.00% 0.00%
37. /a3.aspx google 12 (0.10%) 1 (0.02%) 00:01:14 0.00% 0.00%
38. /a3.aspx m.facebook.com 2 (0.02%) 1 (0.02%) 00:00:02 0.00% 0.00%
39. /a3.aspx t.co 175 (1.53%) 17 (0.33%) 00:00:35 0.00% 1.71%
40. /demograph.aspx (direct) 1,433 (12.52%) 916 (17.53%) 00:00:57 57.14% 6.49%
41. /demograph.aspx csp.org.uk 48 (0.42%) 41 (0.78%) 00:01:16 0.00% 6.25%
42. /demograph.aspx exchange14.net.addenbrookes.nhs.uk 2 (0.02%) 2 (0.04%) 00:00:31 0.00% 0.00%
43. /demograph.aspx facebook.com 6 (0.05%) 3 (0.06%) 00:00:42 0.00% 16.67%
44. /demograph.aspx google 7 (0.06%) 5 (0.10%) 00:00:39 0.00% 14.29%
45. /demograph.aspx keele.ac.uk 6 (0.05%) 2 (0.04%) 00:00:16 0.00% 0.00%
46. /demograph.aspx m.facebook.com 15 (0.13%) 6 (0.11%) 00:01:12 0.00% 0.00%
47. /demograph.aspx physiospot.com 15 (0.13%) 8 (0.15%) 00:00:46 0.00% 6.67%
48. /demograph.aspx t.co 186 (1.62%) 133 (2.54%) 00:00:45 80.00% 10.75%
49. /demograph.aspx twitter.com 2 (0.02%) 2 (0.04%) 00:00:47 0.00% 50.00%
50. /demograph.aspx uk­mg42.mail.yahoo.com 3 (0.03%) 2 (0.04%) 00:01:30 0.00% 0.00%
51.
/Demograph.aspx
(direct) 17 (0.15%) 10 (0.19%) 00:00:47 0.00% 17.65%
52.
/Demograph.aspx
keele.ac.uk 2 (0.02%) 1 (0.02%) 00:13:53 0.00% 0.00%
53. /FinalQs.aspx (direct) 1,093 (9.55%) 312 (5.97%) 00:01:00 40.00% 2.01%
54. /FinalQs.aspx csp.org.uk 60 (0.52%) 16 (0.31%) 00:00:56 0.00% 1.67%
55. /FinalQs.aspx dub128.mail.live.com 3 (0.03%) 1 (0.02%) 00:00:49 0.00% 0.00%
56. /FinalQs.aspx dub130.mail.live.com 9 (0.08%) 2 (0.04%) 00:00:56 0.00% 11.11%
57. /FinalQs.aspx exchange14.net.addenbrookes.nhs.uk 5 (0.04%) 1 (0.02%) 00:00:12 0.00% 0.00%
58. /FinalQs.aspx facebook.com 4 (0.03%) 2 (0.04%) 00:02:51 0.00% 0.00%
59. /FinalQs.aspx google 7 (0.06%) 2 (0.04%) 00:00:35 0.00% 0.00%
60. /FinalQs.aspx m.facebook.com 3 (0.03%) 1 (0.02%) 00:02:02 0.00% 0.00%
61. /FinalQs.aspx physiospot.com 3 (0.03%) 1 (0.02%) 00:01:11 0.00% 0.00%
62. /FinalQs.aspx t.co 122 (1.07%) 34 (0.65%) 00:00:50 0.00% 1.64%
63. /FinalQs.aspx uk­mg42.mail.yahoo.com 3 (0.03%) 1 (0.02%) 00:01:49 0.00% 0.00%
64. /FinalQs.aspx web.nhs.net 3 (0.03%) 1 (0.02%) 00:02:10 0.00% 0.00%
65. /FinalQs.aspx webmail.vgregion.se 1 (0.01%) 1 (0.02%) 00:00:09 0.00% 0.00%
66. /guid.aspx (direct) 2 (0.02%) 2 (0.04%) 00:00:13 0.00% 0.00%
67. /guid.aspx t.co 2 (0.02%) 1 (0.02%) 00:00:38 0.00% 50.00%
68.
/guidend.aspx?
sender=a1
(direct) 14 (0.12%) 9 (0.17%) 00:03:32 0.00% 50.00%
69.
/guidend.aspx?
sender=a1
t.co 3 (0.03%) 1 (0.02%) 00:00:24 0.00% 33.33%
70.
/guidend.aspx?
sender=a2
(direct) 14 (0.12%) 10 (0.19%) 00:00:25 0.00% 50.00%
71.
/guidend.aspx?
sender=a2
t.co 2 (0.02%) 2 (0.04%) 00:00:44 0.00% 50.00%
72.
/guidend.aspx?
sender=a3
(direct) 18 (0.16%) 11 (0.21%) 00:00:15 0.00% 55.56%
73.
/guidend.aspx?
sender=a3
t.co 1 (0.01%) 1 (0.02%) 00:00:00 0.00% 100.00%
74. /pre.aspx (direct) 492 (4.30%) 435 (8.32%) 00:01:08 23.91% 12.20%
75. /pre.aspx csp.org.uk 24 (0.21%) 22 (0.42%) 00:01:21 50.00% 16.67%
76. /pre.aspx dk­mg5.mail.yahoo.com 1 (0.01%) 1 (0.02%) 00:00:00 100.00% 100.00%
77. /pre.aspx dub118.mail.live.com 1 (0.01%) 1 (0.02%) 00:00:00 100.00% 100.00%
78. /pre.aspx dub128.mail.live.com 1 (0.01%) 1 (0.02%) 00:00:54 0.00% 0.00%
79. /pre.aspx dub130.mail.live.com 2 (0.02%) 2 (0.04%) 00:01:33 0.00% 0.00%
80. /pre.aspx exchange14.net.addenbrookes.nhs.uk 1 (0.01%) 1 (0.02%) 00:00:16 0.00% 0.00%
81. /pre.aspx facebook.com 2 (0.02%) 2 (0.04%) 00:00:31 0.00% 0.00%
82. /pre.aspx google 3 (0.03%) 2 (0.04%) 00:01:14 0.00% 0.00%
83. /pre.aspx keele.ac.uk 3 (0.03%) 1 (0.02%) 00:00:04 0.00% 0.00%
84. /pre.aspx m.facebook.com 4 (0.03%) 2 (0.04%) 00:00:33 0.00% 0.00%
85. /pre.aspx outlook.office365.com 1 (0.01%) 1 (0.02%) 00:00:00 100.00% 100.00%
86. /pre.aspx physiospot.com 3 (0.03%) 3 (0.06%) 00:00:59 0.00% 0.00%
87. /pre.aspx t.co 55 (0.48%) 53 (1.01%) 00:00:51 100.00% 10.91%
88. /pre.aspx uk­mg42.mail.yahoo.com 3 (0.03%) 2 (0.04%) 00:00:55 100.00% 33.33%
89. /pre.aspx web.nhs.net 1 (0.01%) 1 (0.02%) 00:00:07 0.00% 0.00%
90. /pre.aspx webmail.vgregion.se 5 (0.04%) 1 (0.02%) 00:00:09 0.00% 20.00%
91. /thankyou.aspx (direct) 301 (2.63%) 299 (5.72%) 00:02:14 100.00% 93.02%
92. /thankyou.aspx csp.org.uk 20 (0.17%) 18 (0.34%) 00:00:17 100.00% 85.00%
93. /thankyou.aspx dub128.mail.live.com 1 (0.01%) 1 (0.02%) 00:00:00 0.00% 100.00%
94. /thankyou.aspx dub130.mail.live.com 2 (0.02%) 2 (0.04%) 00:00:07 0.00% 50.00%
95. /thankyou.aspx exchange14.net.addenbrookes.nhs.uk 1 (0.01%) 1 (0.02%) 00:00:00 0.00% 100.00%
96. /thankyou.aspx facebook.com 1 (0.01%) 1 (0.02%) 00:00:00 0.00% 100.00%
97. /thankyou.aspx google 3 (0.03%) 2 (0.04%) 00:06:24 0.00% 66.67%
98. /thankyou.aspx m.facebook.com 1 (0.01%) 1 (0.02%) 00:00:00 0.00% 100.00%
99. /thankyou.aspx physiospot.com 1 (0.01%) 1 (0.02%) 00:00:00 0.00% 100.00%
100. /thankyou.aspx t.co 33 (0.29%) 33 (0.63%) 00:11:34 0.00% 93.94%
Rows 1 ­ 102 of 102
101. /thankyou.aspx uk­mg42.mail.yahoo.com 1 (0.01%) 1 (0.02%) 00:00:00 0.00% 100.00%
102. /thankyou.aspx web.nhs.net 1 (0.01%) 1 (0.02%) 00:00:00 0.00% 100.00%
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CJM ERP application – 02.0215 – V2.0 
 
ETHICAL REVIEW PANEL 
Application Form (Staff and PGR Students) 
 
 
• To be completed for every research project involving human participants/subjects;   
• The form must be authorised by your Research Institute Director / (or for applicants who are members of RI 
Social Sciences the application can be signed off by your Research Centre Head)/Supervisor /Head of School 
as appropriate 
• Both an electronic copy & hard copy of all documentation must be provided. 
 
APPROVAL MUST BE OBTAINED BEFORE potential participants are approached to take part in any research. 
 
Information regarding the completion of the ethical review panel application form: 
Section A – To be completed by all applicants.  
Section B – To be completed by applicants who have already obtained Ethics Approval from a separate committee. 
Section C – To be completed by applicants requiring approval from a University Ethical Review Panel 
Section D – To be completed by all applicants. 
 
Further information regarding the completion of the application can be found in Section E (at the end of this document) 
 
SECTION A (to be completed by all applicants)  
 
Project Title:  
 
Musculoskeletal Shoulder Disorders: Which Treatment for Whom? 
Proposed start date:  
 
17th March 2015 
Proposed end date for ‘field work’ 
(eg interviews): 
31th October 2015 
Name of Researcher (applicant): Cliona McRobert 
Status:  
 
POSTGRADUATE RESEARCH STUDENT  
Research Institute or School if not 
in an Research Institute 
Primary Care Sciences 
Keele Email address: c.j.mcrobert@keele.ac.uk 
Correspondence address: Arthritis Research UK Primary Care Centre 
Primary Care Sciences 
Keele University 
Staffordshire, ST5 5BG 
Keele Telephone number: 
 
01782 734889 
 
 
SECTION B (to be completed by applicants who have already obtained ethics approval from a separate committee) 
 
Has your project already been approved by an ethics committee? (for example, an NHS research 
ethics committee)  
 
If YES the following documentation should be sent directly to the Chair of the University Research Ethics 
Committee, C/O Nicola Leighton, University Research Ethics Committee Administrator, Research & 
Enterprise Services, Dorothy Hodgkin Building, e-mail n.leighton@keele.ac.uk, telephone 01782 733306 
 
NO  
 
A completed and signed hard copy of this application form (please 
complete Sections A, B and D) and an electronic copy should also be 
e-mailed to n.leighton@keele.ac.uk 
 
 
Signed hard copy:  
 
Electronic copy:  
N/A 
N/A 
Evidence of prior ethics approval from the hosting institution. 
 
Copy of approval document: N/A 
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SECTION C (to be completed by applicants who have NOT already obtained ethics approval from a separate committee)                                                                                                                                                                         
If your project requires approval by a University Ethical Review Panel (ERP).   
 
The following documentation should be forwarded to Nicola Leighton, Research & Enterprise Services, Dorothy 
Hodgkin Building, telephone 01782 733306.  An electronic copy of the application form and all necessary 
documentation should also be e-mailed to uso.erps@keele.ac.uk   An application cannot be considered until a signed 
copy is received and accompanied by an electronic copy.  
       
A completed and signed hard copy of this application form (please 
complete Sections A, C and D) and an electronic copy should also be 
e-mailed to uso.erps@keele.ac.uk 
 
Signed copy attached:  
 
Electronic copy: 
 
YES  
 
YES  
A hard copy of the summary document attached to this form, NO MORE THAN two sides of A4  
It may help the review of your project if you include a diagram to clearly explain the project (eg what 
activities will undertaken, by whom and when) 
 
An electronic copy of the summary document 
Please ensure that the version number and date is clearly stated in footer of the summary 
document (approval may be delayed if these details are not included) 
 
YES  
 
 
 
YES  
And, if (and only if) they are appropriate given the study’s design and approaches; 
A letter of invitation for participants  
Please ensure that the version number and date is clearly stated in the footer of the letter 
(approval may be delayed if these details are not included) 
 
YES  
(including 
combined 
participant 
information 
sheet)  
An information sheet which should normally include the following sections:  
o Why the participant has been chosen;  
o What will happen to participants if they take part 
o A discussion of the possible disadvantages, risks and benefits of taking part 
o The procedures for ensuring confidentially and anonymity (if appropriate) 
o The proposed use of the research findings 
o Contact details of the principal investigator plus details of additional support agencies (if 
  Necessary) 
o Version number and date is clearly stated in the footer of the information sheet  (approval 
may be delayed if these details are not included) 
 
 
A template for a participant information sheet is available from the Research & Enterprise Services 
website via the following link  
http://www.keele.ac.uk/researchsupport/researchgovernance/researchethics/ 
 
YES 
(Combined 
with 
invitation 
letter)  
A copy of the participant consent form/s; 
Please ensure that the version number and date is clearly stated in the footer of the consent form 
(approval may be delayed if these details are not included) 
 
Templates for consent forms are available from the Research & Enterprise Services website via the 
following link http://www.keele.ac.uk/researchsupport/researchgovernance/researchethics/ 
 
Health professionals will decide if they wish to participate after reading the combined invitation letter and 
participant information sheet. Consent to participate is implied by clicking next on the first page of the 
online survey and proceeding to provide responses to the questions. PLEASE NOTE: there is only one 
online survey to be completed for this study.  
 
 
NO  
Copies of any questionnaire, interview schedules or topic guides. 
Please ensure that the version number and date is clearly stated in the footer of these 
documents (approval may be delayed if these details are not included) 
 
YES  
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(PARTICIPANTS’ CONSENTS) 
 
1.  Will the researchers inform participants of all aspects of the research that might reasonably 
be expected to influence willingness to participate and in particular, any negative consequences 
that might occur? 
 
If YES, please give details:  
Participants will be provided with a combined letter of invitation and participant information sheet 
detailing why they have been chosen to participate, the purpose of the study, anticipated length of time 
taken to complete the survey, what is expected of them, the possible disadvantages of taking part and 
their right to withdraw from the survey at any point. Other than the use of their time, no negative 
consequences or harm to respondents associated with taking part are anticipated.  
 
The survey does not have an actual 'escape survey' button but respondents may choose to close 
the internet browser window at any point in order to escape the survey. At the end of the data collection 
period, in the event of a respondent not providing responses to the 12 patient cases, this will be 
understood as having dropped out from the study. As the planned statistical analysis relies 
upon complete data i.e., responses to all 12 patient cases, only data from respondents who have 
provided responses to all 12 patient cases will be analysed. The number of participants starting the 
survey but dropping out at any point will be recorded. 
 
If NO, please explain: 
 
 
2.  Will all participants be provided with a written information sheet and be provided with an 
opportunity to provide (or withhold) written consent?   
 
If YES, please ensure that these documents are attached (see above).   
If NO, please explain why written consent &/or information is not appropriate for this study. 
 
This study is an online survey. The combined participant invitation and information sheet will be 
available via a hyperlink on the first page of the online survey. Page 1 of the survey states that by ticking 
the consent box the respondent indicates that they have read the combined participant invite and 
information sheet and provide consent to take part in the survey. 
 
3.  Is consent being sought for the dataset collected to be used for future research projects?  
Results from this survey will inform the design of a future individual patient data analysis study which 
seeks to assess the validity of the result of this survey. The actual data from this survey will not be used 
in this future study. 
 
4.  What are the exclusion/inclusion criteria for this study (i.e. who will be allowed to / not allowed 
to participate)? 
 
Inclusion: Health or medical practitioners, clinical academics or academics (including but not limited to 
physiotherapists, general practitioners (GPs), rheumatologists and orthopaedic surgeons) who: 
(i) Clinically manage or have a clinical or research interest in patients with musculoskeletal 
shoulder disorders as part of their normal clinical practice 
(ii) Can read and write English 
 
Exclusion: Individuals who: 
(i) Are not practicing health or medical practitioners, clinical academics or academics 
(ii) Have no clinical or academic interest in musculoskeletal shoulder disorders 
(iii) Do not read or write English 
 
5.  Please explain briefly (and in ‘lay’ terms) why you plan to use these particular criteria? 
The purpose of the survey is to assess how clinicians from across the world make treatment decisions in 
the care for patients with shoulder pain. Clinicians who do not treat shoulder disorders or unqualified 
individuals do not hold the necessary qualification, experience or knowledge will not be able to provide 
data for this survey. 
 
YES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NO 
 
 
 
 
 
 
 
 
 
 
 
NO 
 
 
 
6. Will people who are vulnerable be allowed to take part in this study?  For these purposes, 
vulnerable participants are those whose abilities to protect their own interests are impaired or reduced in 
comparison to the population as a whole.  Vulnerability may arise from personal characteristics (such as 
mental or physical impairment) or from social context and disadvantage (e.g. lack of power, education, 
NO 
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or resources).  Prospective participants, who are at high risk of consenting under duress, or as a result 
of manipulation or coercion, should also be considered as vulnerable.  All children and adults who lack 
mental capacity are presumed to be vulnerable. 
 
If NO, please outline the rationale for excluding them:  
Participants will be health professionals and/or academics with a special interest in shoulder disorders.   
 
 
If YES, what special arrangements (if any) are in place to protect vulnerable participants’ interests? 
 
7. Does the research activity proposed require a Disclosure & Barring Scheme (DBS) disclosure?  
(information concerning activities which require DBS checks are required can be accessed via 
https://www.gov.uk/government/publications/dbs-check-eligible-positions-guidance and 
http://www.keele.ac.uk/hr/policiesandprocedures/crbsafeguarding/ If you are unsure whether a DBS 
disclosure is required please contact Human Resources or Nicola Leighton prior to submission of this 
application form.  If you answer YES please complete the relevant section below.   If you answer no 
please go to question 8. 
 
STAFF ONLY 
7a   Have you (and other individuals who will be working on the research project) had a DBS 
       disclosure initiated by Keele University? 
 
 
7b   If you have answered YES to question 7a please contact Human Resources to obtain a 
       confirmation note indicating that a DBS disclosure has been previously initiated by Keele and that it  
       was satisfactory.  Is the confirmation note attached to this form? 
 
       If you have answered NO to question 7a please contact Human Resources immediately to arrange  
       for a DBS disclosure to be applied for.  You will still be able to apply for ethical approval in parallel  
       to applying for a DBS disclosure.  However, your project will not be approved by the ERP until you  
       have forwarded the confirmation note from Human Resources indicating that a DBS disclosure has  
       been undertaken and is satisfactory.       Has Human Resources been contacted about this?  
 
 
 
 
HOME/EU STUDENTS ONLY 
7c   Have you (and other individuals who will be working on the research project) had a DBS  
       Disclosure (or equivalent) initiated by Keele University? 
 
 
 
7d   If you have answered YES to question 7c please contact the Admissions Officer, Admissions to  
       obtain a confirmation note indicating that a DBS disclosure (or equivalent) has been previously  
       initiated by Keele and that it was satisfactory.  Is the confirmation note attached to this form? 
 
 
       If you have answered NO to question 7c please contact the Admissions Officer 
       immediately to arrange for a DBS disclosure (or equivalent) to be applied for.  You will still be able        
       to apply for ethical approval in parallel to applying for a DBS disclosure.  However, your project will  
       not be approved by the ERP until you have forwarded the confirmation note from Nicola Leighton 
       indicating that a DBS disclosure has been undertaken and is satisfactory.   I confirm the  
       Admissions Officer has been contacted and a DBS disclosure (or equivalent) has been initiated. 
 
I have contacted the Home/EU Admissions Officer, and was informed that a CRB disclosure is not 
required for this project, as I am not dealing with patients, minors or vulnerable adults but 
healthcare practitioners only 
 
 
INTERNATIONALSTUDENTS ONLY  
Please contact Nicola Leighton on 01782 733306 or e-mail n.leighton@keele.ac.uk before completing 
this section 
 
7e   Have you (and other individuals who will be working on the research project) had a DBS 
 
 
 
 
 
 
 
 
 
 
NO 
 
 
 
 
 
 
 
 
N/A 
 
 
 
N/A 
 
 
 
N/A 
 
 
 
 
 
 
 
 
 
NO  
 
 
 
 
N/A 
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       Disclosure (or equivalent) initiated by Keele University? 
 
 
7f   If you have answered YES to question 7e please contact the appropriate person (as advised by  
      Nicola Leighton) to obtain a confirmation note indicating that a DBS disclosure (or equivalent) has  
      been previously initiated by Keele and that it was satisfactory.  Is the confirmation note attached to  
      this form.    
 
       If you have answered NO to question 7e please contact the appropriate person (as advised by  
       Nicola Leighton) immediately to arrange for a DBS disclosure (or equivalent) to be applied for.  You  
       will still be able  to apply for ethical approval in parallel to applying for a DBS disclosure.  However,  
       your project will not be approved by the ERP until you have forwarded the confirmation note from  
       Human Resources indicating that DBS disclosure has been undertaken and is satisfactory.   I  
       confirm the relevant person has been contacted and a DBS disclosure (or equivalent) has been  
       initiated. 
 
8. Will the study involve participants who are unable to give valid (informed) consent (e.g. 
children and adults lacking mental capacity)? 
 
If YES, what procedures will be in place to ensure that informed consent is obtained, where appropriate, 
from third parties (e.g. parents or carers)?  And what procedures will be in place (if any) to give the 
participants an opportunity to have their objections recognised and respected? 
 
 
NO 
 
9.  Does the investigation involve observing participants unawares? 
 
If YES, what efforts will be made to respect their privacy, values and well-being?    
 
NO 
 
10.  Will the confidentiality of participants be maintained? 
 
If NOT, please give rationale: 
 
If YES, how? 
 
Information provided by respondents (up to 260 respondents) during the course of the research will be 
kept strictly confidential. Respondents will not be asked to provide information that could be used to 
identify them. Demographic data collected will be limited to profession, postgraduate training specific to 
musculoskeletal shoulder disorders, country of clinical practice, percentage of clinical time funded by 
government/state and privately funded, and frequency of referral/recommendation to three commonly 
used treatments. This survey will be hosted by Keele University on a secure password protected and 
backed up server. Once the sample size requirements have been met and data collection has been 
completed, the link to the survey will be disabled and the survey will no longer be available for access 
online. All data will be maintained in an anonymous form that cannot be linked with any respondent. A 
separate password protected database (accessible only by Tim Smale (software programmer) and the 
research team comprising of the lead researcher, lead researcher’s three academic supervisors and the 
statistical advisor on the project) will be maintained for respondents who email the researcher to indicate 
that they would like to receive notification of results. Individuals populating this database will receive two 
sets of results, results of the survey and results of a further study that will assess the validity of the 
results. This database will be destroyed after the second results email has been sent. Data will be stored 
on the secure University server, which is password protected with only designated members of the 
research team and survey development team authorised to access it. All research staff work to robust 
data security procedures and have explicit duties of confidentiality, equivalent to the duty placed on NHS 
staff, written into their employment contracts, in line with the Data Protection Act (1998) and the NHS 
Research Governance Framework.  
 
YES 
 
11. Will participants require any support to take part in the research (eg. disability support, 
interpreter)? 
 
If YES, what sort of support is required and how will it be delivered? 
 
NO 
 
 
 
(PROCEDURES) 
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12.  Does the research involve people being investigated for a condition or disorder which has 
received medical, psychiatric, clinical psychological or similar attention? 
 
If YES, please give details: 
 
NO 
 
13.  Are drugs, placebos or other substances (eg food substances, vitamins) to be administered 
to participants or will the study involve invasive, intrusive or potentially harmful procedures of 
any kind? 
 
If YES, please give details and justify: 
 
NO 
 
 
14.  Will blood or other bodily fluids/tissues (including hair, nails and sebum) be obtained from   
       participants? 
 
If YES, please give details and justify: 
NO 
 
 
15.  Is pain or more than mild discomfort likely to result from the study? 
 
If YES, please give details and justify: 
 
NO 
 
 
 (RESEARCH PROCESS) 
 
16.  Will participants receive any reimbursements or other payments 
 
If YES, please give details: 
 
NO 
 
17.  Does the research involve the analysis of data participants will not realise would be used by 
you for research purposes (e.g. confidential criminal, medical or financial records)? 
 
If YES, please give rationale: 
 
NO 
 
18.  Does the research involve the possible disclosure of confidential information to other 
participants (e.g. in focus groups)? 
 
If YES, please explain how this will be handled: 
 
 
NO 
 
19.  Will the researchers de-brief participants to ensure that they understand the nature of the 
research and to monitor possible misconceptions or negative effects? 
 
IF YES, how will this be done? 
 
If NO, please explain why not: 
As participants cannot be identified, they will not be individually de-briefed.  
 
 
NO  
20.  Are there any other ethical issues that you think might be raised by the research? 
 
If YES, please give details: 
 
 
NO 
 
(Health & Safety) 
 
21.  Does the project have any health & safety implications for the researcher? 
 
 
If YES, please outline the arrangements which are in place to manage these risks: 
NO 
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FOR STAFF ONLY 
 
22.  Does your research involve travel overseas? 
 
 
 
If YES,  
Have you consulted the Foreign and Commonwealth Office website for guidance/travel advice? 
http://www.fco.gov.uk/en/travel-and-living-abroad/ 
 
 
Have you completed and submitted the risk assessment form?  Available from 
http://www.keele.ac.uk/finance/insurance/travelinsurance/travellingoverseas-policyriskassessment/ 
 
 
 
 
 
 
N/A 
 
 
 
N/A 
 
 
 
N/A 
 
 
 
FOR STUDENTS ONLY 
 
23.  Will any research take place outside the UK? 
This is an online survey that will be completed by respondents internationally. The researcher does not 
need to travel in order to obtain the data. 
 
 
If YES 
For home students - have you consulted the Foreign and Commonwealth Office website for 
guidance/travel advice?   http://www.fco.gov.uk/en/travel-and-living-abroad/ 
 
 
For international students - have you also sought advice/guidance from the Foreign Office (or 
equivalent body) of your country? 
 
 
For all students - will you be visiting any areas for which particular risks have been identified or for 
which the advice given is not to travel to this area? 
 
 
If YES 
(a) Please give details 
 
 
(b) Please outline the arrangements in place to manage these risks. 
 
 
 
24.  What insurance arrangements are in place?   (Please contact Alan Slater on 01782 733525 to 
ascertain if you will be covered by University Insurance) 
 
 
NO 
 
 
 
 
 
N/A 
 
 
 
N/A 
 
 
 
 
N/A 
 
 
 
 
 
 
 
 
 
 
N/A 
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SECTION D (to be completed by all applicants) 
 
Please complete the checklist below to indicate the version number and date of any supporting documents included 
with this application. 
 
Document(s) Version Number Date 
Summary document V2.0 02.02.15 
Combined participant invitation letter and 
information sheet  
V2.0 30.01.15 
Questionnaire(s) (paper copy) V2.0 02.02.15 
Consent Form(s) N/A N/A 
Consent Form(s) for use of quotes N/A N/A 
Interview Topic Guide(s) N/A N/A 
   
 
Signatures  
 
Principal Investigator / Research Student:  
 
I understand that I must comply with the University’s 
regulations and other applicable codes of ethics at all 
times. 
 
 
 
 
 
Cliona McRobert 
Research Student 
 
02.02.15 
 
 
 
 
 
 
 
 
 
Professor Danielle van der Windt 
Lead supervisor 
 
02.02.15 
Signatures 
 
 
The following permissions must be obtained 
before this form is submitted: 
 
- for staff who are members of a research 
institute, the signature of your Research 
Institute Director (or, for RI Social Sciences, 
Research Centre Head); 
- for staff who are NOT members of a 
research institute, the signature of your Head 
of School (of, if not in a School, other line 
manager) 
- for postgraduate research students, the 
signature of your lead supervisor. 
 
I have read this application and confirm that:- 
• The academic and/or scientific quality of the 
application is satisfactory. 
• Arrangements are in place for the management and 
governance of this project 
 
 
……………………………………………………………………..    
Research Institute Director / Research Centre Head / 
Supervisor / Head of School / Other Line Manager 
 
………………………… 
Date     
 
 
 
*please delete as appropriate 
 
Please ensure when submitting your application that you have provided a hard copy and e-mailed a copy of 
all the documentation to Hannah Reidy, ERP Administrator, Research & Enterprise Services, Dorothy Hodgkin 
Building, Keele, e-mail uso.erps@keele.ac.uk 
 
Applicants who have already obtained ethics approval from a separate committee should forward documentation to  
Nicola Leighton, University Research Ethics Committee Administrator, Research & Enterprise Services, Dorothy 
Hodgkin Building, e-mail n.leighton@keele.ac.uk, telephone 01782 733306. 
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Applications which require approval by an University Ethical Review Panel should forward documentation to 
Nicola Leighton, Research & Enterprise Services, Dorothy Hodgkin Building, e-mail uso.erps@keele.ac.uk, telephone 
01782 733306. 
 
Please note that it is your responsibility to follow the University’s Code of good research practice 
http://www.keele.ac.uk/researchsupport/researchgovernance/ and any relevant academic or professional guidelines in 
the conduct of your study. This includes providing appropriate information sheets and consent forms, and 
ensuring confidentiality in the storage and use of data. Any significant change in the question, design or conduct 
over the course of the research should be notified to the Research Institute Director/Supervisor and may require a new 
application for ethics approval.  
 
This form was developed from the Ethics application forms used within Humanities and Social Sciences with kind 
permission from the HUMSS Research Ethics Committee.  
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SECTION E 
 
Information regarding the completion of the ethical review panel application form 
Section A – To be completed by all applicants.  
Section B – To be completed by applicants who have already obtained Ethics Approval from a separate committee. 
Section C – To be completed by applicants requiring approval from a University Ethical Review Panel 
Section D – To be completed by all applicants. 
 
PLEASE NOTE:  Ethics Approval for Research Projects 
All projects involving human research participants/subjects and/or data about identifiable individuals, need to be approved by 
an ethics committee before the fieldwork for projects can commence.  The University has established Ethical Review Panels 
to review proposed research projects to be undertaken by staff and postgraduate research students.  The information below 
provides more details about the role of these panels and the documents that need to be submitted to support the review 
process. 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
1. If your project has already been approved by a recognised ethics committee (for example, an NHS research ethics 
committee), the following documentation should be sent directly to the Chair of the University Research Ethics 
Committee, C/o Nicola Leighton, University Research Ethics Committee Administrator, Research & Enterprise Services, 
Dorothy Hodgkin Building, e-mail n.leighton@keele.ac.uk, telephone 01782 733306. 
• A completed and signed ethical review application form (Sections A, B and D) accompanied by an electronic copy; 
• Evidence of prior ethics approval from the hosting institution. 
 
  
2. If your project requires approval by a University Ethical Review Panel, the following documentation should be sent 
directly to Nicola Leighton, Research & Enterprise Services, Dorothy Hodgkin Building, e-mail uso.erps@keele.ac.uk, 
telephone 01782 733306 
• A completed and signed ethical review application form (Sections A, C and D) accompanied by an electronic copy of 
the application form and relevant documentation.  An application  cannot be considered until a signed copy is 
received and also by an electronic copy; 
• A summary document, NO MORE THAN two sides of A4 paper; 
  And, if they are applicable given the study’s design and approaches, 
• A letter of invitation for participants; 
• An information sheet which should normally include following sections: invitation paragraph; the purpose of the 
study; why the participant has been chosen; what will happen to participants if they take part; a discussion of the 
possible disadvantages, risks and benefits of taking part; the procedures for ensuring confidentiality and anonymity, 
if any; the proposed use of the research findings; and contact details of the principal investigator plus details of 
additional support agencies (if necessary); 
• A copy of the participant consent form; 
• Copies of any questionnaire, interview schedules or topic guides. 
 
  
3. The review will be undertaken at the next available ethical review panel meeting.  Please access 
http://www.keele.ac.uk/researchsupport/researchgovernance/researchethics/ for a list of meeting dates and submission 
deadlines.  Following the review process you will be informed of the panel’s decision which will be either: 
• Study approved; 
• Study approved subject to clarification of issues, modification of design or provision of additional information which 
will be itemised in the letter of response; 
• Study rejected with supporting reasons. 
 
4. If ethical approval is not granted, applicants have the right of appeal to the University’s Research Ethics Committee. 
 
5.    Correspondence informing applicants of the outcome of the panel’s decision will be copied to the relevant Research  
       Administrators.  It is the responsibility of applicants to keep their respective Institutes informed of their research activities  
       for the purposes of research governance. 
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Participant Invitation & Information Sheet 
Study Title: Musculoskeletal Shoulder Disorders Which Treatment for Whom? 
2nd Feb. 2015 
 
Dear Professional Colleague, 
 
I invite you to take part in an online international survey on the topic: clinical 
management of musculoskeletal shoulder disorders. This survey may be accessed 
via the web link www.keele.ac.uk/shoulder. My name is Cliona McRobert, I am a 
musculoskeletal physiotherapist undertaking a PhD at the Arthritis Research UK 
Primary Care Centre, Keele University (UK), where my PhD is funded by the National 
Institute of Health Research (NIHR) School for Primary Care Research. I am leading 
this research in a research team with Prof Danielle van der Windt (Professor in 
Primary Care Epidemiology), Prof Elaine Hay (Professor of Community 
Rheumatology) and Dr Jonathan Hill (Arthritis Research UK Senior Lecturer), Dr 
John Belcher (Senior Lecturer in Biostatistics), Mr Tim Smale (E-Learning Fellow) of 
Keele University and Prof John F.P. Bridges (Associate Professor in the Departments 
of Health Policy and Management and International Health, Johns Hopkins 
Bloomberg School of Public Health, US). 
As you know, musculoskeletal shoulder disorders are common and cause 
considerable reductions in social function, work ability and quality of life. Achieving 
consistently successful outcomes for patients with shoulder disorders has proven 
difficult to achieve. Although some characteristics predicting who will improve or not 
improve over time have already been identified, currently very little is known about 
which patients are likely to respond to commonly used treatments such as: (i) 
prescription of pain medication and advice, (ii) physiotherapy treatment or (iii) steroid 
injection and advice. This research will develop the foundation for a model of 
shoulder ‘stratified care’: a treatment targeting method that enables patients to be 
provided with specific treatments that they are most likely to respond to. 
We conducted a systematic review, which identified the clinical factors already known 
to predict response to these specific treatments i.e. ‘treatment moderators’. Our 
research with UK-based clinical experts highlighted additional clinical characteristics 
considered by shoulder clinicians when identifying patients likely to respond to these 
treatments. We do not currently know how or if these clinical characteristics combine 
to form profiles of likely best responders to these three treatments. This online 
international survey of clinicians is based on a method called conjoint analysis. 
Conjoint analysis allows us, the research team, to tap into clinical expertise by asking 
you to tell us how you would deal with hypothetical clinical scenarios. This enables us 
to analyse your responses using statistical techniques to identify the international 
clinical impression of likely best responders to each of the three treatments. 
I invite you, a clinician working with musculoskeletal shoulder disorders, to be 
involved with this research via the web link www.keele.ac.uk/shoulder. Your 
involvement would require completing a brief and simple online survey 
(approximately 20 minutes). Firstly, you will be required to tell us a little about 
yourself, including your profession, number of years of experience, country of clinical 
practice, funder of your clinical role, how often you treat shoulders and how often you 
refer to common treatments. Secondly, you will be required to indicate a treatment 
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recommendation for 12 hypothetical patients and finally answer some short questions 
about how easy or difficult you found answering the clinical case questions. Your 
responses will enable us to understand more about how clinicians make treatment 
decisions for patients with shoulder disorders. We do not anticipate any harm or risk 
to you by taking part in this survey.  
 
Consent to take part is indicated by ticking a box on the first page next to the 
statement ‘I have read the information sheet, understand the instructions and 
consent to taking part in this survey’ and by submitting responses during the survey. 
After ticking the consent box and clicking next on the first page, you will be shown 
your unique identifier number. This number is unique to you and relates to the 
responses provided by you during the survey. You will be prompted to write this 
number down and store it in a safe place and/or take a screen shot. You are free to 
withdraw from the survey at any time. You may withdraw from the study either by not 
ticking the consent box or at any time during the survey by closing the web browser. 
Should you choose to exit the survey before completing all questions, your 
responses will be excluded from the planned statistical analyses. Should you wish to 
withdraw your consent after the survey has been completed, you may contact the 
research team to indicate this quoting your unique identifier number. Your responses 
will be then excluded from the analyses.  
 
All responses will be strictly confidential and it will not be possible to identify you from 
the information that you will be asked to provide. Your responses will be stored on a 
password-protected database on a secure server at Keele University accessible only 
by members of the research team. Your responses will be combined with responses 
from others participants and will be analysed using statistical techniques to answer 
the research questions. At the end of the survey, you will be given an opportunity to 
indicate via email to the research team that you would like to receive notification of 
results of the survey. If you indicate that you would like to be contacted with results, 
the research team will contact you via email as soon as survey results are available 
and again when the output of the survey has been tested in a further validation study. 
The research team will store your responses in a separate password-protected 
database on a secure server at Keele University. This email database will be 
destroyed after the second results email has been sent. All anonymised electronic 
data will be stored securely for a minimum of five years and according to Keele 
University regulations. 
 
Contact for further information. If you require any further information regarding this 
study please contact Cliona McRobert by email on c.j.mcrobert@keele.ac.uk. 
 
If you experience any problems completing this survey or have any concerns about 
any aspect of the study, you may wish to speak to the researchers who will do their 
best to answer your questions. You can contact Cliona McRobert at 
c.j.mcrobert@keele.ac.uk or via telephone on 01782 734889 or Danielle van der 
Windt on d.van.der.windt@keele.ac.uk or via telephone on 01782 734830. 
Alternatively, if you do not wish to contact the researchers you may contact Nicola 
Leighton, Research Governance Officer on n.leighton@keele.ac.uk. If you remain 
unhappy about the research and/or wish to raise a complaint about any aspect of 
your experience whilst taking part in the study please write to Nicola Leighton who is 
the University’s contact for complaints regarding research at n.leighton@keele.ac.uk, 
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or at the following address: Nicola Leighton, Research Governance Officer, Research 
& Enterprise Services, Innovation Centre 1, Keele University, ST5 5BG.  
 
 
Best wishes and kind regards, 
 
Cliona McRobert, Principal Investigator; Danielle van der Windt, Academic 
Supervisor 
e-mail: c.j.mcrobert@keele.ac.uk or telephone: 01782 734889 
e-mail: d.van.der.windt@keele.ac.uk or telephone: 01782 734830 
 
 
 
Appendix 12: Ethical approval for conjoint analysis study 
 	
 
              
Research and Enterprise Services, Keele University, Staffordshire, ST5 5BG, UK 
Telephone: + 44 (0)1782 734466   Fax: + 44 (0)1782 733740 
 
RESEARCH AND ENTERPRISE SERVICES 
 
Ref: ERP324 
 
12th February 2015 
 
Cliona McRobert 
Arthritis Research UK Primary Care Centre 
Keele University 
 
Dear Cliona, 
 
Re: Musculoskeletal Shoulder Disorders: Which treatment for whom? 
 
Thank you for submitting your application for review.  I am pleased to inform you that your 
application has been approved by the Ethics Review Panel.   
 
The following documents have been reviewed and approved by the panel as follows: 
 
Document Version Date 
Summary Document 2 02/02/2015 
Letter of Invitation and Information Sheet 
Combined 
2 30/01/2015 
Questionnaires 2 02/02/2015 
 
If the fieldwork goes beyond the date stated in your application, you must notify the Ethical Review 
Panel via the ERP administrator at uso.erps@keele.ac.uk stating ERP3 in the subject line of the e-
mail. 
 
If there are any other amendments to your study you must submit an ‘application to amend study’ 
form to the ERP administrator stating ERP3 in the subject line of the e-mail.  This form is available via 
http://www.keele.ac.uk/researchsupport/researchethics/ 
 
If you have any queries, please do not hesitate to contact me via the ERP administrator on 
uso.erps@keele.ac.uk   stating ERP3 in the subject line of the e-mail. 
 
Yours sincerely 
 
 
Val Ball 
Vice Chair – Ethical Review Panel 
 
CC  RI Manager 
Appendix 13: Social Media recruitment proforma 
 
Social Media Recruitment Strategy Proforma 
 	
Study Title  
 
Study Live Period Beginning  Ending  
Pre-launch activity plan 
 
 
Sample Frame - Inclusion criteria - Exclusion criteria 
 
 
 
 
Method of identification of 
key individuals/organisations - Social Media Analytics 
Software (e.g., 
FollowerWonk or similar) - Key posting times - Key individuals - Key 
groups/organisations 
 
 
Social media post wording: - Twitter - Facebook  - LinkedIn  - Google+  - Other 
 
 
Visual resources: - Photograph of study 
team/lead researcher - QR code - Study logo (for use as 
email banner, social 
media) - Other 
 
 
Final Social Media 
Recruitment Schedule  - Daily plan - Weekly plan - Monthly plan - Automated scheduling 
system (e.g., Hootsuite 
or similar) - Review/Iteration plan 
 
 
Additional study invitation 
dissemination plans: - Newsletters/Blogs - Email - Postal - Noticeboards - Other 
 
	
